#BEGIN_DRUGCARD DB02379

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
50-99-7

# ChEBI_ID:
15903

# Chemical_Formula:
C6H12O6

# Chemical_IUPAC_Name:
(2S,3S,4R,5R,6S)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
37915

# Description:
A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. [PubChem]

# Dosage_Forms:
Not Available

# Drug_Category:
Sweetening Agents

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
-3.24

# Experimental_Logs:
0.74

# Experimental_Water_Solubility:
1.2E+006 mg/L (at 30 °C)

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Beta-D-Glucose

# HET_ID:
BGC

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3-,4+,5-,6-/m0/s1

# InChI_Key:
InChIKey=WQZGKKKJIJFFOK-QYESYBIKSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C00221

# KEGG_Drug_ID:
D00009

# LIMS_Drug_ID:
2379

# Mechanism_Of_Action:
Not Available

# Melting_Point:
83 °C

# Molecular_Weight_Avg:
180.1559

# Molecular_Weight_Mono:
180.063388116

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1PIG

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-2.6

# Predicted_LogS:
0.64

# Predicted_Water_Solubility:
7.82e+02 g/l

# Primary_Accession_No:
DB02379

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
6992084

# PubChem_Substance_ID:
46505414

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00455
EXPT00685
EXPT01603

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
OC[C@@H]1O[C@H](O)[C@@H](O)[C@H](O)[C@H]1O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:21:05 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
12.9 (at 0 °C)

# Phase_1_Metabolizing_Enzyme_1_Gene_Name:
AMY2A

# Phase_1_Metabolizing_Enzyme_1_ID:
4513

# Phase_1_Metabolizing_Enzyme_1_Name:
Pancreatic alpha-amylase

# Phase_1_Metabolizing_Enzyme_1_Protein_Sequence:
>Pancreatic alpha-amylase
MKFFLLLFTIGFCWAQYSPNTQQGRTSIVHLFEWRWVDIALECERYLAPKGFGGVQVSPP
NENVAIYNPFRPWWERYQPVSYKLCTRSGNEDEFRNMVTRCNNVGVRIYVDAVINHMCGN
AVSAGTSSTCGSYFNPGSRDFPAVPYSGWDFNDGKCKTGSGDIENYNDATQVRDCRLTGL
LDLALEKDYVRSKIAEYMNHLIDIGVAGFRLDASKHMWPGDIKAILDKLHNLNSNWFPAG
SKPFIYQEVIDLGGEPIKSSDYFGNGRVTEFKYGAKLGTVIRKWNGEKMSYLKNWGEGWG
FVPSDRALVFVDNHDNQRGHGAGGASILTFWDARLYKMAVGFMLAHPYGFTRVMSSYRWP
RQFQNGNDVNDWVGPPNNNGVIKEVTINPDTTCGNDWVCEHRWRQIRNMVIFRNVVDGQP
FTNWYDNGSNQVAFGRGNRGFIVFNNDDWSFSLTLQTGLPAGTYCDVISGDKINGNCTGI
KIYVSDDGKAHFSISNSAEDPFIAIHAESKL

# Phase_1_Metabolizing_Enzyme_1_SwissProt_ID:
P04746

# Drug_Target_10_Cellular_Location:
Not Available

# Drug_Target_10_Chromosome_Location:
Not Available

# Drug_Target_10_Drug_References:
Not Available

# Drug_Target_10_Essentiality:
Non-Essential

# Drug_Target_10_GenAtlas_ID:
Not Available

# Drug_Target_10_GenBank_ID_Gene:
BA000004

# Drug_Target_10_GenBank_ID_Protein:
Not Available

# Drug_Target_10_GeneCard_ID:
Not Available

# Drug_Target_10_Gene_Name:
BH0236

# Drug_Target_10_Gene_Sequence:
>3063 bp
ATGAAGGGGAAAAACGTTCAGTTACTTTTCGCATTGGTGGTGATCATATTGTTGTTTCCA
ACAGGAGCTTCGGCCTCCCCTCATGCGGTGAGCGTCGGGAAAGGAAGTTATGCGACCGAG
TTTCCGGAAATTGATTTTGGCGGAATTAATGATCCGGGCTTTCGGGATCAGCAGGGGGAG
CCGCCTGCAACCATTTATCGTTCAGATCGTGTAACAGGACCGATGCAAACCAATTCATGG
TGGGGATCGTTAGCAGTTGACCGGTTTTCGATGAATCAATATCCTCACCCGTTTAGTGTT
CGCCATCGGGCAGAGGGGTTACATGTATTCTATGATGCCCCGCACAATATGGTCGTCCAT
GAAAACCGTGAAGCAGGAACGTGGCACATTCATGGCGCGATTGGAACGGACTTTACCATT
AAACATTCTGGAACAGCCAATTTTGAGCAGGCTGTTGTCGACGACTATAACGATTGGTAT
GTGCGAGGGCTACTTGAAAATGGCGCTCATCAAATGGCCATTACATACGGGGTTGGATCA
CCGTACATTTTTGTCGAATATGAAGACGGAAGTGCGGTTTTAGACTTTGATATTGCTCCG
GATGTATGGGAAATGAACGGTCATGTCATTGGCTTCTCGACCCATGATCATAAGCATTAC
GCTGCATTTGCTCCTCCTGGACAAAACTGGTCTGGCATCGGTTCAAAAACGCTTACGAAC
AATGCCGATTATATCGCCATTGCGAAGCTCCCGGAAAAGGACGGAAACATGCTAGCGAAG
TTTGAGCAGTATGCGTACTCTGTCGTTCGAGACGCCGTAGCTGACTGGACATATGACGAA
GCGACGGGAACAGTAACGACCACATTTGAGGTCACAACAGAGGCAAAGGTGCAAGGAGCG
CCCGACGGTACGATCTTTGCATTATATCCACATCAATATCGCCACTTGGCTTCATCCTCT
GAGAACCAGCTACTTCAGAACTACCAGTACGAGATCATCCGCGGCACGATGATTGGACTA
GAAGGTAAGCGCTTCACGACCGAATTAACCTATCCCGGTGTGCTCCCTTCCTTGCCGGAT
TTAGGTGATTACGATCGGGAGCGATTGATCGGTTATCTTCATGATGCTACATCCGATTAC
CCAACCGGTTCGGATACGTATGAGCTAGGAAAATATATAGGCAAGCTTGCTACTCTTGCG
CCAATTGCTGATCAAATGGGCGAGTATGAATTAGCGGAACAGTTTCGCGGAGAGCTAAAA
GACATTTTAGAGGATTGGTTACAGGCGACGAATGCTAGTGGTCAACTAAAAGGGAAAAAT
CTTTTTTATTACAACGAAAATTGGGGGACGATTTTAGGCTATCACGCGGCTCACAGCTCT
GCGACGCGAATTAATGACCATCATTTCCATTACGGATACTTTGTCAAAGCTGCAGCCGAA
ATTGCCCGCGCAGACCAAGAGTGGGCGAAAAGCGAAAATTGGGGTGGGATGATCGATTTA
CTCATCCGCGACTTTATGGCCGATCGAGACGATGATTTGTTTCCATACTTAAGAATGTTT
GACCCGTACTCGGGGAATTCGTGGGCGGACGGGCTTGCTACCTTTGATGCGGGGAACAAT
CAGGAATCTTCCTCGGAAGCGATGCACGCTTGGACAAATGTTATCCTATGGGCGGAAGCC
ACAGGGAATAAGGCGCTCAGAGACCGAGCGATTTACTTGTACACGACCGAGATGAGCGCG
ATCAATGAATACTTCTTTGATGTTCATCAAGAGATTTTCCCTGAGGAATATGGACCTGAA
ATTGTAACGATTAACTGGGGCGGAAAAATGGATCATGCTACGTGGTGGAATTCAGGAAAG
GTGGAAAAATATGCGATTAACTGGTTGCCGTTCCATGGTGGTTCGCTGTATCTTGGACAC
CACCCTGACTATGTCGACCGGGCCTACGAAGAGCTTCGGCGAGATATCGGTTCCACCGAC
TGGAACTTATGGTCAAATCTCGTTTGGATGTACCGAGCTTTTACCAATCCAGACGATGCT
CTTCAACAAATGGAAGCTTCGATCGATGACTACGGCTTGTTTGACCCAGGAAATGAAAAA
ATTATTGAGCGTGGAAGCACGAAAGCACAGACGTATCATTGGATTCACAATTTAGCTGAA
CTTGGACGAGTGGATCCTACGGTAACGGCCAATCACCCGATTTACGCCGTCTTTAATAAA
AATGGTAATCGAACGTATATTGTCTATAACTTTTCTGACTCTCCAATCACGGTCCAATTT
TCCGATGGACATTCCATTCAAGTGGAGCCACATAGCTTTAATATTGGCAACGGGGACGGC
CCCACAAACCCAGATCCTTCAGAGCCGGATTTGAAAAATCCTTACGAGCGAATTCAGGCG
GAGGCGTATGATGCGATGAGCGGCATTCAGACAGAAGGGACGGACGATGACGGTGGCGGT
GACAACATCGGTTGGATTAACGATGGTGATTGGGTCAAGTATGAGCGCGTTCATTTCGAA
CGGGACGCTTCCTCTATTGAAGTTCGCGTAGCTAGTGATACACCGGGAGGAAGGATTGAA
ATACGCACAGGAAGCCCAACAGGAACGCTCTTAGGAGACGTACAGGTACCGAATACCGGC
GGGTGGCAGCAGTGGCAGACGGTGACAGGAAATGTGCAAATTCAACCTGGGACCTACGAT
GTATATTTAGTGTTTAAAGGGAGTCCCGAGTATGACTTAATGAATGTGAACTGGTTTGTT
TTCCGAGCAAACGGCCAAGGGAATGGCGATTCGCATACACACCCTGATTACACAGCAGGA
ATTAGAGGGATTACAGGTAATGAAGTGACGATCTTTTTTGCGCCGACAACAGAAGCACGG
TATGTGGATGTACATTTAAAAGTGAACAATGGTCAACAACTCAATTATCGGATGACCGAA
CGGAACGGAGAATGGGAACGGGTTGTCGAGAATTTATCGAGCGGCGATGTACTTGAATAT
AGCTTCACGTATGAAAAGCTCGGACCCCAATATACGACTGAATGGTTTACGTATTCGCGT
TAA

# Drug_Target_10_General_Function:
Involved in carbohydrate binding

# Drug_Target_10_General_References:
11058132	Takami H, Nakasone K, Takaki Y, Maeno G, Sasaki R, Masui N, Fuji F, Hirama C, Nakamura Y, Ogasawara N, Kuhara S, Horikoshi K: Complete genome sequence of the alkaliphilic bacterium Bacillus halodurans and genomic sequence comparison with Bacillus subtilis. Nucleic Acids Res. 2000 Nov 1;28(21):4317-31.

# Drug_Target_10_HGNC_ID:
Not Available

# Drug_Target_10_HPRD_ID:
Not Available

# Drug_Target_10_ID:
4667

# Drug_Target_10_Locus:
Not Available

# Drug_Target_10_Molecular_Weight:
114877

# Drug_Target_10_Name:
BH0236 protein

# Drug_Target_10_Number_of_Residues:
1020

# Drug_Target_10_PDB_ID:
1W9W

# Drug_Target_10_Pathway:
Not Available

# Drug_Target_10_Pfam_Domain_Function:
PF03422	CBM_6
PF03639	Glyco_hydro_81

# Drug_Target_10_Protein_Sequence:
>BH0236 protein
MKGKNVQLLFALVVIILLFPTGASASPHAVSVGKGSYATEFPEIDFGGINDPGFRDQQGE
PPATIYRSDRVTGPMQTNSWWGSLAVDRFSMNQYPHPFSVRHRAEGLHVFYDAPHNMVVH
ENREAGTWHIHGAIGTDFTIKHSGTANFEQAVVDDYNDWYVRGLLENGAHQMAITYGVGS
PYIFVEYEDGSAVLDFDIAPDVWEMNGHVIGFSTHDHKHYAAFAPPGQNWSGIGSKTLTN
NADYIAIAKLPEKDGNMLAKFEQYAYSVVRDAVADWTYDEATGTVTTTFEVTTEAKVQGA
PDGTIFALYPHQYRHLASSSENQLLQNYQYEIIRGTMIGLEGKRFTTELTYPGVLPSLPD
LGDYDRERLIGYLHDATSDYPTGSDTYELGKYIGKLATLAPIADQMGEYELAEQFRGELK
DILEDWLQATNASGQLKGKNLFYYNENWGTILGYHAAHSSATRINDHHFHYGYFVKAAAE
IARADQEWAKSENWGGMIDLLIRDFMADRDDDLFPYLRMFDPYSGNSWADGLATFDAGNN
QESSSEAMHAWTNVILWAEATGNKALRDRAIYLYTTEMSAINEYFFDVHQEIFPEEYGPE
IVTINWGGKMDHATWWNSGKVEKYAINWLPFHGGSLYLGHHPDYVDRAYEELRRDIGSTD
WNLWSNLVWMYRAFTNPDDALQQMEASIDDYGLFDPGNEKIIERGSTKAQTYHWIHNLAE
LGRVDPTVTANHPIYAVFNKNGNRTYIVYNFSDSPITVQFSDGHSIQVEPHSFNIGNGDG
PTNPDPSEPDLKNPYERIQAEAYDAMSGIQTEGTDDDGGGDNIGWINDGDWVKYERVHFE
RDASSIEVRVASDTPGGRIEIRTGSPTGTLLGDVQVPNTGGWQQWQTVTGNVQIQPGTYD
VYLVFKGSPEYDLMNVNWFVFRANGQGNGDSHTHPDYTAGIRGITGNEVTIFFAPTTEAR
YVDVHLKVNNGQQLNYRMTERNGEWERVVENLSSGDVLEYSFTYEKLGPQYTTEWFTYSR

# Drug_Target_10_Reaction:
Not Available

# Drug_Target_10_Signals:
None

# Drug_Target_10_Specific_Function:
Not Available

# Drug_Target_10_SwissProt_ID:
Q9KG76

# Drug_Target_10_SwissProt_Name:
Q9KG76_BACHD

# Drug_Target_10_Synonyms:
Not Available

# Drug_Target_10_Theoretical_pI:
4.53

# Drug_Target_10_Transmembrane_Regions:
None

# Drug_Target_11_Cellular_Location:
Cytoplasmic

# Drug_Target_11_Chromosome_Location:
Not Available

# Drug_Target_11_Drug_References:
Not Available

# Drug_Target_11_Essentiality:
Non-Essential

# Drug_Target_11_GenAtlas_ID:
Not Available

# Drug_Target_11_GenBank_ID_Gene:
AE000512

# Drug_Target_11_GenBank_ID_Protein:
Not Available

# Drug_Target_11_GeneCard_ID:
Not Available

# Drug_Target_11_Gene_Name:
TM_0024

# Drug_Target_11_Gene_Sequence:
>1929 bp
TCATTGAGGGCTCACCGTGACATCATCGAAATAAATCGTAGTTGCCGTTCCTTCTCCGAG
TTCGAAACTGATCTGAACGACCTCATCCGCATCGTCTGGATGCGTGTAGGTGAACGTGAA
CGTCTGCCAGTCCGCTGTGAGATTCACCGTTTGAGCAAAATAGTTGGTCCAGGGATCGTG
ATTCTGCAGAATTTTCACATTTATAGGTCTTGGTGTATCCGCTTTTGCTTTGAAAGAAAT
GGTGTAGGTTTTTCCTCTGTAAAGACCTATCCACTGGTTGAACTGAATATGCCACGTGTC
AGTTCCAGGATCGGCTATCGTGATATAAGCGTAGCCATCCCTGACACCGTAATCGGAGAC
CCTGGCACCGCTGATCCCGTAATCTCCCGCCTGCCAAATGAACCATTCGTCCGGGTTGTT
GGCCTGATCGTTCACAATAGGTTCGTCGAAAGTGCCGTTATTTATCTGTTCATAGGTCAC
CTCGGGACCTGCCTGCTGCTGTGCTTGTTCATATTCGCAGTCATCCACTTCCCCGGTGAT
TGTTTCCGGATTCATATCTTTATAGACTCTGATGTAGTCGATGTACATTCTCTGCGGGAA
TTGGGTGGTTTCGTCGGGATAACCCGGCCAGTAGCCTCCCACGGCAACGTTCAGAATGAG
GAAGAACGGATGGTCGAAAACCCACTCAAGACCGAGTTCGGCCAGTTCATCCTTGCTGAG
GACGTGGTAGAGCTGTCCGTCCACGTACCACTCCACTTCGTCTTCGTCCCACTCGATGGA
GAAAATGTGGAAGTCTTCGGAGAAATCAGGAACTCCTTCTGGAAGATGATAGGCAACACC
TATACTCGCACCACCAGAATATCCCGGACCGTGTGCTGTTCCATAAACGGTTCTGGTGTC
GTGGCCAAGCATTTCCATGATGTCTATCTCACCACAGGTGGGCCATCCGACCTCTCCTAT
GTTGTTTCCGAGCATCCAGAGAGCGGGCCAGATACCTTTTCCTTTTGGAAGTTTTGCCCT
TATTTCGATTTTTCCGTACTTTATTTCGAATTTTCCTTCTGTGGTCATCCTGGCTGAGGT
GTAGTCGTAGGTTCCGTACTCATCGGAAACCTGTTCTTTTCTTGCCTCAATCACAAGACA
GCCGTTCTCAACGAACGCGTTTTCGTCTGTATAGTACTCGAGTTCCCCGTTACCCCAGCC
TGGAATACCTTTTGCATGACCGTTTCCTATCTCGAAGTTCCAGATGTTCGGATCGATAAC
ACCGTCATCGAACTCCTGACTCCAAACGAGCTGCCAGTCTTCCACTTTGTCTTCATCCTC
CTCGGTGTAGATTTCGTTTTCCTCACCGCTTACCTCGAGAACACCGATGTCCTCCATCAC
TACGTCGTCTATCCAGACCGTGCCGGTATACCTTCCAAGCTGAAACTCGAAACGAGCATT
TTCATCGGTCTCCTGTCTCATGACGAATTCGAACTCGTACTTCTGCCAATCTGTTCCGAG
CTCGAAGACCATGCCGCCGGATTCGTCGGTACCGGGGTTGTACGCGGTCCATCCTCTTCC
GGCCGTTCCTCCTATCTTCACCCCGATGTTCTTTTGAGAGGAAGCCTTGGCTCGGAAAGA
AACTCTGTACTTGTGGAGTTTCTCAACACGTATGGGAGCCTGTATGATCTGAACCGACCA
GGTGTGATCTCCTCCGTTTGTTATCTCAACCACGAGAACGCCGTTTTCGACTCGAGCCGT
TCCCTCACCGTTTGAATTGGTGAAGAATACCCAGTTTCCTCCTGTGTCTATAGAGCCATC
CTCTGCGGGTGGGTCTATATCCACACCTGCGATGAGAATTGGTTCATCGAAAGAAGCGTT
GCCAAGGATGTTTTGAGCCAGAATGAAAACAGGAAAGAGAAGCAGAGCGAAAACCAGCCT
GCTCATCAT

# Drug_Target_11_General_Function:
Involved in hydrolase activity, hydrolyzing O-glycosyl compounds

# Drug_Target_11_General_References:
10360571	Nelson KE, Clayton RA, Gill SR, Gwinn ML, Dodson RJ, Haft DH, Hickey EK, Peterson JD, Nelson WC, Ketchum KA, McDonald L, Utterback TR, Malek JA, Linher KD, Garrett MM, Stewart AM, Cotton MD, Pratt MS, Phillips CA, Richardson D, Heidelberg J, Sutton GG, Fleischmann RD, Eisen JA, White O, Salzberg SL, Smith HO, Venter JC, Fraser CM: Evidence for lateral gene transfer between Archaea and bacteria from genome sequence of Thermotoga maritima. Nature. 1999 May 27;399(6734):323-9.
12079353	Boraston AB, Nurizzo D, Notenboom V, Ducros V, Rose DR, Kilburn DG, Davies GJ: Differential oligosaccharide recognition by evolutionarily-related beta-1,4 and beta-1,3 glucan-binding modules. J Mol Biol. 2002 Jun 21;319(5):1143-56.

# Drug_Target_11_HGNC_ID:
Not Available

# Drug_Target_11_HPRD_ID:
Not Available

# Drug_Target_11_ID:
4668

# Drug_Target_11_Locus:
Not Available

# Drug_Target_11_Molecular_Weight:
72541

# Drug_Target_11_Name:
Laminarinase

# Drug_Target_11_Number_of_Residues:
642

# Drug_Target_11_PDB_ID:
1GUI

# Drug_Target_11_Pathway:
Not Available

# Drug_Target_11_Pfam_Domain_Function:
PF00722	Glyco_hydro_16
PF02018	CBM_4_9

# Drug_Target_11_Protein_Sequence:
>Laminarinase
MMSRLVFALLLFPVFILAQNILGNASFDEPILIAGVDIDPPAEDGSIDTGGNWVFFTNSN
GEGTARVENGVLVVEITNGGDHTWSVQIIQAPIRVEKLHKYRVSFRAKASSQKNIGVKIG
GTAGRGWTAYNPGTDESGGMVFELGTDWQKYEFEFVMRQETDENARFEFQLGRYTGTVWI
DDVVMEDIGVLEVSGEENEIYTEEDEDKVEDWQLVWSQEFDDGVIDPNIWNFEIGNGHAK
GIPGWGNGELEYYTDENAFVENGCLVIEARKEQVSDEYGTYDYTSARMTTEGKFEIKYGK
IEIRAKLPKGKGIWPALWMLGNNIGEVGWPTCGEIDIMEMLGHDTRTVYGTAHGPGYSGG
ASIGVAYHLPEGVPDFSEDFHIFSIEWDEDEVEWYVDGQLYHVLSKDELAELGLEWVFDH
PFFLILNVAVGGYWPGYPDETTQFPQRMYIDYIRVYKDMNPETITGEVDDCEYEQAQQQA
GPEVTYEQINNGTFDEPIVNDQANNPDEWFIWQAGDYGISGARVSDYGVRDGYAYITIAD
PGTDTWHIQFNQWIGLYRGKTYTISFKAKADTPRPINVKILQNHDPWTNYFAQTVNLTAD
WQTFTFTYTHPDDADEVVQISFELGEGTATTIYFDDVTVSPQ

# Drug_Target_11_Reaction:
Not Available

# Drug_Target_11_Signals:
None

# Drug_Target_11_Specific_Function:
Not Available

# Drug_Target_11_SwissProt_ID:
Q9WXN1

# Drug_Target_11_SwissProt_Name:
Q9WXN1_THEMA

# Drug_Target_11_Synonyms:
Not Available

# Drug_Target_11_Theoretical_pI:
3.97

# Drug_Target_11_Transmembrane_Regions:
None

# Drug_Target_12_Cellular_Location:
Secreted protein

# Drug_Target_12_Chromosome_Location:
Not Available

# Drug_Target_12_Drug_References:
Not Available

# Drug_Target_12_Essentiality:
Non-Essential

# Drug_Target_12_GenAtlas_ID:
Not Available

# Drug_Target_12_GenBank_ID_Gene:
AJ508403

# Drug_Target_12_GenBank_ID_Protein:
Not Available

# Drug_Target_12_GeneCard_ID:
Not Available

# Drug_Target_12_Gene_Name:
xynA

# Drug_Target_12_Gene_Sequence:
>1965 bp
ATGAAGCGTAAGGTTAAGAAGATGGCAGCTATGGCAACGAGTATAATTATGGCTATCATG
ATCATCCTACATAGTATACCAGTACTCGCCGGGCGAATAATTTACGACAATGAGACAGGC
ACACATGGAGGCTACGACTATGAGCTCTGGAAAGACTACGGAAATACGATTATGGAACTT
AACGACGGTGGTACTTTTAGTTGTCAATGGAGTAATATCGGTAATGCACTATTTAGAAAA
GGGAGAAAATTTAATTCCGACAAAACCTATCAAGAATTAGGAGATATAGTAGTTGAATAT
GGCTGTGATTACAATCCAAACGGAAATTCCTATTTGTGTGTTTACGGTTGGACAAGAAAT
CCACTGGTTGAATATTACATTGTAGAAAGCTGGGGCAGCTGGCGTCCACCTGGAGCAACA
CCCAAAGGAACCATCACAGTGGATGGCGGTACTTATGAAATATATGAAACTACCCGGGTA
AATCAGCCTTCCATCGATGGAACTGCGACATTCCAACAATATTGGAGTGTTCGTACATCC
AAGAGAACAAGCGGAACAATATCTGTCACTGAACATTTTAAACAGTGGGAAAGAATGGGC
ATGCGAATGGGTAAGATGTATGAAGTTGCTCTTACCGTTGAAGGTTATCAGAGCAGTGGG
TACGCTAATGTATACAAGAATGAAATCAGAATAGGTGCAAATCCAACTCCTGCCCCATCT
CAAAGCCCAATTAGAAGAGATGCATTTTCAATAATCGAAGCGGAAGAATATAACAGCACA
AATTCCTCCACTTTACAAGTGATTGGAACGCCAAATAATGGCAGAGGAATTGGTTATATT
GAAAATGGTAATACCGTAACTTACAGCAATATAGATTTTGGTAGTGGTGCAACAGGGTTC
TCTGCAACTGTTGCAACGGAGGTTAATACCTCAATTCAAATCCGTTCTGACAGTCCTACC
GGAACTCTACTTGGTACCTTATATGTAAGTTCTACCGGCAGCTGGAATACATATCAAACC
GTATCTACAAACATCAGCAAAATTACCGGCGTTCATGATATTGTATTGGTATTCTCAGGT
CCAGTCAATGTGGACAACTTCATATTTAGCAGAAGTTCACCAGTGCCTGCACCTGGTGAT
AACACAAGAGACGCATATTCTATCATTCAGGCCGAGGATTATGACAGCAGTTATGGCCCC
AACCTTCAAATCTTTAGCTTACCAGGCGGTGGCAGCGCCATTGGCTATATTGAAAATGGT
TATTCCACTACCTATAATAACGTTAATTTCGCCAACGGCTTAAGTTCTATAACAGCAAGA
GTTGCCACTCAGATCTCAACTTCCATTCAGGTGAGAGCAGGAGGAGCAACCGGTACTTTA
CTTGGTACAATATATGTTCCTTCGACAAATAGTTGGGATTCTTATCAGAATGTAACTGCC
AACCTTAGCAATATTACAGGTGTGCATGATATTACCCTTGTCTTTTCAGGACCAGTGAAT
GTGGACTACTTCGTATTTACACCAGCAAATGTAAATTCAGGGCCTACCTCCCCTGTCGGA
GGTACAAGAAGTGCATTTTCCAATATTCAAGCCGAAGATTATGACAGCAGTTATGGTCCC
AACCTTCAAATCTTTAGCTTACCAGGTGGTGGCAGCGCCATTGGCTATATTGAAAATGGT
TATTCCACTACCTATAAAAATATTGATTTTGGTGACGGCGCAACGTCCGTAACAGCAAGA
GTAGCTACCCAGAATGCTACTACCATTCAGGTAAGATTGGGAAGTCCATCGGGTACATTA
CTTGGAACAATTTACGTGGGGTCCACAGGAAGCTTTGATACTTATAGGGATGTATCCGCT
ACCATTAGTAATACTGCGGGTGTAAAAGATATTGTTCTTGTATTCTCAGGTCCTGTTAAT
GTTGACTGGTTTGTATTCTCAAAATTCAGGAACTTAAGGGTATAG

# Drug_Target_12_General_Function:
Involved in carbohydrate binding

# Drug_Target_12_General_References:
11849546	Boraston AB, McLean BW, Chen G, Li A, Warren RA, Kilburn DG: Co-operative binding of triplicate carbohydrate-binding modules from a thermophilic xylanase. Mol Microbiol. 2002 Jan;43(1):187-94.

# Drug_Target_12_HGNC_ID:
Not Available

# Drug_Target_12_HPRD_ID:
Not Available

# Drug_Target_12_ID:
4669

# Drug_Target_12_Locus:
Not Available

# Drug_Target_12_Molecular_Weight:
70151

# Drug_Target_12_Name:
Endo-1,4-beta-xylanase A

# Drug_Target_12_Number_of_Residues:
651

# Drug_Target_12_PDB_ID:
Not Available

# Drug_Target_12_Pathway:
Not Available

# Drug_Target_12_Pfam_Domain_Function:
PF00457	Glyco_hydro_11
PF03422	CBM_6

# Drug_Target_12_Protein_Sequence:
>Endo-1,4-beta-xylanase A
MKRKVKKMAAMATSIIMAIMIILHSIPVLAGRIIYDNETGTHGGYDYELWKDYGNTIMEL
NDGGTFSCQWSNIGNALFRKGRKFNSDKTYQELGDIVVEYGCDYNPNGNSYLCVYGWTRN
PLVEYYIVESWGSWRPPGATPKGTITVDGGTYEIYETTRVNQPSIDGTATFQQYWSVRTS
KRTSGTISVTEHFKQWERMGMRMGKMYEVALTVEGYQSSGYANVYKNEIRIGANPTPAPS
QSPIRRDAFSIIEAEEYNSTNSSTLQVIGTPNNGRGIGYIENGNTVTYSNIDFGSGATGF
SATVATEVNTSIQIRSDSPTGTLLGTLYVSSTGSWNTYQTVSTNISKITGVHDIVLVFSG
PVNVDNFIFSRSSPVPAPGDNTRDAYSIIQAEDYDSSYGPNLQIFSLPGGGSAIGYIENG
YSTTYNNVNFANGLSSITARVATQISTSIQVRAGGATGTLLGTIYVPSTNSWDSYQNVTA
NLSNITGVHDITLVFSGPVNVDYFVFTPANVNSGPTSPVGGTRSAFSNIQAEDYDSSYGP
NLQIFSLPGGGSAIGYIENGYSTTYKNIDFGDGATSVTARVATQNATTIQVRLGSPSGTL
LGTIYVGSTGSFDTYRDVSATISNTAGVKDIVLVFSGPVNVDWFVFSKSGT

# Drug_Target_12_Reaction:
Not Available

# Drug_Target_12_Signals:
1-30

# Drug_Target_12_Specific_Function:
Endoxylanase that degrades arabinoxylan and glucuronoxylan to xylobiose and xylotriose (in vitro)

# Drug_Target_12_SwissProt_ID:
Q8GJ44

# Drug_Target_12_SwissProt_Name:
XYNA1_CLOSR

# Drug_Target_12_Synonyms:
1,4-beta-D-xylan xylanohydrolase A
EC 3.2.1.8
Endo-1,4-beta-xylanase A precursor
Xylanase 11A
Xyn11A

# Drug_Target_12_Theoretical_pI:
4.88

# Drug_Target_12_Transmembrane_Regions:
None

# Drug_Target_13_Cellular_Location:
Cytoplasmic

# Drug_Target_13_Chromosome_Location:
Not Available

# Drug_Target_13_Drug_References:
Not Available

# Drug_Target_13_Essentiality:
Non-Essential

# Drug_Target_13_GenAtlas_ID:
Not Available

# Drug_Target_13_GenBank_ID_Gene:
AF003697

# Drug_Target_13_GenBank_ID_Protein:
Not Available

# Drug_Target_13_GeneCard_ID:
Not Available

# Drug_Target_13_Gene_Name:
celB

# Drug_Target_13_Gene_Sequence:
>1869 bp
ATGAAGAATAATCATCCCGGTTGCGCAGCGCCAACTGCTGCGCGCTCCACAAATCCACGC
AACAGGCTATTCGCAAGCTTGGTTACAGGCCTTGCCAGTATTGCTTTCTGCAGTACAGCG
CTAGCTGCCGTACCCGCGTTACAGGTGCAGGGCAATAAAGTCCTCGTCGGCGGTAAATCC
GTCAGCCTTGAAGGTGTCTCCCTGTTTTGGAGCAATACCGGCTGGGGCGCAGAAAAGTTT
TATACCGCCGCTGCGGTCAAACGCGCTAAAACCGAATTCAACGCCAACCTGATCCGCGCC
GCCATCGGCCACGGGGAAGGTGGTGGTATCCAGGATGACTGGAACGGCAACATGGCGCGC
CTCGATACCGTTATCCAGGCAGCTATCGACAACGATATGTATGTAATCGTTGACTATCAC
AGCCACAAAGCCCATGAGAATTGGGGTTCAGCAGAAGCCTTCTTCAAGCAAGTGGCGCAA
AAGTGGGGCCAACATAACAACGTTATTTACGAACTCTACAACGAGCCACTGGGCGTGGAT
TGGCACTCAGTGCTCAAACCCTATGCAGAGCATGTGGGTGGAAAAATCCGCGCGATCGAC
CCGGACAACCTGATCATTATGGGTACGCCCAACTGGTCGCAAGATGTCGATGTCGCCTCC
ACCAACAAAGCCAACGTCTCCAACTTGGCCTACACCGTCCACTTCTATGCCGATAGCCAT
CGCGGTTCCTACCGTGCCAAAGCGCAGACCGCACTCAACAACGGTGCTGCATTGTTTGCC
ACTGAGTGGGGCGTAGGCCACGCGAACGGCAGAGGAACAGTGAATCACGCAGAGACTTGG
GCCTGGATCGACTTTCTACGCGCCAACGGTATCAGCCATGCAGGCTGGGCATTCCACGAT
AAAGAGCGCGATCAGGCGACGGGCGAAGTGGAAACCTCATCCTTTTTCTGGGCCGATGGC
TCATTGAAAGAATCCGGCAGATTTGTGAAAGAAATTCTCGCGGGCCGTAAACCCATCGAT
GGCGGCGGCGGTGACGGTGGTGGCGACGGCTCTGGTGGTACCTGCACCAAAGCCAATCCG
GGCGATGCCATCCAGGCCGAAAGCTGGTGCCAGATGTCTGGCGTGAAGACCGAAACGACC
AGCGATGCAGGTGATGGTTTGAATGTCGGCTATATCGATGGCGGCGACTGGATGACTTAC
TCAGTCAATATACCTACCACCGGTACCTACAAAGTTAGCTACCGCGTTGCAGCTCAGGCA
GGTGGCGGACAGCTCCAATTGGAAAAAGCCGGTGGCAGCCCGGTGTATAGCAATATCAAC
GTTCCCGCGACGGGCGGCTGGCAAAACTGGCAGACCATTTCCCACAATGTAGTTTTGCCC
GCAGGCGAGCAACTGATCGCGCTCTCGGCGATTACCGGCGGCTTCAATATCAACTGGCTG
AAAGTAGAAAGCACTGGCGGTGACAACTCCGGTACCGTAATCGCGACTATTCAGGCGGAA
GACCATAGCCAACAGAGCGGCACACAGCAGGAAACCACAACCGATACCGGCGGTGGTAAA
AACGTTGGCTATATCGATGCCGGGGACTGGCTCTCTTACGCGGGTACGCCGGTCAACATC
CCCAGCAGTGGCAGCTATTTGATTGAGTACCGTGTGGCCAGCCAAAACGGCGGTGGCAGC
CTGACATTTGAAGAAGCAGGCGGCGCACCGGTGCATGGCACCATCGCCATCCCTGCAACC
GGTGGCTGGCAAACCTGGACGACCATCCAACACACAGTCAACCTGAGTGCGGGCAGCCAT
CAATTTGGGATTAAAGCCAATGCCGGTGGTTGGAACCTCAATTGGATTCGCATCAACAAG
ACACATTAA

# Drug_Target_13_General_Function:
Involved in carbohydrate binding

# Drug_Target_13_General_References:
Not Available

# Drug_Target_13_HGNC_ID:
Not Available

# Drug_Target_13_HPRD_ID:
Not Available

# Drug_Target_13_ID:
4670

# Drug_Target_13_Locus:
Not Available

# Drug_Target_13_Molecular_Weight:
65889

# Drug_Target_13_Name:
Cellulase B

# Drug_Target_13_Number_of_Residues:
622

# Drug_Target_13_PDB_ID:
Not Available

# Drug_Target_13_Pathway:
Not Available

# Drug_Target_13_Pfam_Domain_Function:
PF00150	Cellulase
PF03422	CBM_6

# Drug_Target_13_Protein_Sequence:
>Cellulase B
MKNNHPGCAAPTAARSTNPRNRLFASLVTGLASIAFCSTALAAVPALQVQGNKVLVGGKS
VSLEGVSLFWSNTGWGAEKFYTAAAVKRAKTEFNANLIRAAIGHGEGGGIQDDWNGNMAR
LDTVIQAAIDNDMYVIVDYHSHKAHENWGSAEAFFKQVAQKWGQHNNVIYELYNEPLGVD
WHSVLKPYAEHVGGKIRAIDPDNLIIMGTPNWSQDVDVASTNKANVSNLAYTVHFYADSH
RGSYRAKAQTALNNGAALFATEWGVGHANGRGTVNHAETWAWIDFLRANGISHAGWAFHD
KERDQATGEVETSSFFWADGSLKESGRFVKEILAGRKPIDGGGGDGGGDGSGGTCTKANP
GDAIQAESWCQMSGVKTETTSDAGDGLNVGYIDGGDWMTYSVNIPTTGTYKVSYRVAAQA
GGGQLQLEKAGGSPVYSNINVPATGGWQNWQTISHNVVLPAGEQLIALSAITGGFNINWL
KVESTGGDNSGTVIATIQAEDHSQQSGTQQETTTDTGGGKNVGYIDAGDWLSYAGTPVNI
PSSGSYLIEYRVASQNGGGSLTFEEAGGAPVHGTIAIPATGGWQTWTTIQHTVNLSAGSH
QFGIKANAGGWNLNWIRINKTH

# Drug_Target_13_Reaction:
Not Available

# Drug_Target_13_Signals:
None

# Drug_Target_13_Specific_Function:
Endohydrolysis of 1,4-beta-D-glucosidic linkages in cellulose, lichenin and cereal beta-D-glucans

# Drug_Target_13_SwissProt_ID:
O07653

# Drug_Target_13_SwissProt_Name:
O07653_9GAMM

# Drug_Target_13_Synonyms:
Not Available

# Drug_Target_13_Theoretical_pI:
6.26

# Drug_Target_13_Transmembrane_Regions:
None

# Drug_Target_14_Cellular_Location:
Cytoplasmic

# Drug_Target_14_Chromosome_Location:
Not Available

# Drug_Target_14_Drug_References:
Not Available

# Drug_Target_14_Essentiality:
Non-Essential

# Drug_Target_14_GenAtlas_ID:
Not Available

# Drug_Target_14_GenBank_ID_Gene:
X57858

# Drug_Target_14_GenBank_ID_Protein:
Not Available

# Drug_Target_14_GeneCard_ID:
Not Available

# Drug_Target_14_Gene_Name:
cenC

# Drug_Target_14_Gene_Sequence:
>3306 bp
GTGGTTTCTCGCAGGTCATCACAGGCGCGCGGCGCGCTCACGGCCGTCGTCGCGACGCTC
GCCCTCGCGCTCGCCGGGAGCGGCACCGCGCTCGCCGCGTCGCCGATCGGGGAGGGAACG
TTCGACGACGGGCCCGAGGGGTGGGTCGCGTACGGCACCGACGGCCCCCTCGACACGAGC
ACGGGCGCGCTGTGCGTCGCCGTGCCGGCCGGATCCGCGCAGTACGGCGTCGGCGTCGTG
CTCAACGGCGTCGCGATCGAGGAAGGGACCACCTACACGCTCCGGTACACCGCGACGGCC
TCGACCGACGTCACCGTGCGGGCGCTCGTCGGGCAGAACGGCGCCCCCTACGGCACCGTG
CTCGACACGAGCCCGGCCCTGACGTCCGAGCCGCGGCAGGTGACCGAGACGTTCACGGCC
TCGGCGACGTACCCCGCGACACCCGCCGCCGACGACCCCGAGGGGCAGATCGCCTTCCAG
CTCGGCGGGTTCAGCGCCGACGCGTGGACGTTCTGCCTCGACGACGTCGCGCTCGACTCC
GAGGTCGAGCTCCTGCCGCACACGTCGTTCGCCGAGTCGCTCGGCCCGTGGTCCCTGTAC
GGCACGAGCGAGCCGGTGTTCGCCGACGGCCGGATGTGCGTCGACCTGCCCGGCGGGCAG
GGCAACCCCTGGGACGCGGGCCTCGTCTACAACGGCGTTCCCGTCGGCGAGGGCGAGAGC
TACGTCCTGTCGTTCACCGCGAGCGCGACGCCCGACATGCCGGTGCGCGTGCTCGTCGGC
GAGGGCGGCGGCGCCTACCGGACCGCCTTCGAGCAGGGGTCGGCACCGCTGACCGGCGAG
CCCGCGACCCGCGAGTACGCGTTCACCTCGAACCTGACGTTCCCGCCCGACGGCGACGCA
CCCGGCCAGGTCGCGTTCCACCTCGGCAAGGCCGGTGCGTACGAGTTCTGCATCTCGCAG
GTGTCGCTCACCACCTCGGCGACGCCGCCGCCCGGGTACGAGCCCGACACCGGCCCGCGC
GTGCGGGTCAACCAGGTGGGCTACCTGCCGTTCGGGCCGAAGCGCGCCACCCTCGTCACC
GACGCGGCCGAGCCGGTCGCGTGGGAGCTGCGCGACGCCGACGGCGTGGTCGTCGCCGAC
GGGACCAGCGAGCCGCGCGGCGTCGAGCCGTCGGCCGCGCAGGCGGTGCACGTGCTCGAC
TTCTCCGACGTCACGACGCAGGGCGCGGGGTACACGCTCGTCGCCGACGGCGAGACGAGC
CGCCCCTTCGACATCGACGGCGACCTGTACCAGCAGCTCCGGTACGACGCGCTCAACTAC
TTCTACCTCGCGCGCTCCGGCACCGAGATCGAGGCGGACGTGGTCGGCGAGGAGTACGCC
CGCGAGGCGGGCCACGTCGGCGTCGCGCCCAACCAGGGCGACACCGACGTGCCGTGCATC
GGCCCGCGCGACTACTACGACGGCTGGACGTGCGACTACCGGCTCGACGTGAGCGGCGGC
TGGTACGACGCCGGCGACCACGGCAAGTACGTCGTCAACGGCGGCATCGCGGTCGGGCAG
CTCCTGCAGACGTACGAGCGGGCGCTGCACGCGGGCACCGCCGACGCGCTCGCGGACGGC
ACCCTCGACGTGCCCGAGCACGGCAACGACGTGCCCGACGTCCTGGACGAGGCGCGCTGG
GAGCTCGAGTGGATGCTCTCGATGATCGTGCCCGAGGGGGAGTACGCGGGGATGGTGCAC
CACAAGGTGCACGACGAGGGCTGGACCGGGCTGCCGCTGCTGCCGGCCGACGACCCGCAG
GCGCGCTCGCTGCACCGGCCGTCGACCGCGGCGACGCTCAACCTGTCCGCCGTCGCGGCG
CAGGGGGCGCGCCTGCTCGAGCCGTACGACCCGCAGCTCGCGCAGACGCTGCTGGAGGCG
GCACGCACGACCTGGGCTGCGGCCCAGGAGCACCCGGCGCTGTACGCCCCGGGCGAGGCC
GGCGCGGACGGCGGTGGCGCGTACAACGACTCCCAGGTGGCCGACGAGTTCTACTGGGCG
GCCGCCGAGCTCTACCTGACGACGGGCGAGGACGCGTTCGCCACCGCGGTGACGACCTCG
CCGCTGCACACCGCGGACGTGTTCACCGCGGACGGGTTCGGCTGGGGGAGCGTCGCCGCG
CTGGGTCGCCTCGACCTCGCGACGGTGCCGAACGAGCTGCCGGGTCTCGACGCGGTGCAA
TCGTCGGTCGTCGAGGGGGCGCAGGAGTACCTCGCGGCGCAGGCGGGGCAGGGATTCGGC
TCGCTGTACTCCCCGCCCGGCGGCGAGTACGTCTGGGGCTCGAGCTCGCAGGTCGCGAAC
AACCTCGTCGTCGTCGCGACCGCGTACGACCTCACGGGCGACGAGCGGTTCCGGGCGGCG
ACGCTCGAGGGGCTCGACTACCTGTTCGGCCGCAACGCGCTCAACCAGTCGTACGTGACG
GGCTGGGGCGAGGTCGCCTCGCACCAGCAGCACAGCCGGTGGTTCGCGCACCAGCTCGAC
CCGTCGCTCCCGAGCCCGCCGCCCGGCTCGCTCGCGGGCGGCCCGAACTCGCAGGCCGCG
ACGTGGGACCCGACGACGAAGGCGGCGTTCCCCGACGGCTGCGCGCCGTCCGCGTGCTAC
GTCGACGAGATCCAGGCGTGGTCGACGAACGAGCTCACCGTCAACTGGAACTCCGCGCTG
TCCTGGGTCGCCTCGTGGGTGGCCGACCAGGGCTCGGCCGAGCCGGTGCCGACGGCGCCG
GTGGTGACGCGGCAGCCCGTCGACGCGACCGTCGCGCTCGGTGCCGACGCCACGTTCACC
GCGGAGGCGAGCGGCGTGCCCGCGCCGACCGTCCGGTGGCAGGTGCGGGCCGGCCGCGGC
TGGAAGGACGTCGCCGGCGCGACCGGGACCACGCTCACGGTCCGCGCGACCGCCCGCACC
GACGGCACGCGGTACCGGGCGGTGTTCACCAACGCGGCCGGCTCGGTCGAGAGCGCCGTC
GTGCGGCTCACCGTCGAGCGCGCGGCACCCGTCGTGACGCAGCACCCGGCCGACGTCCGG
GCACGGGTCGGCACGCGTGCCGTGTTCCGCGCGGCCGCCGACGGGTACCCCACGCCCTGC
GTCGTGTGGCAGGTGCGGTGGGGCGGCGGGAGCTGGCGGCCGATCCCGTGGGCCACCTCG
ACGACGCTCTCCGTGCCGGTCACGGTGCTCGCGGCGGGCACGGAGTACCGCGCGGTGTTC
ACCAACGCCGTCGGCACCGCGGCGACCGAGCCTGCCGAGCTCGCCGTGCAGCGTCCGCGC
AGCTGA

# Drug_Target_14_General_Function:
Involved in catalytic activity

# Drug_Target_14_General_References:
1375311	Coutinho JB, Gilkes NR, Warren RA, Kilburn DG, Miller RC Jr: The binding of Cellulomonas fimi endoglucanase C (CenC) to cellulose and Sephadex is mediated by the N-terminal repeats. Mol Microbiol. 1992 May;6(9):1243-52.
1956299	Coutinho JB, Moser B, Kilburn DG, Warren RA, Miller RC Jr: Nucleotide sequence of the endoglucanase C gene (cenC) of Cellulomonas fimi, its high-level expression in Escherichia coli, and characterization of its products. Mol Microbiol. 1991 May;5(5):1221-33.
2604391	Moser B, Gilkes NR, Kilburn DG, Warren RA, Miller RC Jr: Purification and characterization of endoglucanase C of Cellulomonas fimi, cloning of the gene, and analysis of in vivo transcripts of the gene. Appl Environ Microbiol. 1989 Oct;55(10):2480-7.
8880921	Bateman A, Eddy SR, Chothia C: Members of the immunoglobulin superfamily in bacteria. Protein Sci. 1996 Sep;5(9):1939-41.
8916925	Johnson PE, Joshi MD, Tomme P, Kilburn DG, McIntosh LP: Structure of the N-terminal cellulose-binding domain of Cellulomonas fimi CenC determined by nuclear magnetic resonance spectroscopy. Biochemistry. 1996 Nov 12;35(45):14381-94.

# Drug_Target_14_HGNC_ID:
Not Available

# Drug_Target_14_HPRD_ID:
Not Available

# Drug_Target_14_ID:
4671

# Drug_Target_14_Locus:
Not Available

# Drug_Target_14_Molecular_Weight:
115216

# Drug_Target_14_Name:
Endoglucanase C

# Drug_Target_14_Number_of_Residues:
1101

# Drug_Target_14_PDB_ID:
Not Available

# Drug_Target_14_Pathway:
Not Available

# Drug_Target_14_Pfam_Domain_Function:
PF00047	ig
PF00759	Glyco_hydro_9
PF02018	CBM_4_9
PF02927	CelD_N
PF07679	I-set

# Drug_Target_14_Protein_Sequence:
>Endoglucanase C
MVSRRSSQARGALTAVVATLALALAGSGTALAASPIGEGTFDDGPEGWVAYGTDGPLDTS
TGALCVAVPAGSAQYGVGVVLNGVAIEEGTTYTLRYTATASTDVTVRALVGQNGAPYGTV
LDTSPALTSEPRQVTETFTASATYPATPAADDPEGQIAFQLGGFSADAWTFCLDDVALDS
EVELLPHTSFAESLGPWSLYGTSEPVFADGRMCVDLPGGQGNPWDAGLVYNGVPVGEGES
YVLSFTASATPDMPVRVLVGEGGGAYRTAFEQGSAPLTGEPATREYAFTSNLTFPPDGDA
PGQVAFHLGKAGAYEFCISQVSLTTSATPPPGYEPDTGPRVRVNQVGYLPFGPKRATLVT
DAAEPVAWELRDADGVVVADGTSEPRGVEPSAAQAVHVLDFSDVTTQGAGYTLVADGETS
RPFDIDGDLYQQLRYDALNYFYLARSGTEIEADVVGEEYAREAGHVGVAPNQGDTDVPCI
GPRDYYDGWTCDYRLDVSGGWYDAGDHGKYVVNGGIAVGQLLQTYERALHAGTADALADG
TLDVPEHGNDVPDVLDEARWELEWMLSMIVPEGEYAGMVHHKVHDEGWTGLPLLPADDPQ
ARSLHRPSTAATLNLSAVAAQGARLLEPYDPQLAQTLLEAARTTWAAAQEHPALYAPGEA
GADGGGAYNDSQVADEFYWAAAELYLTTGEDAFATAVTTSPLHTADVFTADGFGWGSVAA
LGRLDLATVPNELPGLDAVQSSVVEGAQEYLAAQAGQGFGSLYSPPGGEYVWGSSSQVAN
NLVVVATAYDLTGDERFRAATLEGLDYLFGRNALNQSYVTGWGEVASHQQHSRWFAHQLD
PSLPSPPPGSLAGGPNSQAATWDPTTKAAFPDGCAPSACYVDEIQAWSTNELTVNWNSAL
SWVASWVADQGSAEPVPTAPVVTRQPVDATVALGADATFTAEASGVPAPTVRWQVRAGRG
WKDVAGATGTTLTVRATARTDGTRYRAVFTNAAGSVESAVVRLTVERAAPVVTQHPADVR
ARVGTRAVFRAAADGYPTPCVVWQVRWGGGSWRPIPWATSTTLSVPVTVLAAGTEYRAVF
TNAVGTAATEPAELAVQRPRS

# Drug_Target_14_Reaction:
Not Available

# Drug_Target_14_Signals:
1-32

# Drug_Target_14_Specific_Function:
The biological conversion of cellulose to glucose generally requires three types of hydrolytic enzymes:(1) Endoglucanases which cut internal beta-1,4-glucosidic bonds; (2) Exocellobiohydrolases that cut the dissaccharide cellobiose from the nonreducing end of the cellulose polymer chain; (3) Beta-1,4- glucosidases which hydrolyze the cellobiose and other short cello- oligosaccharides to glucose

# Drug_Target_14_SwissProt_ID:
P14090

# Drug_Target_14_SwissProt_Name:
GUNC_CELFI

# Drug_Target_14_Synonyms:
Cellulase C
EC 3.2.1.4
Endo-1,4-beta-glucanase C
Endoglucanase C precursor

# Drug_Target_14_Theoretical_pI:
4.11

# Drug_Target_14_Transmembrane_Regions:
None

# Drug_Target_15_Cellular_Location:
Secreted protein

# Drug_Target_15_Chromosome_Location:
Not Available

# Drug_Target_15_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_15_Essentiality:
Non-Essential

# Drug_Target_15_GenAtlas_ID:
Not Available

# Drug_Target_15_GenBank_ID_Gene:
Not Available

# Drug_Target_15_GenBank_ID_Protein:
Not Available

# Drug_Target_15_GeneCard_ID:
Not Available

# Drug_Target_15_Gene_Name:
celS

# Drug_Target_15_Gene_Sequence:
Not Available

# Drug_Target_15_General_Function:
Not Available

# Drug_Target_15_General_References:
8664281	Choi SK, Ljungdahl LG: Dissociation of the cellulosome of Clostridium thermocellum in the presence of ethylenediaminetetraacetic acid occurs with the formation of trucated polypeptides. Biochemistry. 1996 Apr 16;35(15):4897-905.

# Drug_Target_15_HGNC_ID:
Not Available

# Drug_Target_15_HPRD_ID:
Not Available

# Drug_Target_15_ID:
3744

# Drug_Target_15_Locus:
Not Available

# Drug_Target_15_Molecular_Weight:
83559

# Drug_Target_15_Name:
Endoglucanase SS precursor

# Drug_Target_15_Number_of_Residues:
741

# Drug_Target_15_PDB_ID:
1L2A

# Drug_Target_15_Pathway:
Not Available

# Drug_Target_15_Pfam_Domain_Function:
Not Available

# Drug_Target_15_Protein_Sequence:
>Endoglucanase SS precursor
MVKSRKISILLAVAMLVSIMIPTTAFAGPTKAPTKDGTSYKDLFLELYGKIKDPKNGYFS
PDEGIPYHSIETLIVEAPDYGHVTTSEAFSYYVWLEAMYGNLTGNWSGVETAWKVMEDWI
IPDSTEQPGMSSYNPNSPATYADEYEDPSYYPSELKFDTVRVGSDPVHNDLVSAYGPNMY
LMHWLMDVDNWYGFGTGTRATFINTFQRGEQESTWETIPHPSIEEFKYGGPNGFLDLFTK
DRSYAKQWRYTNAPDAEGRAIQAVYWANKWAKEQGKGSAVASVVSKAAKMGDFLRNDMFD
KYFMKIGAQDKTPATGYDSAHYLMAWYTAWGGGIGASWAWKIGCSHAHFGYQNPFQGWVS
ATQSDFAPKSSNGKRDWTTSYKRQLEFYQWLQSAEGGIAGGATNSWNGRYEKYPAGTSTF
YGMAYVPHPVYADPGSNQWFGFQAWSMQRVMEYYLETGDSSVKNLIKKWVDWVMSEIKLY
DDGTFAIPSDLEWSGQPDTWTGTYTGNPNLHVRVTSYGTDLGVAGSLANALATYAAATER
WEGKLDTKARDMAAELVNRAWYNFYCSEGKGVVTEEARADYKRFFEQEVYVPAGWSGTMP
NGDKIQPGIKFIDIRTKYRQDPYYDIVYQAYLRGEAPVLNYHRFWHEVDLAVAMGVLATY
FPDMTYKVPGTPSTKLYGDVNDDGKVNSTDAVALKRYVLRSGISINTDNADLNEDGRVNS
TDLGILKRYILKEIDTLPYKN

# Drug_Target_15_Reaction:
Endohydrolysis of 1,4-beta-D-glucosidic linkages in cellulose, lichenin and cereal beta-D-glucans

# Drug_Target_15_Signals:
1-27

# Drug_Target_15_Specific_Function:
This enzyme catalyzes the endohydrolysis of 1,4-beta- glucosidic linkages in cellulose, lichenin and cereal beta-D- glucans

# Drug_Target_15_SwissProt_ID:
P0C2S5

# Drug_Target_15_SwissProt_Name:
GUNS_CLOTM

# Drug_Target_15_Synonyms:
Cellulase SS
EC 3.2.1.4
EGSS
Endo-1,4-beta- glucanase

# Drug_Target_15_Theoretical_pI:
5.10

# Drug_Target_15_Transmembrane_Regions:
None

# Drug_Target_16_Cellular_Location:
Periplasm

# Drug_Target_16_Chromosome_Location:
Not Available

# Drug_Target_16_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_16_Essentiality:
Non-Essential

# Drug_Target_16_GenAtlas_ID:
Not Available

# Drug_Target_16_GenBank_ID_Gene:
M59444

# Drug_Target_16_GenBank_ID_Protein:
Not Available

# Drug_Target_16_GeneCard_ID:
Not Available

# Drug_Target_16_Gene_Name:
mglB

# Drug_Target_16_Gene_Sequence:
Not Available

# Drug_Target_16_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_16_General_References:
1719366	Hogg RW, Voelker C, Von Carlowitz I: Nucleotide sequence and analysis of the mgl operon of Escherichia coli K12. Mol Gen Genet. 1991 Oct;229(3):453-9.
3057628	Vyas NK, Vyas MN, Quiocho FA: Sugar and signal-transducer binding sites of the Escherichia coli galactose chemoreceptor protein. Science. 1988 Dec 2;242(4883):1290-5.
3302609	Scholle A, Vreemann J, Blank V, Nold A, Boos W, Manson MD: Sequence of the mglB gene from Escherichia coli K12: comparison of wild-type and mutant galactose chemoreceptors. Mol Gen Genet. 1987 Jun;208(1-2):247-53.
3600760	Vyas NK, Vyas MN, Quiocho FA: A novel calcium binding site in the galactose-binding protein of bacterial transport and chemotaxis. Nature. 1987 Jun 18-24;327(6123):635-8.
6340108	Vyas NK, Vyas MN, Quiocho FA: The 3 A resolution structure of a D-galactose-binding protein for transport and chemotaxis in Escherichia coli. Proc Natl Acad Sci U S A. 1983 Apr;80(7):1792-6.
6885805	Scripture JB, Hogg RW: The nucleotide sequences defining the signal peptides of the galactose-binding protein and the arabinose-binding protein. J Biol Chem. 1983 Sep 25;258(18):10853-5.
7012152	Mahoney WC, Hogg RW, Hermodson MA: The amino acid sequence of the D-galactose-binding protein from Escherichia coli B/r. J Biol Chem. 1981 May 10;256(9):4350-6.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9298646	Link AJ, Robison K, Church GM: Comparing the predicted and observed properties of proteins encoded in the genome of Escherichia coli K-12. Electrophoresis. 1997 Aug;18(8):1259-313.

# Drug_Target_16_HGNC_ID:
Not Available

# Drug_Target_16_HPRD_ID:
Not Available

# Drug_Target_16_ID:
3741

# Drug_Target_16_Locus:
Not Available

# Drug_Target_16_Molecular_Weight:
35713

# Drug_Target_16_Name:
D-galactose-binding periplasmic protein precursor

# Drug_Target_16_Number_of_Residues:
332

# Drug_Target_16_PDB_ID:
2GBP

# Drug_Target_16_Pathway:
Not Available

# Drug_Target_16_Pfam_Domain_Function:
PF00532	Peripla_BP_1

# Drug_Target_16_Protein_Sequence:
>D-galactose-binding periplasmic protein precursor
MNKKVLTLSAVMASMLFGAAAHAADTRIGVTIYKYDDNFMSVVRKAIEQDAKAAPDVQLL
MNDSQNDQSKQNDQIDVLLAKGVKALAINLVDPAAAGTVIEKARGQNVPVVFFNKEPSRK
ALDSYDKAYYVGTDSKESGIIQGDLIAKHWAANQGWDLNKDGQIQFVLLKGEPGHPDAEA
RTTYVIKELNDKGIKTEQLQLDTAMWDTAQAKDKMDAWLSGPNANKIEVVIANNDAMAMG
AVEALKAHNKSSIPVFGVDALPEALALVKSGALAGTVLNDANNQAKATFDLAKNLADGKG
AADGTNWKIDNKVVRVPYVGVDKDNLAEFSKK

# Drug_Target_16_Reaction:
Not Available

# Drug_Target_16_Signals:
1-23

# Drug_Target_16_Specific_Function:
This protein is involved in the active transport of galactose and glucose. It plays a role in the chemotaxis towards the two sugars by interacting with the trg chemoreceptor

# Drug_Target_16_SwissProt_ID:
P0AEE5

# Drug_Target_16_SwissProt_Name:
DGAL_ECOLI

# Drug_Target_16_Synonyms:
D-galactose/ D-glucose-binding protein
GBP
GGBP

# Drug_Target_16_Theoretical_pI:
5.78

# Drug_Target_16_Transmembrane_Regions:
None

# Drug_Target_17_Cellular_Location:
Not Available

# Drug_Target_17_Chromosome_Location:
Not Available

# Drug_Target_17_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_17_Essentiality:
Non-Essential

# Drug_Target_17_GenAtlas_ID:
Not Available

# Drug_Target_17_GenBank_ID_Gene:
Not Available

# Drug_Target_17_GenBank_ID_Protein:
Not Available

# Drug_Target_17_GeneCard_ID:
Not Available

# Drug_Target_17_Gene_Name:
GLT6D1

# Drug_Target_17_Gene_Sequence:
Not Available

# Drug_Target_17_General_Function:
Not Available

# Drug_Target_17_General_References:
Not Available

# Drug_Target_17_HGNC_ID:
Not Available

# Drug_Target_17_HPRD_ID:
Not Available

# Drug_Target_17_ID:
7011

# Drug_Target_17_Locus:
Not Available

# Drug_Target_17_Molecular_Weight:
Not Available

# Drug_Target_17_Name:
Glycosyltransferase 6 domain-containing protein 1

# Drug_Target_17_Number_of_Residues:
0

# Drug_Target_17_PDB_ID:
Not Available

# Drug_Target_17_Pathway:
Not Available

# Drug_Target_17_Pfam_Domain_Function:
Not Available

# Drug_Target_17_Protein_Sequence:
Not Available

# Drug_Target_17_Reaction:
Not Available

# Drug_Target_17_Signals:
Not Available

# Drug_Target_17_Specific_Function:
Not Available

# Drug_Target_17_SwissProt_ID:
Q7Z4J2

# Drug_Target_17_SwissProt_Name:
GL6D1_HUMAN

# Drug_Target_17_Synonyms:
Not Available

# Drug_Target_17_Theoretical_pI:
Not Available

# Drug_Target_17_Transmembrane_Regions:
Not Available

# Drug_Target_18_Cellular_Location:
Cytoplasm

# Drug_Target_18_Chromosome_Location:
Not Available

# Drug_Target_18_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_18_Essentiality:
Non-Essential

# Drug_Target_18_GenAtlas_ID:
GNPDA1

# Drug_Target_18_GenBank_ID_Gene:
AF048826

# Drug_Target_18_GenBank_ID_Protein:
2935438

# Drug_Target_18_GeneCard_ID:
GNPDA1

# Drug_Target_18_Gene_Name:
GNPDA1

# Drug_Target_18_Gene_Sequence:
>870 bp
ATGAAGCTCATCATCCTGGAGCACTATTCTCAGGCGAGCGAGTGGGCGGCTAAATACATC
AGGAACCGTATCATCCAGTTTAACCCAGGGCCAGAGAAGTACTTCACCCTGGGGCTCCCC
ACTGGGAGTACCCCACTTGGCTGCTACAAGAAGCTGATTGAATACTATAAGAATGGGGAC
CTGTCCTTTAAATATGTGAAGACCTTCAACATGGATGAGTACGTGGGCCTTCCTCGAGAC
CACCCGGAGAGTTACCACTCCTTCATGTGGAACAACTTCTTCAAGCACATTGACATCCAC
CCAGAAAACACCCACATTCTGGATGGGAATGCAGTCGACCTACAGGCAGAATGTGATGCC
TTTGAAGAGAAGATCAAGGCTGCAGGTGGGATCGAGCTATTTGTTGGAGGCATCGGCCCT
GATGGACACATTGCCTTCAACGAGCCAGGCTCCAGTCTGGTGTCCAGGACCCGTGTGAAG
ACGCTGGCCATGGATACCATCCTGGCCAATGCTAGGTTCTTCGATGGAGAACTCACCAAG
GTGCCCACCATGGCCTTGACGGTGGGGGTGGGCACTGTCATGGATGCTAGAGAGGTGATG
ATCCTTATCACAGGTGCTCACAAGGCATTTGCTCTGTACAAGGCCATCGAGGAGGGAGTG
AACCACATGTGGACCGTGTCTGCCTTCCAGCAGCATCCCCGCACCGTGTTTGTGTGTGAC
GAGGATGCCACCTTGGAGCTGAAAGTGAAGACTGTCAAGTATTTCAAAGGTTTAATGCTT
GTTCATAACAAGTTGGTGGACCCCTTGTACAGTATCAAAGAGAAAGAAACTGAGAAAAGC
CAATCTTCGAAGAAACCATACAGCGATTAG

# Drug_Target_18_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_18_General_References:
7584044	Nomura N, Nagase T, Miyajima N, Sazuka T, Tanaka A, Sato S, Seki N, Kawarabayasi Y, Ishikawa K, Tabata S: Prediction of the coding sequences of unidentified human genes. II. The coding sequences of 40 new genes (KIAA0041-KIAA0080) deduced by analysis of cDNA clones from human cell line KG-1. DNA Res. 1994;1(5):223-9.
9438414	Wolosker H, Kline D, Bian Y, Blackshaw S, Cameron AM, Fralich TJ, Schnaar RL, Snyder SH: Molecularly cloned mammalian glucosamine-6-phosphate deaminase localizes to transporting epithelium and lacks oscillin activity. FASEB J. 1998 Jan;12(1):91-9.

# Drug_Target_18_HGNC_ID:
HGNC:4417

# Drug_Target_18_HPRD_ID:
09048

# Drug_Target_18_ID:
2856

# Drug_Target_18_Locus:
5q21

# Drug_Target_18_Molecular_Weight:
32669

# Drug_Target_18_Name:
Glucosamine-6-phosphate isomerase

# Drug_Target_18_Number_of_Residues:
289

# Drug_Target_18_PDB_ID:
1NE7

# Drug_Target_18_Pathway:
Not Available

# Drug_Target_18_Pfam_Domain_Function:
PF01182	Glucosamine_iso

# Drug_Target_18_Protein_Sequence:
>Glucosamine-6-phosphate isomerase
MKLIILEHYSQASEWAAKYIRNRIIQFNPGPEKYFTLGLPTGSTPLGCYKKLIEYYKNGD
LSFKYVKTFNMDEYVGLPRDHPESYHSFMWNNFFKHIDIHPENTHILDGNAVDLQAECDA
FEEKIKAAGGIELFVGGIGPDGHIAFNEPGSSLVSRTRVKTLAMDTILANARFFDGELTK
VPTMALTVGVGTVMDAREVMILITGAHKAFALYKAIEEGVNHMWTVSAFQQHPRTVFVCD
EDATLELKVKTVKYFKGLMLVHNKLVDPLYSIKEKETEKSQSSKKPYSD

# Drug_Target_18_Reaction:
D-glucosamine 6-phosphate + H2O = D-fructose 6-phosphate + NH3

# Drug_Target_18_Signals:
None

# Drug_Target_18_Specific_Function:
D-glucosamine 6-phosphate + H(2)O = D-fructose 6-phosphate + NH(3)

# Drug_Target_18_SwissProt_ID:
P46926

# Drug_Target_18_SwissProt_Name:
GNPI1_HUMAN

# Drug_Target_18_Synonyms:
EC 3.5.99.6
GNPDA
GlcN6P deaminase
Glucosamine-6- phosphate deaminase
Oscillin

# Drug_Target_18_Theoretical_pI:
6.91

# Drug_Target_18_Transmembrane_Regions:
None

# Drug_Target_19_Cellular_Location:
Cytoplasmic

# Drug_Target_19_Chromosome_Location:
Not Available

# Drug_Target_19_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_19_Essentiality:
Non-Essential

# Drug_Target_19_GenAtlas_ID:
Not Available

# Drug_Target_19_GenBank_ID_Gene:
AB024519

# Drug_Target_19_GenBank_ID_Protein:
4520330

# Drug_Target_19_GeneCard_ID:
Not Available

# Drug_Target_19_Gene_Name:
spoII

# Drug_Target_19_Gene_Sequence:
>1641 bp
ATGAAAAATCAGTTTCAATATTGTTGTATTGTCATTTTGTCTGTAGTGATGTTATTTGTA
TCATTATTAATTCCGCAAGCGAGTTCGGCAGCTGTAAATGGAAAAGGAATGAATCCAGAT
TACAAAGCATATTTAATGGCGCCATTAAAAAAGATACCGGAAGTAACAAATTGGGAGACA
TTTGAAAATGATTTACGATGGGCAAAACAAAATGGTTTTTATGCTATTACAGTTGATTTT
TGGTGGGGGGATATGGAAAAGAACGGAGATCAGCAATTTGATTTTTCATACGCACAGCGC
TTTGCTCAATCGGTAAAAAATGCAGGTATGAAAATGATTCCTATTATTTCCACACATCAG
TGCGGTGGAAATGTTGGGGATGATTGCAATGTACCAATTCCTTCATGGGTTTGGAATCAA
AAATCCGATGATAGCCTTTATTTTAAGTCTGAAACAGGAACTGTCAATAAAGAAACATTA
AATCCACTTGCTTCAGATGTAATTCGAAAGGAATATGGTGAACTATATACAGCATTCGCA
GCAGCTATGAAACCGTATAAAGATGTAATTGCAAAAATATATTTATCTGGAGGACCAGCT
GGTGAACTAAGATATCCTTCATATACAACTTCCGATGGGACAGGATATCCCTCACGTGGA
AAGTTTCAAGCGTATACAGAGTTTGCAAAATCTAAATTTCGTTTATGGGTATTAAATAAA
TATGGTTCTCTAAATGAAGTGAATAAAGCATGGGGCACGAAACTGATTTCAGAGTTAGCA
ATTTTACCACCAAGCGATGGGGAACAATTCTTAATGAATGGATATCTTTCTATGTATGGA
AAAGACTATTTAGAATGGTATCAGGGCATCTTGGAAAATCATACAAAATTAATTGGTGAA
TTAGCACATAACGCATTTGACACAACTTTCCAAGTACCAATTGGTGCAAAAATTGCAGGC
GTACATTGGCAATATAATAACCCAACAATACCTCATGGAGCTGAAAAGCCTGCAGGGTAT
AATGATTATAGCCATTTACTTGATGCTTTCAAAAGTGCAAAGCTAGATGTAACATTTACT
TGCTTAGAAATGACAGATAAAGGTAGTTATCCGGAATATTCAATGCCAAAAACATTGGTA
CAAAATATTGCAACATTAGCCAATGAAAAGGGAATTGTATTAAACGGTGAAAATGCTTTA
AGTATCGGAAATGAAGAAGAGTATAAAAGAGTTGCAGAAATGGCTTTCAATTATAATTTT
GCTGGATTTACGTTACTTCGTTATCAAGATGTAATGTATAACAATTCATTAATGGGGAAA
TTTAAAGATTTATTAGGTGTAACCCCTGTTATGCAAACGATTGTAGTAAAAAATGTTCCT
ACAACAATAGGAGATACTGTTTATATTACTGGGAATCGTGCGGAATTAGGAAGTTGGGAC
ACAAAACAGTATCCAATTCAATTATATTATGATTCTCATAGTAATGATTGGAGAGGAAAT
GTTGTGTTGCCAGCTGAAAGAAATATAGAATTTAAAGCATTTATTAAAAGTAAAGATGGA
ACGGTTAAATCATGGCAAACAATACAACAAAGTTGGAATCCAGTGCCACTAAAGACTACC
TCTCATACAAGTAGTTGGTAA

# Drug_Target_19_General_Function:
Involved in beta-amylase activity

# Drug_Target_19_General_References:
10353816	Mikami B, Adachi M, Kage T, Sarikaya E, Nanmori T, Shinke R, Utsumi S: Structure of raw starch-digesting Bacillus cereus beta-amylase complexed with maltose. Biochemistry. 1999 Jun 1;38(22):7050-61.
8434930	Nanmori T, Nagai M, Shimizu Y, Shinke R, Mikami B: Cloning of the beta-amylase gene from Bacillus cereus and characteristics of the primary structure of the enzyme. Appl Environ Microbiol. 1993 Feb;59(2):623-7.

# Drug_Target_19_HGNC_ID:
Not Available

# Drug_Target_19_HPRD_ID:
Not Available

# Drug_Target_19_ID:
3365

# Drug_Target_19_Locus:
Not Available

# Drug_Target_19_Molecular_Weight:
61629

# Drug_Target_19_Name:
Beta-amylase

# Drug_Target_19_Number_of_Residues:
546

# Drug_Target_19_PDB_ID:
1J12

# Drug_Target_19_Pathway:
Not Available

# Drug_Target_19_Pfam_Domain_Function:
PF00686	CBM_20
PF01373	Glyco_hydro_14

# Drug_Target_19_Protein_Sequence:
>Beta-amylase precursor
MKNQFQYCCIVILSVVMLFVSLLIPQASSAAVNGKGMNPDYKAYLMAPLKKIPEVTNWET
FENDLRWAKQNGFYAITVDFWWGDMEKNGDQQFDFSYAQRFAQSVKNAGMKMIPIISTHQ
CGGNVGDDCNVPIPSWVWNQKSDDSLYFKSETGTVNKETLNPLASDVIRKEYGELYTAFA
AAMKPYKDVIAKIYLSGGPAGELRYPSYTTSDGTGYPSRGKFQAYTEFAKSKFRLWVLNK
YGSLNEVNKAWGTKLISELAILPPSDGEQFLMNGYLSMYGKDYLEWYQGILENHTKLIGE
LAHNAFDTTFQVPIGAKIAGVHWQYNNPTIPHGAEKPAGYNDYSHLLDAFKSAKLDVTFT
CLEMTDKGSYPEYSMPKTLVQNIATLANEKGIVLNGENALSIGNEEEYKRVAEMAFNYNF
AGFTLLRYQDVMYNNSLMGKFKDLLGVTPVMQTIVVKNVPTTIGDTVYITGNRAELGSWD
TKQYPIQLYYDSHSNDWRGNVVLPAERNIEFKAFIKSKDGTVKSWQTIQQSWNPVPLKTT
SHTSSW

# Drug_Target_19_Reaction:
Hydrolysis of 1,4-alpha-D-glucosidic linkages in polysaccharides so as to remove successive maltose units from the non-reducing ends of the chains ALL_REAC (other) R02112 R06159(G)

# Drug_Target_19_Signals:
1-30

# Drug_Target_19_Specific_Function:
Hydrolysis of 1,4-alpha-D-glucosidic linkages in polysaccharides so as to remove successive maltose units from the non-reducing ends of the chains

# Drug_Target_19_SwissProt_ID:
P36924

# Drug_Target_19_SwissProt_Name:
AMYB_BACCE

# Drug_Target_19_Synonyms:
1,4-alpha-D-glucan maltohydrolase
Beta-amylase precursor
EC 3.2.1.2

# Drug_Target_19_Theoretical_pI:
6.72

# Drug_Target_19_Transmembrane_Regions:
None

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
PYGM

# Drug_Target_1_GenBank_ID_Gene:
M32598

# Drug_Target_1_GenBank_ID_Protein:
190784

# Drug_Target_1_GeneCard_ID:
PYGM

# Drug_Target_1_Gene_Name:
PYGM

# Drug_Target_1_Gene_Sequence:
>2529 bp
ATGTCCCGGCCCCTGTCAGACCAAGAGAAAAGAAAGCAAATCAGTGTGCGTGGCCTGGCC
GGCGTGGAGAACGTGACTGAGCTGAAAAAGAACTTCAACCGGCACCTGCATTTCACACTC
GTAAAGGACCGCAATGTGGCCACCCCACGAGACTACTACTTTGCTCTGGCCCATACCGTG
CGCGACCACCTCGTGGGGCGGTGGATCCGCACGCAGCAGCACTACTATGAGAAGGACCCC
AAGAGGATCTACTACCTGTCTTTAGAGTTCTATATGGGACGGACGCTACAGAACACCATG
GTGAACCTGGCCTTAGAGAATGCCTGTGACGAGGCCACCTACCAGCTGGGCCTGGACATG
GAGGAGCTGGAGGAAATTGAGGAGGATGCGGGGCTGGGCAACGGGGGCCTGGGCCGGCTG
GCAGCCTGCTTTCTTGACTCCATGGCAACACTGGGCCTGGCTGCCTATGGCTACGGGATT
CGCTATGAGTTTGGGATTTTTAACCAGAAGATCTCCGGGGGCTGGCAGATGGAGGAGGCC
GATGACTGGCTTCGCTACGGCAACCCCTGGGAGAAGGCCCGGCCCGAGTTCACGCTACCT
GTGCACTTCTACGGCCATGTGGAGCACACCAGCCAGGGTGCCAAGTGGGTGGACACACAG
GTGGTACTGGCCATGCCCTACGATACCCCGGTGCCTGGCTATCGCAACAATGTTGTCAAC
ACCATGCGCCTCTGGTCTGCCAAGGCTCCCAATGACTTCAACCTCAAGGACTTCAATGTC
GGTGGCTACATCCAGGCTGTGTTGGACCGAAACCTGGCGGAGAACATCTCTCGTGTCCTG
TACCCCAATGATAATTTCTTCGAAGGGAAGGAGCTGCGGCTGAAGCAGGAGTATTTCGTG
GTGGCTGCCACCCTCCAGGACATCATCCGTCGCTTCAAGTCTTCCAAGTTCGGCTGCCGT
GATCCCGTGCGCACGAACTTCGATGCCTTCCCAGATAAGGTGGCCATCCAGCTCAATGAC
ACCCACCCCTCCCTGGCCATCCCCGAGCTGATGAGGATCCTGGTGGACCTGGAACGGATG
GACTGGGACAAGGCGTGGGATGTGACAGTGAGGACCTGTGCCTACACCAACCACACGGTG
CTGCCCGAGGCCCTGGAGCGCTGGCCGGTGCACCTCTTGGAGACGCTGCTGCCGCGGCAC
CTCCAGATCATCTACGAGATCAACCAGCGCTTCCTCAACCGGGTGGCGGCCGCATTCCCA
GGGGACGTAGACCGGCTGCGGCGCATGTCGCTGGTGGAGGAGGGCGCAGTGAAGCGCATC
AACATGGCACACCTGTGCATCGCGGGGTCGCACGCCGTCAACGGTGTGGCCCGCATCCAC
TCGGAGATCCTCAAGAAGACCATCTTCAAAGACTTCTATGAGCTGGAGCCTCATAAGTTC
CAGAATAAGACCAACGGCATCACCCCTCGGCGCTGGCTGGTTCTGTGTAACCCCGGGCTG
GCAGAGGTCATTGCTGAGCGCATCGGGGAGGACTTCATCTCTGACCTGGACCAGCTGCGC
AAACTGCTCTCCTTTGTGGATGATGAAGCTTTCATTCGGGATGTGGCCAAAGTGAAGCAG
GAAAACAAGTTGAAGTTTGCTGCCTACCTAGAGAGGGAATACAAAGTCCACATCAACCCC
AACTCACTCTTCGACATCCAGGTGAAGCGGATTCACGAATATAAACGACAGCTCCTCAAC
TGCCTCCATGTCATCACCCTGTACAACCGCATCAAGAGGGAGCCCAATAAGTTTTTTGTG
CCTCGGACTGTGATGATTGGAGGGAAGGCTGCACCTGGGTACCACATGGCCAAGATGATC
ATCAGACTCGTCACAGCCATCGGGGATGTGGTCAACCATGACCCGGCAGTGGGTGACCGC
CTCCGTGTCATCTTCCTGGAGAACTACCGAGTCTCACTGGCCGAGAAAGTGATCCCAGCT
GCAGACCTCTCTGAGCAGATCTCCACTGCGGGCACTGAAGCCTCAGGCACCGGCAACATG
AAGTTCATGCTCAACGGGGCTCTGACCATTGGCACCATGGACGGGGCCAATGTGGAGATG
GCAGAAGAGGCGGGAGAGGAAAACTTCTTCATCTTTGGCATGCGGGTGGAGGATGTGGAT
AAGCTTGACCAAAGAGGGTACAATGCCCAGGAGTACTACGATCGCATTCCTGAGCTTCGG
CAGGTCATTGAGCAGCTGAGCAGTGGCTTCTTCTCCCCCAAACAACCCGACCTGTTCAAG
GACATTGTCAATATGCTCATGCACCATGACCGGTTTAAAGTCTTCGCAGATTATGAAGAC
TACATTAAATGCCAGGAGAAAGTCAGCGCCTGGTACAAGAACCCAAGAGAGTGGACGCGG
ATGGTGATCCGGAACATAGCCACTTCTGGCAAGTTCTCCAGTGACCGCACCATTGCCCAG
TATGCCCGGGAGATCTGGGGTGTGGAGCCTTCCCGCCAGCGCCTGCCAGCCCCGGATGAG
GCCATCTGA

# Drug_Target_1_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_1_General_References:
10382911	Andreu AL, Bruno C, Tamburino L, Gamez J, Shanske S, Cervera C, Navarro C, DiMauro S: A new mutation in the myophosphorylase gene (Asn684Tyr) in a Spanish patient with McArdle's disease. Neuromuscul Disord. 1999 May;9(3):171-3.
10382912	Rubio JC, Martin MA, Garcia A, Campos Y, Cabello A, Culebras JM, Arenas J: McArdle's disease associated with homozygosity for the missense mutation Gly204Ser of the myophosphorylase gene in a Spanish patient. Neuromuscul Disord. 1999 May;9(3):174-5.
10417800	Gamez J, Fernandez R, Bruno C, Andreu AL, Cervera C, Navarro C, Schwartz S, Dimauro S: A new mutation in the regulatory domain of the myophosphorylase gene affecting protein dimer contact. Muscle Nerve. 1999 Aug;22(8):1136-8.
10590419	Rubio JC, Martin MA, Campos Y, Auciello R, Cabello A, Arenas J: A missense mutation W797R in the myophosphorylase gene in a Spanish patient with McArdle's disease. Muscle Nerve. 2000 Jan;23(1):129-31.
10681080	Fernandez R, Navarro C, Andreu AL, Bruno C, Shanske S, Gamez J, Teijeira S, Hernandez I, Teijeiro A, Fernandez JM, Musumeci O, DiMauro S: A novel missense mutation (W797R) in the myophosphorylase gene in Spanish patients with McArdle disease. Arch Neurol. 2000 Feb;57(2):217-9.
10714589	Rubio JC, Martin MA, Campos Y, Cabello A, Arenas J: A missense mutation T487N in the myophosphorylase gene in a Spanish patient with McArdle's disease. Neuromuscul Disord. 2000 Feb;10(2):138-40.
10899452	Martin MA, Rubio JC, Campos Y, Ricoy JR, Cabello A, Arenas J: A homozygous missense mutation (A659D) in the myophosphorylase gene in a Spanish patient with McArdle's disease. Neuromuscul Disord. 2000 Aug;10(6):447-9.
11706962	Martin MA, Rubio JC, Buchbinder J, Fernandez-Hojas R, del Hoyo P, Teijeira S, Gamez J, Navarro C, Fernandez JM, Cabello A, Campos Y, Cervera C, Culebras JM, Andreu AL, Fletterick R, Arenas J: Molecular heterogeneity of myophosphorylase deficiency (McArdle's disease): a genotype-phenotype correlation study. Ann Neurol. 2001 Nov;50(5):574-81.
12031624	Bruno C, Lanzillo R, Biedi C, Iadicicco L, Minetti C, Santoro L: Two new mutations in the myophosphorylase gene in Italian patients with McArdle's disease. Neuromuscul Disord. 2002 Jun;12(5):498-500.
3447177	Burke J, Hwang P, Anderson L, Lebo R, Gorin F, Fletterick R: Intron/exon structure of the human gene for the muscle isozyme of glycogen phosphorylase. Proteins. 1987;2(3):177-87.
3466902	Gautron S, Daegelen D, Mennecier F, Dubocq D, Kahn A, Dreyfus JC: Molecular mechanisms of McArdle's disease (muscle glycogen phosphorylase deficiency). RNA and DNA analysis. J Clin Invest. 1987 Jan;79(1):275-81.
3840433	Hwang PK, See YP, Vincentini AM, Powers MA, Fletterick RJ, Crerar MM: Comparative sequence analysis of rat, rabbit, and human muscle glycogen phosphorylase cDNAs. Eur J Biochem. 1985 Oct 15;152(2):267-74.
7603523	Tsujino S, Shanske S, Nonaka I, DiMauro S: The molecular genetic basis of myophosphorylase deficiency (McArdle's disease). Muscle Nerve. 1995;3:S23-7.
8316268	Tsujino S, Shanske S, DiMauro S: Molecular genetic heterogeneity of myophosphorylase deficiency (McArdle's disease). N Engl J Med. 1993 Jul 22;329(4):241-5.
8535454	Tsujino S, Shanske S, Martinuzzi A, Heiman-Patterson T, DiMauro S: Two novel missense mutations (E654K, L396P) in Caucasian patients with myophosphorylase deficiency (McArdle's disease). Hum Mutat. 1995;6(3):276-7.
9506549	Vorgerd M, Kubisch C, Burwinkel B, Reichmann H, Mortier W, Tettenborn B, Pongratz D, Lindemuth R, Tegenthoff M, Malin JP, Kilimann MW: Mutation analysis in myophosphorylase deficiency (McArdle's disease). Ann Neurol. 1998 Mar;43(3):326-31.

# Drug_Target_1_HGNC_ID:
HGNC:9726

# Drug_Target_1_HPRD_ID:
01986

# Drug_Target_1_ID:
1152

# Drug_Target_1_Locus:
11q12-q13.2

# Drug_Target_1_Molecular_Weight:
97093

# Drug_Target_1_Name:
Glycogen phosphorylase, muscle form

# Drug_Target_1_Number_of_Residues:
842

# Drug_Target_1_PDB_ID:
1XL1

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00343	Phosphorylase

# Drug_Target_1_Protein_Sequence:
>Glycogen phosphorylase, muscle form
MSRPLSDQEKRKQISVRGLAGVENVTELKKNFNRHLHFTLVKDRNVATPRDYYFALAHTV
RDHLVGRWIRTQQHYYEKDPKRIYYLSLEFYMGRTLQNTMVNLALENACDEATYQLGLDM
EELEEIEEDAGLGNGGLGRLAACFLDSMATLGLAAYGYGIRYEFGIFNQKISGGWQMEEA
DDWLRYGNPWEKARPEFTLPVHFYGHVEHTSQGAKWVDTQVVLAMPYDTPVPGYRNNVVN
TMRLWSAKAPNDFNLKDFNVGGYIQAVLDRNLAENISRVLYPNDNFFEGKELRLKQEYFV
VAATLQDIIRRFKSSKFGCRDPVRTNFDAFPDKVAIQLNDTHPSLAIPELMRILVDLERM
DWDKAWDVTVRTCAYTNHTVLPEALERWPVHLLETLLPRHLQIIYEINQRFLNRVAAAFP
GDVDRLRRMSLVEEGAVKRINMAHLCIAGSHAVNGVARIHSEILKKTIFKDFYELEPHKF
QNKTNGITPRRWLVLCNPGLAEVIAERIGEDFISDLDQLRKLLSFVDDEAFIRDVAKVKQ
ENKLKFAAYLEREYKVHINPNSLFDIQVKRIHEYKRQLLNCLHVITLYNRIKREPNKFFV
PRTVMIGGKAAPGYHMAKMIIRLVTAIGDVVNHDPAVGDRLRVIFLENYRVSLAEKVIPA
ADLSEQISTAGTEASGTGNMKFMLNGALTIGTMDGANVEMAEEAGEENFFIFGMRVEDVD
KLDQRGYNAQEYYDRIPELRQVIEQLSSGFFSPKQPDLFKDIVNMLMHHDRFKVFADYED
YIKCQEKVSALYKNPREWTRMVIRNIATSGKFSSDRTIAQYAREIWGVEPSRQRLPAPDE
AI

# Drug_Target_1_Reaction:
(1,4-alpha-D-glucosyl)n + phosphate = (1,4-alpha-D-glucosyl)n-1 + alpha-D-glucose 1-phosphate

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Phosphorylase is an important allosteric enzyme in carbohydrate metabolism. Enzymes from different sources differ in their regulatory mechanisms and in their natural substrates. However, all known phosphorylases share catalytic and structural properties

# Drug_Target_1_SwissProt_ID:
P11217

# Drug_Target_1_SwissProt_Name:
PYGM_HUMAN

# Drug_Target_1_Synonyms:
EC 2.4.1.1
Myophosphorylase

# Drug_Target_1_Theoretical_pI:
7.03

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_20_Cellular_Location:
Isoform 1:Mitochondrion

# Drug_Target_20_Chromosome_Location:
Not Available

# Drug_Target_20_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_20_Essentiality:
Non-Essential

# Drug_Target_20_GenAtlas_ID:
NUDT9

# Drug_Target_20_GenBank_ID_Gene:
AY026252

# Drug_Target_20_GenBank_ID_Protein:
14160858

# Drug_Target_20_GeneCard_ID:
NUDT9

# Drug_Target_20_Gene_Name:
NUDT9

# Drug_Target_20_Gene_Sequence:
>1053 bp
ATGGCGGGACGCCTCCTGGGAAAGGCTTTAGCCGCGGTGTCTCTCTCTCTGGCCTTGGCC
TCTGTGACTATCAGGTCCTCGCGCTGCCGCGGCATCCAGGCGTTCAGAAACTCGTTTTCA
TCTTCTTGGTTTCATCTTAATACCAACGTCATGTCTGGTTCTAATGGTTCCAAAGAAAAT
TCTCACAATAAGGCTCGGACGTCTCCTTACCCAGGTTCAAAAGTTGAACGAAGCCAGGTT
CCTAATGAGAAAGTGGGCTGGCTTGTTGAGTGGCAAGACTATAAGCCTGTGGAATACACT
GCAGTCTCTGTCTTGGCTGGACCCAGGTGGGCAGATCCTCAGATCAGTGAAAGTAATTTT
TCTCCCAAGTTTAACGAAAAGGATGGGCATGTTGAGAGAAAGAGCAAGAATGGCCTGTAT
GAGATTGAAAATGGAAGACCGAGAAATCCTGCAGGACGGACTGGACTGGTGGGCCGGGGG
CTTTTGGGGCGATGGGGCCCAAATCACGCTGCAGATCCCATTATAACCAGATGGAAAAGG
GATAGCAGTGGAAATAAAATCATGCATCCTGTTTCTGGGAAGCATATCTTACAATTTGTT
GCAATAAAAAGGAAAGACTGTGGAGAATGGGCAATCCCAGGGGGGATGGTGGATCCAGGA
GAGAAGATTAGTGCCACACTGAAAAGAGAATTTGGTGAGGAAGCTCTCAACTCCTTACAG
AAAACCAGTGCTGAGAAGAGAGAAATAGAGGAAAAGTTGCACAAACTCTTCAGCCAAGAC
CACCTAGTGATATATAAGGGATATGTTGATGATCCTCGAAACACTGATAATGCATGGATG
GAGACAGAAGCTGTGAACTACCATGACGAAACAGGTGAGATAATGGATAATCTTATGCTA
GAAGCTGGAGATGATGCTGGAAAAGTGAAATGGGTGGACATCAATGATAAACTGAAGCTT
TATGCCAGTCACTCTCAATTCATCAAACTTGTGGCTGAGAAACGAGATGCACACTGGAGC
GAGGACTCTGAAGCTGACTGCCATGCGTTGTAG

# Drug_Target_20_General_Function:
Involved in hydrolase activity

# Drug_Target_20_General_References:
11385575	Perraud AL, Fleig A, Dunn CA, Bagley LA, Launay P, Schmitz C, Stokes AJ, Zhu Q, Bessman MJ, Penner R, Kinet JP, Scharenberg AM: ADP-ribose gating of the calcium-permeable LTRPC2 channel revealed by Nudix motif homology. Nature. 2001 May 31;411(6837):595-9.
12975309	Clark HF, Gurney AL, Abaya E, Baker K, Baldwin D, Brush J, Chen J, Chow B, Chui C, Crowley C, Currell B, Deuel B, Dowd P, Eaton D, Foster J, Grimaldi C, Gu Q, Hass PE, Heldens S, Huang A, Kim HS, Klimowski L, Jin Y, Johnson S, Lee J, Lewis L, Liao D, Mark M, Robbie E, Sanchez C, Schoenfeld J, Seshagiri S, Simmons L, Singh J, Smith V, Stinson J, Vagts A, Vandlen R, Watanabe C, Wieand D, Woods K, Xie MH, Yansura D, Yi S, Yu G, Yuan J, Zhang M, Zhang Z, Goddard A, Wood WI, Godowski P, Gray A: The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment. Genome Res. 2003 Oct;13(10):2265-70. Epub 2003 Sep 15.

# Drug_Target_20_HGNC_ID:
HGNC:8056

# Drug_Target_20_HPRD_ID:
09353

# Drug_Target_20_ID:
3525

# Drug_Target_20_Locus:
4q22.1

# Drug_Target_20_Molecular_Weight:
39125

# Drug_Target_20_Name:
ADP-ribose pyrophosphatase, mitochondrial

# Drug_Target_20_Number_of_Residues:
350

# Drug_Target_20_PDB_ID:
1QVJ

# Drug_Target_20_Pathway:
Not Available

# Drug_Target_20_Pfam_Domain_Function:
PF00293	NUDIX

# Drug_Target_20_Protein_Sequence:
>ADP-ribose pyrophosphatase, mitochondrial precursor
MAGRLLGKALAAVSLSLALASVTIRSSRCRGIQAFRNSFSSSWFHLNTNVMSGSNGSKEN
SHNKARTSPYPGSKVERSQVPNEKVGWLVEWQDYKPVEYTAVSVLAGPRWADPQISESNF
SPKFNEKDGHVERKSKNGLYEIENGRPRNPAGRTGLVGRGLLGRWGPNHAADPIITRWKR
DSSGNKIMHPVSGKHILQFVAIKRKDCGEWAIPGGMVDPGEKISATLKREFGEEALNSLQ
KTSAEKREIEEKLHKLFSQDHLVIYKGYVDDPRNTDNAWMETEAVNYHDETGEIMDNLML
EAGDDAGKVKWVDINDKLKLYASHSQFIKLVAEKRDAHWSEDSEADCHAL

# Drug_Target_20_Reaction:
ADP-ribose + H2O = AMP + D-ribose 5-phosphate

# Drug_Target_20_Signals:
None

# Drug_Target_20_Specific_Function:
Hydrolyzes ADP-ribose (ADPR) to AMP and ribose 5'- phosphate

# Drug_Target_20_SwissProt_ID:
Q9BW91

# Drug_Target_20_SwissProt_Name:
NUDT9_HUMAN

# Drug_Target_20_Synonyms:
ADP-ribose diphosphatase
ADP-ribose phosphohydrolase
ADP-ribose pyrophosphatase, mitochondrial precursor
ADPR-PPase
Adenosine diphosphoribose pyrophosphatase
EC 3.6.1.13
Nucleoside diphosphate- linked moiety X motif 9
Nudix motif 9

# Drug_Target_20_Theoretical_pI:
8.45

# Drug_Target_20_Transmembrane_Regions:
None

# Drug_Target_21_Cellular_Location:
Not Available

# Drug_Target_21_Chromosome_Location:
Not Available

# Drug_Target_21_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_21_Essentiality:
Non-Essential

# Drug_Target_21_GenAtlas_ID:
Not Available

# Drug_Target_21_GenBank_ID_Gene:
Not Available

# Drug_Target_21_GenBank_ID_Protein:
Not Available

# Drug_Target_21_GeneCard_ID:
Not Available

# Drug_Target_21_Gene_Name:
SMARCA5

# Drug_Target_21_Gene_Sequence:
Not Available

# Drug_Target_21_General_Function:
Not Available

# Drug_Target_21_General_References:
Not Available

# Drug_Target_21_HGNC_ID:
Not Available

# Drug_Target_21_HPRD_ID:
Not Available

# Drug_Target_21_ID:
7091

# Drug_Target_21_Locus:
Not Available

# Drug_Target_21_Molecular_Weight:
Not Available

# Drug_Target_21_Name:
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5

# Drug_Target_21_Number_of_Residues:
0

# Drug_Target_21_PDB_ID:
Not Available

# Drug_Target_21_Pathway:
Not Available

# Drug_Target_21_Pfam_Domain_Function:
Not Available

# Drug_Target_21_Protein_Sequence:
Not Available

# Drug_Target_21_Reaction:
Not Available

# Drug_Target_21_Signals:
Not Available

# Drug_Target_21_Specific_Function:
Not Available

# Drug_Target_21_SwissProt_ID:
O60264

# Drug_Target_21_SwissProt_Name:
SMCA5_HUMAN

# Drug_Target_21_Synonyms:
Not Available

# Drug_Target_21_Theoretical_pI:
Not Available

# Drug_Target_21_Transmembrane_Regions:
Not Available

# Drug_Target_22_Cellular_Location:
Periplasm

# Drug_Target_22_Chromosome_Location:
Not Available

# Drug_Target_22_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_22_Essentiality:
Non-Essential

# Drug_Target_22_GenAtlas_ID:
Not Available

# Drug_Target_22_GenBank_ID_Gene:
M57692

# Drug_Target_22_GenBank_ID_Protein:
1004352

# Drug_Target_22_GeneCard_ID:
Not Available

# Drug_Target_22_Gene_Name:
amyA

# Drug_Target_22_Gene_Sequence:
>2133 bp
ATGAAAAAAACGTTTAAATTGATATTGGTGCTGATGCTTTCACTTACACTTGTTTTTGGA
TTGACAGCACCAATACAGGCAGCTTCTGATACAGCAGTAAGTAATGTTGTCAATTACTCG
ACGGATGTAATTTATCAGATTGTCACTGATAGATTTGTTGATGGAAATACCAGCAACAAT
CCAACTGGTGATTTGTATGATCCAACACATACAAGTCTGAAAAAGTACTTTGGTGGAGAC
TGGCAGGGTATTATTAACAAGATAAATGATGGTTATCTAACAGGAATGGGTGTAACAGCA
ATTTGGATATCTCAGCCTGTAGAAAATATTTATGCAGTCTTACCTGATTCAACTTTTGGT
GGAAGTACATCGTACCATGGTTATTGGGCTCGTGATTTTAAGAGAACAAATCCATACTTT
GGAAGCTTTACTGATTTTCAAAATTTGATTAATACAGCTCATGCACATAACATAAAAGTA
ATTATCGATTTTGCACCAAATCATACTTCACCTGCATCTGAAACCGATCCGACTTATGCT
GAAAATGGAAGGCTATACGACAATGGAACATTACTTGGTGGGTATACAAATGATACAAAC
GGGTATTTTCATCATTATGGAGGAACAGATTTTTCATCTTATGAAGATGGCATTTATCGT
AACTTATTTGATTTAGCAGATTTAAATCAACAGAATAGTACAATCGATTCATACTTAAAA
TCAGCAATTAAGGTGTGGCTCGATATGGGAATAGACGGTATACGTCTAGATGCTGTAAAA
CATATGCCGTTTGGATGGCAGAAGAATTTTATGGATAGCATATTGAGCTATAGGCCTGTA
TTTACATTTGGAGAGTGGTTTCTTGGAACGAATGAAATTGATGTAAATAACACATACTTT
GCAAATGAAAGCGGTATGAGTCTTTTGGACTTTAGGTTTTCTCAAAAAGTGAGGCAGGTA
TTTAGGGATAATACGGATACTATGTATGGACTTGATTCAATGATTCAATCAACTGCATCT
GATTATAATTTTATAAATGATATGGTTACTTTTATTGATAATCATGATATGGATAGATTC
TATAATGGTGGTTCTACTCGTCCAGTTGAACAAGCATTAGCATTTACTTTGACTTCGAGG
GGAGTACCTGCTATATATTATGGAACAGAACAGTATATGACAGGCAATGGAGACCCTTAT
AATAGAGCTATGATGACCTCATTTAATACATCAACTACAGCATATAATGTAATTAAAAAA
CTTGCTCCTTTGCGCAAATCTAATCCTGCAATTGCTTATGGTACTACTCAGCAACGTTGG
ATAAACAATGATGTTTATATATATGAAAGAAAATTTGGGAATAATGTTGCTCTTGTTGCT
ATAAATAGAAATCTTTCAACAAGTTATAATATAACAGGACTGTATACAGCGCTTCCTGCT
GGTACTTATACTGATGTTCTTGGTGGACTTTTAAATGGTAATAGTATTTCTGTCGCGAGT
GATGGTTCTGTAACACCATTTACACTTAGTGCCGGTGAAGTTGCAGTATGGCAGTATGTA
AGTTCAAGTAATTCTCCGTTGATAGGACATGTTGGGCCAACAATGACAAAAGCAGGGCAA
ACTATAACAATAGATGGAAGAGGTTTTGGTACGACATCAGGACAAGTTTTGTTTGGTTCG
ACGGCTGGTACTATTGTCTCTTGGGATGATACAGAGGTAAAAGTAAAAGTTCCTTCGGTG
ACACCTGGTAAATATAATATATCATTAAAAACTTCAAGTGGTGCTACAAGCAATACTTAT
AATAATATTAACATTCTTACAGGCAATCAGATATGTGTTAGATTTGTTGTAAATAATGCA
AGTACAGTGTATGGAGAGAATGTTTATCTTACTGGTAATGTAGCTGAATTGGGAAACTGG
GATACGTCAAAAGCAATAGGACCAATGTTTAATCAGGTAGTATATCAGTATCCTACATGG
TATTATGATGTAAGTGTTCCAGCGGGTACAACAATACAATTTAAGTTTATAAAGAAAAAT
GGCAATACGATAACATGGGAAGGTGGTAGTAACCATACTTATACAGTTCCATCATCTAGT
ACAGGTACTGTAATTGTAAACTGGCAACAATAG

# Drug_Target_22_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_22_General_References:
1854207	Bahl H, Burchhardt G, Spreinat A, Haeckel K, Wienecke A, Schmidt B, Antranikian G: alpha-Amylase of Clostridium thermosulfurogenes EM1: nucleotide sequence of the gene, processing of the enzyme, and comparison of other alpha-amylases. Appl Environ Microbiol. 1991 May;57(5):1554-9.
1874408	Bahl H, Burchhardt G, Wienecke A: Nucleotide sequence of two Clostridium thermosulfurogenes EM1 genes homologous to Escherichia coli genes encoding integral membrane components of binding protein-dependent transport systems. FEMS Microbiol Lett. 1991 Jun 1;65(1):83-7.
7747949	Wind RD, Liebl W, Buitelaar RM, Penninga D, Spreinat A, Dijkhuizen L, Bahl H: Cyclodextrin formation by the thermostable alpha-amylase of Thermoanaerobacterium thermosulfurigenes EM1 and reclassification of the enzyme as a cyclodextrin glycosyltransferase. Appl Environ Microbiol. 1995 Apr;61(4):1257-65.
8604143	Knegtel RM, Wind RD, Rozeboom HJ, Kalk KH, Buitelaar RM, Dijkhuizen L, Dijkstra BW: Crystal structure at 2.3 A resolution and revised nucleotide sequence of the thermostable cyclodextrin glycosyltransferase from Thermonanaerobacterium thermosulfurigenes EM1. J Mol Biol. 1996 Mar 1;256(3):611-22.
9488711	Wind RD, Uitdehaag JC, Buitelaar RM, Dijkstra BW, Dijkhuizen L: Engineering of cyclodextrin product specificity and pH optima of the thermostable cyclodextrin glycosyltransferase from Thermoanaerobacterium thermosulfurigenes EM1. J Biol Chem. 1998 Mar 6;273(10):5771-9.

# Drug_Target_22_HGNC_ID:
Not Available

# Drug_Target_22_HPRD_ID:
Not Available

# Drug_Target_22_ID:
3207

# Drug_Target_22_Locus:
Not Available

# Drug_Target_22_Molecular_Weight:
78418

# Drug_Target_22_Name:
Cyclomaltodextrin glucanotransferase

# Drug_Target_22_Number_of_Residues:
710

# Drug_Target_22_PDB_ID:
1CIU

# Drug_Target_22_Pathway:
Not Available

# Drug_Target_22_Pfam_Domain_Function:
PF00128	Alpha-amylase
PF00686	CBM_20
PF01833	TIG
PF02806	Alpha-amylase_C

# Drug_Target_22_Protein_Sequence:
>Cyclomaltodextrin glucanotransferase precursor
MKKTFKLILVLMLSLTLVFGLTAPIQAASDTAVSNVVNYSTDVIYQIVTDRFVDGNTSNN
PTGDLYDPTHTSLKKYFGGDWQGIINKINDGYLTGMGVTAIWISQPVENIYAVLPDSTFG
GSTSYHGYWARDFKRTNPYFGSFTDFQNLINTAHAHNIKVIIDFAPNHTSPASETDPTYA
ENGRLYDNGTLLGGYTNDTNGYFHHYGGTDFSSYEDGIYRNLFDLADLNQQNSTIDSYLK
SAIKVWLDMGIDGIRLDAVKHMPFGWQKNFMDSILSYRPVFTFGEWFLGTNEIDVNNTYF
ANESGMSLLDFRFSQKVRQVFRDNTDTMYGLDSMIQSTASDYNFINDMVTFIDNHDMDRF
YNGGSTRPVEQALAFTLTSRGVPAIYYGTEQYMTGNGDPYNRAMMTSFNTSTTAYNVIKK
LAPLRKSNPAIAYGTTQQRWINNDVYIYERKFGNNVALVAINRNLSTSYNITGLYTALPA
GTYTDVLGGLLNGNSISVASDGSVTPFTLSAGEVAVWQYVSSSNSPLIGHVGPTMTKAGQ
TITIDGRGFGTTSGQVLFGSTAGTIVSWDDTEVKVKVPSVTPGKYNISLKTSSGATSNTY
NNINILTGNQICVRFVVNNASTVYGENVYLTGNVAELGNWDTSKAIGPMFNQVVYQYPTW
YYDVSVPAGTTIQFKFIKKNGNTITWEGGSNHTYTVPSSSTGTVIVNWQQ

# Drug_Target_22_Reaction:
Cyclizes part of a 1,4-alpha-D-glucan chain by formation of a 1,4-alpha-D-glucosidic bond

# Drug_Target_22_Signals:
1-27

# Drug_Target_22_Specific_Function:
Degrades starch to alpha-, beta-, and gamma- cyclodextrins, as well as linear sugars

# Drug_Target_22_SwissProt_ID:
P26827

# Drug_Target_22_SwissProt_Name:
CDGT_THETU

# Drug_Target_22_Synonyms:
CGTase
Cyclodextrin-glycosyltransferase
Cyclomaltodextrin glucanotransferase precursor
EC 2.4.1.19

# Drug_Target_22_Theoretical_pI:
5.44

# Drug_Target_22_Transmembrane_Regions:
None

# Drug_Target_23_Cellular_Location:
Secreted protein

# Drug_Target_23_Chromosome_Location:
Not Available

# Drug_Target_23_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_23_Essentiality:
Non-Essential

# Drug_Target_23_GenAtlas_ID:
Not Available

# Drug_Target_23_GenBank_ID_Gene:
M11118

# Drug_Target_23_GenBank_ID_Protein:
153000

# Drug_Target_23_GeneCard_ID:
Not Available

# Drug_Target_23_Gene_Name:
entB

# Drug_Target_23_Gene_Sequence:
>801 bp
ATGTATAAGAGATTATTTATTTCACATGTAATTTTGATATTCGCACTGATATTAGTTATT
TCTACACCCAACGTTTTAGCAGAGAGTCAACCAGATCCTAAACCAGATGAGTTGCACAAA
TCGAGTAAATTCACTGGTTTGATGGAAAATATGAAAGTTTTGTATGATGATAATCATGTA
TCAGCAATAAACGTTAAATCTATAGATCAATTTCTATACTTTGACTTAATATATTCTATT
AAGGACACTAAGTTAGGGAATTATGATAATGTTCGAGTCGAATTTAAAAACAAAGATTTA
GCTGATAAATACAAAGATAAATACGTAGATGTGTTTGGAGCTAATTATTATTATCAATGT
TATTTTTCTAAAAAAACGAATGATATTAATTCGCATCAAACTGACAAACGAAAAACTTGT
ATGTATGGTGGTGTAACTGAGCATAATGGAAACCAATTAGATAAATATAGAAGTATTACT
GTTCGGGTATTTGAAGATGGTAAAAATTTATTATCTTTTGACGTACAAACTAATAAGAAA
AAGGTGACTGCTCAAGAATTAGATTACCTAACTCGTCACTATTTGGTGAAAAATAAAAAA
CTCTATGAATTTAACAACTCGCCTTATGAAACGGGATATATTAAATTTATAGAAAATGAG
AATAGCTTTTGGTATGACATGATGCCTGCACCAGGAGATAAATTTGACCAATCTAAATAT
TTAATGATGTACAATGACAATAAAATGGTTGATTCTAAAGATGTGAAGATTGAAGTTTAT
CTTACGACAAAGAAAAAGTGA

# Drug_Target_23_General_Function:
Not Available

# Drug_Target_23_General_References:
1436058	Swaminathan S, Furey W, Pletcher J, Sax M: Crystal structure of staphylococcal enterotoxin B, a superantigen. Nature. 1992 Oct 29;359(6398):801-6.
3898073	Ranelli DM, Jones CL, Johns MB, Mussey GJ, Khan SA: Molecular cloning of staphylococcal enterotoxin B gene in Escherichia coli and Staphylococcus aureus. Proc Natl Acad Sci U S A. 1985 Sep;82(17):5850-4.
3957869	Jones CL, Khan SA: Nucleotide sequence of the enterotoxin B gene from Staphylococcus aureus. J Bacteriol. 1986 Apr;166(1):29-33.
5470821	Huang IY, Bergdoll MS: The primary structure of staphylococcal enterotoxin B. 3. The cyanogen bromide peptides of reduced and aminoethylated enterotoxin B, and the complete amino acid sequence. J Biol Chem. 1970 Jul 25;245(14):3518-25.
8152483	Jardetzky TS, Brown JH, Gorga JC, Stern LJ, Urban RG, Chi YI, Stauffacher C, Strominger JL, Wiley DC: Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature. 1994 Apr 21;368(6473):711-8.
9514739	Papageorgiou AC, Tranter HS, Acharya KR: Crystal structure of microbial superantigen staphylococcal enterotoxin B at 1.5 A resolution: implications for superantigen recognition by MHC class II molecules and T-cell receptors. J Mol Biol. 1998 Mar 20;277(1):61-79.
9881971	Li H, Llera A, Tsuchiya D, Leder L, Ysern X, Schlievert PM, Karjalainen K, Mariuzza RA: Three-dimensional structure of the complex between a T cell receptor beta chain and the superantigen staphylococcal enterotoxin B. Immunity. 1998 Dec;9(6):807-16.

# Drug_Target_23_HGNC_ID:
Not Available

# Drug_Target_23_HPRD_ID:
Not Available

# Drug_Target_23_ID:
3547

# Drug_Target_23_Locus:
Not Available

# Drug_Target_23_Molecular_Weight:
31436

# Drug_Target_23_Name:
Enterotoxin type B

# Drug_Target_23_Number_of_Residues:
266

# Drug_Target_23_PDB_ID:
1D5M

# Drug_Target_23_Pathway:
Not Available

# Drug_Target_23_Pfam_Domain_Function:
PF01123	Stap_Strp_toxin
PF02876	Stap_Strp_tox_C

# Drug_Target_23_Protein_Sequence:
>Enterotoxin type B precursor
MYKRLFISHVILIFALILVISTPNVLAESQPDPKPDELHKSSKFTGLMENMKVLYDDNHV
SAINVKSIDQFLYFDLIYSIKDTKLGNYDNVRVEFKNKDLADKYKDKYVDVFGANYYYQC
YFSKKTNDINSHQTDKRKTCMYGGVTEHNGNQLDKYRSITVRVFEDGKNLLSFDVQTNKK
KVTAQELDYLTRHYLVKNKKLYEFNNSPYETGYIKFIENENSFWYDMMPAPGDKFDQSKY
LMMYNDNKMVDSKDVKIEVYLTTKKK

# Drug_Target_23_Reaction:
Not Available

# Drug_Target_23_Signals:
1-27

# Drug_Target_23_Specific_Function:
Staphylococcal enterotoxins cause the intoxication staphylococcal food poisoning syndrome. The illness characterized by high fever, hypotension, diarrhea, shock, and in some cases death

# Drug_Target_23_SwissProt_ID:
P01552

# Drug_Target_23_SwissProt_Name:
ETXB_STAAU

# Drug_Target_23_Synonyms:
Enterotoxin type B precursor
SEB

# Drug_Target_23_Theoretical_pI:
8.94

# Drug_Target_23_Transmembrane_Regions:
None

# Drug_Target_24_Cellular_Location:
Secreted protein

# Drug_Target_24_Chromosome_Location:
Not Available

# Drug_Target_24_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_24_Essentiality:
Non-Essential

# Drug_Target_24_GenAtlas_ID:
AMY1A

# Drug_Target_24_GenBank_ID_Gene:
M18786

# Drug_Target_24_GenBank_ID_Protein:
178585

# Drug_Target_24_GeneCard_ID:
AMY1A

# Drug_Target_24_Gene_Name:
AMY1A

# Drug_Target_24_Gene_Sequence:
>1536 bp
ATGAAGCTCTTTTGGTTGCTTTTCACCATTGGGTTCTGCTGGGCTCAGTATTCCTCAAAT
ACACAACAAGGACGAACATCTATTGTTCATCTGTTTGAATGGCGATGGGTTGATATTGCT
CTTGAATGTGAGCGATATTTAGCTCCCAAGGGATTTGGAGGGGTTCAGGTCTCTCCACCA
AATGAAAATGTTGCCATTCACAACCCTTTCAGACCTTGGTGGGAAAGATACCAACCAGTT
AGCTATAAATTATGCACAAGATCTGGAAATGAAGATGAATTTAGAAACATGGTGACTAGA
TGCAACAATGTTGGGGTTCGTATTTATGTGGATGCTGTAATTAATCATATGTGTGGTAAT
GCTGTGAGTGCAGGAACAAGCAGTACCTGTGGAAGTTACTTCAACCCTGGAAGTAGGGAC
TTTCCAGCAGTCCCATATTCTGGATGGGATTTTAATGATGGTAAATGTAAAACTGGAAGT
GGAGATATCGAGAACTATAATGATGCTACTCAGGTCAGAGATTGTCGTCTGTCTGGTCTT
CTCGATCTTGCACTGGGGAAGGATTATGTGCGTTCTAAGATTGCCGAATATATGAACCAT
CTCATTGACATTGGTGTTGCAGGGTTCAGAATTGATGCTTCCAAGCACATGTGGCCTGGA
GACATAAAGGCAATTTTGGACAAACTGCATAATCTAAACAGTAACTGGTTCCCGGAAGGT
AGTAAACCTTTCATTTACCAGGAGGTAATTGATCTGGGTGGTGAGCCAATTAAAAGCAGT
GACTACTTTGGTAATGGCCGGGTGACAGAATTCAAGTATGGTGCAAAACTCGGCACAGTT
ATTCGCAAGTGGAATGGAGAGAAGATGTCTTACTTAAAGAACTGGGGAGAAGGTTGGGGT
TTCATGCCTTCTGACAGAGCGCTTGTCTTTGTGGATAACCATGACAATCAACGAGGACAT
GGCGCTGGAGGAGCCTCTATACTTACCTTCTGGGATGCTAGGCTGTACAAAATGGCAGTT
GGATTTATGCTTGCTCATCCTTATGGATTTACACGAGTAATGTCAAGCTACCGTTGGCCA
AGATATTTTGAAAATGGAAANGATGTTAATGATTGGGTTGGGCCACCAAATGATAATGGA
GTAACTAAAGAAGTTACTATTAATCCAGACACTACTTGTGGCAATGACTGGGTCTGTGAA
CATCGATGGCGCCAAATAAGGAACATGGTTAATTTCCGCAATGTAGTGGATGGCCAGCCT
TTTACAAACTGGTATGATAATGGGAGCAACCAAGTGGCTTTTGGGAGAGGAAACAGAGGA
TTCATTGTTTTCAACAATGATGACTGGACATTTTCTTTAACTTTGCAAACTGGTCTTCCT
GCTGGCACATACTGTGATGTCATTTCTGGAGATAAAATTAATGGCAACTGCACAGGCATT
AAAATCTACGTTTCTGATGATGGCAAAGCTCATTTTTCTATTAGTAACTCTGCTGAAGAT
CCATTTATTGCAATTCATGCTGAATCTAAATTGTAA

# Drug_Target_24_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_24_General_References:
12527308	Ramasubbu N, Ragunath C, Mishra PJ: Probing the role of a mobile loop in substrate binding and enzyme activity of human salivary amylase. J Mol Biol. 2003 Jan 31;325(5):1061-76.
1710976	Bank RA, Hettema EH, Arwert F, Amerongen AV, Pronk JC: Electrophoretic characterization of posttranslational modifications of human parotid salivary alpha-amylase. Electrophoresis. 1991 Jan;12(1):74-9.
2423416	Nishide T, Nakamura Y, Emi M, Yamamoto T, Ogawa M, Mori T, Matsubara K: Primary structure of human salivary alpha-amylase gene. Gene. 1986;41(2-3):299-304.
2452973	Gumucio DL, Wiebauer K, Caldwell RM, Samuelson LC, Meisler MH: Concerted evolution of human amylase genes. Mol Cell Biol. 1988 Mar;8(3):1197-205.
6610603	Nishide T, Emi M, Nakamura Y, Matsubara K: Corrected sequences of cDNAs for human salivary and pancreatic alpha-amylases [corrected] Gene. 1984 May;28(2):263-70.

# Drug_Target_24_HGNC_ID:
HGNC:474

# Drug_Target_24_HPRD_ID:
00096

# Drug_Target_24_ID:
3030

# Drug_Target_24_Locus:
1p21

# Drug_Target_24_Molecular_Weight:
57768

# Drug_Target_24_Name:
Salivary alpha-amylase

# Drug_Target_24_Number_of_Residues:
511

# Drug_Target_24_PDB_ID:
1MFV

# Drug_Target_24_Pathway:
Not Available

# Drug_Target_24_Pfam_Domain_Function:
PF00128	Alpha-amylase
PF02806	Alpha-amylase_C

# Drug_Target_24_Protein_Sequence:
>Salivary alpha-amylase precursor
MKLFWLLFTIGFCWAQYSSNTQQGRTSIVHLFEWRWVDIALECERYLAPKGFGGVQVSPP
NENVAIHNPFRPWWERYQPVSYKLCTRSGNEDEFRNMVTRCNNVGVRIYVDAVINHMCGN
AVSAGTSSTCGSYFNPGSRDFPAVPYSGWDFNDGKCKTGSGDIENYNDATQVRDCRLSGL
LDLALGKDYVRSKIAEYMNHLIDIGVAGFRIDASKHMWPGDIKAILDKLHNLNSNWFPEG
SKPFIYQEVIDLGGEPIKSSDYFGNGRVTEFKYGAKLGTVIRKWNGEKMSYLKNWGEGWG
FMPSDRALVFVDNHDNQRGHGAGGASILTFWDARLYKMAVGFMLAHPYGFTRVMSSYRWP
RYFENGKDVNDWVGPPNDNGVTKEVTINPDTTCGNDWVCEHRWRQIRNMVNFRNVVDGQP
FTNWYDNGSNQVAFGRGNRGFIVFNNDDWTFSLTLQTGLPAGTYCDVISGDKINGNCTGI
KIYVSDDGKAHFSISNSAEDPFIAIHAESKL

# Drug_Target_24_Reaction:
Endohydrolysis of 1,4-alpha-D-glucosidic linkages in polysaccharides containing three or more 1,4-alpha-linked D-glucose units ALL_REAC (other) R02108 R06209(G)

# Drug_Target_24_Signals:
1-15

# Drug_Target_24_Specific_Function:
Endohydrolysis of 1,4-alpha-D-glucosidic linkages in oligosaccharides and polysaccharides

# Drug_Target_24_SwissProt_ID:
P04745

# Drug_Target_24_SwissProt_Name:
AMY1_HUMAN

# Drug_Target_24_Synonyms:
1,4-alpha-D-glucan glucanohydrolase
EC 3.2.1.1
Salivary alpha-amylase precursor

# Drug_Target_24_Theoretical_pI:
6.92

# Drug_Target_24_Transmembrane_Regions:
None

# Drug_Target_25_Cellular_Location:
Not Available

# Drug_Target_25_Chromosome_Location:
Not Available

# Drug_Target_25_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_25_Essentiality:
Non-Essential

# Drug_Target_25_GenAtlas_ID:
Not Available

# Drug_Target_25_GenBank_ID_Gene:
X06791

# Drug_Target_25_GenBank_ID_Protein:
41964

# Drug_Target_25_GeneCard_ID:
Not Available

# Drug_Target_25_Gene_Name:
malP

# Drug_Target_25_Gene_Sequence:
>2394 bp
ATGTCACAACCTATTTTTAACGATAAGCAATTTCAGGAAGCGCTTTCACGTCAGTGGCAG
CGTTATGGCTTAAATTCTGCGGCTGAAATGACTCCTCGCCAGTGGTGGCTAGCAGTGAGT
GAAGCACTGGCCGAAATGCTGCGTGCTCAGCCATTCGCCAAGCCGGTGGCGAATCAGCGA
CATGTTAACTACATCTCAATGGAGTTTTTGATTGGTCGCCTGACGGGCAACAACCTGTTG
AATCTCGGCTGGTATCAGGATGTACAGGATTCGTTGAAGGCTTATGACATCAATCTGACG
GACCTGCTGGAAGAAGAGATCGACCCGGCGCTGGGTAACGGTGGTCTGGGACGTCTGGCG
GCGTGCTTCCTCGACTCAATGGCAACTGTCGGTCAGTCTGCGACGGGTTACGGTCTGAAC
TATCAATATGGTTTGTTCCGCCAGTCTTTTGTCGATGGCAAACAGGTTGAAGCGCCGGAT
GACTGGCATCGCAGTAACTACCCGTGGTTCCGCCACAACGAAGCACTGGATGTGCAGGTA
GGGATTGGCGGTAAAGTGACGAAAGACGGACGCTGGGAGCCGGAGTTTACCATTACCGGT
CAAGCGTGGGATCTCCCCGTTGTCGGCTATCGTAATGGCGTGGCGCAGCCGCTGCGTCTG
TGGCAGGCGACGCACGCGCATCCGTTTGATCTGACTAAATTTAACGACGGTGATTTCTTG
CGTGCCGAACAGCAGGGCATCAATGCGGAAAAACTGACCAAAGTTCTCTATCCAAACGAC
AACCATACTGCCGGTAAAAAGCTGCGCCTGATGCAGCAATACTTCCAGTGTGCCTGTTCG
GTAGCGGATATTTTGCGTCGCCATCATCTGGCGGGGCGTGAACTGCACGAACTGGCGGAT
TACGAAGTTATTCAGCTGAACGATACCCACCCAACTATCGCGATTCCAGAACTGCTGCGC
GTGCTGATCGACGAGCACCAGATGAGCTGGGATGACGCTTGGGCCATTACCAGCAAAACT
TTCGCTTACACCAACCATACCCTGATGCCAGAAGCGCTGGAACGCTGGGATGTGAAACTG
GTGAAAGGCTTACTGCCGCGCCACATGCAGATTATTAACGAAATTAATACTCGCTTTAAA
ACGCTGGTAGAGAAAACCTGGCCGGGCGATGAAAAAGTGTGGGCCAAACTGGCGGTGGTG
CACGACAAACAAGTGCATATGGCGAACCTGTGTGTGGTTGGCGGTTTCGCGGTGAACGGT
GTTGCGGCGCTGCACTCGGATCTGGTGGTGAAAGATCTGTTCCCGGAATATCACCAGCTA
TGGCCGAACAAATTCCATAACGTCACCAACGGTATTACCCCACGTCGCTGGATCAAACAG
TGCAACCCGGCACTGGCGGCTCTGTTGGATAAATCACTGCAAAAAGAGTGGGCTAACGAT
CTCGATCAGCTGATCAATCTGGTTAAATTGGCTGATGATGCGAAATTCCGTGACCTTTAT
CGCGTGATCAAGCAGGCGAATAAAGTCCGTCTGGCGGAGTTTGTGAAAGTTCGTACCGGT
ATTGACATCAATCCACAGGCGATTTTCGATATTCAGATCAAACGTTTGCACGAGTACAAA
CGCCAGCACCTGAATCTGCTGCATATTCTGGCGTTGTACAAAGAAATTCGTGAAAACCCG
CAGGCTGATCGCGTACCGCGCGTCTTCCTCTTCGGCGCGAAAGCGGCACCGGGCTACTAC
CTGGCTAAGAATATTATCTTTGCGATCAACAAAGTGGCTGACGTGATCAACAACGATCCG
CTGGTTGGCGATAAGTTGAAGGTGGTGTTCCTGCCGGATTATTGCGTTTCGGCGGCGGAA
AAACTGATCCCGGCGGCGGATATCTCCGAACAAATTTCGACTGCAGGTAAAGAAGCTTCC
GGTACCGGCAATATGAAACTGGCGCTCAATGGTGCGCTTACTGTCGGTACGCTGGATGGG
GCGAACGTTGAAATCGCCGAGAAAGTCGGTGAAGAAAATATCTTTATTTTTGGTCATACG
GTGAAACAAGTGAAGGCAATTCTGGCCAAAGGCTACGACCCGGTGAAATGGCGGAAGAAA
GATAAGGTGCTGGACGCAGTATTGAAAGAGCTGGAAAGCGGTAAATACAGCGACGGCGAT
AAGCATGCCTTCGACCAGATGCTGCACAGTATCGGCAAACAGGGCGGCGATCCGTATCTG
GTGATGGCGGATTTCGCAGCCTATGTAGAGGCACAAAAGCAGGTGGATGTGCTGTACCGC
GACCAGGAGGCCTGGACTCGCGCGGCGATCCTCAATACCGCCCGCTGCGGTATGTTTAGC
TCGGATCGCTCTATTCGCGATTATCAGGCTCGTATCTGGCAGGCAAAACGCTAA

# Drug_Target_25_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_25_General_References:
10220320	O'Reilly M, Watson KA, Johnson LN: The crystal structure of the Escherichia coli maltodextrin phosphorylase-acarbose complex. Biochemistry. 1999 Apr 27;38(17):5337-45.
10469642	Watson KA, McCleverty C, Geremia S, Cottaz S, Driguez H, Johnson LN: Phosphorylase recognition and phosphorolysis of its oligosaccharide substrate: answers to a long outstanding question. EMBO J. 1999 Sep 1;18(17):4619-32.
2845225	Pugsley AP, Dubreuil C: Molecular characterization of malQ, the structural gene for the Escherichia coli enzyme amylomaltase. Mol Microbiol. 1988 Jul;2(4):473-9.
3037809	Palm D, Goerl R, Weidinger G, Zeier R, Fischer B, Schinzel R: E. coli maltodextrin phosphorylase: primary structure and deletion mapping of the C-terminal site. Z Naturforsch [C]. 1987 Apr;42(4):394-400.
3155826	Palm D, Goerl R, Burger KJ: Evolution of catalytic and regulatory sites in phosphorylases. Nature. 1985 Feb 7-13;313(6002):500-2.
6283313	Debarbouille M, Cossart P, Raibaud O: A DNA sequence containing the control sites for gene malT and for the malPQ operon. Mol Gen Genet. 1982;185(1):88-92.
6339728	Raibaud O, Debarbouille M, Schwartz M: Use of deletions created in vitro to map transcriptional regulatory signals in the malA region of Escherichia coli. J Mol Biol. 1983 Jan 25;163(3):395-408.
6986282	Schiltz E, Palm D, Klein HW: N-terminal sequences of Escherichia coli and potato phosphorylase. FEBS Lett. 1980 Jan 1;109(1):59-62.
9009262	Watson KA, Schinzel R, Palm D, Johnson LN: The crystal structure of Escherichia coli maltodextrin phosphorylase provides an explanation for the activity without control in this basic archetype of a phosphorylase. EMBO J. 1997 Jan 2;16(1):1-14.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_25_HGNC_ID:
Not Available

# Drug_Target_25_HPRD_ID:
Not Available

# Drug_Target_25_ID:
3091

# Drug_Target_25_Locus:
Not Available

# Drug_Target_25_Molecular_Weight:
90523

# Drug_Target_25_Name:
Maltodextrin phosphorylase

# Drug_Target_25_Number_of_Residues:
797

# Drug_Target_25_PDB_ID:
1QM5

# Drug_Target_25_Pathway:
Not Available

# Drug_Target_25_Pfam_Domain_Function:
PF00343	Phosphorylase

# Drug_Target_25_Protein_Sequence:
>Maltodextrin phosphorylase
MSQPIFNDKQFQEALSRQWQRYGLNSAAEMTPRQWWLAVSEALAEMLRAQPFAKPVANQR
HVNYISMEFLIGRLTGNNLLNLGWYQDVQDSLKAYDINLTDLLEEEIDPALGNGGLGRLA
ACFLDSMATVGQSATGYGLNYQYGLFRQSFVDGKQVEAPDDWHRSNYPWFRHNEALDVQV
GIGGKVTKDGRWEPEFTITGQAWDLPVVGYRNGVAQPLRLWQATHAHPFDLTKFNDGDFL
RAEQQGINAEKLTKVLYPNDNHTAGKKLRLMQQYFQCACSVADILRRHHLAGRKLHELAD
YEVIQLNDTHPTIAIPELLRVLIDEHQMSWDDAWAITSKTFAYTNHTLMPEALERWDVKL
VKGLLPRHMQIINEINTRFKTLVEKTWPGDEKVWAKLAVVHDKQVHMANLCVVGGFAVNG
VAALHSDLVVKDLFPEYHQLWPNKFHNVTNGITPRRWIKQCNPALAALLDKSLQKEWAND
LDQLINLEKFADDAKFRQQYREIKQANKVRLAEFVKVRTGIEINPQAIFDIQIKRLHEYK
RQHLNLLHILALYKEIRENPQADRVPRVFLFGAKAAPGYYLAKNIIFAINKVADVINNDP
LVGDKLKVVFLPDYCVSAAEKLIPAADISEQISTAGKEASGTGNMKLALNGALTVGTLDG
ANVEIAEKVGEENIFIFGHTVEQVKAILAKGYDPVKWRKKDKVLDAVLKELESGKYSDGD
KHAFDQMLHSIGKQGGDPYLVMADFAAYVEAQKQVDVLYRDQEAWTRAAILNTARCGMFS
SDRSIRDYQARIWQAKR

# Drug_Target_25_Reaction:
(1,4-alpha-D-glucosyl)n + phosphate = (1,4-alpha-D-glucosyl)n-1 + alpha-D-glucose 1-phosphate

# Drug_Target_25_Signals:
None

# Drug_Target_25_Specific_Function:
Phosphorylase is an important allosteric enzyme in carbohydrate metabolism. Enzymes from different sources differ in their regulatory mechanisms and in their natural substrates. However, all known phosphorylases share catalytic and structural properties

# Drug_Target_25_SwissProt_ID:
P00490

# Drug_Target_25_SwissProt_Name:
PHSM_ECOLI

# Drug_Target_25_Synonyms:
EC 2.4.1.1

# Drug_Target_25_Theoretical_pI:
7.41

# Drug_Target_25_Transmembrane_Regions:
None

# Drug_Target_26_Cellular_Location:
Not Available

# Drug_Target_26_Chromosome_Location:
Not Available

# Drug_Target_26_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_26_Essentiality:
Non-Essential

# Drug_Target_26_GenAtlas_ID:
Not Available

# Drug_Target_26_GenBank_ID_Gene:
X07903

# Drug_Target_26_GenBank_ID_Protein:
736314

# Drug_Target_26_GeneCard_ID:
Not Available

# Drug_Target_26_Gene_Name:
stxB

# Drug_Target_26_Gene_Sequence:
>211 bp
ATGAAAAAAACATTATTAATAGCTGCATCGCTTTCATTTTTTTCAGCAAGTGCGCTGGCG
ACGCCTGATTGTGTAACTGGAAAGGTGGAGTATACAAAATATAATGATGACGATACCTTT
ACAGTTAAAGTGGGTGATAAAGAATTATTTACCAACAGATGGAATCTTCAGTCTCTTCTT
CTCAGTGCGCAAATTACGGGGATGACTGTAA

# Drug_Target_26_General_Function:
Not Available

# Drug_Target_26_General_References:
2830229	Strockbine NA, Jackson MP, Sung LM, Holmes RK, O'Brien AD: Cloning and sequencing of the genes for Shiga toxin from Shigella dysenteriae type 1. J Bacteriol. 1988 Mar;170(3):1116-22.
3049254	Kozlov YuV, Kabishev AA, Lukyanov EV, Bayev AA: The primary structure of the operons coding for Shigella dysenteriae toxin and temperature phage H30 shiga-like toxin. Gene. 1988 Jul 30;67(2):213-21.
3771511	Seidah NG, Donohue-Rolfe A, Lazure C, Auclair F, Keusch GT, Chretien M: Complete amino acid sequence of Shigella toxin B-chain. A novel polypeptide containing 69 amino acids and one disulfide bridge. J Biol Chem. 1986 Oct 25;261(30):13928-31.

# Drug_Target_26_HGNC_ID:
Not Available

# Drug_Target_26_HPRD_ID:
Not Available

# Drug_Target_26_ID:
3225

# Drug_Target_26_Locus:
Not Available

# Drug_Target_26_Molecular_Weight:
9743

# Drug_Target_26_Name:
Shiga toxin B-chain

# Drug_Target_26_Number_of_Residues:
89

# Drug_Target_26_PDB_ID:
1R4Q

# Drug_Target_26_Pathway:
Not Available

# Drug_Target_26_Pfam_Domain_Function:
PF02258	SLT_beta

# Drug_Target_26_Protein_Sequence:
>Shiga toxin B-chain precursor
MKKTLLIAASLSFFSASALATPDCVTGKVEYTKYNDDDTFTVKVGDKELFTNRWNLQSLL
LSAQITGMTVTIKTNACHNGGGFSEVIFR

# Drug_Target_26_Reaction:
Not Available

# Drug_Target_26_Signals:
1-20

# Drug_Target_26_Specific_Function:
The B-chain is responsible for binding the holotoxin to specific receptors on the target cell surface

# Drug_Target_26_SwissProt_ID:
P69178

# Drug_Target_26_SwissProt_Name:
STXB_BPH30

# Drug_Target_26_Synonyms:
Shiga toxin B-chain precursor

# Drug_Target_26_Theoretical_pI:
8.22

# Drug_Target_26_Transmembrane_Regions:
None

# Drug_Target_27_Cellular_Location:
Not Available

# Drug_Target_27_Chromosome_Location:
Not Available

# Drug_Target_27_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_27_Essentiality:
Non-Essential

# Drug_Target_27_GenAtlas_ID:
Not Available

# Drug_Target_27_GenBank_ID_Gene:
Not Available

# Drug_Target_27_GenBank_ID_Protein:
Not Available

# Drug_Target_27_GeneCard_ID:
Not Available

# Drug_Target_27_Gene_Name:
NCAN

# Drug_Target_27_Gene_Sequence:
Not Available

# Drug_Target_27_General_Function:
Not Available

# Drug_Target_27_General_References:
Not Available

# Drug_Target_27_HGNC_ID:
Not Available

# Drug_Target_27_HPRD_ID:
Not Available

# Drug_Target_27_ID:
7022

# Drug_Target_27_Locus:
Not Available

# Drug_Target_27_Molecular_Weight:
Not Available

# Drug_Target_27_Name:
Neurocan core protein

# Drug_Target_27_Number_of_Residues:
0

# Drug_Target_27_PDB_ID:
Not Available

# Drug_Target_27_Pathway:
Not Available

# Drug_Target_27_Pfam_Domain_Function:
Not Available

# Drug_Target_27_Protein_Sequence:
Not Available

# Drug_Target_27_Reaction:
Not Available

# Drug_Target_27_Signals:
Not Available

# Drug_Target_27_Specific_Function:
Not Available

# Drug_Target_27_SwissProt_ID:
O14594

# Drug_Target_27_SwissProt_Name:
NCAN_HUMAN

# Drug_Target_27_Synonyms:
Not Available

# Drug_Target_27_Theoretical_pI:
Not Available

# Drug_Target_27_Transmembrane_Regions:
Not Available

# Drug_Target_28_Cellular_Location:
Cytoplasmic

# Drug_Target_28_Chromosome_Location:
Not Available

# Drug_Target_28_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_28_Essentiality:
Non-Essential

# Drug_Target_28_GenAtlas_ID:
Not Available

# Drug_Target_28_GenBank_ID_Gene:
X55959

# Drug_Target_28_GenBank_ID_Protein:
296716

# Drug_Target_28_GeneCard_ID:
Not Available

# Drug_Target_28_Gene_Name:
Not Available

# Drug_Target_28_Gene_Sequence:
>714 bp
ATGAAAAAGAAGTCCTGTTTTACACTGGTGACCACATTTGCGTTTTCTTTGATTTTTTCT
GTAAGCGCTTTAGCGGGGAGTGTGTTCTGGGAACCATTAAGTTATTTTAATCGTAGTACA
TGGGAAAAGGCAGATGGGTATTCCAATGGGGGGGTGTTCAATTGCACATGGCGTGCCAAC
AATGTTAATTTTACGAATGATGGAAAGCTCAAGCTGGGCTTAACGAGTTCTGCGTACAAC
AAATTTGACTGCGCGGAGTACCGATCAACGAACATTTACGGATACGGCCTGTACGAGGTC
AGTATGAAGCCAGCCAAAAATACAGGAATTGTCTCATCCTTTTTCACGTATACAGGACCT
GCTCATGGCACACAATGGGATGAAATAGATATCGAATTTCTAGGAAAAGACACGACAAAA
GTGCAGTTTAACTATTATACCAATGGGGTTGGCGGTCATGAAAAGGTTATCTCTCTTGGC
TTTGATGCATCAAAGGGCTTCCATACCTATGCTTTCGATTGGCAGCCAGGGTATATTAAA
TGGTATGTAGACGGTGTTTTGAAACATACCGCCACCGCGAATATTCCGAGTACGCCAGGC
AAAATTATGATGAATCTATGGAACGGAACCGGAGTGGATGACTGGTTAGGTTCTTATAAT
GGAGCGAATCCGTTGTACGCTGAATATGACTGGGTAAAATATACGAGCAATTAA

# Drug_Target_28_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_28_General_References:
1360982	Hoj PB, Condron R, Traeger JC, McAuliffe JC, Stone BA: Identification of glutamic acid 105 at the active site of Bacillus amyloliquefaciens 1,3-1,4-beta-D-glucan 4-glucanohydrolase using epoxide-based inhibitors. J Biol Chem. 1992 Dec 15;267(35):25059-66.
2274030	Borriss R, Buettner K, Maentsaelae P: Structure of the beta-1,3-1,4-glucanase gene of Bacillus macerans: homologies to other beta-glucanases. Mol Gen Genet. 1990 Jul;222(2-3):278-83.
7588726	Hahn M, Keitel T, Heinemann U: Crystal and molecular structure at 0.16-nm resolution of the hybrid Bacillus endo-1,3-1,4-beta-D-glucan 4-glucanohydrolase H(A16-M). Eur J Biochem. 1995 Sep 15;232(3):849-58.
8099449	Keitel T, Simon O, Borriss R, Heinemann U: Molecular and active-site structure of a Bacillus 1,3-1,4-beta-glucanase. Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):5287-91.

# Drug_Target_28_HGNC_ID:
Not Available

# Drug_Target_28_HPRD_ID:
Not Available

# Drug_Target_28_ID:
3009

# Drug_Target_28_Locus:
Not Available

# Drug_Target_28_Molecular_Weight:
26589

# Drug_Target_28_Name:
Beta-glucanase

# Drug_Target_28_Number_of_Residues:
237

# Drug_Target_28_PDB_ID:
1MAC

# Drug_Target_28_Pathway:
Not Available

# Drug_Target_28_Pfam_Domain_Function:
PF00722	Glyco_hydro_16

# Drug_Target_28_Protein_Sequence:
>Beta-glucanase precursor
MKKKSCFTLVTTFAFSLIFSVSALAGSVFWEPLSYFNRSTWEKADGYSNGGVFNCTWRAN
NVNFTNDGKLKLGLTSSAYNKFDCAEYRSTNIYGYGLYEVSMKPAKNTGIVSSFFTYTGP
AHGTQWDEIDIEFLGKDTTKVQFNYYTNGVGGHEKVISLGFDASKGFHTYAFDWQPGYIK
WYVDGVLKHTATANIPSTPGKIMMNLWNGTGVDDWLGSYNGANPLYAEYDWVKYTSN

# Drug_Target_28_Reaction:
Hydrolysis of 1,4-beta-D-glucosidic linkages in beta-D-glucans containing 1,3- and 1,4-bonds

# Drug_Target_28_Signals:
1-23

# Drug_Target_28_Specific_Function:
Hydrolysis of 1,4-beta-D-glucosidic linkages in beta-D-glucans containing 1,3- and 1,4-bonds

# Drug_Target_28_SwissProt_ID:
P23904

# Drug_Target_28_SwissProt_Name:
GUB_PAEMA

# Drug_Target_28_Synonyms:
1,3-1,4-beta-D-glucan 4-glucanohydrolase
Beta-glucanase precursor
EC 3.2.1.73
Endo-beta-1,3-1,4 glucanase
Lichenase

# Drug_Target_28_Theoretical_pI:
7.48

# Drug_Target_28_Transmembrane_Regions:
None

# Drug_Target_29_Cellular_Location:
Not Available

# Drug_Target_29_Chromosome_Location:
Not Available

# Drug_Target_29_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_29_Essentiality:
Non-Essential

# Drug_Target_29_GenAtlas_ID:
Not Available

# Drug_Target_29_GenBank_ID_Gene:
X15871

# Drug_Target_29_GenBank_ID_Protein:
38708

# Drug_Target_29_GeneCard_ID:
Not Available

# Drug_Target_29_Gene_Name:
gdhB

# Drug_Target_29_Gene_Sequence:
>1437 bp
ATGAATAAACATTTATTGGCTAAAATTGCTTTATTAAGCGCTGTTCAGCTAGTTACACTC
TCAGCATTTGCTGATGTTCCTCTAACTCCATCTCAATTTGCTAAAGCGAAATCAGAGAAC
TTTGACAAGAAAGTTATTCTATCTAATCTAAATAAGCCGCATGCTTTGTTATGGGGACCA
GATAATCAAATTTGGTTAACTGAGCGAGCAACAGGTAAGATTCTAAGAGTTAATCCAGAG
TCGGGTAGTGTAAAAACAGTTTTTCAGGTACCAGAGATTGTCAATGATGCTGATGGGCAG
AATGGTTTATTAGGTTTTGCCTTCCATCCTGATTTTAAAAATAATCCTTATATCTATATT
TCAGGTACATTTAAAAATCCGAAATCTACAGATAAAGAATTACCGAACCAAACGATTATT
CGTCGTTATACCTATAATAAATCAACAGATACGCTCGAGAAGCCAGTCGATTTATTAGCA
GGATTACCTTCATCAAAAGACCATCAGTCAGGTCGTCTTGTCATTGGGCCAGATCAAAAG
ATTTATTATACGATTGGTGACCAAGGGCGTAACCAGCTTGCTTATTTGTTCTTGCCAAAT
CAAGCACAACATACGCCAACTCAACAAGAACTGAATGGTAAAGACTATCACACCTATATG
GGTAAAGTACTACGCTTAAATCTTGATGGAAGTATTCCAAAGGATAATCCAAGTTTTAAC
GGGGTGGTTAGCCATATTTATACACTTGGACATCGTAATCCGCAGGGCTTAGCATTCACT
CCAAATGGTAAATTATTGCAGTCTGAACAAGGCCCAAACTCTGACGATGAAATTAACCTC
ATTGTCAAAGGTGGCAATTATGGTTGGCCGAATGTAGCAGGTTATAAAGATGATAGTGGC
TATGCTTATGCAAATTATTCAGCAGCAGCCAATAAGTCAATTAAGGATTTAGCTCAAAAT
GGAGTAAAAGTAGCCGCAGGGGTCCCTGTGACGAAAGAATCTGAATGGACTGGTAAAAAC
TTTGTCCCACCATTAAAAACTTTATATACCGTTCAAGATACCTACAACTATAACGATCCA
ACTTGTGGAGAGATGACCTACATTTGCTGGCCAACAGTTGCACCGTCATCTGCCTATGTC
TATAAGGGCGGTAAAAAAGCAATTACTGGTTGGGAAAATACATTATTGGTTCCATCTTTA
AAACGTGGTGTCATTTTCCGTATTAAGTTAGATCCAACTTATAGCACTACTTATGATGAC
GCTGTACCGATGTTTAAGAGCAACAACCGTTATCGTGATGTGATTGCAAGTCCAGATGGG
AATGTCTTATATGTATTAACTGATACTGCCGGAAATGTCCAAAAAGATGATGGCTCAGTA
ACAAATACATTAGAAAACCCAGGATCTCTCATTAAGTTCACCTATAAGGCTAAGTAA

# Drug_Target_29_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_29_General_References:
10366508	Oubrie A, Rozeboom HJ, Kalk KH, Duine JA, Dijkstra BW: The 1.7 A crystal structure of the apo form of the soluble quinoprotein glucose dehydrogenase from Acinetobacter calcoaceticus reveals a novel internal conserved sequence repeat. J Mol Biol. 1999 Jun 4;289(2):319-33.
10508152	Oubrie A, Rozeboom HJ, Kalk KH, Olsthoorn AJ, Duine JA, Dijkstra BW: Structure and mechanism of soluble quinoprotein glucose dehydrogenase. EMBO J. 1999 Oct 1;18(19):5187-94.
2671663	Cleton-Jansen AM, Goosen N, Vink K, van de Putte P: Cloning, characterization and DNA sequencing of the gene encoding the Mr 50,000 quinoprotein glucose dehydrogenase from Acinetobacter calcoaceticus. Mol Gen Genet. 1989 Jun;217(2-3):430-6.

# Drug_Target_29_HGNC_ID:
Not Available

# Drug_Target_29_HPRD_ID:
Not Available

# Drug_Target_29_ID:
3153

# Drug_Target_29_Locus:
Not Available

# Drug_Target_29_Molecular_Weight:
52773

# Drug_Target_29_Name:
Quinoprotein glucose dehydrogenase-B

# Drug_Target_29_Number_of_Residues:
478

# Drug_Target_29_PDB_ID:
1CQ1

# Drug_Target_29_Pathway:
Not Available

# Drug_Target_29_Pfam_Domain_Function:
PF07995	GSDH

# Drug_Target_29_Protein_Sequence:
>Quinoprotein glucose dehydrogenase-B precursor
MNKHLLAKIALLSAVQLVTLSAFADVPLTPSQFAKAKSENFDKKVILSNLNKPHALLWGP
DNQIWLTERATGKILRVNPESGSVKTVFQVPEIVNDADGQNGLLGFAFHPDFKNNPYIYI
SGTFKNPKSTDKELPNQTIIRRYTYNKSTDTLEKPVDLLAGLPSSKDHQSGRLVIGPDQK
IYYTIGDQGRNQLAYLFLPNQAQHTPTQQELNGKDYHTYMGKVLRLNLDGSIPKDNPSFN
GVVSHIYTLGHRNPQGLAFTPNGKLLQSEQGPNSDDEINLIVKGGNYGWPNVAGYKDDSG
YAYANYSAAANKSIKDLAQNGVKVAAGVPVTKESEWTGKNFVPPLKTLYTVQDTYNYNDP
TCGEMTYICWPTVAPSSAYVYKGGKKAITGWENTLLVPSLKRGVIFRIKLDPTYSTTYDD
AVPMFKSNNRYRDVIASPDGNVLYVLTDTAGNVQKDDGSVTNTLENPGSLIKFTYKAK

# Drug_Target_29_Reaction:
D-glucose + ubiquinone = D-glucono-1,5-lactone + ubiquinol

# Drug_Target_29_Signals:
1-24

# Drug_Target_29_Specific_Function:
Oxidizes glucose to gluconolactone

# Drug_Target_29_SwissProt_ID:
P13650

# Drug_Target_29_SwissProt_Name:
DHGB_ACICA

# Drug_Target_29_Synonyms:
EC 1.1.5.2
Glucose dehydrogenase-B [pyrroloquinoline-quinone]
Quinoprotein glucose dehydrogenase-B precursor
Soluble glucose dehydrogenase
s-GDH

# Drug_Target_29_Theoretical_pI:
9.27

# Drug_Target_29_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Cytoplasm

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
Not Available

# Drug_Target_2_GenBank_ID_Protein:
Not Available

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
xylA

# Drug_Target_2_Gene_Sequence:
Not Available

# Drug_Target_2_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_2_General_References:
2510821	Farber GK, Glasfeld A, Tiraby G, Ringe D, Petsko GA: Crystallographic studies of the mechanism of xylose isomerase. Biochemistry. 1989 Sep 5;28(18):7289-97.
3508293	Farber GK, Petsko GA, Ringe D: The 3.0 A crystal structure of xylose isomerase from Streptomyces olivochromogenes. Protein Eng. 1987 Dec;1(6):459-66.
8180169	Lavie A, Allen KN, Petsko GA, Ringe D: X-ray crystallographic structures of D-xylose isomerase-substrate complexes position the substrate and provide evidence for metal movement during catalysis. Biochemistry. 1994 May 10;33(18):5469-80.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
2431

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
42924

# Drug_Target_2_Name:
Xylose isomerase

# Drug_Target_2_Number_of_Residues:
387

# Drug_Target_2_PDB_ID:
2GYI

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF01261	AP_endonuc_2

# Drug_Target_2_Protein_Sequence:
>Xylose isomerase
MSYQPTPEDRFTFGLWTVGWQGRDPFGDATRPALDPVETVQRLAELGAHGVTFHDDDLIP
FGSSDTERESHIKRFRQALDATGMTVPMATTNLFTHPVFKDGGFTANDRDVRRYALRKTI
RNIDLAVELGAKTYVAWGGREGAESGAAKDVRVALDRMKEAFDLLGEYVTSQGYDTRFAI
EPKPNEPRGDILLPTVGHALAFIERLERPELYGVNPEVGHEQMAGLNFPHGIAQALWAGK
LFHIDLNGQSGIKYDQDLRFGAGDLRAAFWLVDLLESAGYEGPRHFDFKPPRTEDIDGVW
ASAAGCMRNYLILKERAAAFRADPEVQEALRASRLDELAQPTAADGVQELLADRTAFEDF
DVDAAAARGMAFERLDQLAMDHLLGAR

# Drug_Target_2_Reaction:
D-xylose = D-xylulose

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Involved in D-xylose catabolism

# Drug_Target_2_SwissProt_ID:
P15587

# Drug_Target_2_SwissProt_Name:
XYLA_STROL

# Drug_Target_2_Synonyms:
EC 5.3.1.5

# Drug_Target_2_Theoretical_pI:
4.76

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_30_Cellular_Location:
Secreted protein

# Drug_Target_30_Chromosome_Location:
Not Available

# Drug_Target_30_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_30_Essentiality:
Non-Essential

# Drug_Target_30_GenAtlas_ID:
Not Available

# Drug_Target_30_GenBank_ID_Gene:
J01542

# Drug_Target_30_GenBank_ID_Protein:
142429

# Drug_Target_30_GeneCard_ID:
Not Available

# Drug_Target_30_Gene_Name:
Not Available

# Drug_Target_30_Gene_Sequence:
>1545 bp
ATGATTCAAAAACGAAAGCGGACAGTTTCGTTCAGACTTGTGCTTATGTGCACGCTGTTA
TTTGTCAGTTTGCCGATTACAAAAACATCAGCCGTAAATGGCACGCTGATGCAGTATTTT
GAATGGTATACGCCGAACGACGGCCAGCATTGGAAACGATTGCAGAATGATGCGGAACAT
TTATCGGATATCGGAATCACTGCCGTCTGGATTCCTCCCGCATACAAAGGATTGAGCCAA
TCCGATAACGGATACGGACCTTATGATTTGTATGATTTAGGAGAATTCCAGCAAAAAGGG
ACGGTCAGAACGAAATACGGCACAAAATCAGAGCTTCAAGATGCGATCGGCTCACTGCAT
TCCCGGAACGTCCAAGTATACGGAGATGTGGTTTTGAATCATAAGGCTGGTGCTGATGCA
ACAGAAGATGTAACTGCCGTCGAAGTCAATCCGGCCAATAGAAATCAGGAAACTTCGGAG
GAATATCAAATCAAAGCGTGGACGGATTTTCGTTTTCCGGGCCGTGGAAACACGTACAGT
GATTTTAAATGGCATTGGTATCATTTCGACGGAGCGGACTGGGATGAATCCCGGAAGATC
AGCCGCATCTTTAAGTTTCGTGGGGAAGGAAAAGCGTGGGATTGGGAAGTATCAAGTGAA
AACGGCAACTATGACTATTTAATGTATGCTGATGTTGACTACGACCACCCTGATGTCGTG
GCAGAGACAAAAAAATGGGGTATCTGGTATGCGAATGAACTGTCATTAGACGGCTTCCGT
ATTGATGCCGCCAAACATATTAAATTTTCATTTCTGCGTGATTGGGTTCAGGCGGTCAGA
CAGGCGACGGGAAAAGAAATGTTTACGGTTGCGGAGTATTGGCAGAATAATGCCGGGAAA
CTCGAAAACTACTTGAATAAAACAAGCTTTAATCAATCCGTGTTTGATGTTCCGCTTCAT
TTCAATTTACAGGCGGCTTCCTCACAAGGAGGCGGATATGATATGAGGCGTTTGCTGGAC
GGTACCGTTGTGTCCAGGCATCCGGAAAAGGCGGTTACATTTGTTGAAAATCATGACACA
CAGCCGGGACAGTCATTGGAATCGACAGTCCAAACTTGGTTTAAACCGCTTGCATACGCC
TTTATTTTGACAAGAGAATCCGGTTATCCTCAGGTGTTCTATGGGGATATGTACGGGACA
AAAGGGACATCGCCAAAGGAAATTCCCTCACTGAAAGATAATATAGAGCCGATTTTAAAA
GCGCGTAAGGAGTACGCATACGGGCCCCAGCACGATTATATTGACCACCCGGATGTGATC
GGATGGACGAGGGAAGGTGACAGCTCCGCCGCCAAATCAGGTTTGGCCGCTTTAATCACG
GACGGACCCGGCGGATCAAAGCGGATGTATGCCGGCCTGAAAAATGCCGGCGAGACATGG
TATGACATAACGGGCAACCGTTCAGATACTGTAAAAATCGGATCTGACGGCTGGGGAGAG
TTTCATGTAAACGATGGGTCCGTCTCCATTTATGTTCAGAAATAA

# Drug_Target_30_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_30_General_References:
10924103	Brzozowski AM, Lawson DM, Turkenburg JP, Bisgaard-Frantzen H, Svendsen A, Borchert TV, Dauter Z, Wilson KS, Davies GJ: Structural analysis of a chimeric bacterial alpha-amylase. High-resolution analysis of native and ligand complexes. Biochemistry. 2000 Aug 8;39(31):9099-107.
2830166	Ruohonen L, Hackman P, Lehtovaara P, Knowles JK, Keranen S: Efficient secretion of Bacillus amyloliquefaciens alpha-amylase by [corrected] its own signal peptide from Saccharomyces cerevisiae host cells [corrected] Gene. 1987;59(2-3):161-70.
6156671	Chung H, Friedberg F: Sequence of the N-terminal half of Bacillus amyloliquefaciens alpha-amylase. Biochem J. 1980 Feb 1;185(2):387-95.
6170539	Palva I, Pettersson RF, Kalkkinen N, Lehtovaara P, Sarvas M, Soderlund H, Takkinen K, Kaariainen L: Nucleotide sequence of the promoter and NH2-terminal signal peptide region of the alpha-amylase gene from Bacillus amyloliquefaciens. Gene. 1981 Oct;15(1):43-51.
6185474	Takkinen K, Pettersson RF, Kalkkinen N, Palva I, Soderlund H, Kaariainen L: Amino acid sequence of alpha-amylase from Bacillus amyloliquefaciens deduced from the nucleotide sequence of the cloned gene. J Biol Chem. 1983 Jan 25;258(2):1007-13.

# Drug_Target_30_HGNC_ID:
Not Available

# Drug_Target_30_HPRD_ID:
Not Available

# Drug_Target_30_ID:
3169

# Drug_Target_30_Locus:
Not Available

# Drug_Target_30_Molecular_Weight:
58403

# Drug_Target_30_Name:
Alpha-amylase

# Drug_Target_30_Number_of_Residues:
514

# Drug_Target_30_PDB_ID:
1E40

# Drug_Target_30_Pathway:
Not Available

# Drug_Target_30_Pfam_Domain_Function:
PF00128	Alpha-amylase

# Drug_Target_30_Protein_Sequence:
>Alpha-amylase precursor
MIQKRKRTVSFRLVLMCTLLFVSLPITKTSAVNGTLMQYFEWYTPNDGQHWKRLQNDAEH
LSDIGITAVWIPPAYKGLSQSDNGYGPYDLYDLGEFQQKGTVRTKYGTKSELQDAIGSLH
SRNVQVYGDVVLNHKAGADATEDVTAVEVNPANRNQETSEEYQIKAWTDFRFPGRGNTYS
DFKWHWYHFDGADWDESRKISRIFKFRGEGKAWDWEVSSENGNYDYLMYADVDYDHPDVV
AETKKWGIWYANELSLDGFRIDAAKHIKFSFLRDWVQAVRQATGKEMFTVAEYWQNNAGK
LENYLNKTSFNQSVFDVPLHFNLQAASSQGGGYDMRRLLDGTVVSRHPEKAVTFVENHDT
QPGQSLESTVQTWFKPLAYAFILTRESGYPQVFYGDMYGTKGTSPKEIPSLKDNIEPILK
ARKEYAYGPQHDYIDHPDVIGWTREGDSSAAKSGLAALITDGPGGSKRMYAGLKNAGETW
YDITGNRSDTVKIGSDGWGEFHVNDGSVSIYVQK

# Drug_Target_30_Reaction:
Endohydrolysis of 1,4-alpha-D-glucosidic linkages in polysaccharides containing three or more 1,4-alpha-linked D-glucose units ALL_REAC (other) R02108 R06209(G)

# Drug_Target_30_Signals:
1-31

# Drug_Target_30_Specific_Function:
Endohydrolysis of 1,4-alpha-D-glucosidic linkages in oligosaccharides and polysaccharides

# Drug_Target_30_SwissProt_ID:
P00692

# Drug_Target_30_SwissProt_Name:
AMY_BACAM

# Drug_Target_30_Synonyms:
1,4-alpha-D-glucan glucanohydrolase
Alpha-amylase precursor
EC 3.2.1.1

# Drug_Target_30_Theoretical_pI:
6.04

# Drug_Target_30_Transmembrane_Regions:
None

# Drug_Target_31_Cellular_Location:
Nucleus and mitochondria

# Drug_Target_31_Chromosome_Location:
Not Available

# Drug_Target_31_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_31_Essentiality:
Non-Essential

# Drug_Target_31_GenAtlas_ID:
Not Available

# Drug_Target_31_GenBank_ID_Gene:
Not Available

# Drug_Target_31_GenBank_ID_Protein:
Not Available

# Drug_Target_31_GeneCard_ID:
Not Available

# Drug_Target_31_Gene_Name:
Not Available

# Drug_Target_31_Gene_Sequence:
>Example: Dickerson dodecamer
CGCGAATTCGCG

# Drug_Target_31_General_Function:
Biological information storage and information transfer

# Drug_Target_31_General_References:
1234	Nadeau D, Marchand C: Change in the kinetics of sulphacetamide tissue distribution in Walker tumor-bearing rats. Drug Metab Dispos. 1975 Nov-Dec;3(6):565-76.

# Drug_Target_31_HGNC_ID:
Not Available

# Drug_Target_31_HPRD_ID:
Not Available

# Drug_Target_31_ID:
874

# Drug_Target_31_Locus:
All loci

# Drug_Target_31_Molecular_Weight:
7656 (double strand)

# Drug_Target_31_Name:
DNA

# Drug_Target_31_Number_of_Residues:
0

# Drug_Target_31_PDB_ID:
1BNA

# Drug_Target_31_Pathway:
Not Available

# Drug_Target_31_Pfam_Domain_Function:
Not Available

# Drug_Target_31_Protein_Sequence:
Not Available

# Drug_Target_31_Reaction:
DNA + DNA polymerase + nNTP = 2 DNA + nNDP; DNA + RNA polymerase + NTP = mRNA + nNDP

# Drug_Target_31_Signals:
None

# Drug_Target_31_Specific_Function:
DNA is the molecule of heredity, as it is responsible for the genetic propagation of most inherited traits. It is a polynucleic acid that carries genetic information on cell growth, division, and function. DNA consists of two long strands of nucleotides twisted into a double helix and held together by hydrogen bonds. The sequence of nucleotides determines hereditary characteristics. Each strand serves as the template for subsequent DNA replication and as a template for mRNA production, leading to protein synthesis via ribosomes.

# Drug_Target_31_SwissProt_ID:
Not Available

# Drug_Target_31_SwissProt_Name:
Not Available

# Drug_Target_31_Synonyms:
Deoxyribonucleic acid

# Drug_Target_31_Theoretical_pI:
Not Available

# Drug_Target_31_Transmembrane_Regions:
None

# Drug_Target_32_Cellular_Location:
Cytoplasmic

# Drug_Target_32_Chromosome_Location:
Not Available

# Drug_Target_32_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_32_Essentiality:
Non-Essential

# Drug_Target_32_GenAtlas_ID:
Not Available

# Drug_Target_32_GenBank_ID_Gene:
X58627

# Drug_Target_32_GenBank_ID_Protein:
2879820

# Drug_Target_32_GeneCard_ID:
Not Available

# Drug_Target_32_Gene_Name:
amy

# Drug_Target_32_Gene_Sequence:
>2010 bp
ATGAAACTCAATAAAATAATCACCACCGCAGGTTTAAGCCTAGGGTTGCTCTTACCTAGC
ATTGCGACTGCTACGCCCACCACATTTGTACATTTGTTTGAATGGAATTGGCAAGATGTA
GCGCAAGAATGTGAGCAATACCTAGGACCAAAAGGCTACGCTGCAGTACAGGTCTCGCCA
CCTAATGAGCACATTACAGGAAGCCAATGGTGGACACGTTATCAGCCAGTAAGTTATGAA
CTGCAAAGTCGTGGCGGAAACCGTGCACAGTTTATCGATATGGTAAATCGCTGTAGTGCA
GCTGGGGTTGATATTTACGTTGATACGCTTATTAACCATATGGCAGCAGGAAGTGGCACA
GGCACGGCGGGAAATAGCTTTGGTAATAAAAGCTTTCCTATTTATAGCCCACAAGATTTT
CATGAAAGTTGTACCATTAATAACTCTGATTATGGCAACGATCGCTACCGAGTACAAAAC
TGTGAACTAGTTGGACTTGCCGATTTAGATACCGCTTCAAACTATGTGCAAAATACCATT
GCAGCATATATTAACGACTTACAAGCTATTGGCGTAAAAGGCTTTCGGTTTGATGCTTCT
AAACATGTTGCAGCAAGCGATATCCAAAGTTTAATGGCCAAAGTAAATGGCTCGCCAGTG
GTTTTTCAAGAAGTGATCGATCAAGGTGGGGAGGCTGTTGGTGCCTCTGAATATTTAAGC
ACAGGTTTAGTAACTGAATTTAAATATAGCACTGAGCTTGGTAACACTTTTAGAAACGGC
TCGCTTGCATGGCTGAGTAATTTTGGCGAAGGGTGGGGCTTTATGCCAAGCTCTTCTGCG
GTGGTTTTTGTAGACAATCACGACAATCAGCGCGGGCACGGCGGCGCTGGCAATGTTATT
ACCTTTGAAGATGGCCGCTTATATGACTTAGCCAATGTATTTATGTTGGCTTATCCGTAC
GGTTATCCAAAAGTAATGTCGAGTTATGATTTTCATGGTGATACAGATGCTGGTGGGCCA
AATGTACCGGTACATAATAATGGTAACTTAGAGTGTTTTGCGAGTAATTGGAAGTGTGAG
CATCGCTGGTCATATATTGCAGGCGGGGTCGATTTTAGAAATAACACCGCCGACAACTGG
GCAGTAACAAATTGGTGGGATAACACAAATAATCAAATTTCATTTGGCCGAGGTAGCTCG
GGTCATATGGCTATTAACAAAGAAGACTCAACACTTACTGCAACTGTGCAAACCGATATG
GCGTCAGGGCAATACTGTAATGTGCTAAAAGGCGAACTGTCAGCTGATGCTAAAAGTTGT
AGTGGTGAGGTTATAACGGTTAATTCCGACGGTACTATTAATCTTAATATTGGCGCTTGG
GATGCGATGGCAATTCATAAAAATGCCAAGTTAAATACCAGTTCTGCCTCAAGCACTGAA
AGTGACTGGCAGCGAACGGTTATTTTTATTAATGCACAAACACAAAGCGGACAAGATATG
TTTATCCGTGGTGGAATTGACCACGCTTATGCAAACGCAAACCTTGGTCGAAATTGCCAA
ACAAGTAATTTTGAGTGTGCAATGCCTATTCGTCATAACAATTTAAAAAATGTCACAACA
AGCCCTTGGAAAGCAAATGATAACTACCTTGATTGGTATGGTATAGAAAATGGGCAAAGT
AGCGAAGCAGAAGGTTCTGCTACCGACTGGACAACGAACGTTTGGCCAGCAGGTTGGGGC
GCTGAAAAAACGGTAAACACAGATGGTTTTGGTGTGACACCTTTAAATATATGGGGCGAA
CACTATTGGATGCTTGATGTAGATATGGATTGCAGTAAAGCGGTTAATGGATGGTTTGAA
CTAAAAGCATTCATTAAAAATGGCCAAGGATGGGAGACTGCCATTGCACAAGACAATGCA
CCTTATACAAGTACTAATCATATGGCGCAATGCGGAAAAATTAATAAATTTGAGTTTAAT
AATTCAGGTGTAGTAATTCGTAGTTTTTAA

# Drug_Target_32_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_32_General_References:
1544904	Feller G, Lonhienne T, Deroanne C, Libioulle C, Van Beeumen J, Gerday C: Purification, characterization, and nucleotide sequence of the thermolabile alpha-amylase from the antarctic psychrotroph Alteromonas haloplanctis A23. J Biol Chem. 1992 Mar 15;267(8):5217-21.
9541387	Aghajari N, Feller G, Gerday C, Haser R: Crystal structures of the psychrophilic alpha-amylase from Alteromonas haloplanctis in its native form and complexed with an inhibitor. Protein Sci. 1998 Mar;7(3):564-72.
9575155	Feller G, D'Amico S, Benotmane AM, Joly F, Van Beeumen J, Gerday C: Characterization of the C-terminal propeptide involved in bacterial wall spanning of alpha-amylase from the psychrophile Alteromonas haloplanctis. J Biol Chem. 1998 May 15;273(20):12109-15.

# Drug_Target_32_HGNC_ID:
Not Available

# Drug_Target_32_HPRD_ID:
Not Available

# Drug_Target_32_ID:
2948

# Drug_Target_32_Locus:
Not Available

# Drug_Target_32_Molecular_Weight:
73268

# Drug_Target_32_Name:
Alpha-amylase

# Drug_Target_32_Number_of_Residues:
669

# Drug_Target_32_PDB_ID:
1B0I

# Drug_Target_32_Pathway:
Not Available

# Drug_Target_32_Pfam_Domain_Function:
PF00128	Alpha-amylase
PF02806	Alpha-amylase_C

# Drug_Target_32_Protein_Sequence:
>Alpha-amylase precursor
MKLNKIITTAGLSLGLLLPSIATATPTTFVHLFEWNWQDVAQECEQYLGPKGYAAVQVSP
PNEHITGSQWWTRYQPVSYELQSRGGNRAQFIDMVNRCSAAGVDIYVDTLINHMAAGSGT
GTAGNSFGNKSFPIYSPQDFHESCTINNSDYGNDRYRVQNCELVGLADLDTASNYVQNTI
AAYINDLQAIGVKGFRFDASKHVAASDIQSLMAKVNGSPVVFQEVIDQGGEAVGASEYLS
TGLVTEFKYSTELGNTFRNGSLAWLSNFGEGWGFMPSSSAVVFVDNHDNQRGHGGAGNVI
TFEDGRLYDLANVFMLAYPYGYPKVMSSYDFHGDTDAGGPNVPVHNNGNLECFASNWKCE
HRWSYIAGGVDFRNNTADNWAVTNWWDNTNNQISFGRGSSGHMAINKEDSTLTATVQTDM
ASGQYCNVLKGELSADAKSCSGEVITVNSDGTINLNIGAWDAMAIHKNAKLNTSSASSTE
SDWQRTVIFINAQTQSGQDMFIRGGIDHAYANANLGRNCQTSNFECAMPIRHNNLKNVTT
SPWKANDNYLDWYGIENGQSSEAEGSATDWTTNVWPAGWGAEKTVNTDGFGVTPLNIWGE
HYWMLDVDMDCSKAVNGWFELKAFIKNGQGWETAIAQDNAPYTSTNHMAQCGKINKFEFN
NSGVVIRSF

# Drug_Target_32_Reaction:
Endohydrolysis of 1,4-alpha-D-glucosidic linkages in polysaccharides containing three or more 1,4-alpha-linked D-glucose units ALL_REAC (other) R02108 R06209(G)

# Drug_Target_32_Signals:
1-24

# Drug_Target_32_Specific_Function:
Endohydrolysis of 1,4-alpha-D-glucosidic linkages in oligosaccharides and polysaccharides

# Drug_Target_32_SwissProt_ID:
P29957

# Drug_Target_32_SwissProt_Name:
AMY_PSEHA

# Drug_Target_32_Synonyms:
1,4-alpha-D-glucan glucanohydrolase
Alpha-amylase precursor
EC 3.2.1.1

# Drug_Target_32_Theoretical_pI:
4.70

# Drug_Target_32_Transmembrane_Regions:
None

# Drug_Target_33_Cellular_Location:
Cytoplasmic

# Drug_Target_33_Chromosome_Location:
Not Available

# Drug_Target_33_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_33_Essentiality:
Non-Essential

# Drug_Target_33_GenAtlas_ID:
Not Available

# Drug_Target_33_GenBank_ID_Gene:
U04629

# Drug_Target_33_GenBank_ID_Protein:
Not Available

# Drug_Target_33_GeneCard_ID:
Not Available

# Drug_Target_33_Gene_Name:
celB

# Drug_Target_33_Gene_Sequence:
Not Available

# Drug_Target_33_General_Function:
Not Available

# Drug_Target_33_General_References:
10200171	Sulzenbacher G, Mackenzie LF, Wilson KS, Withers SG, Dupont C, Davies GJ: The crystal structure of a 2-fluorocellotriosyl complex of the Streptomyces lividans endoglucanase CelB2 at 1.2 A resolution. Biochemistry. 1999 Apr 13;38(15):4826-33.
8017952	Wittmann S, Shareck F, Kluepfel D, Morosoli R: Purification and characterization of the CelB endoglucanase from Streptomyces lividans 66 and DNA sequence of the encoding gene. Appl Environ Microbiol. 1994 May;60(5):1701-3.
9440876	Sulzenbacher G, Shareck F, Morosoli R, Dupont C, Davies GJ: The Streptomyces lividans family 12 endoglucanase: construction of the catalytic cre, expression, and X-ray structure at 1.75 A resolution. Biochemistry. 1997 Dec 23;36(51):16032-9.

# Drug_Target_33_HGNC_ID:
Not Available

# Drug_Target_33_HPRD_ID:
Not Available

# Drug_Target_33_ID:
3747

# Drug_Target_33_Locus:
Not Available

# Drug_Target_33_Molecular_Weight:
39239

# Drug_Target_33_Name:
Cellulase B precursor

# Drug_Target_33_Number_of_Residues:
381

# Drug_Target_33_PDB_ID:
Not Available

# Drug_Target_33_Pathway:
Not Available

# Drug_Target_33_Pfam_Domain_Function:
PF00553	CBM_2
PF01670	Glyco_hydro_12

# Drug_Target_33_Protein_Sequence:
>Cellulase B precursor
MRTLRPQARAPRGLLAALGAVLAAFALVSSLVTAAAPAQADTTICEPFGTTTIQGRYVVQ
NNRWGSTAPQCVTATDTGFRVTQADGSAPTNGAPKSYPSVFNGCHYTNCSPGTDLPVRLD
TVSAAPSSISYGFVDGAVYNASYDIWLDPTARTDGVNQTEIMIWFNRVGPIQPIGSPVGT
ASVGGRTWEVWSGGNGSNDVLSFVAPSAISGWSFDVMDFVRATVARGLAENDWYLTSVQA
GFEPWQNGAGLAVNSFSSTVETGTPGGTDPGDPGGPSACAVSYGTNVWQDGFTADVTVTN
TGTAPVDGWQLAFTLPSGQRITNAWNASLTPSSGSVTATGASHNARIAPGGSLSFGFQGT
YGGAFAEPTGFRLNGTACTTV

# Drug_Target_33_Reaction:
Not Available

# Drug_Target_33_Signals:
1-40

# Drug_Target_33_Specific_Function:
Not Available

# Drug_Target_33_SwissProt_ID:
Q54331

# Drug_Target_33_SwissProt_Name:
Q54331_STRLI

# Drug_Target_33_Synonyms:
Not Available

# Drug_Target_33_Theoretical_pI:
4.47

# Drug_Target_33_Transmembrane_Regions:
None

# Drug_Target_34_Cellular_Location:
Not Available

# Drug_Target_34_Chromosome_Location:
Not Available

# Drug_Target_34_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_34_Essentiality:
Non-Essential

# Drug_Target_34_GenAtlas_ID:
Not Available

# Drug_Target_34_GenBank_ID_Gene:
U27584

# Drug_Target_34_GenBank_ID_Protein:
1002527

# Drug_Target_34_GeneCard_ID:
Not Available

# Drug_Target_34_Gene_Name:
cslB

# Drug_Target_34_Gene_Sequence:
>1521 bp
ATGAAGATGCTGAATAAACTAGCCGGATACTTATTGCCGATCATGGTGCTGCTGAATGTG
GCACCATGCTTAGGTCAGGTTGTTGCTTCAAATGAAACTTTATACCAGGTTGTAAAGGAG
GTAAAACCCGGTGGTCTGGTACAGATTGCCGATGGGACTTATAAAGATGTTCAGCTGATT
GTCAGCAATTCAGGAAAATCTGGTTTGCCCATCACTATTAAAGCCCTGAACCCGGGTAAG
GTTTTTTTTACCGGAGATGCTAAAGTAGAGCTGAGGGGCGAGCACCTGATACTGGAAGGC
ATCTGGTTTAAAGACGGGAACAGAGCTATTCAGGCATGGAAATCACATGGACCCGGATTG
GTGGCTATATATGGTAGCTATAACCGCATTACCGCATGTGTATTTGATTGTTTTGATGAA
GCCAATTCTGCTTACATTACTACTTCGCTTACCGAAGACGGAAAGGTACCTCAACATTGC
CGCATAGACCATTGCAGTTTTACCGATAAGATCACTTTTGACCAGGTAATTAACCTGAAC
AATACAGCCAGAGCTATTAAAGACGGTTCGGTGGGAGGACCGGGGATGTACCATCGTGTT
GATCACTGTTTTTTTTCCAATCCGCAAAAACCGGGTAATGCCGGAGGGGGAATCAGGATT
GGCTATTACCGTAATGATATAGGCCGTTGTCTGGTAGACTCTAACCTGTTTATGCGTCAG
GATTCGGAAGCAGAGATCATCACCAGCAAATCGCAGGAAAATGTTTATTATGGTAATACT
TACCTGAATTGCCAGGGCACCATGAACTTTCGTCACGGTGATCATCAGGTGGCCATTAAC
AATTTTTATATAGGCAATGACCAGCGATTTGGATACGGGGGAATGTTTGTTTGGGGAAGC
AGGCATGTCATAGCCTGTAATTATTTTGAGCTGTCCGAAACCATAAAGTCGAGGGGGAAC
GCCGCATTGTATTTAAACCCCGGTGCTATGGCTTCGGAGCATGCTCTTGCTTTCGATATG
TTGATAGCCAACAACGCTTTCATCAATGTAAATGGGTATGCCATCCATTTTAATCCATTG
GATGAGCGCAGAAAAGAATATTGTGCAGCCAATAGGCTTAAGTTCGAAACCCCGCACCAG
CTAATGTTAAAAGGCAATCTTTTCTTTAAGGATAAACCTTATGTTTACCCATTTTTTAAA
GATGATTATTTTATAGCAGGGAAAAATAGCTGGACTGGTAATGTAGCCTTAGGTGTGGAA
AAGGGAATCCCTGTTAACATTTCGGCCAATAGGTCTGCCTATAAGCCGGTAAAAATTAAA
GATATCCAGCCCATAGAAGGAATCGCTCTTGATCTCAATGCGCTGATCAGCAAAGGCATT
ACAGGAAAGCCCCTTAGCTGGGATGAAGTAAGGCCCTACTGGTTAAAAGAAATGCCCGGG
ACGTATGCTTTAACGGCCAGGCTTTCTGCAGATAGGGCTGCAAAGTTTAAAGCCGTAATT
AAAAGAAATAAAGAGCACTGA

# Drug_Target_34_General_Function:
Not Available

# Drug_Target_34_General_References:
10600383	Huang W, Matte A, Li Y, Kim YS, Linhardt RJ, Su H, Cygler M: Crystal structure of chondroitinase B from Flavobacterium heparinum and its complex with a disaccharide product at 1.7 A resolution. J Mol Biol. 1999 Dec 17;294(5):1257-69.
10618199	Tkalec AL, Fink D, Blain F, Zhang-Sun G, Laliberte M, Bennett DC, Gu K, Zimmermann JJ, Su H: Isolation and expression in Escherichia coli of cslA and cslB, genes coding for the chondroitin sulfate-degrading enzymes chondroitinase AC and chondroitinase B, respectively, from Flavobacterium heparinum. Appl Environ Microbiol. 2000 Jan;66(1):29-35.
11327856	Huang W, Boju L, Tkalec L, Su H, Yang HO, Gunay NS, Linhardt RJ, Kim YS, Matte A, Cygler M: Active site of chondroitin AC lyase revealed by the structure of enzyme-oligosaccharide complexes and mutagenesis. Biochemistry. 2001 Feb 27;40(8):2359-72.
12063249	Pojasek K, Raman R, Kiley P, Venkataraman G, Sasisekharan R: Biochemical characterization of the chondroitinase B active site. J Biol Chem. 2002 Aug 23;277(34):31179-86. Epub 2002 Jun 12.

# Drug_Target_34_HGNC_ID:
Not Available

# Drug_Target_34_HPRD_ID:
Not Available

# Drug_Target_34_ID:
2430

# Drug_Target_34_Locus:
Not Available

# Drug_Target_34_Molecular_Weight:
56323

# Drug_Target_34_Name:
Chondroitinase B

# Drug_Target_34_Number_of_Residues:
506

# Drug_Target_34_PDB_ID:
1DBO

# Drug_Target_34_Pathway:
Not Available

# Drug_Target_34_Pfam_Domain_Function:
Not Available

# Drug_Target_34_Protein_Sequence:
>Chondroitinase B precursor
MKMLNKLAGYLLPIMVLLNVAPCLGQVVASNETLYQVVKEVKPGGLVQIADGTYKDVQLI
VSNSGKSGLPITIKALNPGKVFFTGDAKVELRGEHLILEGIWFKDGNRAIQAWKSHGPGL
VAIYGSYNRITACVFDCFDEANSAYITTSLTEDGKVPQHCRIDHCSFTDKITFDQVINLN
NTARAIKDGSVGGPGMYHRVDHCFFSNPQKPGNAGGGIRIGYYRNDIGRCLVDSNLFMRQ
DSEAEIITSKSQENVYYGNTYLNCQGTMNFRHGDHQVAINNFYIGNDQRFGYGGMFVWGS
RHVIACNYFELSETIKSRGNAALYLNPGAMASEHALAFDMLIANNAFINVNGYAIHFNPL
DERRKEYCAANRLKFETPHQLMLKGNLFFKDKPYVYPFFKDDYFIAGKNSWTGNVALGVE
KGIPVNISANRSAYKPVKIKDIQPIEGIALDLNALISKGITGKPLSWDEVRPYWLKEMPG
TYALTARLSADRAAKFKAVIKRNKEH

# Drug_Target_34_Reaction:
Eliminative cleavage of dermatan sulfate containing 1,4-beta-D-hexosaminyl and 1,3-beta-D-glucurosonyl or 1,3-alpha-L-iduronosyl linkages to disaccharides containing 4-deoxy-beta-D-gluc-4-enuronosyl groups to yield a 4,5-unsaturated dermatan-sulfate disaccharide (deltaUA-GalNAc-4S).

# Drug_Target_34_Signals:
1-25

# Drug_Target_34_Specific_Function:
Cleaves the glycosaminoglycan, dermatan sulfate

# Drug_Target_34_SwissProt_ID:
Q46079

# Drug_Target_34_SwissProt_Name:
CSLB_PEDHD

# Drug_Target_34_Synonyms:
Chondroitin B eliminase
Chondroitin B lyase
Chondroitin sulfate B lyase
Chondroitinase B precursor
EC 4.2.2.19

# Drug_Target_34_Theoretical_pI:
8.94

# Drug_Target_34_Transmembrane_Regions:
None

# Drug_Target_35_Cellular_Location:
Not Available

# Drug_Target_35_Chromosome_Location:
Not Available

# Drug_Target_35_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_35_Essentiality:
Non-Essential

# Drug_Target_35_GenAtlas_ID:
Not Available

# Drug_Target_35_GenBank_ID_Gene:
X02307

# Drug_Target_35_GenBank_ID_Protein:
Not Available

# Drug_Target_35_GeneCard_ID:
Not Available

# Drug_Target_35_Gene_Name:
aspA

# Drug_Target_35_Gene_Sequence:
Not Available

# Drug_Target_35_General_Function:
Amino acid transport and metabolism

# Drug_Target_35_General_References:
2987841	Takagi JS, Ida N, Tokushige M, Sakamoto H, Shimura Y: Cloning and nucleotide sequence of the aspartase gene of Escherichia coli W. Nucleic Acids Res. 1985 Mar 25;13(6):2063-74.
3541901	Woods SA, Miles JS, Roberts RE, Guest JR: Structural and functional relationships between fumarase and aspartase. Nucleotide sequences of the fumarase (fumC) and aspartase (aspA) genes of Escherichia coli K12. Biochem J. 1986 Jul 15;237(2):547-57.
7610040	Burland V, Plunkett G 3rd, Sofia HJ, Daniels DL, Blattner FR: Analysis of the Escherichia coli genome VI: DNA sequence of the region from 92.8 through 100 minutes. Nucleic Acids Res. 1995 Jun 25;23(12):2105-19.
9230045	Shi W, Dunbar J, Jayasekera MM, Viola RE, Farber GK: The structure of L-aspartate ammonia-lyase from Escherichia coli. Biochemistry. 1997 Jul 29;36(30):9136-44.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_35_HGNC_ID:
Not Available

# Drug_Target_35_HPRD_ID:
Not Available

# Drug_Target_35_ID:
3793

# Drug_Target_35_Locus:
Not Available

# Drug_Target_35_Molecular_Weight:
52357

# Drug_Target_35_Name:
Aspartate ammonia-lyase

# Drug_Target_35_Number_of_Residues:
478

# Drug_Target_35_PDB_ID:
1JSW

# Drug_Target_35_Pathway:
Not Available

# Drug_Target_35_Pfam_Domain_Function:
PF00206	Lyase_1

# Drug_Target_35_Protein_Sequence:
>Aspartate ammonia-lyase
MSNNIRIEEDLLGTREVPADAYYGVHTLRAIENFYISNNKISDIPEFVRGMVMVKKAAAM
ANKELQTIPKSVANAIIAACDEVLNNGKCMDQFPVDVYQGGAGTSVNMNTNEVLANIGLE
LMGHQKGEYQYLNPNDHVNKCQSTNDAYPTGFRIAVYSSLIKLVDAINQLREGFERKAVE
FQDILKMGRTQLQDAVPMTLGQEFRAFSILLKEEVKNIQRTAELLLEVNLGATAIGTGLN
TPKEYSPLAVKKLAEVTGFPCVPAEDLIEATSDCGAYVMVHGALKRLAVKMSKICNDLRL
LSSGPRAGLNEINLPELQAGSSIMPAKVNPVVPEVVNQVCFKVIGNDTTVTMAAEAGQLQ
LNVMEPVIGQAMFESVHILTNACYNLLEKCINGITANKEVCEGYVYNSIGIVTYLNPFIG
HHNGDIVGKICAETGKSVREVVLERGLLTEAELDDIFSVQNLMHPAYKAKRYTDESEQ

# Drug_Target_35_Reaction:
L-aspartate = fumarate + NH3

# Drug_Target_35_Signals:
None

# Drug_Target_35_Specific_Function:
L-aspartate = fumarate + NH(3)

# Drug_Target_35_SwissProt_ID:
P0AC38

# Drug_Target_35_SwissProt_Name:
ASPA_ECOLI

# Drug_Target_35_Synonyms:
Aspartase
EC 4.3.1.1

# Drug_Target_35_Theoretical_pI:
4.96

# Drug_Target_35_Transmembrane_Regions:
None

# Drug_Target_36_Cellular_Location:
Cytoplasmic

# Drug_Target_36_Chromosome_Location:
Not Available

# Drug_Target_36_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_36_Essentiality:
Non-Essential

# Drug_Target_36_GenAtlas_ID:
Not Available

# Drug_Target_36_GenBank_ID_Gene:
AF067428

# Drug_Target_36_GenBank_ID_Protein:
3193120

# Drug_Target_36_GeneCard_ID:
Not Available

# Drug_Target_36_Gene_Name:
cel5A

# Drug_Target_36_Gene_Sequence:
>1203 bp
ATGAAAAAGATAACTACTATTTTTGTCGTATTGCTTATGACAGTGGCGTTGTTCAGTATA
GGAAACACGACTGCTGCTGATAATGATTCAGTTGTAGAAGAACATGGGCAATTAAGTATT
AGTAACGGTGAATTAGTCAATGAACGAGGCGAACAAGTTCAGTTAAAAGGGATGAGTTCC
CATGGTTTGCAATGGTACGGTCAATTTGTAAACTATGAAAGTATGAAATGGCTAAGAGAT
GATTGGGGAATAAATGTATTCCGAGCAGCAATGTATACCTCTTCAGGAGGATATATTGAT
GATCCATCAGTAAAGGAAAAAGTAAAAGAGGCTGTTGAAGCTGCGATAGACCTTGATATA
TATGTGATCATTGATTGGCATATCCTTTCAGACAATGACCCAAATATATATAAAGAAGAA
GCGAAGGATTTCTTTGATGAAATGTCAGAGTTGTATGGAGACTATCCGAATGTGATATAC
GAAATTGCAAATGAACCGAATGGTAGTGATGTTACGTGGGGCAATCAAATAAAACCGTAT
GCAGAGGAAGTCATTCCGATTATTCGTAACAATGACCCTAATAACATTATTATTGTAGGT
ACAGGTACATGGAGTCAGGATGTCCATCATGCAGCTGATAATCAGCTTGCAGATCCTAAC
GTCATGTATGCATTTCATTTTTATGCAGGGACACATGGTCAAAATTTACGAGACCAAGTA
GATTATGCATTAGATCAAGGAGCAGCGATATTTGTTAGTGAATGGGGAACAAGTGCAGCT
ACAGGTGATGGTGGCGTGTTTTTAGATGAAGCACAAGTGTGGATTGACTTTATGGATGAA
AGAAATTTAAGCTGGGCCAACTGGTCTCTAACGCATAAAGATGAGTCATCTGCAGCGTTA
ATGCCAGGTGCAAATCCAACTGGTGGTTGGACAGAGGCTGAACTATCTCCATCTGGTACA
TTTGTGAGGGAAAAAATAAGAGAATCAGCATCTATTCCGCCAAGCGATCCAACACCGCCA
TCTGATCCAGGAGAACCGGATCCAACGCCCCCAAGTGATCCAGGAGAGTATCCAGCATGG
GATCCAAATCAAATTTACACAAATGAAATTGTGTACCATAACGGCCAGCTATGGCAAGCA
AAATGGTGGACACAAAATCAAGAGCCAGGTGACCCGTACGGTCCGTGGGAACCACTCAAT
TAA

# Drug_Target_36_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_36_General_References:
9485319	Davies GJ, Dauter M, Brzozowski AM, Bjornvad ME, Andersen KV, Schulein M: Structure of the Bacillus agaradherans family 5 endoglucanase at 1.6 A and its cellobiose complex at 2.0 A resolution. Biochemistry. 1998 Feb 17;37(7):1926-32.
9718293	Davies GJ, Mackenzie L, Varrot A, Dauter M, Brzozowski AM, Schulein M, Withers SG: Snapshots along an enzymatic reaction coordinate: analysis of a retaining beta-glycoside hydrolase. Biochemistry. 1998 Aug 25;37(34):11707-13.

# Drug_Target_36_HGNC_ID:
Not Available

# Drug_Target_36_HPRD_ID:
Not Available

# Drug_Target_36_ID:
2252

# Drug_Target_36_Locus:
Not Available

# Drug_Target_36_Molecular_Weight:
44702

# Drug_Target_36_Name:
Endoglucanase 5A

# Drug_Target_36_Number_of_Residues:
400

# Drug_Target_36_PDB_ID:
1E5J

# Drug_Target_36_Pathway:
Not Available

# Drug_Target_36_Pfam_Domain_Function:
PF00150	Cellulase
PF02839	CBM_5_12

# Drug_Target_36_Protein_Sequence:
>Endoglucanase 5A
MKKITTIFVVLLMTVALFSIGNTTAADNDSVVEEHGQLSISNGELVNERGEQVQLKGMSS
HGLQWYGQFVNYESMKWLRDDWGINVFRAAMYTSSGGYIDDPSVKEKVKEAVEAAIDLDI
YVIIDWHILSDNDPNIYKEEAKDFFDEMSELYGDYPNVIYEIANEPNGSDVTWGNQIKPY
AEEVIPIIRNNDPNNIIIVGTGTWSQDVHHAADNQLADPNVMYAFHFYAGTHGQNLRDQV
DYALDQGAAIFVSEWGTSAATGDGGVFLDEAQVWIDFMDERNLSWANWSLTHKDESSAAL
MPGANPTGGWTEAELSPSGTFVREKIRESASIPPSDPTPPSDPGEPDPTPPSDPGEYPAW
DPNQIYTNEIVYHNGQLWQAKWWTQNQEPGDPYGPWEPLN

# Drug_Target_36_Reaction:
Endohydrolysis of 1,4-beta-D-glucosidic linkages in cellulose, lichenin and cereal beta-D-glucans ALL_REAC (other) R02886 R06200(G)

# Drug_Target_36_Signals:
None

# Drug_Target_36_Specific_Function:
Endohydrolysis of 1,4-beta-D-glucosidic linkages in cellulose, lichenin and cereal beta-D-glucans

# Drug_Target_36_SwissProt_ID:
O85465

# Drug_Target_36_SwissProt_Name:
GUN5_BACAG

# Drug_Target_36_Synonyms:
Alkaline cellulase
EC 3.2.1.4
Endo-1,4-beta-glucanase 5A

# Drug_Target_36_Theoretical_pI:
3.96

# Drug_Target_36_Transmembrane_Regions:
None

# Drug_Target_37_Cellular_Location:
Endoplasmic reticulum membrane

# Drug_Target_37_Chromosome_Location:
1

# Drug_Target_37_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_37_Essentiality:
Non-Essential

# Drug_Target_37_GenAtlas_ID:
Not Available

# Drug_Target_37_GenBank_ID_Gene:
AY358729

# Drug_Target_37_GenBank_ID_Protein:
37182579

# Drug_Target_37_GeneCard_ID:
LCTL

# Drug_Target_37_Gene_Name:
LCTL

# Drug_Target_37_Gene_Sequence:
>1704 bp
ATGAAGCCAGTGTGGGTCGCCACCCTTCTGTGGATGCTACTGCTGGTGCCCAGGCTGGGG
GCCGCCCGGAAGGGGTCCCCAGAAGAGGCCTCCTTCTACTATGGAACCTTCCCTCTTGGC
TTCTCCTGGGGCGTGGGCAGTTCTGCCTACCAGACGGAGGGCGCCTGGGACCAGGACGGG
AAAGGGCCTAGCATCTGGGACGTCTTCACACACAGTGGGAAGGGGAAAGTGCTTGGGAAT
GAGACGGCAGATGTAGCCTGTGACGGCTACTACAAGGTCCAGGAGGACATCATTCTGCTG
AGGGAACTGCACGTCAACCACTACCGATTCTCCCTGTCTTGGCCCCGGCTCCTGCCCACA
GGCATCCGAGCCGAGCAGGTGAACAAGAAGGGAATCGAATTCTACAGTGATCTTATCGAT
GCCCTTCTGAGCAGCAACATCACTCCCATCGTGACCTTGCACCACTGGGATCTGCCACAG
CTGCTCCAGGTCAAATACGGTGGGTGGCAGAATGTGAGCATGGCCAACTACTTCAGAGAC
TACGCCAACCTGTGCTTTGAGGCCTTTGGGGACCGTGTGAAGCACTGGATCACGTTCAGT
GATCCTCGGGCAATGGCAGAAAAAGGCTATGAGACGGGCCACCATGCGCCGGGCCTGAAG
CTCCGCGGCACCGGCCTGTACAAGGCAGCACACCACATCATTAAGGCCCACGCCAAAACC
TGGCATTCTTATAACACCACGTGGCGCAGCAAGCAGCAAGGTCTGGTGGGAATTTCACTG
AACTGTGACTGGGGGGAACCTGTGGACATTAGTAACCCCAAGGACCTAGAGGCTGCCGAG
AGATACCTACAGTTCTGTCTGGGCTGGTTTGCCAACCCCATTTATGCCGGTGACTACCCC
CAAGTCATGAAGGACTACATTGGAAGAAAGAGTGCAGAGCAAGGCCTGGAGATGTCGAGG
TTACCGGTGTTCTCACTCCAGGAGAAGAGCTACATTAAAGGCACATCCGATTTCTTGGGA
TTAGGTCATTTTACTACTCGGTACATCACGGAAAGGAACTACCCCTCCCGCCAGGGGCCC
AGCTACCAGAACGATCGTGACTTGATAGAGCTGGTTGACCCAAACTGGCCAGATCTGGGG
TCTAAATGGCTATATTCTGTGCCATGGGGATTTAGGAGGCTCCTTAACTTTGCTCAGACT
CAATACGGTGATCCTCCCATATATGTGATGGAAAATGGAGCATCTCAAAAATTCCACTGT
ACTCAATTATGTGATGAGTGGAGAATTCAATACCTTAAAGGATACATAAATGAAATGCTA
AAAGCTATAAAAGATGGTGCTAATATAAAGGGGTATACTTCCTGGTCTCTGTTGGATAAG
TTTGAATGGGAGAAAGGATACTCAGATAGATATGGATTCTACTATGTTGAATTTAACGAC
AGAAATAAGCCTCGCTATCCAAAGGCTTCAGTTCAATATTACAAGAAGATTATCATTGCC
AATGGGTTTCCCAATCCAAGAGAGGTGGAAAGTTGGTACCTCAAAGCTTTGGAAACTTGC
TCTATCAACAATCAGATGCTTGCTGCAGAGCCTTTGCTAAGTCACATGCAAATGGTTACG
GAGATCGTGGTACCCACTGTCTGCTCCCTCTGTGTCCTCATCACTGCTGTTCTACTAATG
CTCCTCCTGAGGAGGCAGAGCTGA

# Drug_Target_37_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_37_General_References:
12975309	Clark HF, Gurney AL, Abaya E, Baker K, Baldwin D, Brush J, Chen J, Chow B, Chui C, Crowley C, Currell B, Deuel B, Dowd P, Eaton D, Foster J, Grimaldi C, Gu Q, Hass PE, Heldens S, Huang A, Kim HS, Klimowski L, Jin Y, Johnson S, Lee J, Lewis L, Liao D, Mark M, Robbie E, Sanchez C, Schoenfeld J, Seshagiri S, Simmons L, Singh J, Smith V, Stinson J, Vagts A, Vandlen R, Watanabe C, Wieand D, Woods K, Xie MH, Yansura D, Yi S, Yu G, Yuan J, Zhang M, Zhang Z, Goddard A, Wood WI, Godowski P, Gray A: The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment. Genome Res. 2003 Oct;13(10):2265-70. Epub 2003 Sep 15.
15340161	Zhang Z, Henzel WJ: Signal peptide prediction based on analysis of experimentally verified cleavage sites. Protein Sci. 2004 Oct;13(10):2819-24. Epub 2004 Aug 31.

# Drug_Target_37_HGNC_ID:
GNC:15583

# Drug_Target_37_HPRD_ID:
Not Available

# Drug_Target_37_ID:
6614

# Drug_Target_37_Locus:
15q22.31

# Drug_Target_37_Molecular_Weight:
65087.8

# Drug_Target_37_Name:
Lactase-like protein

# Drug_Target_37_Number_of_Residues:
567

# Drug_Target_37_PDB_ID:
Not Available

# Drug_Target_37_Pathway:
Not Available

# Drug_Target_37_Pfam_Domain_Function:
PF00232	Glyco_hydro_1

# Drug_Target_37_Protein_Sequence:
>Lactase-like protein
MKPVWVATLLWMLLLVPRLGAARKGSPEEASFYYGTFPLGFSWGVGSSAYQTEGAWDQDG
KGPSIWDVFTHSGKGKVLGNETADVACDGYYKVQEDIILLRELHVNHYRFSLSWPRLLPT
GIRAEQVNKKGIEFYSDLIDALLSSNITPIVTLHHWDLPQLLQVKYGGWQNVSMANYFRD
YANLCFEAFGDRVKHWITFSDPRAMAEKGYETGHHAPGLKLRGTGLYKAAHHIIKAHAKA
WHSYNTTWRSKQQGLVGISLNCDWGEPVDISNPKDLEAAERYLQFCLGWFANPIYAGDYP
QVMKDYIGRKSAEQGLEMSRLPVFSLQEKSYIKGTSDFLGLGHFTTRYITERNYPSRQGP
SYQNDRDLIELVDPNWPDLGSKWLYSVPWGFRRLLNFAQTQYGDPPIYVMENGASQKFHC
TQLCDEWRIQYLKGYINEMLKAIKDGANIKGYTSWSLLDKFEWEKGYSDRYGFYYVEFND
RNKPRYPKASVQYYKKIIIANGFPNPREVESWYLKALETCSINNQMLAAEPLLSHMQMVT
EIVVPTVCSLCVLITAVLLMLLLRRQS

# Drug_Target_37_Reaction:
Not Available

# Drug_Target_37_Signals:
1-21

# Drug_Target_37_Specific_Function:
Not Available

# Drug_Target_37_SwissProt_ID:
Q6UWM7

# Drug_Target_37_SwissProt_Name:
LCTL_HUMAN

# Drug_Target_37_Synonyms:
Klotho/lactase-phlorizin hydrolase-related protein

# Drug_Target_37_Theoretical_pI:
8.12

# Drug_Target_37_Transmembrane_Regions:
542-562

# Drug_Target_38_Cellular_Location:
Secreted protein

# Drug_Target_38_Chromosome_Location:
Not Available

# Drug_Target_38_Drug_References:
Not Available

# Drug_Target_38_Essentiality:
Non-Essential

# Drug_Target_38_GenAtlas_ID:
Not Available

# Drug_Target_38_GenBank_ID_Gene:
AJ011781

# Drug_Target_38_GenBank_ID_Protein:
Not Available

# Drug_Target_38_GeneCard_ID:
Not Available

# Drug_Target_38_Gene_Name:
ams

# Drug_Target_38_Gene_Sequence:
>1911 bp
ATGTTGACCCCCACGCAGCAAGTCGGTTTGATTTTACAGTACCTCAAAACACGCATCTTG
GACATCTACACGCCCGAACAGCGCGCCGGCATCGAAAAATCCGAAGACTGGCGGCAGTTT
TCGCGCCGCATGGATACGCATTTCCCCAAACTGATGAACGAACTCGACAGCGTGTACGGC
AACAACGAAGCCCTGCTGCCTATGCTGGAAATGCTGCTGGCGCAGGCATGGCAAAGCTAT
TCCCAACGCAACTCATCCTTAAAAGATATCGATATCGCGCGCGAAAACAACCCCGATTGG
ATTTTGTCCAACAAACAAGTCGGCGGCGTGTGCTACGTTGATTTGTTTGCCGGCGATTTG
AAGGGCTTGAAAGATAAAATTCCTTATTTTCAAGAGCTTGGTTTGACTTATCTGCACCTG
ATGCCGCTGTTTAAATGCCCTGAAGGCAAAAGCGACGGCGGCTATGCGGTCAGCAGCTAC
CGCGATGTCAATCCGGCACTGGGCACAATAGGCGACTTGCGCGAAGTCATTGCTGCGCTG
CACGAAGCCGGCATTTCCGCCGTCGTCGATTTTATCTTCAACCACACCTCCAACGAACAC
GAATGGGCGCAACGCTGCGCCGCCGGCGACCCGCTTTTCGACAATTTCTACTATATTTTC
CCCGACCGCCGGATGCCCGACCAATACGACCGCACCCTGCGCGAAATCTTCCCCGACCAG
CACCCGGGCGGCTTCTCGCAACTGGAAGACGGACGCTGGGTGTGGACGACCTTCAATTCC
TTCCAATGGGACTTGAATTACAGCAACCCGTGGGTATTCCGCGCAATGGCGGGCGAAATG
CTGTTCCTTGCCAACTTGGGCGTTGACATCCTGCGTATGGATGCGGTTGCCTTTATTTGG
AAACAAATGGGGACAAGCTGCGAAAACCTGCCGCAGGCGCACGCCCTCATCCGCGCGTTC
AATGCCGTTATGCGTATTGCCGCGCCCGCCGTGTTCTTCAAATCCGAAGCCATCGTCCAC
CCCGACCAAGTCGTCCAATACATCGGGCAGGACGAATGCCAAATCGGTTACAACCCCCTG
CAAATGGCATTGTTGTGGAACACCCTTGCCACGCGCGAAGTCAACCTGCTCCATCAGGCG
CTGACCTACCGCCACAACCTGCCCGAGCATACCGCCTGGGTCAACTACGTCCGCAGCCAC
GACGACATCGGCTGGACGTTTGCCGATGAAGACGCGGCATATCTGGGCATAAGCGGCTAC
GACCACCGCCAATTCCTCAACCGCTTCTTCGTCAACCGTTTCGACGGCAGCTTCGCTCGT
GGCGTACCGTTCCAATACAACCCAAGCACAGGCGACTGCCGTGTCAGTGGTACAGCCGCG
GCATTGGTCGGCTTGGCGCAAGACGATCCCCACGCCGTTGACCGCATCAAACTCTTGTAC
AGCATTGCTTTGAGTACCGGCGGTCTGCCGCTGATTTACCTAGGCGACGAAGTGGGTACG
CTCAATGACGACGACTGGTCGCAAGACAGCAATAAGAGCGACGACAGCCGTTGGGCGCAC
CGTCCGCGCTACAACGAAGCCCTGTACGCGCAACGCAACGATCCGTCGACCGCAGCCGGG
CAAATCTATCAGGGCTTGCGCCATATGATTGCCGTCCGCCAAAGCAATCCGCGCTTCGAC
GGCGGCAGGCTGGTTACATTCAACACCAACAACAAGCACATCATCGGCTACATCCGCAAC
AATGCGCTTTTGGCATTCGGTAACTTCAGCGAATATCCGCAAACCGTTACCGCGCATACC
CTGCAAGCCATGCCCTTCAAGGCGCACGACCTCATCGGTGGCAAAACTGTCAGCCTGAAT
CAGGATTTGACGCTTCAGCCCTATCAGGTCATGTGGCTCGAAATCGCCTGA

# Drug_Target_38_General_Function:
Involved in catalytic activity

# Drug_Target_38_General_References:
10767427	Potocki de Montalk G, Remaud-Simeon M, Willemot RM, Sarcabal P, Planchot V, Monsan P: Amylosucrase from Neisseria polysaccharea: novel catalytic properties. FEBS Lett. 2000 Apr 14;471(2-3):219-23.
10828446	Sarcabal P, Remaud-Simeon M, Willemot R, Potocki de Montalk G, Svensson B, Monsan P: Identification of key amino acid residues in Neisseria polysaccharea amylosucrase. FEBS Lett. 2000 May 26;474(1):33-7.
12517860	Zhu P, Tsang RS, Tsai CM: Nonencapsulated Neisseria meningitidis strain produces amylopectin from sucrose: altering the concept for differentiation between N. meningitidis and N. polysaccharea. J Clin Microbiol. 2003 Jan;41(1):273-8.
9882648	De Montalk GP, Remaud-Simeon M, Willemot RM, Planchot V, Monsan P: Sequence analysis of the gene encoding amylosucrase from Neisseria polysaccharea and characterization of the recombinant enzyme. J Bacteriol. 1999 Jan;181(2):375-81.

# Drug_Target_38_HGNC_ID:
Not Available

# Drug_Target_38_HPRD_ID:
Not Available

# Drug_Target_38_ID:
4811

# Drug_Target_38_Locus:
Not Available

# Drug_Target_38_Molecular_Weight:
72344

# Drug_Target_38_Name:
Amylosucrase

# Drug_Target_38_Number_of_Residues:
636

# Drug_Target_38_PDB_ID:
1MW3

# Drug_Target_38_Pathway:
Not Available

# Drug_Target_38_Pfam_Domain_Function:
PF00128	Alpha-amylase

# Drug_Target_38_Protein_Sequence:
>Amylosucrase
MLTPTQQVGLILQYLKTRILDIYTPEQRAGIEKSEDWRQFSRRMDTHFPKLMNELDSVYG
NNEALLPMLEMLLAQAWQSYSQRNSSLKDIDIARENNPDWILSNKQVGGVCYVDLFAGDL
KGLKDKIPYFQELGLTYLHLMPLFKCPEGKSDGGYAVSSYRDVNPALGTIGDLREVIAAL
HEAGISAVVDFIFNHTSNEHEWAQRCAAGDPLFDNFYYIFPDRRMPDQYDRTLREIFPDQ
HPGGFSQLEDGRWVWTTFNSFQWDLNYSNPWVFRAMAGEMLFLANLGVDILRMDAVAFIW
KQMGTSCENLPQAHALIRAFNAVMRIAAPAVFFKSEAIVHPDQVVQYIGQDECQIGYNPL
QMALLWNTLATREVNLLHQALTYRHNLPEHTAWVNYVRSHDDIGWTFADEDAAYLGISGY
DHRQFLNRFFVNRFDGSFARGVPFQYNPSTGDCRVSGTAAALVGLAQDDPHAVDRIKLLY
SIALSTGGLPLIYLGDEVGTLNDDDWSQDSNKSDDSRWAHRPRYNEALYAQRNDPSTAAG
QIYQGLRHMIAVRQSNPRFDGGRLVTFNTNNKHIIGYIRNNALLAFGNFSEYPQTVTAHT
LQAMPFKAHDLIGGKTVSLNQDLTLQPYQVMWLEIA

# Drug_Target_38_Reaction:
Not Available

# Drug_Target_38_Signals:
None

# Drug_Target_38_Specific_Function:
Catalyzes the synthesis of alpha-glucan from sucrose. Catalyzes, in addition, sucrose hydrolysis, maltose and maltotriose synthesis by successive transfers of the glucosyl moiety of sucrose onto the released glucose, and finally turanose and trehalulose synthesis, these two sucrose isomers being obtained by glucosyl transfer onto fructose

# Drug_Target_38_SwissProt_ID:
Q9ZEU2

# Drug_Target_38_SwissProt_Name:
AMYS_NEIPO

# Drug_Target_38_Synonyms:
EC 2.4.1.4

# Drug_Target_38_Theoretical_pI:
5.55

# Drug_Target_38_Transmembrane_Regions:
None

# Drug_Target_39_Cellular_Location:
Secreted protein

# Drug_Target_39_Chromosome_Location:
Not Available

# Drug_Target_39_Drug_References:
Not Available

# Drug_Target_39_Essentiality:
Non-Essential

# Drug_Target_39_GenAtlas_ID:
AMY2A

# Drug_Target_39_GenBank_ID_Gene:
M18785

# Drug_Target_39_GenBank_ID_Protein:
Not Available

# Drug_Target_39_GeneCard_ID:
Not Available

# Drug_Target_39_Gene_Name:
AMY2A

# Drug_Target_39_Gene_Sequence:
>1536 bp
ATGAAGTTCTTTCTGTTGCTTTTCACCATTGGGTTCTGCTGGGCTCAGTATTCCCCAAAT
ACACAACAAGGACGGACATCTATTGTTCATCTGTTTGAATGGCGATGGGTTGATATTGCT
CTTGAATGTGAGCGATATTTAGCTCCGAAGGGATTTGGAGGGGTTCAGGTCTCTCCACCA
AATGAAAATGTTGCAATTTACAACCCTTTCAGACCTTGGTGGGAAAGATACCAACCAGTT
AGCTATAAATTATGCACAAGATCTGGAAATGAAGATGAATTTAGAAACATGGTGACTAGA
TGTAACAATGTTGGGGTTCGTATTTATGTGGATGCTGTAATTAATCATATGTGTGGTAAC
GCTGTGAGTGCAGGAACAAGCAGTACCTGTGGAAGTTACTTCAACCCTGGAAGTAGGGAC
TTTCCAGCAGTCCCATATTCTGGATGGGATTTCAATGATGGTAAATGTAAAACTGGAAGT
GGAGATATCGAGAACTACAATGATGCTACTCAGGTCAGAGATTGTCGTCTGACTGGTCTT
CTTGATCTTGCACTGGAGAAGGATTACGTGCGTTCTAAGATTGCCGAATATATGAACCAT
CTCATTGACATTGGTGTTGCAGGGTTCAGACTTGATGCTTCCAAGCACATGTGGCCTGGA
GACATAAAGGCAATTTTGGACAAACTGCATAATCTAAACAGTAACTGGTTCCCTGCAGGA
AGTAAACCTTTCATTTACCAGGAGGTAATTGATCTGGGTGGTGAGCCAATTAAAAGCAGT
GACTACTTTGGTAATGGCCGGGTGACAGAATTCAAGTATGGTGCAAAACTCGGCACAGTT
ATTCGCAAGTGGAATGGAGAGAAGATGTCTTACTTAAAGAACTGGGGAGAAGGTTGGGGT
TTCGTACCTTCTGACAGAGCGCTTGTCTTTGTGGATAACCATGACAATCAACGAGGACAT
GGGGCTGGAGGAGCCTCTATTCTTACCTTCTGGGATGCTAGGCTGTACAAAATGGCAGTT
GGATTTATGCTTGCTCATCCTTACGGATTTACACGAGTAATGTCAAGCTACCGTTGGCCA
AGACAGTTTCAAAATGGAAACGATGTTAATGATTGGGTTGGGCCACCAAATAATAATGGA
GTAATTAAAGAAGTTACTATTAATCCAGACACTACTTGTGGCAATGACTGGGTCTGTGAA
CATCGATGGCGCCAAATAAGGAACATGGTTATTTTCCGCAATGTAGTGGATGGCCAGCCT
TTTACAAATTGGTATGATAATGGGAGCAACCAAGTGGCTTTTGGGAGAGGAAACAGAGGA
TTCATTGTTTTCAACAATGATGACTGGTCATTTTCTTTAACTTTGCAAACTGGTCTTCCT
GCTGGCACATACTGTGATGTCATTTCTGGAGATAAAATTAATGGCAATTGCACAGGCATT
AAAATTTACGTTTCTGATGATGGCAAAGCTCATTTTTCTATTAGTAACTCTGCTGAAGAT
CCATTTATTGCAATTCATGCTGAATCTAAATTGTAA

# Drug_Target_39_General_Function:
Involved in alpha-amylase activity

# Drug_Target_39_General_References:
10091666	Rydberg EH, Sidhu G, Vo HC, Hewitt J, Cote HC, Wang Y, Numao S, MacGillivray RT, Overall CM, Brayer GD, Withers SG: Cloning, mutagenesis, and structural analysis of human pancreatic alpha-amylase expressed in Pichia pastoris. Protein Sci. 1999 Mar;8(3):635-43.
2450054	Horii A, Emi M, Tomita N, Nishide T, Ogawa M, Mori T, Matsubara K: Primary structure of human pancreatic alpha-amylase gene: its comparison with human salivary alpha-amylase gene. Gene. 1987;60(1):57-64.
2452973	Gumucio DL, Wiebauer K, Caldwell RM, Samuelson LC, Meisler MH: Concerted evolution of human amylase genes. Mol Cell Biol. 1988 Mar;8(3):1197-205.
3260028	Groot PC, Bleeker MJ, Pronk JC, Arwert F, Mager WH, Planta RJ, Eriksson AW, Frants RR: Human pancreatic amylase is encoded by two different genes. Nucleic Acids Res. 1988 May 25;16(10):4724.
6336237	Wise RJ, Karn RC, Larsen SH, Hodes ME, Gardell SJ, Rutter WJ: A complementary DNA sequence that predicts a human pancreatic amylase primary structure consistent with the electrophoretic mobility of the common isozyme, Amy2 A. Mol Biol Med. 1984 Oct;2(5):307-22.
6610603	Nishide T, Emi M, Nakamura Y, Matsubara K: Corrected sequences of cDNAs for human salivary and pancreatic alpha-amylases [corrected] Gene. 1984 May;28(2):263-70.
8193143	Qian M, Haser R, Buisson G, Duee E, Payan F: The active center of a mammalian alpha-amylase. Structure of the complex of a pancreatic alpha-amylase with a carbohydrate inhibitor refined to 2.2-A resolution. Biochemistry. 1994 May 24;33(20):6284-94.
8528071	Brayer GD, Luo Y, Withers SG: The structure of human pancreatic alpha-amylase at 1.8 A resolution and comparisons with related enzymes. Protein Sci. 1995 Sep;4(9):1730-42.

# Drug_Target_39_HGNC_ID:
HGNC:477

# Drug_Target_39_HPRD_ID:
Not Available

# Drug_Target_39_ID:
4513

# Drug_Target_39_Locus:
1p21

# Drug_Target_39_Molecular_Weight:
57707

# Drug_Target_39_Name:
Pancreatic alpha-amylase

# Drug_Target_39_Number_of_Residues:
511

# Drug_Target_39_PDB_ID:
1B2Y

# Drug_Target_39_Pathway:
Not Available

# Drug_Target_39_Pfam_Domain_Function:
PF00128	Alpha-amylase
PF02806	Alpha-amylase_C

# Drug_Target_39_Protein_Sequence:
>Pancreatic alpha-amylase
MKFFLLLFTIGFCWAQYSPNTQQGRTSIVHLFEWRWVDIALECERYLAPKGFGGVQVSPP
NENVAIYNPFRPWWERYQPVSYKLCTRSGNEDEFRNMVTRCNNVGVRIYVDAVINHMCGN
AVSAGTSSTCGSYFNPGSRDFPAVPYSGWDFNDGKCKTGSGDIENYNDATQVRDCRLTGL
LDLALEKDYVRSKIAEYMNHLIDIGVAGFRLDASKHMWPGDIKAILDKLHNLNSNWFPAG
SKPFIYQEVIDLGGEPIKSSDYFGNGRVTEFKYGAKLGTVIRKWNGEKMSYLKNWGEGWG
FVPSDRALVFVDNHDNQRGHGAGGASILTFWDARLYKMAVGFMLAHPYGFTRVMSSYRWP
RQFQNGNDVNDWVGPPNNNGVIKEVTINPDTTCGNDWVCEHRWRQIRNMVIFRNVVDGQP
FTNWYDNGSNQVAFGRGNRGFIVFNNDDWSFSLTLQTGLPAGTYCDVISGDKINGNCTGI
KIYVSDDGKAHFSISNSAEDPFIAIHAESKL

# Drug_Target_39_Reaction:
Not Available

# Drug_Target_39_Signals:
1-15

# Drug_Target_39_Specific_Function:
Endohydrolysis of 1,4-alpha-D-glucosidic linkages in oligosaccharides and polysaccharides

# Drug_Target_39_SwissProt_ID:
P04746

# Drug_Target_39_SwissProt_Name:
AMYP_HUMAN

# Drug_Target_39_Synonyms:
1,4-alpha-D- glucan glucanohydrolase
EC 3.2.1.1
PA
Pancreatic alpha-amylase precursor

# Drug_Target_39_Theoretical_pI:
7.05

# Drug_Target_39_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Not Available

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
GCK

# Drug_Target_3_GenBank_ID_Gene:
M88011

# Drug_Target_3_GenBank_ID_Protein:
179427

# Drug_Target_3_GeneCard_ID:
GCK

# Drug_Target_3_Gene_Name:
GCK

# Drug_Target_3_Gene_Sequence:
>1398 bp
ATGCTGGACGACAGAGCCAGGATGGAGGCCGCCAAGAAGGAGAAGGTAGAGCAGATCCTG
GCAGAGTTCCAGCTGCAGGAGGAGGACCTGAAGAAGGTGATGAGACGGATGCAGAAGGAG
ATGGACCGCGGCCTGAGGCTGGAGACCCATGAAGAGGCCAGTGTGAAGATGCTGCCCACC
TACGTGCGCTCCACCCCAGAAGGCTCAGAAGTCGGGGACTTCCTCTCCCTGGACCTGGGT
GGCACTAACTTCAGGGTGATGCTGGTGAAGGTGGGAGAAGGTGAGGAGGGGCAGTGGAGC
GTGAAGACCAAACACCAGATGTACTCCATCCCCGAGGACGCCATGACCGGCACTGCTGAG
ATGCTCTTCGACTACATCTCTGAGTGCATCTCCGACTTCCTGGACAAGCATCAGATGAAA
CACAAGAAGCTGCCCCTGGGCTTCACCTTCTCCTTTCCTGTGAGGCACGAAGACATCGAT
AAGGGCATCCTTCTCAACTGGACCAAGGGCTTCAAGGCCTCAGGAGCAGAAGGGAACAAT
GTCGTGGGGCTTCTGCGAGACGCTATCAAACGGAGAGGGGACTTTGAAATGGATGTGGTG
GCAATGGTGAATGACACGGTGGCCACGATGATCTCCTGCTACTACGAAGACCATCAGTGC
GAGGTCGGCATGATCGTGGGCACGGGCTGCAATGCCTGCTACATGGAGGAGATGCAGAAT
GTGGAGCTGGTGGAGGGGGACGAGGGCCGCATGTGCGTCAATACCGAGTGGGGCGCCTTC
GGGGACTCCGGCGAGCTGGACGAGTTCCTGCTGGAGTATGACCGCCTGGTGGACGAGAGC
TCTGCAAACCCCGGTCAGCAGCTGTATGAGAAGCTCATAGGTGGCAAGTACATGGGCGAG
CTGGTGCGGCTTGTGCTGCTCAGGCTCGTGGACGAAAACCTGCTCTTCCACGGGGAGGCC
TCCGAGCAGCTGCGCACACGCGGAGCCTTCGAGACGCGCTTCGTGTCGCAGGTGGAGAGC
GACACGGGCGACCGCAAGCAGATCTACAACATCCTGAGCACGCTGGGGCTGCGACCCTCG
ACCACCGACTGCGACATCGTGCGCCGCGCCTGCGAGAGCGTGTCTACGCGCGCTGCGCAC
ATGTGCTCGGCGGGGCTGGCGGGCGTCATCAACCGCATGCGCGAGAGCCGCAGCGAGGAC
GTAATGCGCATCACTGTGGGCGTGGATGGCTCCGTGTACAAGCTGCACCCCAGCTTCAAG
GAGCGGTTCCATGCCAGCGTGCGCAGGCTGACGCCCAGCTGCGAGATCACCTTCATCGAG
TCGGAGGAGGGCAGTGGCCGGGGCGCGGCCCTGGTCTCGGCGGTGGCCTGTAAGAAGGCC
TGTATGCTGGGCCAGTGA

# Drug_Target_3_General_Function:
Involved in hexokinase activity

# Drug_Target_3_General_References:
10588527	Ng MC, Cockburn BN, Lindner TH, Yeung VT, Chow CC, So WY, Li JK, Lo YM, Lee ZS, Cockram CS, Critchley JA, Bell GI, Chan JC: Molecular genetics of diabetes mellitus in Chinese subjects: identification of mutations in glucokinase and hepatocyte nuclear factor-1alpha genes in patients with early-onset type 2 diabetes mellitus/MODY. Diabet Med. 1999 Nov;16(11):956-63.
11106831	Nam JH, Lee HC, Kim YH, Cha BS, Song YD, Lim SK, Kim KR, Huh KB: Identification of glucokinase mutation in subjects with post-renal transplantation diabetes mellitus. Diabetes Res Clin Pract. 2000 Dec;50(3):169-76.
11372010	Njolstad PR, Sovik O, Cuesta-Munoz A, Bjorkhaug L, Massa O, Barbetti F, Undlien DE, Shiota C, Magnuson MA, Molven A, Matschinsky FM, Bell GI: Neonatal diabetes mellitus due to complete glucokinase deficiency. N Engl J Med. 2001 May 24;344(21):1588-92.
1303265	Stoffel M, Patel P, Lo YM, Hattersley AT, Lucassen AM, Page R, Bell JI, Bell GI, Turner RC, Wainscoat JS: Missense glucokinase mutation in maturity-onset diabetes of the young and mutation screening in late-onset diabetes. Nat Genet. 1992 Oct;2(2):153-6.
1354840	Tanizawa Y, Matsutani A, Chiu KC, Permutt MA: Human glucokinase gene: isolation, structural characterization, and identification of a microsatellite repeat polymorphism. Mol Endocrinol. 1992 Jul;6(7):1070-81.
1464666	Sakura H, Eto K, Kadowaki H, Simokawa K, Ueno H, Koda N, Fukushima Y, Akanuma Y, Yazaki Y, Kadowaki T: Structure of the human glucokinase gene and identification of a missense mutation in a Japanese patient with early-onset non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1992 Dec;75(6):1571-3.
1502186	Stoffel M, Froguel P, Takeda J, Zouali H, Vionnet N, Nishi S, Weber IT, Harrison RW, Pilkis SJ, Lesage S, et al.: Human glucokinase gene: isolation, characterization, and identification of two missense mutations linked to early-onset non-insulin-dependent (type 2) diabetes mellitus. Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7698-702.
1511800	Nishi S, Stoffel M, Xiang K, Shows TB, Bell GI, Takeda J: Human pancreatic beta-cell glucokinase: cDNA sequence and localization of the polymorphic gene to chromosome 7, band p 13. Diabetologia. 1992 Aug;35(8):743-7.
1612194	Koranyi LI, Tanizawa Y, Welling CM, Rabin DU, Permutt MA: Human islet glucokinase gene. Isolation and sequence analysis of full-length cDNA. Diabetes. 1992 Jul;41(7):807-11.
1871135	Tanizawa Y, Koranyi LI, Welling CM, Permutt MA: Human liver glucokinase gene: cloning and sequence determination of two alternatively spliced cDNAs. Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):7294-7.
8168652	Hager J, Blanche H, Sun F, Vaxillaire NV, Poller W, Cohen D, Czernichow P, Velho G, Robert JJ, Cohen N, et al.: Six mutations in the glucokinase gene identified in MODY by using a nonradioactive sensitive screening technique. Diabetes. 1994 May;43(5):730-3.
8194664	St Charles R, Harrison RW, Bell GI, Pilkis SJ, Weber IT: Molecular model of human beta-cell glucokinase built by analogy to the crystal structure of yeast hexokinase B. Diabetes. 1994 Jun;43(6):784-91.
8325892	Takeda J, Gidh-Jain M, Xu LZ, Froguel P, Velho G, Vaxillaire M, Cohen D, Shimada F, Makino H, Nishi S, et al.: Structure/function studies of human beta-cell glucokinase. Enzymatic properties of a sequence polymorphism, mutations associated with diabetes, and other site-directed mutants. J Biol Chem. 1993 Jul 15;268(20):15200-4.
8446612	Gidh-Jain M, Takeda J, Xu LZ, Lange AJ, Vionnet N, Stoffel M, Froguel P, Velho G, Sun F, Cohen D, et al.: Glucokinase mutations associated with non-insulin-dependent (type 2) diabetes mellitus have decreased enzymatic activity: implications for structure/function relationships. Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1932-6.
8454109	Chiu KC, Tanizawa Y, Permutt MA: Glucokinase gene variants in the common form of NIDDM. Diabetes. 1993 Apr;42(4):579-82.
8495817	Stoffel M, Bell KL, Blackburn CL, Powell KL, Seo TS, Takeda J, Vionnet N, Xiang KS, Gidh-Jain M, Pilkis SJ, et al.: Identification of glucokinase mutations in subjects with gestational diabetes mellitus. Diabetes. 1993 Jun;42(6):937-40.
9049484	Velho G, Blanche H, Vaxillaire M, Bellanne-Chantelot C, Pardini VC, Timsit J, Passa P, Deschamps I, Robert JJ, Weber IT, Marotta D, Pilkis SJ, Lipkind GM, Bell GI, Froguel P: Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families. Diabetologia. 1997 Feb;40(2):217-24.
9435328	Glaser B, Kesavan P, Heyman M, Davis E, Cuesta A, Buchs A, Stanley CA, Thornton PS, Permutt MA, Matschinsky FM, Herold KC: Familial hyperinsulinism caused by an activating glucokinase mutation. N Engl J Med. 1998 Jan 22;338(4):226-30.
9662401	Hattersley AT, Beards F, Ballantyne E, Appleton M, Harvey R, Ellard S: Mutations in the glucokinase gene of the fetus result in reduced birth weight. Nat Genet. 1998 Jul;19(3):268-70.

# Drug_Target_3_HGNC_ID:
HGNC:4195

# Drug_Target_3_HPRD_ID:
00680

# Drug_Target_3_ID:
1675

# Drug_Target_3_Locus:
7p15.3-p15.1

# Drug_Target_3_Molecular_Weight:
52192

# Drug_Target_3_Name:
Glucokinase

# Drug_Target_3_Number_of_Residues:
465

# Drug_Target_3_PDB_ID:
1V4T

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF00349	Hexokinase_1
PF03727	Hexokinase_2

# Drug_Target_3_Protein_Sequence:
>Glucokinase
MLDDRARMEAAKKEKVEQILAEFQLQEEDLKKVMRRMQKEMDRGLRLETHEEASVKMLPT
YVRSTPEGSEVGDFLSLDLGGTNFRVMLVKVGEGEEGQWSVKTKHQMYSIPEDAMTGTAE
MLFDYISECISDFLDKHQMKHKKLPLGFTFSFPVRHEDIDKGILLNWTKGFKASGAEGNN
VVGLLRDAIKRRGDFEMDVVAMVNDTVATMISCYYEDHQCEVGMIVGTGCNACYMEEMQN
VELVEGDEGRMCVNTEWGAFGDSGELDEFLLEYDRLVDESSANPGQQLYEKLIGGKYMGE
LVRLVLLRLVDENLLFHGEASEQLRTRGAFETRFVSQVESDTGDRKQIYNILSTLGLRPS
TTDCDIVRRACESVSTRAAHMCSAGLAGVINRMRESRSEDVMRITVGVDGSVYKLHPSFK
ERFHASVRRLTPSCEITFIESEEGSGRGAALVSAVACKKACMLGQ

# Drug_Target_3_Reaction:
ATP + D-glucose = ADP + D-glucose 6-phosphate

# Drug_Target_3_Signals:
None

# Drug_Target_3_Specific_Function:
Catalyzes the initial step in utilization of glucose by the beta-cell and liver at physiological glucose concentration. Glucokinase has a high Km for glucose, and so it is effective only when glucose is abundant. The role of GCK is to provide G6P for the synthesis of glycogen. Pancreatic glucokinase plays an important role in modulating insulin secretion. Hepatic glucokinase helps to facilitate the uptake and conversion of glucose by acting as an insulin-sensitive determinant of hepatic glucose usage

# Drug_Target_3_SwissProt_ID:
P35557

# Drug_Target_3_SwissProt_Name:
HXK4_HUMAN

# Drug_Target_3_Synonyms:
EC 2.7.1.2
HK IV
HK4
Hexokinase type IV
Hexokinase-4
Hexokinase-D

# Drug_Target_3_Theoretical_pI:
4.85

# Drug_Target_3_Transmembrane_Regions:
None

# Drug_Target_40_Cellular_Location:
Not Available

# Drug_Target_40_Chromosome_Location:
Not Available

# Drug_Target_40_Drug_References:
Not Available

# Drug_Target_40_Essentiality:
Non-Essential

# Drug_Target_40_GenAtlas_ID:
Not Available

# Drug_Target_40_GenBank_ID_Gene:
AF008220

# Drug_Target_40_GenBank_ID_Protein:
Not Available

# Drug_Target_40_GeneCard_ID:
Not Available

# Drug_Target_40_Gene_Name:
moxC

# Drug_Target_40_Gene_Sequence:
>1329 bp
ATGACACGTGCAGATTTTATTCAGTTTGGAGCCATGATTCACGGTGTCGGGGGAACAACT
GACGGCTGGCGTCATCCCGATGTTGATCCCTCGGCCAGCACGAATATTGAATTTTACATG
AAAAAGGCGCAAACAGCTGAAAAAGGTTTGTTTAGTTTTATTTTCATTGCAGACGGCTTA
TTTATTTCTGAAAAATCGATTCCTCATTTTTTAAACCGTTTTGAACCGATCACCATTTTA
TCTGCGCTGGCATCGGTTACCAAAAATATTGGTTTAGTAGGGACGTTCTCTACATCTTTT
ACTGAGCCATTCACTATCTCCAGACAATTGATGTCGCTGGACCATATCAGCGGGGGCAGG
GCCGGCTGGAATCTGGTTACTTCGCCGCAGGAAGGAGCGGCGCGCAACCATAGTAAGTCT
AATTTGCCAGAACACACTGAACGTTACGAGATCGCACAAGAGCATTTGGATGTTGTGCGC
GGGCTGTGGAATTCCTGGGAGCATGACGCATTTATACACAATAAGAAAACAGGGCAGTTT
TTCGATCAGGCGAAGCTTCATCGCCTGAATCATAAAGGGAAGTATTTTCAAGTAGAGGGG
CCCTTGAATATCGGGCGCTCTAAGCAGGGAGAGCCTGTAGTGTTTCAAGCGGGTTCATCA
GAAACAGGCCGGCAGTTTGCTGCTAAAAATGCGGATGCGATTTTTACCCATTCCAATTCA
TTAGAAGAGACAAAAGCGTTTTATGCGGATGTGAAAAGCCGAGCTGCTGATGAAGGGCGT
GATCCTTCAAGTGTGCGGATTTTTCCAGGGATCAGCCCGATTGTGGCAGATACGGAAGAA
GAGGCGGAAAAGAAGTATCGTGAATTTGCAGAATTGATACCGATTGAAAATGCTGTTACT
TATTTGGCCCGTTTTTTTGATGATTATGATCTGAGTGTTTACCCGTTGGATGAGCCATTT
CCCGATATTGGCGATGTGGGAAAGAATGCGTTTCAAAGCACAACAGACCGGATTAAGAGA
GAAGCAAAAGCCAGAAATCTGACATTGCGGGAGGTAGCACAGGAAATGGCTTTTCCACGG
ACTCTATTCATCGGAACACCAGAGCGTGTCGCATCCTTAATTGAAACTTGGTTCAACGCT
GAGGCGGCGGATGGGTTTATCGTTGGGTCGGATATACCGGGAACACTTGATGCTTTTGTA
GAAAAGGTGATTCCGATTCTTCAAGAAAGAGGGCTTTATCGTCAAGATTATCGCGGCGGG
ACATTGCGGGAAAATCTCGGTCTTGGCATTCCGCAGCATCAATCCGTTTTACATTCATCA
CATCATTAG

# Drug_Target_40_General_Function:
Energy production and conversion

# Drug_Target_40_General_References:
9384377	Kunst F, Ogasawara N, Moszer I, Albertini AM, Alloni G, Azevedo V, Bertero MG, Bessieres P, Bolotin A, Borchert S, Borriss R, Boursier L, Brans A, Braun M, Brignell SC, Bron S, Brouillet S, Bruschi CV, Caldwell B, Capuano V, Carter NM, Choi SK, Codani JJ, Connerton IF, Danchin A, et al.: The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature. 1997 Nov 20;390(6657):249-56.
9387221	Lapidus A, Galleron N, Sorokin A, Ehrlich SD: Sequencing and functional annotation of the Bacillus subtilis genes in the 200 kb rrnB-dnaB region. Microbiology. 1997 Nov;143 ( Pt 11):3431-41.

# Drug_Target_40_HGNC_ID:
Not Available

# Drug_Target_40_HPRD_ID:
Not Available

# Drug_Target_40_ID:
5176

# Drug_Target_40_Locus:
Not Available

# Drug_Target_40_Molecular_Weight:
49412

# Drug_Target_40_Name:
YtnJ

# Drug_Target_40_Number_of_Residues:
442

# Drug_Target_40_PDB_ID:
1TVL

# Drug_Target_40_Pathway:
Not Available

# Drug_Target_40_Pfam_Domain_Function:
Not Available

# Drug_Target_40_Protein_Sequence:
>YtnJ
MTRADFIQFGAMIHGVGGTTDGWRHPDVDPSASTNIEFYMKKAQTAEKGLFSFIFIADGL
FISEKSIPHFLNRFEPITILSALASVTKNIGLVGTFSTSFTEPFTISRQLMSLDHISGGR
AGWNLVTSPQEGAARNHSKSNLPEHTERYEIAQEHLDVVRGLWNSWEHDAFIHNKKTGQF
FDQAKLHRLNHKGKYFQVEGPLNIGRSKQGEPVVFQAGSSETGRQFAAKNADAIFTHSNS
LEETKAFYADVKSRAADEGRDPSSVRIFPGISPIVADTEEEAEKKYREFAELIPIENAVT
YLARFFDDYDLSVYPLDEPFPDIGDVGKNAFQSTTDRIKREAKARNLTLREVAQEMAFPR
TLFIGTPERVASLIETWFNAEAADGFIVGSDIPGTLDAFVEKVIPILQERGLYRQDYRGG
TLRENLGLGIPQHQSVLHSSHH

# Drug_Target_40_Reaction:
Not Available

# Drug_Target_40_Signals:
None

# Drug_Target_40_Specific_Function:
Not Available

# Drug_Target_40_SwissProt_ID:
O34974

# Drug_Target_40_SwissProt_Name:
MOXC_BACSU

# Drug_Target_40_Synonyms:
Not Available

# Drug_Target_40_Theoretical_pI:
6.09

# Drug_Target_40_Transmembrane_Regions:
None

# Drug_Target_41_Cellular_Location:
Cytoplasmic

# Drug_Target_41_Chromosome_Location:
Not Available

# Drug_Target_41_Drug_References:
Not Available

# Drug_Target_41_Essentiality:
Non-Essential

# Drug_Target_41_GenAtlas_ID:
Not Available

# Drug_Target_41_GenBank_ID_Gene:
U33212

# Drug_Target_41_GenBank_ID_Protein:
Not Available

# Drug_Target_41_GeneCard_ID:
Not Available

# Drug_Target_41_Gene_Name:
Acel_0614

# Drug_Target_41_Gene_Sequence:
>1689 bp
GTGCCGCGCGCATTGCGGCGAGTGCCTGGCTCGCGGGTGATGCTGCGGGTCGGCGTCGTC
GTCGCGGTGCTGGCATTGGTTGCCGCACTCGCCAACCTAGCCGTGCCGCGGCCGGCTCGC
GCCGCGGGCGGCGGCTATTGGCACACGAGCGGCCGGGAGATCCTGGACGCGAACAACGTG
CCGGTACGGATCGCCGGCATCAACTGGTTTGGGTTCGAAACCTGCAATTACGTCGTGCAC
GGTCTCTGGTCACGCGACTACCGCAGCATGCTCGACCAGATAAAGTCGCTCGGCTACAAC
ACAATCCGGCTGCCGTACTCTGACGACATTCTCAAGCCGGGCACCATGCCGAACAGCATC
AATTTTTACCAGATGAATCAGGACCTGCAGGGTCTGACGTCCTTGCAGGTCATGGACAAA
ATCGTCGCGTACGCCGGTCAGATCGGCCTGCGCATCATTCTTGACCGCCACCGACCGGAT
TGCAGCGGGCAGTCGGCGCTGTGGTACACGAGCAGCGTCTCGGAGGCTACGTGGATTTCC
GACCTGCAAGCGCTGGCGCAGCGCTACAAGGGAAACCCGACGGTCGTCGGCTTTGACTTG
CACAACGAGCCGCATGACCCGGCCTGCTGGGGCTGCGGCGATCCGAGCATCGACTGGCGA
TTGGCCGCCGAGCGGGCCGGAAACGCCGTGCTCTCGGTGAATCCGAACCTGCTCATTTTC
GTCGAAGGTGTGCAGAGCTACAACGGAGACTCCTACTGGTGGGGCGGCAACCTGCAAGGA
GCCGGCCAGTACCCGGTCGTGCTGAACGTGCCGAACCGCCTGGTGTACTCGGCGCACGAC
TACGCGACGAGCGTCTACCCGCAGACGTGGTTCAGCGATCCGACCTTCCCCAACAACATG
CCCGGCATCTGGAACAAGAACTGGGGATACCTCTTCAATCAGAACATTGCACCGGTATGG
CTGGGCGAATTCGGTACGACACTGCAATCCACGACCGACCAGACGTGGCTGAAGACGCTC
GTCCAGTACCTACGGCCGACCGCGCAATACGGTGCGGACAGCTTCCAGTGGACCTTCTGG
TCCTGGAACCCCGATTCCGGCGACACAGGAGGAATTCTCAAGGATGACTGGCAGACGGTC
GACACAGTAAAAGACGGCTATCTCGCGCCGATCAAGTCGTCGATTTTCGATCCTGTCGGC
GCGTCTGCATCGCCTAGCAGTCAACCGTCCCCGTCGGTGTCGCCGTCTCCGTCGCCGAGC
CCGTCGGCGAGTCGGACGCCGACGCCTACTCCGACGCCGACAGCCAGCCCGACGCCAACG
CTGACCCCTACTGCTACGCCCACGCCCACGGCAAGCCCGACGCCGTCACCGACGGCAGCC
TCCGGAGCCCGCTGCACCGCGAGTTACCAGGTCAACAGCGATTGGGGCAATGGCTTCACG
GTAACGGTGGCCGTGACAAATTCCGGATCCGTCGCGACCAAGACATGGACGGTCAGTTGG
ACATTCGGCGGAAATCAGACGATTACCAATTCGTGGAATGCAGCGGTCACGCAGAACGGT
CAGTCGGTAACGGCTCGGAATATGAGTTATAACAACGTGATTCAGCCTGGTCAGAACACC
ACGTTCGGATTCCAGGCGAGCTATACCGGAAGCAACGCGGCACCGACAGTCGCCTGCGCA
GCAAGTTAA

# Drug_Target_41_General_Function:
Involved in carbohydrate binding

# Drug_Target_41_General_References:
8718854	Sakon J, Adney WS, Himmel ME, Thomas SR, Karplus PA: Crystal structure of thermostable family 5 endocellulase E1 from Acidothermus cellulolyticus in complex with cellotetraose. Biochemistry. 1996 Aug 20;35(33):10648-60.

# Drug_Target_41_HGNC_ID:
Not Available

# Drug_Target_41_HPRD_ID:
Not Available

# Drug_Target_41_ID:
5553

# Drug_Target_41_Locus:
Not Available

# Drug_Target_41_Molecular_Weight:
60748

# Drug_Target_41_Name:
Endoglucanase E1

# Drug_Target_41_Number_of_Residues:
562

# Drug_Target_41_PDB_ID:
1ECE

# Drug_Target_41_Pathway:
Not Available

# Drug_Target_41_Pfam_Domain_Function:
PF00150	Cellulase
PF00553	CBM_2

# Drug_Target_41_Protein_Sequence:
>Endoglucanase E1
MPRALRRVPGSRVMLRVGVVVAVLALVAALANLAVPRPARAAGGGYWHTSGREILDANNV
PVRIAGINWFGFETCNYVVHGLWSRDYRSMLDQIKSLGYNTIRLPYSDDILKPGTMPNSI
NFYQMNQDLQGLTSLQVMDKIVAYAGQIGLRIILDRHRPDCSGQSALWYTSSVSEATWIS
DLQALAQRYKGNPTVVGFDLHNEPHDPACWGCGDPSIDWRLAAERAGNAVLSVNPNLLIF
VEGVQSYNGDSYWWGGNLQGAGQYPVVLNVPNRLVYSAHDYATSVYPQTWFSDPTFPNNM
PGIWNKNWGYLFNQNIAPVWLGEFGTTLQSTTDQTWLKTLVQYLRPTAQYGADSFQWTFW
SWNPDSGDTGGILKDDWQTVDTVKDGYLAPIKSSIFDPVGASASPSSQPSPSVSPSPSPS
PSASRTPTPTPTPTASPTPTLTPTATPTPTASPTPSPTAASGARCTASYQVNSDWGNGFT
VTVAVTNSGSVATKTWTVSWTFGGNQTITNSWNAAVTQNGQSVTARNMSYNNVIQPGQNT
TFGFQASYTGSNAAPTVACAAS

# Drug_Target_41_Reaction:
Not Available

# Drug_Target_41_Signals:
1-41

# Drug_Target_41_Specific_Function:
Has a very high specific activity on carboxymethylcellulose

# Drug_Target_41_SwissProt_ID:
P54583

# Drug_Target_41_SwissProt_Name:
GUN1_ACIC1

# Drug_Target_41_Synonyms:
Cellulase E1
EC 3.2.1.4
Endo-1,4-beta-glucanase E1
Endocellulase E1
Endoglucanase E1 precursor

# Drug_Target_41_Theoretical_pI:
7.08

# Drug_Target_41_Transmembrane_Regions:
None

# Drug_Target_42_Cellular_Location:
Periplasm

# Drug_Target_42_Chromosome_Location:
Not Available

# Drug_Target_42_Drug_References:
Not Available

# Drug_Target_42_Essentiality:
Non-Essential

# Drug_Target_42_GenAtlas_ID:
Not Available

# Drug_Target_42_GenBank_ID_Gene:
AE008797

# Drug_Target_42_GenBank_ID_Protein:
Not Available

# Drug_Target_42_GeneCard_ID:
Not Available

# Drug_Target_42_Gene_Name:
mglB

# Drug_Target_42_Gene_Sequence:
>999 bp
TTATTTTTGGGTAAATTCGCTCAGATTGTCTTTGTCCACGCCGACATAAGGCACGCGCAC
GATTTTGTTCTCAATCTTCCAGCTGGTGCCGTCAGCCGCGCCCTTGCCTTCGGCGAGGTT
TTTCGCCAGATCGAATGTCGCTTTCGCCTGATTGTTGGCGTCATTCAGTACCGTACCGGC
CATCGCGCCCGATTTCACCAGCGCCAGGGCTTCCGGTAACGCATCGACGCCAAAGACCGG
AATCGACGATTTATTATGCGCTTTCAGCGCCTCTACCGCGCCCATCGCCATCGCATCGTT
ATTCGCGATAACCACTTCAATCTTGTTAGCGTTCGGGCCAGACAGCCAGGCATCCATCTT
ATCTTTTGCCTGCGCGGTATCCCACATAGCGGTGTCTAACGCCAGTTGCTCGGTCTGAAT
ACCTTTATCATTTAACTCTTTCACCACATACGTCGTACGGGCTTCAGCATCCGGGTGCCC
CGGCTCGCCTTTCAGCAGAACATACTGAATTTTACCGTCTTTATTCAGATCCCAACCCTG
ATTCGCCTGCCAGTGTTTGGCAATCAAGTCGCCCTGAATCACACCGGATTCTTTAGAGTC
AGTCCCGACATAATACGCCTTGTCATAGCTGTCCAGCGCTTTGCGGGAAGGCTCTTTGTT
AAAGAACACCACCGGCACATTTTGCCCGCGCGCTTTCTCAATCACCGTACCGGCGGCTGC
CGGGTCGACCAGGTTAATCGCCAGAGCTTTAACCCCTTTCGCCAATAAAACGTCAATTTG
ATCATTCTGTTTGGACTGATCGTTTTGCGAGTCATTCATCAGTAGCTGAACATCCGGCGC
GGATTTGCCATCTTTTTCAATAGCCTTACGCACCACGGACATAAAGTTATCGTCATATTT
ATAAATCGTCACGCCAATACGAGTATCAGCCGCGTGCGCGTGCGCGCCGAATAACAGACT
TGCCATCACGGCAGAAAGGGTCAGTACCTTCTTATTCAT

# Drug_Target_42_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_42_General_References:
11677609	McClelland M, Sanderson KE, Spieth J, Clifton SW, Latreille P, Courtney L, Porwollik S, Ali J, Dante M, Du F, Hou S, Layman D, Leonard S, Nguyen C, Scott K, Holmes A, Grewal N, Mulvaney E, Ryan E, Sun H, Florea L, Miller W, Stoneking T, Nhan M, Waterston R, Wilson RK: Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature. 2001 Oct 25;413(6858):852-6.
3146019	Benner-Luger D, Boos W: The mglB sequence of Salmonella typhimurium LT2; promoter analysis by gene fusions and evidence for a divergently oriented gene coding for the mgl repressor. Mol Gen Genet. 1988 Nov;214(3):579-87.
6345536	Mowbray SL, Petsko GA: The x-ray structure of the periplasmic galactose binding protein from Salmonella typhimurium at 3.0-A resolution. J Biol Chem. 1983 Jul 10;258(13):7991-7.
8132630	Flocco MM, Mowbray SL: The 1.9 A x-ray structure of a closed unliganded form of the periplasmic glucose/galactose receptor from Salmonella typhimurium. J Biol Chem. 1994 Mar 25;269(12):8931-6.
8240551	Zou JY, Flocco MM, Mowbray SL: The 1.7 A refined X-ray structure of the periplasmic glucose/galactose receptor from Salmonella typhimurium. J Mol Biol. 1993 Oct 20;233(4):739-52.

# Drug_Target_42_HGNC_ID:
Not Available

# Drug_Target_42_HPRD_ID:
Not Available

# Drug_Target_42_ID:
5554

# Drug_Target_42_Locus:
Not Available

# Drug_Target_42_Molecular_Weight:
35814

# Drug_Target_42_Name:
D-galactose-binding periplasmic protein

# Drug_Target_42_Number_of_Residues:
332

# Drug_Target_42_PDB_ID:
1GCG

# Drug_Target_42_Pathway:
Not Available

# Drug_Target_42_Pfam_Domain_Function:
PF00532	Peripla_BP_1

# Drug_Target_42_Protein_Sequence:
>D-galactose-binding periplasmic protein
MNKKVLTLSAVMASLLFGAHAHAADTRIGVTIYKYDDNFMSVVRKAIEKDGKSAPDVQLL
MNDSQNDQSKQNDQIDVLLAKGVKALAINLVDPAAAGTVIEKARGQNVPVVFFNKEPSRK
ALDSYDKAYYVGTDSKESGVIQGDLIAKHWQANQGWDLNKDGKIQYVLLKGEPGHPDAEA
RTTYVVKELNDKGIQTEQLALDTAMWDTAQAKDKMDAWLSGPNANKIEVVIANNDAMAMG
AVEALKAHNKSSIPVFGVDALPEALALVKSGAMAGTVLNDANNQAKATFDLAKNLAEGKG
AADGTSWKIENKIVRVPYVGVDKDNLSEFTQK

# Drug_Target_42_Reaction:
Not Available

# Drug_Target_42_Signals:
1-23

# Drug_Target_42_Specific_Function:
This protein is involved in the active transport of galactose and glucose. It plays a role in the chemotaxis towards the two sugars by interacting with the trg chemoreceptor

# Drug_Target_42_SwissProt_ID:
P23905

# Drug_Target_42_SwissProt_Name:
DGAL_SALTY

# Drug_Target_42_Synonyms:
D-galactose-binding periplasmic protein precursor
D-galactose/ D-glucose-binding protein
GBP
GGBP

# Drug_Target_42_Theoretical_pI:
6.07

# Drug_Target_42_Transmembrane_Regions:
None

# Drug_Target_43_Cellular_Location:
Periplasm

# Drug_Target_43_Chromosome_Location:
Not Available

# Drug_Target_43_Drug_References:
Not Available

# Drug_Target_43_Essentiality:
Non-Essential

# Drug_Target_43_GenAtlas_ID:
Not Available

# Drug_Target_43_GenBank_ID_Gene:
M60876

# Drug_Target_43_GenBank_ID_Protein:
Not Available

# Drug_Target_43_GeneCard_ID:
Not Available

# Drug_Target_43_Gene_Name:
eco

# Drug_Target_43_Gene_Sequence:
>489 bp
ATGAAGACCATTCTACCTGCAGTATTGTTTGCCGCTTTCGCTACCACTTCCGCCTGGGCG
GCAGAAAGCGTCCAGCCACTGGAAAAAATCGCGCCTTATCCACAAGCTGAAAAAGGGATG
AAGCGTCAGGTGATTCAGTTAACCCCGCAAGAAGATGAATCTACCCTGAAAGTAGAACTG
TTAATCGGTCAGACGCTGGAAGTCGATTGCAATTTGCATCGTCTCGGCGGGAAGCTGGAA
AACAAAACGCTGGAAGGCTGGGGCTATGATTATTATGTCTTTGATAAAGTCAGTTCCCCG
GTTTCAACGATGATGGCCTGCCCGGATGGCAAGAAAGAGAAGAAATTTGTCACCGCGTAT
CTGGGCGATGCTGGAATGCTGCGTTACAACAGCAAGCTGCCGATCGTGGTGTATACGCCA
GACAATGTAGATGTGAAGTACCGCGTCTGGAAGGCGGAAGAGAAAATTGACAACGCGGTA
GTTCGCTAA

# Drug_Target_43_General_Function:
Not Available

# Drug_Target_43_General_References:
1879537	Lee HR, Seo JH, Kim OM, Lee CS, Suh SW, Hong YM, Tanaka K, Ichihara A, Ha DB, Chung CH: Molecular cloning of the ecotin gene in Escherichia coli. FEBS Lett. 1991 Aug 5;287(1-2):53-6.
2007606	McGrath ME, Hines WM, Sakanari JA, Fletterick RJ, Craik CS: The sequence and reactive site of ecotin. A general inhibitor of pancreatic serine proteases from Escherichia coli. J Biol Chem. 1991 Apr 5;266(10):6620-5.
8156987	McGrath ME, Erpel T, Bystroff C, Fletterick RJ: Macromolecular chelation as an improved mechanism of protease inhibition: structure of the ecotin-trypsin complex. EMBO J. 1994 Apr 1;13(7):1502-7.
8931142	Shin DH, Song HK, Seong IS, Lee CS, Chung CH, Suh SW: Crystal structure analyses of uncomplexed ecotin in two crystal forms: implications for its function and stability. Protein Sci. 1996 Nov;5(11):2236-47.
9097040	Itoh T, Aiba H, Baba T, Hayashi K, Inada T, Isono K, Kasai H, Kimura S, Kitakawa M, Kitagawa M, Makino K, Miki T, Mizobuchi K, Mori H, Mori T, Motomura K, Nakade S, Nakamura Y, Nashimoto H, Nishio Y, Oshima T, Saito N, Sampei G, Seki Y, Horiuchi T, et al.: A 460-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 40.1-50.0 min region on the linkage map. DNA Res. 1996 Dec 31;3(6):379-92.
9154920	Perona JJ, Tsu CA, Craik CS, Fletterick RJ: Crystal structure of an ecotin-collagenase complex suggests a model for recognition and cleavage of the collagen triple helix. Biochemistry. 1997 May 6;36(18):5381-92.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9298646	Link AJ, Robison K, Church GM: Comparing the predicted and observed properties of proteins encoded in the genome of Escherichia coli K-12. Electrophoresis. 1997 Aug;18(8):1259-313.

# Drug_Target_43_HGNC_ID:
Not Available

# Drug_Target_43_HPRD_ID:
Not Available

# Drug_Target_43_ID:
5046

# Drug_Target_43_Locus:
Not Available

# Drug_Target_43_Molecular_Weight:
18192

# Drug_Target_43_Name:
Ecotin

# Drug_Target_43_Number_of_Residues:
162

# Drug_Target_43_PDB_ID:
1N8O

# Drug_Target_43_Pathway:
Not Available

# Drug_Target_43_Pfam_Domain_Function:
PF03974	Ecotin

# Drug_Target_43_Protein_Sequence:
>Ecotin
MKTILPAVLFAAFATTSAWAAESVQPLEKIAPYPQAEKGMKRQVIQLTPQEDESTLKVEL
LIGQTLEVDCNLHRLGGKLENKTLEGWGYDYYVFDKVSSPVSTMMACPDGKKEKKFVTAY
LGDAGMLRYNSKLPIVVYTPDNVDVKYRVWKAEEKIDNAVVR

# Drug_Target_43_Reaction:
Not Available

# Drug_Target_43_Signals:
1-20

# Drug_Target_43_Specific_Function:
General inhibitor of pancreatic serine proteases:inhibits chymotrypsin, trypsin, elastases, factor X, kallikrein as well as a variety of other proteases. The strength of inhibition does not appear to be correlated with a particular protease specificity

# Drug_Target_43_SwissProt_ID:
P23827

# Drug_Target_43_SwissProt_Name:
ECOT_ECOLI

# Drug_Target_43_Synonyms:
Ecotin precursor

# Drug_Target_43_Theoretical_pI:
7.25

# Drug_Target_43_Transmembrane_Regions:
None

# Drug_Target_44_Cellular_Location:
Cytoplasmic

# Drug_Target_44_Chromosome_Location:
Not Available

# Drug_Target_44_Drug_References:
Not Available

# Drug_Target_44_Essentiality:
Non-Essential

# Drug_Target_44_GenAtlas_ID:
Not Available

# Drug_Target_44_GenBank_ID_Gene:
X52391

# Drug_Target_44_GenBank_ID_Protein:
Not Available

# Drug_Target_44_GeneCard_ID:
Not Available

# Drug_Target_44_Gene_Name:
mutY

# Drug_Target_44_Gene_Sequence:
>1053 bp
ATGCAAGCGTCGCAATTTTCAGCCCAGGTTCTGGACTGGTACGATAAATACGGGCGAAAA
ACTCTGCCCTGGCAAATTGACAAGACGCCCTACAAAGTATGGCTCTCAGAAGTGATGTTG
CAACAAACTCAGGTTGCGACCGTTATCCCCTATTTTGAACGCTTTATGGCGCGCTTCCCG
ACGGTGACCGATCTCGCCAATGCGCCGCTCGACGAAGTTCTCCACTTGTGGACCGGGCTT
GGCTATTACGCCCGCGCGCGCAATCTGCATAAAGCGGCACAACAAGTGGCGACCTTACAC
GGCGGTAAATTCCCGGAAACCTTTGAGGAAGTTGCAGCACTGCCGGGCGTCGGGCGTTCC
ACCGCAGGCGCGATTCTCTCGCTTTCTCTGGGTAAGCACTTTCCGATTCTCGACGGTAAC
GTCAAACGCGTGCTGGCGCGCTGCTATGCTGTAAGCGGCTGGCCTGGGAAAAAAGAGGTC
GAGAATAAATTATGGAGTTTGAGCGAGCAGGTGACGCCCGCGGTTGGCGTGGAACGGTTT
AATCAGGCGATGATGGATTTGGGTGCGATGATTTGTACGCGCTCGAAACCGAAATGTTCG
CTCTGTCCGCTACAAAACGGATGTATTGCCGCCGCCAACAATAGCTGGGCGCTTTATCCG
GGCAAAAAACCGAAACAGACGCTGCCGGAGCGCACCGGCTACTTTTTGCTATTACAGCAC
GAAGATGAAGTATTGCTGGCGCAGCGTCCGCCGAGCGGATTGTGGGGCGGTTTATACTGT
TTCCCGCAGTTTGCCGACGAAGAAAGTTTGCGGCAGTGGCTGGCGCAACGGCAGATTGCT
GCCGATAACCTGACGCAACTGACCGCGTTTCGGCATACCTTCAGCCATTTCCACTTAGAT
ATTGTGCCTATGTGGCTTCCCGTGTCGTCATTCACCGGCTGCATGGATGAAGGCAATGCG
CTCTGGTATAACTTAGCGCAACCGCCGTCAGTTGGCCTAGCGGCTCCCGTGGAGCGTTTG
TTACAGCAGTTACGCACTGGCGCGCCGGTTTAG

# Drug_Target_44_General_Function:
Involved in catalytic activity

# Drug_Target_44_General_References:
2001994	Tsai-Wu JJ, Radicella JP, Lu AL: Nucleotide sequence of the Escherichia coli micA gene required for A/G-specific mismatch repair: identity of micA and mutY. J Bacteriol. 1991 Mar;173(6):1902-10.
2197596	Michaels ML, Pham L, Nghiem Y, Cruz C, Miller JH: MutY, an adenine glycosylase active on G-A mispairs, has homology to endonuclease III. Nucleic Acids Res. 1990 Jul 11;18(13):3841-5.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9846876	Guan Y, Manuel RC, Arvai AS, Parikh SS, Mol CD, Miller JH, Lloyd S, Tainer JA: MutY catalytic core, mutant and bound adenine structures define specificity for DNA repair enzyme superfamily. Nat Struct Biol. 1998 Dec;5(12):1058-64.

# Drug_Target_44_HGNC_ID:
Not Available

# Drug_Target_44_HPRD_ID:
Not Available

# Drug_Target_44_ID:
4692

# Drug_Target_44_Locus:
Not Available

# Drug_Target_44_Molecular_Weight:
39149

# Drug_Target_44_Name:
A/G-specific adenine glycosylase

# Drug_Target_44_Number_of_Residues:
350

# Drug_Target_44_PDB_ID:
1KG3

# Drug_Target_44_Pathway:
Not Available

# Drug_Target_44_Pfam_Domain_Function:
PF00633	HHH
PF00730	HhH-GPD

# Drug_Target_44_Protein_Sequence:
>A/G-specific adenine glycosylase
MQASQFSAQVLDWYDKYGRKTLPWQIDKTPYKVWLSEVMLQQTQVATVIPYFERFMARFP
TVTDLANAPLDEVLHLWTGLGYYARARNLHKAAQQVATLHGGKFPETFEEVAALPGVGRS
TAGAILSLSLGKHFPILDGNVKRVLARCYAVSGWPGKKEVENKLWSLSEQVTPAVGVERF
NQAMMDLGAMICTRSKPKCSLCPLQNGCIAAANNSWALYPGKKPKQTLPERTGYFLLLQH
EDEVLLAQRPPSGLWGGLYCFPQFADEESLRQWLAQRQIAADNLTQLTAFRHTFSHFHLD
IVPMWLPVSSFTGCMDEGNALWYNLAQPPSVGLAAPVERLLQQLRTGAPV

# Drug_Target_44_Reaction:
Not Available

# Drug_Target_44_Signals:
None

# Drug_Target_44_Specific_Function:
Adenine glycosylase active on G-A mispairs. MutY also corrects error-prone DNA synthesis past go lesions which are due to the oxidatively damaged form of guanine:7,8-dihydro-8- oxoguanine

# Drug_Target_44_SwissProt_ID:
P17802

# Drug_Target_44_SwissProt_Name:
MUTY_ECOLI

# Drug_Target_44_Synonyms:
EC 3.2.2.-

# Drug_Target_44_Theoretical_pI:
8.46

# Drug_Target_44_Transmembrane_Regions:
None

# Drug_Target_45_Cellular_Location:
Not Available

# Drug_Target_45_Chromosome_Location:
Not Available

# Drug_Target_45_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_45_Essentiality:
Non-Essential

# Drug_Target_45_GenAtlas_ID:
Not Available

# Drug_Target_45_GenBank_ID_Gene:
Not Available

# Drug_Target_45_GenBank_ID_Protein:
Not Available

# Drug_Target_45_GeneCard_ID:
Not Available

# Drug_Target_45_Gene_Name:
KRTAP5-2

# Drug_Target_45_Gene_Sequence:
Not Available

# Drug_Target_45_General_Function:
Not Available

# Drug_Target_45_General_References:
Not Available

# Drug_Target_45_HGNC_ID:
Not Available

# Drug_Target_45_HPRD_ID:
Not Available

# Drug_Target_45_ID:
7002

# Drug_Target_45_Locus:
Not Available

# Drug_Target_45_Molecular_Weight:
Not Available

# Drug_Target_45_Name:
Keratin-associated protein 5-2

# Drug_Target_45_Number_of_Residues:
0

# Drug_Target_45_PDB_ID:
Not Available

# Drug_Target_45_Pathway:
Not Available

# Drug_Target_45_Pfam_Domain_Function:
Not Available

# Drug_Target_45_Protein_Sequence:
Not Available

# Drug_Target_45_Reaction:
Not Available

# Drug_Target_45_Signals:
Not Available

# Drug_Target_45_Specific_Function:
Not Available

# Drug_Target_45_SwissProt_ID:
Q701N4

# Drug_Target_45_SwissProt_Name:
KRA52_HUMAN

# Drug_Target_45_Synonyms:
Not Available

# Drug_Target_45_Theoretical_pI:
Not Available

# Drug_Target_45_Transmembrane_Regions:
Not Available

# Drug_Target_46_Cellular_Location:
Not Available

# Drug_Target_46_Chromosome_Location:
Not Available

# Drug_Target_46_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_46_Essentiality:
Non-Essential

# Drug_Target_46_GenAtlas_ID:
Not Available

# Drug_Target_46_GenBank_ID_Gene:
Not Available

# Drug_Target_46_GenBank_ID_Protein:
Not Available

# Drug_Target_46_GeneCard_ID:
Not Available

# Drug_Target_46_Gene_Name:
SIGLEC1

# Drug_Target_46_Gene_Sequence:
Not Available

# Drug_Target_46_General_Function:
Not Available

# Drug_Target_46_General_References:
Not Available

# Drug_Target_46_HGNC_ID:
Not Available

# Drug_Target_46_HPRD_ID:
Not Available

# Drug_Target_46_ID:
7102

# Drug_Target_46_Locus:
Not Available

# Drug_Target_46_Molecular_Weight:
Not Available

# Drug_Target_46_Name:
Sialoadhesin

# Drug_Target_46_Number_of_Residues:
0

# Drug_Target_46_PDB_ID:
Not Available

# Drug_Target_46_Pathway:
Not Available

# Drug_Target_46_Pfam_Domain_Function:
Not Available

# Drug_Target_46_Protein_Sequence:
Not Available

# Drug_Target_46_Reaction:
Not Available

# Drug_Target_46_Signals:
Not Available

# Drug_Target_46_Specific_Function:
Not Available

# Drug_Target_46_SwissProt_ID:
Q9BZZ2

# Drug_Target_46_SwissProt_Name:
SN_HUMAN

# Drug_Target_46_Synonyms:
Not Available

# Drug_Target_46_Theoretical_pI:
Not Available

# Drug_Target_46_Transmembrane_Regions:
Not Available

# Drug_Target_47_Cellular_Location:
Cytoplasmic

# Drug_Target_47_Chromosome_Location:
Not Available

# Drug_Target_47_Drug_References:
Not Available

# Drug_Target_47_Essentiality:
Non-Essential

# Drug_Target_47_GenAtlas_ID:
Not Available

# Drug_Target_47_GenBank_ID_Gene:
M28138

# Drug_Target_47_GenBank_ID_Protein:
Not Available

# Drug_Target_47_GeneCard_ID:
Not Available

# Drug_Target_47_Gene_Name:
nplT

# Drug_Target_47_Gene_Sequence:
>1767 bp
ATGAGGAAAGAAGCCATCTACCACCGCCCGGCTGACAACTTCGCCTATGCCTATGATAGT
GAGACACTTCATCTTCGGCTTCGAACAAAAAAAGACGATATCGATCGTGTTGAGCTGCTG
CATGGTGACCCGTATGACTGGCAAAATGGAGCTTGGCAGTTTCAAATGATGCCGATGCGA
AAAACAGGAAGTGACGAGTTGTTTGATTATTGGTTCGCCGAAGTCAAACCTCCCTATCGC
CGGTTACGCTACGGGTTCGTGCTGTATTCAGGAGAGGAGAAGCTCGTTTATACAGAAAAA
GGGTTTTACTTTGAGGTTCCAACCGATGATACGGCTTACTACTTTTGCTTTCCCTTTCTT
CATCGAGTCGACTTGTTCGAGGCGCCGGATTGGGTAAAGGATACAGTCTGGTATCAAATT
TTCCCTGAGCGGTTCGCCAACGGCAACCCATCAATCAGTCCAGAAGGATCGCGGCCGTGG
GGGAGCGAGGATCCAACACCAACCAGCTTTTTTGGCGGCGACTTGCAAGGGATTATCGAT
CATCTCGATTACCTTGTTGACCTTGGTATTACCGGTATTTACTTAACGCCGATCTTCCGT
TCTCCGTCAAACCATAAATACGATACCGCTGATTATTTTGAAGTCGATCCACACTTTGGG
GATAAAGAAACGTTGAAAACGCTCATCGACCGTTGCCATGAAAAAGGTATCCGCGTTATG
CTCGATGCCGTGTTTAACCATTGCGGCTATGAGTTCGCCCCGTTCCAAGATGTATGGAAA
AATGGTGAGTCCTCAAAATATAAGGACTGGTTTCACATTCATGAATTTCCGCTGCAAACA
GAGCCGCGGCCGAATTACGATACATTTCGATTCGTGCCACAAATGCCAAAGCTGAACACC
GCCAATCCAGAAGTGAAGCGTTATTTGCTTGATGTTGCGACATATTGGATTCGTGAGTTT
GACATTGACGGTTGGCGGCTTGATGTTGCCAATGAAATCGACCACGAATTTTGGCGCGAG
TTCCGCCAGGAGGTAAAGGCACTGAAACCGGACGTATACATCCTCGGGGAAATTTGGCAT
GATGCGATGCCGTGGCTGCGCGGTGACCAGTTTGACGCAGTCATGAACTACCCGTTTACA
GACGGGGTGCTCCGCTTTTTCGCCAAGGAAGAGATTAGTGCACGCCAGTTTGCTAATCAA
ATGATGCATGTACTTCATTCGTATCCGAACAATGTCAACGAGGCCGCATTCAATTTGCTC
GGCAGTCATGATACATCAAGAATTCTCACCGTTTGCGGCGGGGATATCCGCAAGGTGAAG
TTGTTATTTTTGTTTCAACTGACGTTCACGGGTTCACCATGCATTTACTATGGGGATGAA
ATCGGCATGACGGGCGGAAACGATCCCGAGTGCCGGAAGTGCATGGTGTGGGATCCGATG
CAACAAAACAAAGAGCTGCACCAACACGTCAAGCAGCTGATAGCGCTGCGCAAACAGTAT
CGGTCACTACGCCGCGGGGAAATCTCCTTTCTTCATGCCGATGATGAAATGAACTATCTT
ATTTACAAAAAAACAGATGGAGATGAAACGGTGTTAGTCATCATCAATCGGAGCGACCAA
AAAGCCGACATCCCGATCCCGCTCGATGCAAGAGGAACATGGCTCGTTAACCTCTTGACT
GGGGAACGGTTTGCAGCCGAGGCAGAAACGCTTTGCACCTCCTTACCGCCCTATGGGTTT
GTACTTTATGCAATAGAACATTGGTAG

# Drug_Target_47_General_Function:
Involved in catalytic activity

# Drug_Target_47_General_References:
12547200	Hondoh H, Kuriki T, Matsuura Y: Three-dimensional structure and substrate binding of Bacillus stearothermophilus neopullulanase. J Mol Biol. 2003 Feb 7;326(1):177-88.
2482332	Kuriki T, Imanaka T: Nucleotide sequence of the neopullulanase gene from Bacillus stearothermophilus. J Gen Microbiol. 1989 Jun;135(6):1521-8.

# Drug_Target_47_HGNC_ID:
Not Available

# Drug_Target_47_HPRD_ID:
Not Available

# Drug_Target_47_ID:
5559

# Drug_Target_47_Locus:
Not Available

# Drug_Target_47_Molecular_Weight:
69146

# Drug_Target_47_Name:
Neopullulanase

# Drug_Target_47_Number_of_Residues:
588

# Drug_Target_47_PDB_ID:
1J0I

# Drug_Target_47_Pathway:
Not Available

# Drug_Target_47_Pfam_Domain_Function:
PF00128	Alpha-amylase
PF02903	Alpha-amylase_N

# Drug_Target_47_Protein_Sequence:
>Neopullulanase
MRKEAIYHRPADNFAYAYDSETLHLRLRTKKDDIDRVELLHGDPYDWQNGAWQFQMMPMR
KTGSDELFDYWFAEVKPPYRRLRYGFVLYSGEEKLVYTEKGFYFEVPTDDTAYYFCFPFL
HRVDLFEAPDWVKDTVWYQIFPERFANGNPSISPEGSRPWGSEDPTPTSFFGGDLQGIID
HLDYLVDLGITGIYLTPIFRSPSNHKYDTADYFEVDPHFGDKETLKTLIDRCHEKGIRVM
LDAVFNHCGYEFAPFQDVWKNGESSKYKDWFHIHEFPLQTEPRPNYDTFRFVPQMPKLNT
ANPEVKRYLLDVATYWIREFDIDGWRLDVANEIDHEFWREFRQEVKALKPDVYILGEIWH
DAMPWLRGDQFDAVMNYPFTDGVLRFFAKEEISARQFANQMMHVLHSYPNNVNEAAFNLL
GSHDTSRILTVCGGDIRKVKLLFLFQLTFTGSPCIYYGDEIGMTGGNDPECRKCMVWDPM
QQNKELHQHVKQLIALRKQYRSLRRGEISFLHADDEMNYLIYKKTDGDETVLVIINRSDQ
KADIPIPLDARGTWLVNLLTGERFAAEAETLCTSLPPYGFVLYAIEHW

# Drug_Target_47_Reaction:
Not Available

# Drug_Target_47_Signals:
None

# Drug_Target_47_Specific_Function:
Hydrolyzes pullulan efficiently but only a small amount of starch. Endohydrolysis of 1,4-alpha-glucosidic linkages in pullulan to form panose. Cleaves also (1-6)-alpha-glucosidic linkages to form maltotriose

# Drug_Target_47_SwissProt_ID:
P38940

# Drug_Target_47_SwissProt_Name:
NEPU_GEOSE

# Drug_Target_47_Synonyms:
EC 3.2.1.135

# Drug_Target_47_Theoretical_pI:
5.09

# Drug_Target_47_Transmembrane_Regions:
None

# Drug_Target_48_Cellular_Location:
Cytoplasmic

# Drug_Target_48_Chromosome_Location:
Not Available

# Drug_Target_48_Drug_References:
Not Available

# Drug_Target_48_Essentiality:
Non-Essential

# Drug_Target_48_GenAtlas_ID:
Not Available

# Drug_Target_48_GenBank_ID_Gene:
Z46264

# Drug_Target_48_GenBank_ID_Protein:
Not Available

# Drug_Target_48_GeneCard_ID:
Not Available

# Drug_Target_48_Gene_Name:
xynA

# Drug_Target_48_Gene_Sequence:
>3180 bp
ATGCAAGTCAGGAAGAGACGGGGTCTTCTGGATGTTTCAACCGCCGTACTGGTGGGGATT
TTAGCGGGTTTTCTCGGTGTCGTACTGGCAGCATCGGGTGTTCTGAGTTTCGGGAAAGAA
GCCTCCTCTAAGGGAGATTCTTCTCTCGAAACAGTTCTTGCTTTGAGTTTTGAAGGAACA
ACAGAAGGTGTGGTCCCATTTGGAAAAGACGTTGTTCTCACAGCTTCTCAGGATGTAGCA
GCAGATGGTGAGTACTCTCTAAAGGTCGAGAACAGAACCTCCCCATGGGATGGGGTAGAA
ATCGACCTGACCGGAAAGGTAAAATCCGGAGCAGATTACCTTCTTTCCTTCCAGGTCTAT
CAATCTTCTGATGCTCCACAGCTGTTCAACGTAGTCGCGAGAACAGAAGATGAGAAGGGA
GAGAGGTACGACGTCATACTCGACAAGGTTGTCGTATCAGATCACTGGAAAGAGATCTTA
GTACCGTTCTCACCCACGTTCGAAGGCACACCCGCAAAATACTCTCTCATCATCGTAGCG
TCTAAAAACACGAATTTCAATTTCTACCTTGACAAGGTTCAGGTACTTGCTCCAAAAGAA
TCGGGCCCAAAGGTCATCTACGAAACATCCTTTGAAAACGGTGTTGGAGACTGGCAGCCC
AGAGGAGACGTGAACATCGAAGCTTCATCTGAAGTGGCACATTCAGGTAAGAGTTCGCTC
TTTATCTCCAACAGGCAGAAGGGCTGGCAGGGTGCCCAGATCAACTTGAAAGGAATCCTG
AAAACAGGAAAAACCTACGCCTTTGAAGCCTGGGTCTATCAGAACTCCGGTCAAGATCAG
ACGATCATCATGACAATGCAGAGAAAGTACTCATCCGACGCGAGCACACAGTACGAATGG
ATAAAATCAGCCACTGTACCATCTGGTCAGTGGGTGCAGCTTTCTGGAACGTACACAATC
CCGGCCGGAGTTACCGTGGAAGATCTCACGCTTTACTTCGAATCTCAAAATCCAACTCTC
GAGTTCTACGTAGACGACGTGAAGATAGTGGATACAACTTCCGCAGAGATAAAGATTGAA
ATGGAACCTGAAAAAGAGATACCTGCTCTGAAAGAAGTACTAAAAGACTACTTCAAAGTC
GGAGTTGCACTGCCGTCCAAGGTCTTCCTCAACCCGAAGGACATAGAACTCATCACGAAA
CACTTCAACAGCATCACCGCAGAAAACGAGATGAAACCAGAGAGCCTGCTCGCGGGCATC
GAAAACGGTAAGCTGAAGTTCAGGTTTGAAACAGCAGACAAATACATTCAGTTCGTCGAG
GAAAACGGCATGGTTATAAGAGGTCACACACTGGTGTGGCACAACCAGACACCCGACTGG
TTCTTCAAAGACGAAAACGGAAACCTCCTCTCCAAAGAAGCGATGACGGAAAGACTCAAA
GAGTACATCCACACCGTTGTCGGACACTTCAAAGGAAAAGTCTACGCATGGGACGTGGTG
AACGAAGCGGTCGATCCGAACCAGCCGGATGGACTGAGAAGATCCACCTGGTACCAGATC
ATGGGGCCTGACTACATAGAACTCGCCTTCAAGTTCGCAAGAGAAGCAGATCCAGATGCA
AAACTCTTCTACAACGACTACAACACATTCGAGCCCAGAAAGAGAGATATCATCTACAAC
CTCGTGAAGGATCTCAAGGAGAAGGGACTCATCGATGGGATAGGCATGCAGTGTCACATC
AGTCTTGCAACAGACATCAAACAGATCGAAGAGGCCATCAAAAAGTTCAGCACCATACCC
GGTATAGAAATTCACATCACAGAACTCGATATGAGTGTCTACAGAGATTCCAGTTCCAAC
TACCCAGAGGCACCGAGGACGGCACTCATCGAACAGGCTCACAAAATGATGCAGCTCTTT
GAGATTTTCAAGAAGTACAGCAACGTGATCACGAACGTCACATTCTGGGGTCTCAAGGAC
GATTACTCCTGGAGAGCAACAAGAAGAAACGACTGGCCGCTCATCTTCGACAAAGATCAC
CAGGCGAAACTCGCTTACTGGGCGATAGTGGCACCTGAGGTCCTTCCACCACTTCCAAAA
GAAAGCAGGATCTCCGAAGGCGAGGCTGTGGTAGTGGGGATGATGGATGACTCGTACCTG
ATGTCGAAGCCGATAGAGATCCTTGACGAAGAAGGGAACGTGAAGGCAACGATCAGGGCG
GTGTGGAAAGACAGCACGATCTACATCTACGGAGAGGTACAGGACAAGACGAAAAAACCA
GCAGAAGACGGAGTGGCCATATTCATCAACCCGAACAACGAAAGAACACCCTATCTGCAG
CCTGATGACACCTACGCTGTGCTGTGGACAAACTGGAAGACGGAGGTCAACAGAGAAGAC
GTACAGGTGAAGAAATTCGTTGGCCCTGGCTTTAGAAGATACAGCTTCGAGATGTCGATC
ACGATACCGGGTGTGGAGTTCAAGAAAGACAGCTACATAGGATTCGACGCTGCGGTGATA
GACGACGGGAAGTGGTACAGCTGGAGCGACACGACGAACAGCCAGAAGACGAACACGATG
AACTACGGAACGCTGAAACTCGAAGGAATAATGGTAGCGACAGCAAAATACGGAACACCG
GTCATCGATGGAGAGATAGACGAGATCTGGAACACGACAGAGGAGATAGAGACGAAAGCG
GTGGCCATGGGATCGCTTGACAAGAACGCGACAGCGAAAGTGAGGGTGCTGTGGGACGAG
AACTACCTGTACGTACTTGCAATCGTGAAAGACCCCGTTCTGAACAAAGACAACAGCAAC
CCGTGGGAACAGGATTCCGTGGAGATCTTCATCGACGAGAACAACCACAAGACAGGATAC
TACGAAGACGACGACGCACAGTTCAGGGTGAACTACATGAACGAGCAGACGTTTGGAACG
GGAGGAAGTCCAGCGAGGTTCAAGACAGCGGTGAAACTGATCGAAGGAGGATACATAGTT
GAGGCAGCGATCAAGTGGAAGACGATCAAACCCACACCGAACACGGTGATAGGATTCAAC
ATCCAGGTGAACGATGCGAACGAGAAAGGGCAGAGGGTCGGTATCATCTCCTGGAGCGAT
CCCACAAACAACAGCTGGAGAGATCCTTCAAAGTTCGGTAACCTCAGGCTCATCAAGTGA

# Drug_Target_48_General_Function:
Involved in hydrolase activity, hydrolyzing O-glycosyl compounds

# Drug_Target_48_General_References:
10360571	Nelson KE, Clayton RA, Gill SR, Gwinn ML, Dodson RJ, Haft DH, Hickey EK, Peterson JD, Nelson WC, Ketchum KA, McDonald L, Utterback TR, Malek JA, Linher KD, Garrett MM, Stewart AM, Cotton MD, Pratt MS, Phillips CA, Richardson D, Heidelberg J, Sutton GG, Fleischmann RD, Eisen JA, White O, Salzberg SL, Smith HO, Venter JC, Fraser CM: Evidence for lateral gene transfer between Archaea and bacteria from genome sequence of Thermotoga maritima. Nature. 1999 May 27;399(6734):323-9.
7783614	Winterhalter C, Heinrich P, Candussio A, Wich G, Liebl W: Identification of a novel cellulose-binding domain within the multidomain 120 kDa xylanase XynA of the hyperthermophilic bacterium Thermotoga maritima. Mol Microbiol. 1995 Feb;15(3):431-44.

# Drug_Target_48_HGNC_ID:
Not Available

# Drug_Target_48_HPRD_ID:
Not Available

# Drug_Target_48_ID:
5560

# Drug_Target_48_Locus:
Not Available

# Drug_Target_48_Molecular_Weight:
119644

# Drug_Target_48_Name:
Endo-1,4-beta-xylanase A

# Drug_Target_48_Number_of_Residues:
1059

# Drug_Target_48_PDB_ID:
1I8U

# Drug_Target_48_Pathway:
Not Available

# Drug_Target_48_Pfam_Domain_Function:
PF00331	Glyco_hydro_10
PF02018	CBM_4_9
PF06452	DUF1083

# Drug_Target_48_Protein_Sequence:
>Endo-1,4-beta-xylanase A
MQVRKRRGLLDVSTAVLVGILAGFLGVVLAASGVLSFGKEASSKGDSSLETVLALSFEGT
TEGVVPFGKDVVLTASQDVAADGEYSLKVENRTSPWDGVEIDLTGKVKSGADYLLSFQVY
QSSDAPQLFNVVARTEDEKGERYDVILDKVVVSDHWKEILVPFSPTFEGTPAKYSLIIVA
SKNTNFNFYLDKVQVLAPKESGPKVIYETSFENGVGDWQPRGDVNIEASSEVAHSGKSSL
FISNRQKGWQGAQINLKGILKTGKTYAFEAWVYQNSGQDQTIIMTMQRKYSSDASTQYEW
IKSATVPSGQWVQLSGTYTIPAGVTVEDLTLYFESQNPTLEFYVDDVKIVDTTSAEIKIE
MEPEKEIPALKEVLKDYFKVGVALPSKVFLNPKDIELITKHFNSITAENEMKPESLLAGI
ENGKLKFRFETADKYIQFVEENGMVIRGHTLVWHNQTPDWFFKDENGNLLSKEAMTERLK
EYIHTVVGHFKGKVYAWDVVNEAVDPNQPDGLRRSTWYQIMGPDYIELAFKFAREADPDA
KLFYNDYNTFEPRKRDIIYNLVKDLKEKGLIDGIGMQCHISLATDIKQIEEAIKKFSTIP
GIEIHITELDMSVYRDSSSNYPEAPRTALIEQAHKMMQLFEIFKKYSNVITNVTFWGLKD
DYSWRATRRNDWPLIFDKDHQAKLAYWAIVAPEVLPPLPKESRISEGEAVVVGMMDDSYL
MSKPIEILDEEGNVKATIRAVWKDSTIYIYGEVQDKTKKPAEDGVAIFINPNNERTPYLQ
PDDTYAVLWTNWKTEVNREDVQVKKFVGPGFRRYSFEMSITIPGVEFKKDSYIGFDAAVI
DDGKWYSWSDTTNSQKTNTMNYGTLKLEGIMVATAKYGTPVIDGEIDEIWNTTEEIETKA
VAMGSLDKNATAKVRVLWDENYLYVLAIVKDPVLNKDNSNPWEQDSVEIFIDENNHKTGY
YEDDDAQFRVNYMNEQTFGTGGSPARFKTAVKLIEGGYIVEAAIKWKTIKPTPNTVIGFN
IQVNDANEKGQRVGIISWSDPTNNSWRDPSKFGNLRLIK

# Drug_Target_48_Reaction:
Not Available

# Drug_Target_48_Signals:
1-30

# Drug_Target_48_Specific_Function:
Endohydrolysis of 1,4-beta-D-xylosidic linkages in xylans

# Drug_Target_48_SwissProt_ID:
Q60037

# Drug_Target_48_SwissProt_Name:
XYNA_THEMA

# Drug_Target_48_Synonyms:
1,4- beta-D-xylan xylanohydrolase A
EC 3.2.1.8
Endo-1,4-beta-xylanase A precursor
Xylanase A

# Drug_Target_48_Theoretical_pI:
4.77

# Drug_Target_48_Transmembrane_Regions:
None

# Drug_Target_49_Cellular_Location:
Cell outer membrane

# Drug_Target_49_Chromosome_Location:
Not Available

# Drug_Target_49_Drug_References:
Not Available

# Drug_Target_49_Essentiality:
Non-Essential

# Drug_Target_49_GenAtlas_ID:
Not Available

# Drug_Target_49_GenBank_ID_Gene:
X54292

# Drug_Target_49_GenBank_ID_Protein:
Not Available

# Drug_Target_49_GeneCard_ID:
Not Available

# Drug_Target_49_Gene_Name:
lamB

# Drug_Target_49_Gene_Sequence:
>1359 bp
TTACCACCAGATTTCCATCTGGGCGCCGAAGGTCCACTCATCGCTATCGCCACGGCTGTT
GGTGGAAATGCCGGAGTTAGTCGCTGCGGCATAACGGGAAATGTTATCGCCGTCTTTGAT
ATAGCCCCATTTCTCATCCCATTTCGCGTAGGTGGCGAAAATACGGATAGCCGGACGCGA
CCAGATGCTGTCGCCCGCCTGCCACTGTTGCGCCAGGGTGATTTTATATTGATTGTTACG
ATCGCCGGTCTGCTGAGATTTCACGTTGTCGTAGCCGACTTCCAGCAGGGTGCTCATGAT
TGGCGTCCACTTGTACATTGGACGTACACCCACGGTCCACCACTCAGTACCCAGGTTATT
ATCCCAATCGATATTCTGGTACATACCGACGTACATCAAATCCCATTTATCACCAAGCGA
GATGGCGCCATGATCCAAAATACGCCACATATTGCCATTATTATTGATGACCTTATTGGC
GTAATTAATTTTGGTTCCATCAGACAATTCTTCAGTGAAAGATGAAGAACCGTCGGAACC
GCGCGCCTGGCCTTTACCCTGCGTGGTCATGGCATCGGTGGCATATTGCACGACAAACTT
GTTATAGCCTTTCAACATGCTTTGCGTGTGTTCGGCGGTGAACATCCAGCCGTCTTTCGA
TGCCCCATCAGCCAGCTTATAACCATCGGTCGTATTGGCGCGACCGTAATCAACGCCTAG
CTCCAGTACGCCGTCCGGGTTCGTTTGCAGACCAGCCAGACGTACGTCAAAGACGTCGTT
AGCGGTATCTTTCACTTCATCATAAATATTCTGGCTGCTGAAGGTGTAAGAGCCGCCCGC
TTCAGTAGACCGGGTCGCCGCCAGTGAAAGCTTACCGAAGCCCAGATCGATATTTTCGAT
ACCTGCGCCAGGACCTGAAATATCCCAGTAGTAGAAGTCGATCATGTGTACGTCATGACG
CTGATAGAAGCGCTTACCGGCCCAGATGGTAGAGCCCGGCAGCCATTCAATCAGGTTTTT
ACCCTGCACGTTCGCTTCGCGGAAGGCGGGATCGGTCGATTCCCAGTCGTTCTGCTGGTT
AACCGAATAGGCGACGTTGGTGTCGAAATAGAAGCTCTTATCGCCCTCTTTCCACACTTC
CTGGCCCAGTTTCAGTTCCGCATAGGTTTCACATTCGTTACCGAGACGGTATTTACTTTG
GGCACCCGTTGCCTGGAAACACTGTTGTTCGCCGCCGCTTCCCGTCCAGCCAATACCGGA
ACGGGCGTAACCGTGGAAATCGACAGCCATTGCCTGAGCGGACATTACGCCCGCTGCGAC
AGCAACCGCCAGTGGGAGTTTGCGCAGAGTAATCATCAT

# Drug_Target_49_General_Function:
Involved in sugar:hydrogen ion symporter activity

# Drug_Target_49_General_References:
11677609	McClelland M, Sanderson KE, Spieth J, Clifton SW, Latreille P, Courtney L, Porwollik S, Ali J, Dante M, Du F, Hou S, Layman D, Leonard S, Nguyen C, Scott K, Holmes A, Grewal N, Mulvaney E, Ryan E, Sun H, Florea L, Miller W, Stoneking T, Nhan M, Waterston R, Wilson RK: Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature. 2001 Oct 25;413(6858):852-6.
1730061	Schneider E, Francoz E, Dassa E: Completion of the nucleotide sequence of the 'maltose B' region in Salmonella typhimurium: the high conservation of the malM gene suggests a selected physiological role for its product. Biochim Biophys Acta. 1992 Jan 6;1129(2):223-7.
2092357	Francoz E, Molla A, Dassa E, Saurin W, Hofnung M: The maltoporin of Salmonella typhimurium: sequence and folding model. Res Microbiol. 1990 Nov-Dec;141(9):1039-59.
9102468	Meyer JE, Hofnung M, Schulz GE: Structure of maltoporin from Salmonella typhimurium ligated with a nitrophenyl-maltotrioside. J Mol Biol. 1997 Mar 7;266(4):761-75.

# Drug_Target_49_HGNC_ID:
Not Available

# Drug_Target_49_HPRD_ID:
Not Available

# Drug_Target_49_ID:
5561

# Drug_Target_49_Locus:
Not Available

# Drug_Target_49_Molecular_Weight:
50549

# Drug_Target_49_Name:
Maltoporin

# Drug_Target_49_Number_of_Residues:
452

# Drug_Target_49_PDB_ID:
1MPR

# Drug_Target_49_Pathway:
Not Available

# Drug_Target_49_Pfam_Domain_Function:
PF02264	LamB

# Drug_Target_49_Protein_Sequence:
>Maltoporin
MMITLRKLPLAVAVAAGVMSAQAMAVDFHGYARSGIGWTGSGGEQQCFQATGAQSKYRLG
NECETYAELKLGQEVWKEGDKSFYFDTNVAYSVNQQNDWESTDPAFREANVQGKNLIEWL
PGSTIWAGKRFYQRHDVHMIDFYYWDISGPGAGIENIDLGFGKLSLAATRSTEAGGSYTF
SSQNIYDEVKDTANDVFDVRLAGLQTNPDGVLELGVDYGRANTTDGYKLADGASKDGWMF
TAEHTQSMLKGYNKFVVQYATDAMTTQGKGQARGSDGSSSFTEELSDGTKINYANKVINN
NGNMWRILDHGAISLGDKWDLMYVGMYQNIDWDNNLGTEWWTVGVRPMYKWTPIMSTLLE
VGYDNVKSQQTGDRNNQYKITLAQQWQAGDSIWSRPAIRIFATYAKWDEKWGYIKDGDNI
SRYAAATNSGISTNSRGDSDEWTFGAQMEIWW

# Drug_Target_49_Reaction:
Not Available

# Drug_Target_49_Signals:
1-25

# Drug_Target_49_Specific_Function:
Involved in the transport of maltose and maltodextrins. Does not act as a receptor for phages

# Drug_Target_49_SwissProt_ID:
P26466

# Drug_Target_49_SwissProt_Name:
LAMB_SALTY

# Drug_Target_49_Synonyms:
Maltoporin precursor
Maltose-inducible porin

# Drug_Target_49_Theoretical_pI:
4.64

# Drug_Target_49_Transmembrane_Regions:
27-35
65-78
81-93
105-115
123-130
149-159
162-173
192-205
210-222
235-248
251-263
301-315
318-333
337-351
354-369
373-388
396-410
437-451

# Drug_Target_4_Cellular_Location:
Cell outer membrane
multi-pass membrane protein

# Drug_Target_4_Chromosome_Location:
Not Available

# Drug_Target_4_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_4_Essentiality:
Non-Essential

# Drug_Target_4_GenAtlas_ID:
Not Available

# Drug_Target_4_GenBank_ID_Gene:
M12486

# Drug_Target_4_GenBank_ID_Protein:
2226438

# Drug_Target_4_GeneCard_ID:
Not Available

# Drug_Target_4_Gene_Name:
fhuA

# Drug_Target_4_Gene_Sequence:
>2244 bp
ATGGCGCGTTCCAAAACTGCTCAGCCAAAACACTCACTGCGTAAAATCGCAGTTGTAGTA
GCCACAGCGGTTAGCGGCATGTCTGTTTATGCACAGGCAGCGGTTGAACCGAAAGAAGAC
ACTATCACCGTTACCGCTGCACCTGCGCCGCAAGAAAGCGCATGGGGGCCTGCTGCAACT
ATTGCGGCGCGACAGTCTGCTACCGGCACTAAAACCGATACGCCGATTCAAAAAGTGCCA
CAGTCTATTTCTGTTGTGACCGCCGAAGAGATGGCGCTGCATCAGCCGAAGTCGGTAAAA
GAAGCGCTTAGCTACACGCCGGGTGTCTCTGTTGGTACGCGTGGCGCATCCAACACCTAT
GACCACCTGATCATTCGCGGCTTTGCGGCAGAAGGCCAAAGCCAGAATAACTATCTGAAT
GGCCTGAAGTTGCAGGGCAACTTCTATAACGATGCGGTCATTGACCCGTATATGCTGGAA
CGCGCTGAAATTATGCGTGGCCCGGTTTCCGTGCTTTACGGTAAAAGCAGTCCTGGCGGC
CTGTTGAATATGGTCAGCAAGCGTCCGACCACCGAACCGCTGAAAGAAGTTCAGTTTAAA
GCCGGTACTGACAGCCTGTTCCAGACTGGTTTTGACTTTAGCGATTCGTTGGATGATGAC
GGTGTTTACTCTTATCGCCTGACCGGTCTTGCGCGTTCTGCCAATGCCCAGCAGAAAGGG
TCAGAAGAGCAGCGTTATGCTATTGCACCGGCGTTCACCTGGCGTCCGGATGATAAAACC
AATTTTACCTTCCTTTCTTACTTCCAGAACGAGCCGGAAACCGGTTATTACGGCTGGTTG
CCGAAAGAGGGAACCGTTGAGCCGCTGCCGAACGGTAAGCGTCTGCCGACAGACTTTAAT
GAAGGGGCGAAGAACAACACCTATTCTCGTAATGAGAAGATGGTCGGCTACAGCTTCGAT
CACGAATTTAACGACACCTTTACTGTGCGTCAGAACCTGCGCTTTGCTGAAAACAAAACC
TCGCAAAACAGCGTTTATGGTTACGGCGTCTGCTCCGATCCGGCGAATGCTTACAGCAAA
CAGTGTGCGGCATTAGCGCCAGCGGATAAAGGCCATTATCTGGCACGTAAATACGTCGTT
GATGATGAGAAGCTGCAAAACTTCTCCGTTGATACCCAGTTGCAGAGCAAGTTTGCCACT
GGCGATATCGACCACACCCTGCTGACCGGTGTCGACTTTATGCGTATGCGTAATGACATC
AACGCCTGGTTTGGTTACGACGACTCTGTGCCACTGCTCAATCTGTACAATCCGGTGAAT
ACCGATTTCGACTTCAATGCCAAAGATCCGGCAAACTCCGGCCCTTACCGCATTCTGAAT
AAACAGAAACAAACGGGCGTTTATGTTCAGGATCAGGCGCAGTGGGATAAAGTGCTGGTC
ACCCTAGGCGGTCGTTATGACTGGGCAGATCAAGAATCTCTTAACCGCGTTGCCGGGACG
ACCGATAAACGTGATGACAAACAGTTTACCTGGCGTGGTGGTGTTAACTACCTGTTTGAT
AATGGTGTAACACCTTACTTCAGCTATAGCGAATCGTTTGAACCTTCTTCGCAAGTTGGG
AAGGATGGTAATATTTTCGCACCGTCTAAAGGTAAGCAGTATGAAGTCGGCGTGAAATAT
GTACCGGAAGATCGTCCGATTGTAGTTACTGGTGCCGTGTATAATCTCACTAAAACCAAC
AACCTGATGGCGGACCCTGAGGGTTCCTTCTTCTCGGTTGAAGGTGGCGAGATCCGCGCA
CGTGGCGTAGAAATCGAAGCGAAAGCGGCGCTGTCGGCGAGTGTTAACGTAGTCGGTTCT
TATACTTACACCGATGCGGAATACACCACCGATACTACCTATAAAGGCAATACGCCTGCA
CAGGTGCCAAAACACATGGCTTCGTTGTGGGCTGACTACACCTTCTTTGACGGTCCGCTT
TCAGGTCTGACGCTGGGCACCGGTGGTCGTTATACTGGCTCCAGTTATGGTGATCCGGCT
AACTCCTTTAAAGTGGGAAGTTATACGGTCGTGGATGCGTTAGTACGTTATGATCTGGCG
CGAGTCGGCATGGCTGGCTCCAACGTGGCGCTGCATGTTAACAACCTGTTCGATCGTGAA
TACGTCGCCAGCTGCTTTAACACTTATGGCTGCTTCTGGGGCGCAGAACGTCAGGTCGTT
GCAACCGCAACCTTCCGTTTCTAA

# Drug_Target_4_General_Function:
Inorganic ion transport and metabolism

# Drug_Target_4_General_References:
10850805	Ferguson AD, Braun V, Fiedler HP, Coulton JW, Diederichs K, Welte W: Crystal structure of the antibiotic albomycin in complex with the outer membrane transporter FhuA. Protein Sci. 2000 May;9(5):956-63.
2823072	Burkhardt R, Braun V: Nucleotide sequence of the fhuC and fhuD genes involved in iron (III) hydroxamate transport: domains in FhuC homologous to ATP-binding proteins. Mol Gen Genet. 1987 Aug;209(1):49-55.
3079747	Coulton JW, Mason P, Cameron DR, Carmel G, Jean R, Rode HN: Protein fusions of beta-galactosidase to the ferrichrome-iron receptor of Escherichia coli K-12. J Bacteriol. 1986 Jan;165(1):181-92.
7515827	Braun V, Killmann H, Benz R: Energy-coupled transport through the outer membrane of Escherichia coli small deletions in the gating loop convert the FhuA transport protein into a diffusion channel. FEBS Lett. 1994 Jun 6;346(1):59-64.
8202364	Fujita N, Mori H, Yura T, Ishihama A: Systematic sequencing of the Escherichia coli genome: analysis of the 2.4-4.1 min (110,917-193,643 bp) region. Nucleic Acids Res. 1994 May 11;22(9):1637-9.
8617231	Bonhivers M, Ghazi A, Boulanger P, Letellier L: FhuA, a transporter of the Escherichia coli outer membrane, is converted into a channel upon binding of bacteriophage T5. EMBO J. 1996 Apr 15;15(8):1850-6.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9856937	Ferguson AD, Hofmann E, Coulton JW, Diederichs K, Welte W: Siderophore-mediated iron transport: crystal structure of FhuA with bound lipopolysaccharide. Science. 1998 Dec 18;282(5397):2215-20.
9865695	Locher KP, Rees B, Koebnik R, Mitschler A, Moulinier L, Rosenbusch JP, Moras D: Transmembrane signaling across the ligand-gated FhuA receptor: crystal structures of free and ferrichrome-bound states reveal allosteric changes. Cell. 1998 Dec 11;95(6):771-8.

# Drug_Target_4_HGNC_ID:
Not Available

# Drug_Target_4_HPRD_ID:
Not Available

# Drug_Target_4_ID:
2427

# Drug_Target_4_Locus:
Not Available

# Drug_Target_4_Molecular_Weight:
82183

# Drug_Target_4_Name:
Ferrichrome-iron receptor

# Drug_Target_4_Number_of_Residues:
747

# Drug_Target_4_PDB_ID:
1BY3

# Drug_Target_4_Pathway:
Not Available

# Drug_Target_4_Pfam_Domain_Function:
PF00593	TonB_dep_Rec
PF07715	Plug

# Drug_Target_4_Protein_Sequence:
>Ferrichrome-iron receptor precursor
MARSKTAQPKHSLRKIAVVVATAVSGMSVYAQAAVEPKEDTITVTAAPAPQESAWGPAAT
IAARQSATGTKTDTPIQKVPQSISVVTAEEMALHQPKSVKEALSYTPGVSVGTRGASNTY
DHLIIRGFAAEGQSQNNYLNGLKLQGNFYNDAVIDPYMLERAEIMRGPVSVLYGKSSPGG
LLNMVSKRPTTEPLKEVQFKAGTDSLFQTGFDFSDSLDDDGVYSYRLTGLARSANAQQKG
SEEQRYAIAPAFTWRPDDKTNFTFLSYFQNEPETGYYGWLPKEGTVEPLPNGKRLPTDFN
EGAKNNTYSRNEKMVGYSFDHEFNDTFTVRQNLRFAENKTSQNSVYGYGVCSDPANAYSK
QCAALAPADKGHYLARKYVVDDEKLQNFSVDTQLQSKFATGDIDHTLLTGVDFMRMRNDI
NAWFGYDDSVPLLNLYNPVNTDFDFNAKDPANSGPYRILNKQKQTGVYVQDQAQWDKVLV
TLGGRYDWADQESLNRVAGTTDKRDDKQFTWRGGVNYLFDNGVTPYFSYSESFEPSSQVG
KDGNIFAPSKGKQYEVGVKYVPEDRPIVVTGAVYNLTKTNNLMADPEGSFFSVEGGEIRA
RGVEIEAKAALSASVNVVGSYTYTDAEYTTDTTYKGNTPAQVPKHMASLWADYTFFDGPL
SGLTLGTGGRYTGSSYGDPANSFKVGSYTVVDALVRYDLARVGMAGSNVALHVNNLFDRE
YVASCFNTYGCFWGAERQVVATATFRF

# Drug_Target_4_Reaction:
Not Available

# Drug_Target_4_Signals:
1-33

# Drug_Target_4_Specific_Function:
This receptor binds the ferrichrome-iron ligand. It interacts with the tonB protein, which is responsible for energy coupling of the ferrichrome-promoted iron transport system. Acts as a receptor for bacteriophage T5 as well as T1, phi80 and colicin M. Binding of T5 triggers the opening of a high conductance ion channel. Can also transport the antibiotic albomycin

# Drug_Target_4_SwissProt_ID:
P06971

# Drug_Target_4_SwissProt_Name:
FHUA_ECOLI

# Drug_Target_4_Synonyms:
Ferric hydroxamate receptor
Ferric hydroxamate uptake
Ferrichrome-iron receptor precursor

# Drug_Target_4_Theoretical_pI:
5.35

# Drug_Target_4_Transmembrane_Regions:
193-201
207-215
223-231
246-255
260-268
313-321
327-335
388-396
405-413
465-473
478-486
509-517
523-531
552-560
566-574
602-610
614-622
646-654
662-670
690-698
706-714
738-746

# Drug_Target_50_Cellular_Location:
Not Available

# Drug_Target_50_Chromosome_Location:
Not Available

# Drug_Target_50_Drug_References:
Not Available

# Drug_Target_50_Essentiality:
Non-Essential

# Drug_Target_50_GenAtlas_ID:
Not Available

# Drug_Target_50_GenBank_ID_Gene:
L04480

# Drug_Target_50_GenBank_ID_Protein:
Not Available

# Drug_Target_50_GeneCard_ID:
Not Available

# Drug_Target_50_Gene_Name:
Not Available

# Drug_Target_50_Gene_Sequence:
>1356 bp
ATGGTGTTTTCAGACCAGCAACTTTTTGAGAAAGTAGTCGAGATACTCAAGCCATTTGAT
CTTTCTGTGGTTGATTATGAGGAGATTTGTGATAGGATGGGAGAATCAATGCGACTAGGT
TTACAGAAGAGTACAAATGAAAAATCATCTATTAAAATGTTTCCATCTTATGTTACAAAA
ACACCAAATGGGACAGAAACCGGAAACTTCTTAGCTTTAGACCTTGGTGGAACAAATTAT
CGAGTGCTTTCAGTTACCCTTGAAGGTAAAGGAAAATCTCCAAGAATTCAAGAGAGAACA
TACTGTATCCCCGCAGAAAAAATGTCAGGTTCCGGAACAGAGCTCTTTAAATATATTGCT
GAGACACTGGCTGACTTTTTGGAAAACAACGGGATGAAGGACAAAAAGTTTGACCTCGGA
TTCACATTCTCTTTTCCATGTGTCCAAAAAGGCCTCACTCATGCTACTTTGGTGAGATGG
ACAAAAGGTTTCTCTGCAGATGGAGTAGAAGGTCATAATGTTGCTGAATTGCTGCAAACT
GAGCTAGACAAAAGAGAATTAAATGTTAAGTGTGTCGCGGTTGTAAACGATACAGTTGGC
ACACTTGCTTCTTGTGCTCTTGAGGACCCAAAATGTGCGGTCGGATTAATAGTTGGGACG
GGGACAAACGTTGCTTATATTGAGGACTCTTCGAAAGTTGAGCTGATGGATGGTGTGAAG
GAACCCGAAGTCGTCATAAACACAGAGTGGGGTGCATTCGGCGAGAAAGGAGAATTAGAC
TGTTGGAGGACACAGTTCGACAAATCAATGGATATAGACAGTCTTCATCCAGGAAAGCAA
CTATATGAAAAAATGGTATCTGGGATGTATCTTGGTGAGCTAGTTCGCCACATCATTGTT
TACCTTGTTGAACAAAAAATTCTCTTTCGTGGAGATCTCCCTGAACGTTTGAAAGTACGC
AATTCTTTGCTAACTAGATACTTAACGGATGTTGAAAGAGATCCTGCTCACCTTTTATAC
AACACTCATTATATGCTTACTGATGACTTGCATGTCCCTGTTGTTGAGCCGATAGATAAC
CGTATAGTACGATATGCCTGTGAAATGGTCGTTAAACGGGCAGCTTACCTAGCAGGTGCA
GGTATTGCCTGCATTCTTCGAAGAATAAACCGCTCAGAAGTAACTGTTGGTGTTGATGGC
TCTTTGTATAAATTCCACCCGAAGTTTTGTGAACGAATGACAGATATGGTTGATAAGCTA
AAACCAAAGAATACACGATTCTGTCTACGTTTATCTGAAGATGGAAGTGGAAAAGGAGCG
GCGGCCATAGCAGCGTCATGTACACGACAAAATTAA

# Drug_Target_50_General_Function:
Involved in hexokinase activity

# Drug_Target_50_General_References:
7821409	Shoemaker CB, Reynolds SR, Wei G, Tielens AG, Harn DA: Schistosoma mansoni hexokinase: cDNA cloning and immunogenicity studies. Exp Parasitol. 1995 Feb;80(1):36-45.
9665168	Mulichak AM, Wilson JE, Padmanabhan K, Garavito RM: The structure of mammalian hexokinase-1. Nat Struct Biol. 1998 Jul;5(7):555-60.

# Drug_Target_50_HGNC_ID:
Not Available

# Drug_Target_50_HPRD_ID:
Not Available

# Drug_Target_50_ID:
5562

# Drug_Target_50_Locus:
Not Available

# Drug_Target_50_Molecular_Weight:
50447

# Drug_Target_50_Name:
Hexokinase

# Drug_Target_50_Number_of_Residues:
451

# Drug_Target_50_PDB_ID:
1BDG

# Drug_Target_50_Pathway:
Not Available

# Drug_Target_50_Pfam_Domain_Function:
PF00349	Hexokinase_1
PF03727	Hexokinase_2

# Drug_Target_50_Protein_Sequence:
>Hexokinase
MVFSDQQLFEKVVEILKPFDLSVVDYEEICDRMGESMRLGLQKSTNEKSSIKMFPSYVTK
TPNGTETGNFLALDLGGTNYRVLSVTLEGKGKSPRIQERTYCIPAEKMSGSGTELFKYIA
ETLADFLENNGMKDKKFDLGFTFSFPCVQKGLTHATLVRWTKGFSADGVEGHNVAELLQT
ELDKRELNVKCVAVVNDTVGTLASCALEDPKCAVGLIVGTGTNVAYIEDSSKVELMDGVK
EPEVVINTEWGAFGEKGELDCWRTQFDKSMDIDSLHPGKQLYEKMVSGMYLGELVRHIIV
YLVEQKILFRGDLPERLKVRNSLLTRYLTDVERDPAHLLYNTHYMLTDDLHVPVVEPIDN
RIVRYACEMVVKRAAYLAGAGIACILRRINRSEVTVGVDGSLYKFHPKFCERMTDMVDKL
KPKNTRFCLRLSEDGSGKGAAAIAASCTRQN

# Drug_Target_50_Reaction:
Not Available

# Drug_Target_50_Signals:
None

# Drug_Target_50_Specific_Function:
ATP + D-hexose = ADP + D-hexose 6-phosphate

# Drug_Target_50_SwissProt_ID:
Q26609

# Drug_Target_50_SwissProt_Name:
HXK_SCHMA

# Drug_Target_50_Synonyms:
EC 2.7.1.1

# Drug_Target_50_Theoretical_pI:
6.14

# Drug_Target_50_Transmembrane_Regions:
None

# Drug_Target_51_Cellular_Location:
Secreted protein

# Drug_Target_51_Chromosome_Location:
Not Available

# Drug_Target_51_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_51_Essentiality:
Non-Essential

# Drug_Target_51_GenAtlas_ID:
Not Available

# Drug_Target_51_GenBank_ID_Gene:
D13177

# Drug_Target_51_GenBank_ID_Protein:
1648826

# Drug_Target_51_GeneCard_ID:
Not Available

# Drug_Target_51_Gene_Name:
tvaI

# Drug_Target_51_Gene_Sequence:
>2001 bp
ATGATCAAATTATTAAAGCCGATGTCTTTGTCCATCCTCCTTGTCTTCATTCTCTCATTT
TCTTTTCCATTTCCCACGGCAAAGGCGGCCGCCAATGACAACAATGTGGAGTGGAATGGA
TTGTTTCATGATCAAGGCCCGCTTTTTGACAACGCGCCGGAGCCCACTTCAACCCAGAGT
GTCACGCTTAAACTGCGAACCTTCAAAGGAGATATTACCAGCGCCAATATCAAGTATTGG
GATACTGCCGACAATGCCTTTCACTGGGTGCCCATGGTTTGGGATTCCAATGACCCGACA
GGCACGTTTGATTACTGGAAAGGGACGATCCCGGCAAGCCCATCGATCAAGTATTACCGT
TTCCAAATTAACGATGGCACAAGCACGGCCTGGTACAACGGCAATGGCCCTTCTTCCACC
GAACCGAATGCCGATGATTTTTATATTATTCCCAATTTCAAAACGCCGGACTGGCTGAAA
AACGGCGTAATGTACCAGATCTTTCCGGATCGTTTCTACAATGGCGATTCTTCAAATGAT
GTCCAGACAGGCTCCTATACCTATAACGGCACCCCAACGGAGAAAAAAGCATGGGGCAGC
AGCGTTTACGCTGATCCGGGGTACGACAATAGTTTGGTCTTTTTTGGCGGAGACCTGGCG
GGAATCGATCAAAAACTGGGCTATATCAAAAAGACTCTCGGCGCGAACATCCTCTATCTG
AATCCCATCTTCAAGGCGCCAACCAACCACAAATACGACACCCAGGACTACATGGCGGTT
GATCCCGCGTTTGGCGACAATTCCACCTTGCAAACGCTGATCAACGACATACACAGCACC
GCGAACGGCCCTAAAGGGTACCTTATTTTGGACGGGGTGTTCAACCACACGGGAGACAGC
CATCCGTGGTTTGACAAATACAATAATTTTTCGTCTCAGGGAGCATACGAGTCACAATCC
AGCCCATGGTACAACTACTATACTTTCTACACATGGCCCGATTCATACGCTTCTTTTCTC
GGATTCAACAGTTTGCCCAAACTAAACTACGGCAACAGCGGTTCAGCCGTACGGGGCGTA
ATCTACAACAACAGCAATTCGGTGGCTAAAACCTATTTAAACCCGCCTTATTCTGTCGAT
GGTTGGCGGCTCGATGCAGCACAATATGTTGACGCAAATGGCAACAATGGAAGTGACGTG
ACCAACCACCAGATTTGGAGCGAATTTCGGAATGCCGTCAAGGGAGTGAATTCAAACGCC
GCAATCATCGGGGAGTATTGGGGCAACGCCAATCCATGGACGGCCCAGGGAAACCAGTGG
GACGCAGCCACCAACTTTGATGGCTTCACCCAGCCTGTTTCTGAATGGATTACCGGCAAA
GACTACCAAAACAATTCGGCTTCGATCAGCACCACACAGTTTGACAGTTGGCTTAGGGGG
ACACGGGCCAACTACCCTACCAATGTCCAACAGTCCATGATGAACTTCCTTTCCAATCAT
GACATCACCCGCTTTGCCACACGTTCCGGCGGAGATCTTTGGAAAACCTACTTGGCCCTG
ATCTTTCAGATGACTTATGTGGGCACTCCGACCATTTACTATGGGGACGAATACGGCATG
CAGGGAGGCGCGGACCCCGACAACCGCCGGTCCTTTGATTGGTCACAAGCCACTCCCTCC
AATAGCGCGGTGGCCCTGACCCAAAAGCTGATCACCATTCGCAACCAATACCCTGCTTTA
AGAACCGGTTCCTTTATGACATTAATCACGGACGACACCAACAAAATTTATTCTTATGGG
CGTTTTGACAACGTCAACCGAATCGCCGTCGTGCTAAACAATGACTCCGTCAGCCATACG
GTCAACGTGCCGGTTTGGCAACTCAGCATGCCAAATGGCAGCACTGTCACGGACAAAATT
ACCGGCCATAGTTACACCGTACAAAACGGCATGGTTACCGTTGCCGTTGACGGGCACTAC
GGCGCTGTCTTGGCACAATAA

# Drug_Target_51_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_51_General_References:
12051850	Kamitori S, Abe A, Ohtaki A, Kaji A, Tonozuka T, Sakano Y: Crystal structures and structural comparison of Thermoactinomyces vulgaris R-47 alpha-amylase 1 (TVAI) at 1.6 A resolution and alpha-amylase 2 (TVAII) at 2.3 A resolution. J Mol Biol. 2002 Apr 26;318(2):443-53.
7548164	Tonozuka T, Mogi S, Shimura Y, Ibuka A, Sakai H, Matsuzawa H, Sakano Y, Ohta T: Comparison of primary structures and substrate specificities of two pullulan-hydrolyzing alpha-amylases, TVA I and TVA II, from Thermoactinomyces vulgaris R-47. Biochim Biophys Acta. 1995 Sep 27;1252(1):35-42.

# Drug_Target_51_HGNC_ID:
Not Available

# Drug_Target_51_HPRD_ID:
Not Available

# Drug_Target_51_ID:
2541

# Drug_Target_51_Locus:
Not Available

# Drug_Target_51_Molecular_Weight:
74296

# Drug_Target_51_Name:
Neopullulanase 1

# Drug_Target_51_Number_of_Residues:
666

# Drug_Target_51_PDB_ID:
1UH3

# Drug_Target_51_Pathway:
Not Available

# Drug_Target_51_Pfam_Domain_Function:
PF00128	Alpha-amylase
PF02903	Alpha-amylase_N

# Drug_Target_51_Protein_Sequence:
>Neopullulanase 1 precursor
MIKLLKPMSLSILLVFILSFSFPFPTAKAAANDNNVEWNGLFHDQGPLFDNAPEPTSTQS
VTLKLRTFKGDITSANIKYWDTADNAFHWVPMVWDSNDPTGTFDYWKGTIPASPSIKYYR
FQINDGTSTAWYNGNGPSSTEPNADDFYIIPNFKTPDWLKNGVMYQIFPDRFYNGDSSND
VQTGSYTYNGTPTEKKAWGSSVYADPGYDNSLVFFGGDLAGIDQKLGYIKKTLGANILYL
NPIFKAPTNHKYDTQDYMAVDPAFGDNSTLQTLINDIHSTANGPKGYLILDGVFNHTGDS
HPWFDKYNNFSSQGAYESQSSPWYNYYTFYTWPDSYASFLGFNSLPKLNYGNSGSAVRGV
IYNNSNSVAKTYLNPPYSVDGWRLDAAQYVDANGNNGSDVTNHQIWSEFRNAVKGVNSNA
AIIGEYWGNANPWTAQGNQWDAATNFDGFTQPVSEWITGKDYQNNSASISTTQFDSWLRG
TRANYPTNVQQSMMNFLSNHDITRFATRSGGDLWKTYLALIFQMTYVGTPTIYYGDEYGM
QGGADPDNRRSFDWSQATPSNSAVALTQKLITIRNQYPALRTGSFMTLITDDTNKIYSYG
RFDNVNRIAVVLNNDSVSHTVNVPVWQLSMPNGSTVTDKITGHSYTVQNGMVTVAVDGHY
GAVLAQ

# Drug_Target_51_Reaction:
Hydrolysis of pullulan to panose (6-alpha-D-glucosylmaltose)

# Drug_Target_51_Signals:
1-29

# Drug_Target_51_Specific_Function:
Endohydrolysis of 1,4-alpha-glucosidic linkages in pullulan to form panose. Also hydrolyzes cyclodextrins

# Drug_Target_51_SwissProt_ID:
Q60053

# Drug_Target_51_SwissProt_Name:
NEPU1_THEVU

# Drug_Target_51_Synonyms:
Alpha-amylase I
EC 3.2.1.135
Neopullulanase 1 precursor
TVA I

# Drug_Target_51_Theoretical_pI:
5.03

# Drug_Target_51_Transmembrane_Regions:
None

# Drug_Target_52_Cellular_Location:
Secreted protein

# Drug_Target_52_Chromosome_Location:
Not Available

# Drug_Target_52_Drug_References:
Not Available

# Drug_Target_52_Essentiality:
Non-Essential

# Drug_Target_52_GenAtlas_ID:
Not Available

# Drug_Target_52_GenBank_ID_Gene:
Z29080

# Drug_Target_52_GenBank_ID_Protein:
Not Available

# Drug_Target_52_GeneCard_ID:
Not Available

# Drug_Target_52_Gene_Name:
Not Available

# Drug_Target_52_Gene_Sequence:
>1224 bp
ATGCGGAACGTCGTGCGTAAACCATTGACAATCGGACTCGCTTTAACACTATTATTGCCC
ATGGGAATGACGGCAACATCAGCGAAGAATGCAGATTCCTATGCGAAAAAACCTCACATC
AGCGCATTGAATGCCCCACAATTGGATCAACGCTACAAAAACGAGTTCACGATTGGTGCG
GCAGTAGAACCTTATCAACTACAAAATGAAAAAGACGTACAAATGCTAAAGCGCCACTTC
AACAGCATTGTTGCCGAGAACGTAATGAAACCGATCAGCATTCAACCTGAGGAAGGAAAA
TTCAATTTTGAACAAGCGGATCGAATTGTGAAGTTCGCTAAGGCAAATGGCATGGATATT
CGCTTCCATACACTCGTTTGGCACAGCCAAGTACCTCAATGGTTCTTTCTTGACAAGGAA
GGTAAGCCAATGGTTAATGAAACAGATCCAGTGAAACGTGAACAAAATAAACAACTGCTG
TTAAAACGACTTGAAACTCATATTAAAACGATCGTCGAGCGGTACAAAGATGACATTAAG
TACTGGGACGTTGTAAATGAGGTTGTGGGGGACGACGGAAAACTGCGCAACTCTCCATGG
TATCAAATCGCCGGCATCGATTATATTAAAGTGGCATTCCAAGCAGCTAGAAAATATGGC
GGAGACAACATTAAGCTTTACATGAATGATTACAATACAGAAGTCGAACCGAAGCGAACC
GCTCTTTACAATTTAGTCAAACAACTGAAAGAAGAGGGTGTTCCGATCGACGGCATCGGC
CATCAATCCCACATCCAAATCGGCTGGCCTTCTGAAGCAGAAATCGAGAAAACGATTAAC
ATGTTCGCCGCTCTCGGTTTAGACAACCAAATCACTGAGCTTGATGTGAGCATGTACGGT
TGGCCGCCGCGCGCTTACCCGACGTATGACGCCATTCCAAAACAAAAGTTTTTGGATCAG
GCAGCGCGCTATGATCGTTTGTTCAAACTGTATGAAAAGTTGAGCGATAAAATTAGCAAC
GTCACCTTCTGGGGCATCGCCGACAATCATACGTGGCTCGACAGCCGTGCGGATGTGTAC
TATGACGCCAACGGGAATGTTGTGGTTGACCCGAACGCTCCGTACGCAAAAGTGGAAAAA
GGGAAAGGAAAAGATGCGCCGTTCGTTTTTGGACCGGATTACAAAGTCAAACCCGCATAT
TGGGCTATTATCGACCACAAATAG

# Drug_Target_52_General_Function:
Involved in hydrolase activity, hydrolyzing O-glycosyl compounds

# Drug_Target_52_General_References:
8031084	Gat O, Lapidot A, Alchanati I, Regueros C, Shoham Y: Cloning and DNA sequence of the gene coding for Bacillus stearothermophilus T-6 xylanase. Appl Environ Microbiol. 1994 Jun;60(6):1889-96.
8328796	Khasin A, Alchanati I, Shoham Y: Purification and characterization of a thermostable xylanase from Bacillus stearothermophilus T-6. Appl Environ Microbiol. 1993 Jun;59(6):1725-30.

# Drug_Target_52_HGNC_ID:
Not Available

# Drug_Target_52_HPRD_ID:
Not Available

# Drug_Target_52_ID:
5247

# Drug_Target_52_Locus:
Not Available

# Drug_Target_52_Molecular_Weight:
46764

# Drug_Target_52_Name:
Endo-1,4-beta-xylanase

# Drug_Target_52_Number_of_Residues:
407

# Drug_Target_52_PDB_ID:
1R87

# Drug_Target_52_Pathway:
Not Available

# Drug_Target_52_Pfam_Domain_Function:
PF00331	Glyco_hydro_10

# Drug_Target_52_Protein_Sequence:
>Endo-1,4-beta-xylanase
MRNVVRKPLTIGLALTLLLPMGMTATSAKNADSYAKKPHISALNAPQLDQRYKNEFTIGA
AVEPYQLQNEKDVQMLKRHFNSIVAENVMKPISIQPEEGKFNFEQADRIVKFAKANGMDI
RFHTLVWHSQVPQWFFLDKEGKPMVNETDPVKREQNKQLLLKRLETHIKTIVERYKDDIK
YWDVVNEVVGDDGKLRNSPWYQIAGIDYIKVAFQAARKYGGDNIKLYMNDYNTEVEPKRT
ALYNLVKQLKEEGVPIDGIGHQSHIQIGWPSEAEIEKTINMFAALGLDNQITELDVSMYG
WPPRAYPTYDAIPKQKFLDQAARYDRLFKLYEKLSDKISNVTFWGIADNHTWLDSRADVY
YDANGNVVVDPNAPYAKVEKGKGKDAPFVFGPDYKVKPAYWAIIDHK

# Drug_Target_52_Reaction:
Not Available

# Drug_Target_52_Signals:
1-28

# Drug_Target_52_Specific_Function:
Endohydrolysis of 1,4-beta-D-xylosidic linkages in xylans

# Drug_Target_52_SwissProt_ID:
P40943

# Drug_Target_52_SwissProt_Name:
XYN1_GEOSE

# Drug_Target_52_Synonyms:
1,4-beta-D- xylan xylanohydrolase
EC 3.2.1.8
Endo-1,4-beta-xylanase precursor
Xylanase

# Drug_Target_52_Theoretical_pI:
8.81

# Drug_Target_52_Transmembrane_Regions:
None

# Drug_Target_53_Cellular_Location:
Cytoplasmic

# Drug_Target_53_Chromosome_Location:
Not Available

# Drug_Target_53_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_53_Essentiality:
Non-Essential

# Drug_Target_53_GenAtlas_ID:
Not Available

# Drug_Target_53_GenBank_ID_Gene:
X78145

# Drug_Target_53_GenBank_ID_Protein:
510492

# Drug_Target_53_GeneCard_ID:
Not Available

# Drug_Target_53_Gene_Name:
cgt

# Drug_Target_53_Gene_Sequence:
>2142 bp
ATGAAGAAATTTCTGAAATCGACAGCTGCGCTTGCCCTGGGATTATCGCTGACGTTCGGG
CTTTTCAGCCCTGCCCAGGCCGCGCCGGATACCTCGGTATCCAACAAGCAAAATTTCAGC
ACCGACGTCATCTATCAAATTTTCACCGACAGGTTTTCGGACGGCAATCCCGCCAACAAT
CCGACCGGCGCGGCGTTTGACGGAACCTGCACGAACCTCCGGCTGTATTGCGGCGGCGAC
TGGCAGGGCATCATCAACAAAATCAACGACGGTTACCTGACCGGGATGGGCGTTACCGCC
ATCTGGATCTCCCAGCCGGTCGAAAACATCTACAGCATCATCAATTATTCCGGCGTAAAC
AACACGGCCTATCACGGCTACTGGGCCCGGGACTTCAAGAAGACGAATCCGGCCTACGGC
ACGATTGCGGACTTCCAGAACCTGATCGCCGCCGCGCATGCAAAAAACATCAAAGTCATT
ATCGACTTTGCCCCGAACCATACGTCGCCCGCCTCGTCCGACCAGCCTTCCTTTGCGGAA
AACGGCCGGCTGTACGATAACGGCACGCTGCTCGGGGGATACACGAACGATACGCAGAAC
CTGTTCCACCATAACGGCGGCACGGACTTTTCCACGACCGAAAACGGCATCTACAAAAAC
CTGTACGATCTCGCCGACCTGAACCATAACAACAGCACCGTGGACGTCTACTTGAAGGAC
GCGATCAAAATGTGGCTGGACCTCGGCATCGACGGCATCCGCATGGATGCGGTGAAGCAT
ATGCCGTTCGGCTGGCAGAAGAGCTTTATGGCTGCCGTCAACAACTATAAGCCGGTCTTT
ACCTTCGGCGAATGGTTCCTGGGCGTAAATGAAGTGAGCCCGGAAAACCATAAGTTTGCC
AACGAATCCGGCATGAGCCTGCTTGATTTCCGTTTTGCCCAAAAGGTGCGGCAGGTGTTC
CGGGACAACACCGACAATATGTACGGCCTGAAGGCGATGCTGGAGGGCTCCGCAGCCGAT
TACGCCCAGGTGGATGACCAGGTGACGTTCATCGACAACCATGACATGGAGCGTTTCCAC
GCAAGCAATGCAAACCGCCGGAAGCTGGAGCAAGCGCTTGCGTTCACGCTGACCTCGCGC
GGCGTCCCCGCCATTTATTACGGCACCGAGCAGTACATGTCGGGCGGGACCGATCCGGAC
AACCGGGCGCGGATCCCTTCCTTCTCCACGTCGACGACCGCCTATCAGGTCATTCAAAAG
CTGGCGCCGCTGCGCAAGTGCAACCCGGCCATCGCCTACGGATCGACGCAGGAGCGCTGG
ATCAACAACGACGTGCTCATTTATGAGCGCAAATTCGGCAGCAACGTTGCCGTCGTTGCC
GTCAACCGCAATTTAAACGCGCCGGCTTCCATTTCGGGACTTGTCACTTCCCTGCCGCAA
GGCAGCTACAACGACGTCCTTGGCGGCCTTCTGAACGGCAACACGTTATCGGTAGGCTCC
GGCGGGGCCGCCTCCAATTTCACGCTTGCGGCCGGCGGCACGGCGGTGTGGCAGTACACC
GCGGCTACGGCGACGCCGACCATCGGGCATGTCGGGCCGATGATGGCCAAGCCGGGCGTG
ACGATCACGATCGACGGCCGCGGCTTCGGCTCTAGCAAAGGCACCGTCTACTTCGGTACG
ACGGCGGTGAGCGGGGCGGACATCACGTCTTGGGAAGACACGCAGATCAAAGTGAAAATT
CCGGCCGTCGCAGGCGGCAACTACAACATTAAAGTCGCAAACGCTGCCGGAACGGCAAGC
AATGTGTATGACAACTTCGAGGTATTGTCCGGAGACCAGGTCAGCGTCCGCTTCGTGGTC
AACAACGCGACGACGGCCCTTGGGCAAAATGTGTACCTGACGGGCAGTGTCAGCGAGCTG
GGGAACTGGGACCCGGCAAAAGCAATCGGGCCGATGTACAATCAGGTCGTTTACCAATAT
CCGAACTGGTATTATGACGTCAGCGTTCCGGCCGGCAAAACGATCGAGTTCAAGTTTTTG
AAAAAACAAGGCTCCACCGTCACGTGGGAAGGCGGCAGCAACCACACCTTCACCGCGCCG
TCCAGCGGCACCGCGACCATTAACGTGAATTGGCAGCCATAA

# Drug_Target_53_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_53_General_References:
7493956	Knegtel RM, Strokopytov B, Penninga D, Faber OG, Rozeboom HJ, Kalk KH, Dijkhuizen L, Dijkstra BW: Crystallographic studies of the interaction of cyclodextrin glycosyltransferase from Bacillus circulans strain 251 with natural substrates and products. J Biol Chem. 1995 Dec 8;270(49):29256-64.
8107143	Lawson CL, van Montfort R, Strokopytov B, Rozeboom HJ, Kalk KH, de Vries GE, Penninga D, Dijkhuizen L, Dijkstra BW: Nucleotide sequence and X-ray structure of cyclodextrin glycosyltransferase from Bacillus circulans strain 251 in a maltose-dependent crystal form. J Mol Biol. 1994 Feb 18;236(2):590-600.
8672460	Strokopytov B, Knegtel RM, Penninga D, Rozeboom HJ, Kalk KH, Dijkhuizen L, Dijkstra BW: Structure of cyclodextrin glycosyltransferase complexed with a maltononaose inhibitor at 2.6 angstrom resolution. Implications for product specificity. Biochemistry. 1996 Apr 2;35(13):4241-9.
8955113	Penninga D, van der Veen BA, Knegtel RM, van Hijum SA, Rozeboom HJ, Kalk KH, Dijkstra BW, Dijkhuizen L: The raw starch binding domain of cyclodextrin glycosyltransferase from Bacillus circulans strain 251. J Biol Chem. 1996 Dec 20;271(51):32777-84.

# Drug_Target_53_HGNC_ID:
Not Available

# Drug_Target_53_HPRD_ID:
Not Available

# Drug_Target_53_ID:
2523

# Drug_Target_53_Locus:
Not Available

# Drug_Target_53_Molecular_Weight:
77310

# Drug_Target_53_Name:
Cyclomaltodextrin glucanotransferase

# Drug_Target_53_Number_of_Residues:
713

# Drug_Target_53_PDB_ID:
2CXG

# Drug_Target_53_Pathway:
Not Available

# Drug_Target_53_Pfam_Domain_Function:
PF00128	Alpha-amylase
PF00686	CBM_20
PF01833	TIG
PF02806	Alpha-amylase_C

# Drug_Target_53_Protein_Sequence:
>Cyclomaltodextrin glucanotransferase precursor
MKKFLKSTAALALGLSLTFGLFSPAQAAPDTSVSNKQNFSTDVIYQIFTDRFSDGNPANN
PTGAAFDGTCTNLRLYCGGDWQGIINKINDGYLTGMGVTAIWISQPVENIYSIINYSGVN
NTAYHGYWARDFKKTNPAYGTIADFQNLIAAAHAKNIKVIIDFAPNHTSPASSDQPSFAE
NGRLYDNGTLLGGYTNDTQNLFHHNGGTDFSTTENGIYKNLYDLADLNHNNSTVDVYLKD
AIKMWLDLGIDGIRMDAVKHMPFGWQKSFMAAVNNYKPVFTFGEWFLGVNEVSPENHKFA
NESGMSLLDFRFAQKVRQVFRDNTDNMYGLKAMLEGSAADYAQVDDQVTFIDNHDMERFH
ASNANRRKLEQALAFTLTSRGVPAIYYGTEQYMSGGTDPDNRARIPSFSTSTTAYQVIQK
LAPLRKCNPAIAYGSTQERWINNDVLIYERKFGSNVAVVAVNRNLNAPASISGLVTSLPQ
GSYNDVLGGLLNGNTLSVGSGGAASNFTLAAGGTAVWQYTAATATPTIGHVGPMMAKPGV
TITIDGRGFGSSKGTVYFGTTAVSGADITSWEDTQIKVKIPAVAGGNYNIKVANAAGTAS
NVYDNFEVLSGDQVSVRFVVNNATTALGQNVYLTGSVSELGNWDPAKAIGPMYNQVVYQY
PNWYYDVSVPAGKTIEFKFLKKQGSTVTWEGGSNHTFTAPSSGTATINVNWQP

# Drug_Target_53_Reaction:
Cyclizes part of a 1,4-alpha-D-glucan chain by formation of a 1,4-alpha-D-glucosidic bond

# Drug_Target_53_Signals:
1-27

# Drug_Target_53_Specific_Function:
Cyclizes part of a 1,4-alpha-D-glucan chain by formation of a 1,4-alpha-D-glucosidic bond

# Drug_Target_53_SwissProt_ID:
P43379

# Drug_Target_53_SwissProt_Name:
CDGT2_BACCI

# Drug_Target_53_Synonyms:
CGTase
Cyclodextrin-glycosyltransferase
Cyclomaltodextrin glucanotransferase precursor
EC 2.4.1.19

# Drug_Target_53_Theoretical_pI:
6.52

# Drug_Target_53_Transmembrane_Regions:
None

# Drug_Target_54_Cellular_Location:
Cell outer membrane

# Drug_Target_54_Chromosome_Location:
Not Available

# Drug_Target_54_Drug_References:
Not Available

# Drug_Target_54_Essentiality:
Non-Essential

# Drug_Target_54_GenAtlas_ID:
Not Available

# Drug_Target_54_GenBank_ID_Gene:
M26131

# Drug_Target_54_GenBank_ID_Protein:
Not Available

# Drug_Target_54_GeneCard_ID:
Not Available

# Drug_Target_54_Gene_Name:
lamB

# Drug_Target_54_Gene_Sequence:
>1341 bp
ATGATGATTACTCTGCGCAAACTTCCTCTGGCGGTTGCCGTCGCAGCGGGCGTAATGTCT
GCTCAGGCAATGGCTGTTGATTTCCACGGCTATGCACGTTCCGGTATTGGTTGGACAGGT
AGCGGCGGTGAACAACAGTGTTTCCAGACTACCGGTGCTCAAAGTAAATACCGTCTTGGC
AACGAATGTGAAACTTATGCTGAATTAAAATTGGGTCAGGAAGTGTGGAAAGAGGGCGAT
AAGAGCTTCTATTTCGACACTAACGTGGCCTATTCCGTCGCACAACAGAATGACTGGGAA
GCTACCGATCCGGCCTTCCGTGAAGCAAACGTGCAGGGTAAAAACCTGATCGAATGGCTG
CCAGGCTCCACCATCTGGGCAGGTAAGCGCTTCTACCAACGTCATGACGTTCATATGATC
GACTTCTACTACTGGGATATTTCTGGTCCTGGTGCCGGTCTGGAAAACATCGATGTTGGC
TTCGGTAAACTCTCTCTGGCAGCAACCCGCTCCTCTGAAGCTGGTGGTTCTTCCTCTTTC
GCCAGCAACAATATTTATGACTATACCAACGAAACCGCGAACGACGTTTTCGATGTGCGT
TTAGCGCAGATGGAAATCAACCCGGGCGGCACATTAGAACTGGGTGTCGACTACGGTCGT
GCCAACTTGCGTGATAACTATCGTCTGGTTGATGGCGCATCGAAAGACGGCTGGTTATTC
ACTGCTGAACATACTCAGAGTGTCCTGAAGGGCTTTAACAAGTTTGTTGTTCAGTACGCT
ACTGACTCGATGACCTCGCAGGGTAAAGGGCTGTCGCAGGGTTCTGGCGTTGCATTTGAT
AACGAAAAATTTGCCTACAATATCAACAACAACGGTCACATGCTGCGTATCCTCGACCAC
GGTGCGATCTCCATGGGCGACAACTGGGACATGATGTACGTGGGTATGTACCAGGATATC
AACTGGGATAACGACAACGGCACCAAGTGGTGGACCGTCGGTATTCGCCCGATGTACAAG
TGGACGCCAATCATGAGCACCGTGATGGAAATCGGCTACGACAACGTCGAATCCCAGCGC
ACCGGCGACAAGAACAATCAGTACAAAATTACCCTCGCACAACAATGGCAGGCTGGCGAC
AGCATCTGGTCACGCCCGGCTATTCGTGTCTTCGCAACCTACGCCAAGTGGGATGAGAAA
TGGGGTTACGACTACACCGGTAACGCTGATAACAACGCGAACTTCGGCAAAGCCGTTCCT
GCTGATTTCAACGGCGGCAGCTTCGGTCGTGGCGACAGCGACGAGTGGACCTTCGGTGCC
CAGATGGAAATCTGGTGGTAA

# Drug_Target_54_General_Function:
Involved in sugar:hydrogen ion symporter activity

# Drug_Target_54_General_References:
161974	Clement JM, Hedgpeth J, Hofnung M: [DNA sequence encoding the signal peptide of the lambda receptor in E. coli K 12] C R Seances Acad Sci D. 1979 Nov 26;289(14):1033-6.
1702781	Charbit A, Ronco J, Michel V, Werts C, Hofnung M: Permissive sites and topology of an outer membrane protein with a reporter epitope. J Bacteriol. 1991 Jan;173(1):262-75.
1988451	Luckey M, Ling R, Dose A, Malloy B: Role of a disulfide bond in the thermal stability of the LamB protein trimer in Escherichia coli outer membrane. J Biol Chem. 1991 Jan 25;266(3):1866-71.
2832377	Heine HG, Francis G, Lee KS, Ferenci T: Genetic analysis of sequences in maltoporin that contribute to binding domains and pore structure. J Bacteriol. 1988 Apr;170(4):1730-8.
3301537	Heine HG, Kyngdon J, Ferenci T: Sequence determinants in the lamB gene of Escherichia coli influencing the binding and pore selectivity of maltoporin. Gene. 1987;53(2-3):287-92.
6086106	Clement JM, Hofnung M: Gene sequence of the lambda receptor, an outer membrane protein of E. coli K12. Cell. 1981 Dec;27(3 Pt 2):507-14.
6446717	Hedgpeth J, Clement JM, Marchal C, Perrin D, Hofnung M: DNA sequence encoding the NH2-terminal peptide involved in transport of lambda receptor, an Escherichia coli secretory protein. Proc Natl Acad Sci U S A. 1980 May;77(5):2621-5.
8265357	Blattner FR, Burland V, Plunkett G 3rd, Sofia HJ, Daniels DL: Analysis of the Escherichia coli genome. IV. DNA sequence of the region from 89.2 to 92.8 minutes. Nucleic Acids Res. 1993 Nov 25;21(23):5408-17.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_54_HGNC_ID:
Not Available

# Drug_Target_54_HPRD_ID:
Not Available

# Drug_Target_54_ID:
5498

# Drug_Target_54_Locus:
Not Available

# Drug_Target_54_Molecular_Weight:
49913

# Drug_Target_54_Name:
Maltoporin

# Drug_Target_54_Number_of_Residues:
446

# Drug_Target_54_PDB_ID:
1MPQ

# Drug_Target_54_Pathway:
Not Available

# Drug_Target_54_Pfam_Domain_Function:
PF02264	LamB

# Drug_Target_54_Protein_Sequence:
>Maltoporin
MMITLRKLPLAVAVAAGVMSAQAMAVDFHGYARSGIGWTGSGGEQQCFQTTGAQSKYRLG
NECETYAELKLGQEVWKEGDKSFYFDTNVAYSVAQQNDWEATDPAFREANVQGKNLIEWL
PGSTIWAGKRFYQRHDVHMIDFYYWDISGPGAGLENIDVGFGKLSLAATRSSEAGGSSSF
ASNNIYDYTNETANDVFDVRLAQMEINPGGTLELGVDYGRANLRDNYRLVDGASKDGWLF
TAEHTQSVLKGFNKFVVQYATDSMTSQGKGLSQGSGVAFDNEKFAYNINNNGHMLRILDH
GAISMGDNWDMMYVGMYQDINWDNDNGTKWWTVGIRPMYKWTPIMSTVMEIGYDNVESQR
TGDKNNQYKITLAQQWQAGDSIWSRPAIRVFATYAKWDEKWGYDYTGNADNNANFGKAVP
ADFNGGSFGRGDSDEWTFGAQMEIWW

# Drug_Target_54_Reaction:
Not Available

# Drug_Target_54_Signals:
1-25

# Drug_Target_54_Specific_Function:
Involved in the transport of maltose and maltodextrins, indispensable for translocation of dextrins containing more than three glucosyl moieties. A hydrophobic path ("greasy slide") of aromatic residues serves to guide and select the sugars for transport through the channel. Also acts as a receptor for several bacteriophages including lambda

# Drug_Target_54_SwissProt_ID:
P02943

# Drug_Target_54_SwissProt_Name:
LAMB_ECOLI

# Drug_Target_54_Synonyms:
Lambda receptor protein
Maltoporin precursor
Maltose-inducible porin

# Drug_Target_54_Theoretical_pI:
4.58

# Drug_Target_54_Transmembrane_Regions:
27-35
65-78
81-93
105-115
123-130
149-159
162-173
192-205
210-222
235-248
251-263
291-305
308-323
327-341
344-359
363-378
386-400
431-445

# Drug_Target_55_Cellular_Location:
Not Available

# Drug_Target_55_Chromosome_Location:
Not Available

# Drug_Target_55_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_55_Essentiality:
Non-Essential

# Drug_Target_55_GenAtlas_ID:
Not Available

# Drug_Target_55_GenBank_ID_Gene:
Not Available

# Drug_Target_55_GenBank_ID_Protein:
Not Available

# Drug_Target_55_GeneCard_ID:
Not Available

# Drug_Target_55_Gene_Name:
MB

# Drug_Target_55_Gene_Sequence:
Not Available

# Drug_Target_55_General_Function:
Not Available

# Drug_Target_55_General_References:
Not Available

# Drug_Target_55_HGNC_ID:
Not Available

# Drug_Target_55_HPRD_ID:
Not Available

# Drug_Target_55_ID:
6977

# Drug_Target_55_Locus:
Not Available

# Drug_Target_55_Molecular_Weight:
Not Available

# Drug_Target_55_Name:
Myoglobin

# Drug_Target_55_Number_of_Residues:
0

# Drug_Target_55_PDB_ID:
Not Available

# Drug_Target_55_Pathway:
Not Available

# Drug_Target_55_Pfam_Domain_Function:
Not Available

# Drug_Target_55_Protein_Sequence:
Not Available

# Drug_Target_55_Reaction:
Not Available

# Drug_Target_55_Signals:
Not Available

# Drug_Target_55_Specific_Function:
Not Available

# Drug_Target_55_SwissProt_ID:
P02144

# Drug_Target_55_SwissProt_Name:
MYG_HUMAN

# Drug_Target_55_Synonyms:
Not Available

# Drug_Target_55_Theoretical_pI:
Not Available

# Drug_Target_55_Transmembrane_Regions:
Not Available

# Drug_Target_56_Cellular_Location:
Not Available

# Drug_Target_56_Chromosome_Location:
Not Available

# Drug_Target_56_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_56_Essentiality:
Non-Essential

# Drug_Target_56_GenAtlas_ID:
LGALS2

# Drug_Target_56_GenBank_ID_Gene:
M87860

# Drug_Target_56_GenBank_ID_Protein:
Not Available

# Drug_Target_56_GeneCard_ID:
Not Available

# Drug_Target_56_Gene_Name:
LGALS2

# Drug_Target_56_Gene_Sequence:
>399 bp
ATGACGGGGGAACTTGAGGTTAAGAACATGGACATGAAGCCGGGGTCAACCCTGAAGATC
ACAGGCAGCATCGCCGATGGCACTGATGGCTTTGTAATTAATCTGGGCCAGGGGACAGAC
AAGCTGAACCTGCATTTCAACCCTCGCTTCAGCGAATCCACCATTGTCTGCAACTCATTG
GACGGCAGCAACTGGGGGCAAGAACAACGGGAAGATCACCTGTGCTTCAGCCCAGGGTCA
GAGGTCAAGTTCACAGTGACCTTTGAGAGTGACAAATTCAAGGTGAAGCTGCCAGATGGG
CACGAGCTGACTTTTCCCAACAGGCTGGGTCACAGCCACCTGAGCTACCTGAGCGTAAGG
GGCGGGTTCAACATGTCCTCTTTCAAGTTAAAAGAATAA

# Drug_Target_56_General_Function:
Involved in sugar binding

# Drug_Target_56_General_References:
10591208	Dunham I, Shimizu N, Roe BA, Chissoe S, Hunt AR, Collins JE, Bruskiewich R, Beare DM, Clamp M, Smink LJ, Ainscough R, Almeida JP, Babbage A, Bagguley C, Bailey J, Barlow K, Bates KN, Beasley O, Bird CP, Blakey S, Bridgeman AM, Buck D, Burgess J, Burrill WD, O'Brien KP, et al.: The DNA sequence of human chromosome 22. Nature. 1999 Dec 2;402(6761):489-95.
1375225	Gitt MA, Massa SM, Leffler H, Barondes SH: Isolation and expression of a gene encoding L-14-II, a new human soluble lactose-binding lectin. J Biol Chem. 1992 May 25;267(15):10601-6.
1988031	Gitt MA, Barondes SH: Genomic sequence and organization of two members of a human lectin gene family. Biochemistry. 1991 Jan 8;30(1):82-9.
3020551	Gitt MA, Barondes SH: Evidence that a human soluble beta-galactoside-binding lectin is encoded by a family of genes. Proc Natl Acad Sci U S A. 1986 Oct;83(20):7603-7.
8262940	Lobsanov YD, Gitt MA, Leffler H, Barondes SH, Rini JM: X-ray crystal structure of the human dimeric S-Lac lectin, L-14-II, in complex with lactose at 2.9-A resolution. J Biol Chem. 1993 Dec 25;268(36):27034-8.

# Drug_Target_56_HGNC_ID:
HGNC:6562

# Drug_Target_56_HPRD_ID:
Not Available

# Drug_Target_56_ID:
5563

# Drug_Target_56_Locus:
22q12-q13|22q13.1

# Drug_Target_56_Molecular_Weight:
14645

# Drug_Target_56_Name:
Galectin-2

# Drug_Target_56_Number_of_Residues:
132

# Drug_Target_56_PDB_ID:
1HLC

# Drug_Target_56_Pathway:
Not Available

# Drug_Target_56_Pfam_Domain_Function:
PF00337	Gal-bind_lectin

# Drug_Target_56_Protein_Sequence:
>Galectin-2
MTGELEVKNMDMKPGSTLKITGSIADGTDGFVINLGQGTDKLNLHFNPRFSESTIVCNSL
DGSNWGQEQREDHLCFSPGSEVKFTVTFESDKFKVKLPDGHELTFPNRLGHSHLSYLSVR
GGFNMSSFKLKE

# Drug_Target_56_Reaction:
Not Available

# Drug_Target_56_Signals:
None

# Drug_Target_56_Specific_Function:
This protein binds beta-galactoside. Its physiological function is not yet known

# Drug_Target_56_SwissProt_ID:
P05162

# Drug_Target_56_SwissProt_Name:
LEG2_HUMAN

# Drug_Target_56_Synonyms:
Beta-galactoside-binding lectin L-14-II
HL14
Lactose-binding lectin 2
S-Lac lectin 2

# Drug_Target_56_Theoretical_pI:
6.35

# Drug_Target_56_Transmembrane_Regions:
None

# Drug_Target_57_Cellular_Location:
Microsome
microsomal membrane
peripheral membrane protein

# Drug_Target_57_Chromosome_Location:
Not Available

# Drug_Target_57_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_57_Essentiality:
Non-Essential

# Drug_Target_57_GenAtlas_ID:
PTGS1

# Drug_Target_57_GenBank_ID_Gene:
M31822

# Drug_Target_57_GenBank_ID_Protein:
387018

# Drug_Target_57_GeneCard_ID:
PTGS1

# Drug_Target_57_Gene_Name:
PTGS1

# Drug_Target_57_Gene_Sequence:
>1800 bp
ATGAGCCGGAGTCTCTTGCTCCGGTTCTTGCTGTTGCTGCTCCTGCTCCCGCCGCTCCCC
GTCCTGCTCGCGGACCCAGGGGCGCCCACGCCAGTGAATCCCTGTTGTTACTATCCATGC
CAGCACCAGGGCATCTGTGTCCGCTTCGGCCTTGACCGCTACCAGTGTGACTGCACCCGC
ACGGGCTATTCCGGCCCCAACTGCACCATCCCTGGCCTGTGGACCTGGCTCCGGAATTCA
CTGCGGCCCAGCCCCTCTTTCACCCACTTCCTGCTCACTCACGGGCGCTGGTTCTGGGAG
TTTGTCAATGCCACCTTCATCCGAGAGATGCTCATGCTCCTGGTACTCACAGTGCGCTCC
AACCTTATCCCCAGTCCCCCCACCTACAACTCTGCACATGACTACATCAGCTGGGAGTCT
TTCTCCAACGTGAGCTATTACACTCGTATTCTGCCCTCTGTGCCTAAAGATTGCCCCACA
CCCATGGGAACCAAAGGGAAGAAGCAGTTGCCAGATGCCCAGCTCCTGGCCCGCCGCTTC
CTGCTCAGGAGGAAGTTCATACCTGACCCCCAAGGCACCAACCTCATGTTTGCCTTCTTT
GCACAACACTTCACCCACCAGTTCTTCAAAACTTCTGGCAAGATGGGTCCTGGCTTCACC
AAGGCCTTGGGCCATGGGGTAGACCTCGGCCACATTTATGGAGACAATCTGGAGCGTCAG
TATCAACTGCGGCTCTTTAAGGATGGGAAACTCAAGTACCAGGTGCTGGATGGAGAAATG
TACCCGCCCTCGGTAGAAGAGGCGCCTGTGTTGATGCACTACCCCCGAGGCATCCCGCCC
CAGAGCCAGATGGCTGTGGGCCAGGAGGTGTTTGGGCTGCTTCCTGGGCTCATGCTGTAT
GCCACGCTCTGGCTACGTGAGCACAACCGTGTGTGTGACCTGCTGAAGGCTGAGCACCCC
ACCTGGGGCGATGAGCAGCTTTTCCAGACGACCCGCCTCATCCTCATAGGGGAGACCATC
AAGATTGTCATCGAGGAGTACGTGCAGCAGCTGAGTGGCTATTTCCTGCAGCTGAAATTT
GACCCAGAGCTGCTGTTCGGTGTCCAGTTCCAATACCGCAACCGCATTGCCACGGAGTTC
AACCATCTCTACCACTGGCACCCCCTCATGCCTGACTCCTTCAAGGTGGGCTCCCAGGAG
TACAGCTACGAGCAGTTCTTGTTCAACACCTCCATGTTGGTGGACTATGGGGTTGAGGCC
CTGGTGGATGCCTTCTCTCGCCAGATTGCTGGCCGGATCGGTGGGGGCAGGAACATGGAC
CACCACATCCTGCATGTGGCTGTGGATGTCATCAGGGAGTCTCGGGAGATGCGGCTGCAG
CCCTTCAATGAGTACCGCAAGAGGTTTGGCATGAAACCCTACACCTCCTTCCAGGAGCTC
GTAGGAGAGAAGGAGATGGCAGCAGAGTTGGAGGAATTGTATGGAGACATTGATGCGTTG
GAGTTCTACCCTGGACTGCTTCTTGAAAAGTGCCATCCAAACTCTATCTTTGGGGAGAGT
ATGATAGAGATTGGGGCTCCCTTTTCCCTCAAGGGTCTCCTAGGGAATCCCATCTGTTCT
CCGGAGTACTGGAAGCCGAGCACATTTGGCGGCGAGGTGGGCTTTAACATTGTCAAGACG
GCCACACTGAAGAAGCTGGTCTGCCTCAACACCAAGACCTGTCCCTACGTTTCCTTCCGT
GTGCCGGATGCCAGTCAGGATGATGGGCCTGCTGTGGAGCGACCATCCACAGAGCTCTGA

# Drug_Target_57_General_Function:
Involved in peroxidase activity

# Drug_Target_57_General_References:
1587858	Diaz A, Reginato AM, Jimenez SA: Alternative splicing of human prostaglandin G/H synthase mRNA and evidence of differential regulation of the resulting transcripts by transforming growth factor beta 1, interleukin 1 beta, and tumor necrosis factor alpha. J Biol Chem. 1992 May 25;267(15):10816-22.
1734857	Takahashi Y, Ueda N, Yoshimoto T, Yamamoto S, Yokoyama C, Miyata A, Tanabe T, Fuse I, Hattori A, Shibata A: Immunoaffinity purification and cDNA cloning of human platelet prostaglandin endoperoxide synthase (cyclooxygenase). Biochem Biophys Res Commun. 1992 Jan 31;182(2):433-8.
1907252	Funk CD, Funk LB, Kennedy ME, Pong AS, Fitzgerald GA: Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment. FASEB J. 1991 Jun;5(9):2304-12.
2512924	Yokoyama C, Tanabe T: Cloning of human gene encoding prostaglandin endoperoxide synthase and primary structure of the enzyme. Biochem Biophys Res Commun. 1989 Dec 15;165(2):888-94.

# Drug_Target_57_HGNC_ID:
HGNC:9604

# Drug_Target_57_HPRD_ID:
07518

# Drug_Target_57_ID:
20

# Drug_Target_57_Locus:
9q32-q33.3

# Drug_Target_57_Molecular_Weight:
68657

# Drug_Target_57_Name:
Prostaglandin G/H synthase 1

# Drug_Target_57_Number_of_Residues:
599

# Drug_Target_57_PDB_ID:
Not Available

# Drug_Target_57_Pathway:
Abciximab Pathway	SMP00265
Acetylsalicylic Acid Pathway	SMP00083
Bromfenac Pathway	SMP00102
Celecoxib Pathway	SMP00096
Cilostazol Pathway	SMP00263
Clopidogrel Pathway	SMP00260
Diclofenac Pathway	SMP00093
Diflunisal Pathway	SMP00289
Dipyridamole (Antiplatelet) Pathway	SMP00264
Eptifibatide Pathway	SMP00266
Etodolac Pathway	SMP00084
Ibuprofen Pathway	SMP00086
Indomethacin Pathway	SMP00104
Ketoprofen Pathway	SMP00085
Ketorolac Pathway	SMP00098
Mefanamic Acid Pathway	SMP00109
Meloxicam Pathway	SMP00106
Nabumetone Pathway	SMP00114
Naproxen Pathway	SMP00120
Oxaprozin Pathway	SMP00113
Piroxicam Pathway	SMP00077
Rofecoxib Pathway	SMP00087
Sulindac Pathway	SMP00094
Suprofen Pathway	SMP00101
Ticlopidine Pathway	SMP00261
Tirofiban Pathway	SMP00267
Valdecoxib Pathway	SMP00116

# Drug_Target_57_Pfam_Domain_Function:
PF00008	EGF
PF03098	An_peroxidase

# Drug_Target_57_Protein_Sequence:
>Prostaglandin G/H synthase 1 precursor
MSRSLLLRFLLFLLLLPPLPVLLADPGAPTPVNPCCYYPCQHQGICVRFGLDRYQCDCTR
TGYSGPNCTIPGLWTWLRNSLRPSPSFTHFLLTHGRWFWEFVNATFIREMLMRLVLTVRS
NLIPSPPTYNSAHDYISWESFSNVSYYTRILPSVPKDCPTPMGTKGKKQLPDAQLLARRF
LLRRKFIPDPQGTNLMFAFFAQHFTHQFFKTSGKMGPGFTKALGHGVDLGHIYGDNLERQ
YQLRLFKDGKLKYQVLDGEMYPPSVEEAPVLMHYPRGIPPQSQMAVGQEVFGLLPGLMLY
ATLWLREHNRVCDLLKAEHPTWGDEQLFQTTRLILIGETIKIVIEEYVQQLSGYFLQLKF
DPELLFGVQFQYRNRIAMEFNHLYHWHPLMPDSFKVGSQEYSYEQFLFNTSMLVDYGVEA
LVDAFSRQIAGRIGGGRNMDHHILHVAVDVIRESREMRLQPFNEYRKRFGMKPYTSFQEL
VGEKEMAAELEELYGDIDALEFYPGLLLEKCHPNSIFGESMIEIGAPFSLKGLLGNPICS
PEYWKPSTFGGEVGFNIVKTATLKKLVCLNTKTCPYVSFRVPDASQDDGPAVERPSTEL

# Drug_Target_57_Reaction:
arachidonate + AH2 + 2 O2 = prostaglandin H2 + A + H2O

# Drug_Target_57_Signals:
1-23

# Drug_Target_57_Specific_Function:
May play an important role in regulating or promoting cell proliferation in some normal and neoplastically transformed cells

# Drug_Target_57_SwissProt_ID:
P23219

# Drug_Target_57_SwissProt_Name:
PGH1_HUMAN

# Drug_Target_57_Synonyms:
COX-1
Cyclooxygenase- 1
EC 1.14.99.1
PGH synthase 1
PGHS-1
PHS 1
Prostaglandin G/H synthase 1 precursor
Prostaglandin H2 synthase 1
Prostaglandin-endoperoxide synthase 1

# Drug_Target_57_Theoretical_pI:
7.39

# Drug_Target_57_Transmembrane_Regions:
None

# Drug_Target_58_Cellular_Location:
Mitochondrion
mitochondrial outer membrane. Note=Its hydrophobic N-terminal sequence may be involve

# Drug_Target_58_Chromosome_Location:
Not Available

# Drug_Target_58_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_58_Essentiality:
Non-Essential

# Drug_Target_58_GenAtlas_ID:
HK1

# Drug_Target_58_GenBank_ID_Gene:
M75126

# Drug_Target_58_GenBank_ID_Protein:
184021

# Drug_Target_58_GeneCard_ID:
HK1

# Drug_Target_58_Gene_Name:
HK1

# Drug_Target_58_Gene_Sequence:
>2754 bp
ATGATCGCCGCGCAGCTCCTGGCCTATTACTTCACGGAGCTGAAGGATGACCAGGTCAAA
AAGATTGACAAGTATCTGTATGCCATGCGGCTCTCCGATGAAACTCTCATAGATATCATG
ACTCGCTTCAGGAAGGAGATGAAGAATGGCCTCTCCCGGGATTTTAATCCAACAGCCACA
GTCAAGATGTTGCCAACATTCGTAAGGTCCATTCCTGATGGCTCTGAAAAGGGAGATTTC
ATTGCCCTGGATCTTGGTGGGTCTTCCTTTCGAATTCTGCGGGTGCAAGTGAATCATGAG
AAAAACCAGAATGTTCACATGGAGTCCGAGGTTTATGACACCCCAGAGAACATCGTGCAC
GGCAGTGGAAGCCAGCTTTTTGATCATGTTGCTGAGTGCCTGGGAGATTTCATGGAGAAA
AGGAAGATCAAGGACAAGAAGTTACCTGTGGGATTCACGTTTTCTTTTCCTTGCCAACAA
TCCAAAATAGATGAGGCCATCCTGATCACCTGGACAAAGCGATTTAAAGCGAGCGGAGTG
GAAGGAGCAGATGTGGTCAAACTGCTTAACAAAGCCATCAAAAAGCGAGGGGACTATGAT
GCCAACATCGTAGCTGTGGTGAATGACACAGTGGGCACCATGATGACCTGTGGCTATGAC
GACCAGCACTGTGAAGTCGGCCTGATCATCGGCACTGGCACCAATGCTTGCTACATGGAG
GAACTGAGGCACATTGATCTGGTGGAAGGAGACGAGGGGAGGATGTGTATCAATACAGAA
TGGGGAGCCTTTGGAGACGATGGATCATTAGAAGACATCCGGACAGAGTTTGACAGGGAG
ATAGACCGGGGATCCCTCAACCCTGGAAAACAGCTGTTTGAGAAGATGGTCAGTGGCATG
TACTTGGGAGAGCTGGTTCGACTGATCCTAGTCAAGATGGCCAAGGAGGGCCTCTTATTT
GAAGGGCGGATCACCCCGGAGCTGCTCACCCGAGGGAAGTTTAACACCAGTGATGTGTCA
GCCATCGAAAAGAATAAGGAAGGCCTCCACAATGCCAAAGAAATCCTGACCCGCCTGGGA
GTGGAGCCGTCCGATGATGACTGTGTCTCAGTCCAGCACGTTTGCACCATTGTCTCATTT
CGCTCAGCCAACTTGGTGGCTGCCACACTGGGCGCCATCTTGAACCGCCTGCGTGATAAC
AAGGGCACACCCAGGCTGCGGACCACGGTTGGTGTCGACGGATCTCTTTACAAGACGCAC
CCACAGTATTCCCGGCGTTTCCACAAGACTCTAAGGCGCTTGGTGCCAGACTCCGATGTG
CGCTTCCTCCTCTCGGAGAGTGGCAGCGGCAAGGGGGCTGCCATGGTGACGGCGGTGGCC
TACCGCTTGGCCGAGCAGCACCGGCAGATAGAGGAGACCCTGGCTCATTTCCACCTCACC
AAAGACATGCTGCTGGAGGTGAAGAAGAGGATGCGGGCCGAGATGGAGCTGGGGCTGAGG
AAGCAGACGCACAACAATGCCGTGGTTAAGATGCTGCCCTCCTTCGTCCGGAGAACTCCC
GACGGGACCGAGAATGGTGACTTCTTGGCCCTGGATCTTGGAGGAACCAATTTCCGTGTG
CTGCTGGTGAAAATCCGTAGTGGGAAAAAGAGAACGGTGGAAATGCACAACAAGATCTAC
GCCATTCCTATTGAAATCATGCAGGGCACTGGGGAAGAGCTGTTTGATCACATTGTCTCC
TGCATCTCTGACTTCTTGGACTACATGGGGATCAAAGGCCCCAGGATGCCTCTGGGCTTC
ACGTTCTCATTTCCCTGCCAGCAGACGAGTCTGGACGCGGGAATCTTGATCACGTGGACA
AAGGGTTTTAAGGCAACAGACTGCGTGGGCCACGATGTAGTCACCTTACTAAGGGATGCG
ATAAAAAGGAGAGAGGAATTTGACCTGGACGTGGTGGCTGTGGTCAACGACACAGTGGGC
ACCATGATGACCTGTGCTTATGAGGAGCCCACCTGTGAGGTTGGACTCATTGTTGGGACC
GGCAGCAATGCCTGCTACATGGAGGAGATGAAGAACGTGGAGATGGTGGAGGGGGACCAG
GGGCAGATGTGCATCAACATGGAGTGGGGGGCCTTTGGGGACAACGGGTGTCTGGATGAT
ATCAGGACACACTACGACAGACTGGTGAACGAATATTCCCTAAATGCTGGGAAACAAAGG
TATGAGAAGATGATCAGTGGTATGTACCTGGGTGAAATCGTCCGCAACATCTTAATCGAC
TTCACCAAGAAGGGATTCCTCTTCCGAGGGCAGATCTCTGAGACGATGAAGACCCGGGGC
ATCTTTGAGACCAAGTTTCTCTCTCAGATCGAGAGTGACCGATTAGCACTGCTCCAGGTC
CGGGCTATCCTCCAGCAGCTAGGTCTGAATAGCACCTGCGATGACAGTATCCTCGTCAAG
ACAGTGTGCGGGGTGGTGTCCAGGAGGGCCGCACAGCTGTGTGGCGCAGGCATGGCTGCG
GTTGTGGATAAGATCCGCGAGAACAGAGGACTGGACCGTCTGAATGTGACTGTGGGAGTG
GACGGGACACTCTACAAGCTTCATCCACACTTCTCCAGAATCATGCACCAGACGGTGAAG
GAACTGTCACCAAAATGTAACGTGTCCTTCCTCCTGTCTGAGGATGGCAGCGGCAAGGGG
GCCGCCCTCATCACGGCCGTGGGCGTGCGGTTACGCACAGAGGCAAGCAGCTAA

# Drug_Target_58_General_Function:
Involved in hexokinase activity

# Drug_Target_58_General_References:
10574795	Rosano C, Sabini E, Rizzi M, Deriu D, Murshudov G, Bianchi M, Serafini G, Magnani M, Bolognesi M: Binding of non-catalytic ATP to human hexokinase I highlights the structural components for enzyme-membrane association control. Structure. 1999 Nov 15;7(11):1427-37.
10686099	Aleshin AE, Kirby C, Liu X, Bourenkov GP, Bartunik HD, Fromm HJ, Honzatko RB: Crystal structures of mutant monomeric hexokinase I reveal multiple ADP binding sites and conformational changes relevant to allosteric regulation. J Mol Biol. 2000 Mar 3;296(4):1001-15.
10978502	Andreoni F, Ruzzo A, Magnani M: Structure of the 5' region of the human hexokinase type I (HKI) gene and identification of an additional testis-specific HKI mRNA. Biochim Biophys Acta. 2000 Sep 7;1493(1-2):19-26.
1637300	Magnani M, Bianchi M, Casabianca A, Stocchi V, Daniele A, Altruda F, Ferrone M, Silengo L: A recombinant human 'mini'-hexokinase is catalytically active and regulated by hexose 6-phosphates. Biochem J. 1992 Jul 1;285 ( Pt 1):193-9.
1985912	Magnani M, Serafini G, Bianchi M, Casabianca A, Stocchi V: Human hexokinase type I microheterogeneity is due to different amino-terminal sequences. J Biol Chem. 1991 Jan 5;266(1):502-5.
3207429	Nishi S, Seino S, Bell GI: Human hexokinase: sequences of amino- and carboxyl-terminal halves are homologous. Biochem Biophys Res Commun. 1988 Dec 30;157(3):937-43.
7655856	Bianchi M, Magnani M: Hexokinase mutations that produce nonspherocytic hemolytic anemia. Blood Cells Mol Dis. 1995;21(1):2-8.
8706938	Aleshin AE, Zeng C, Fromm HJ, Honzatko RB: Crystallization and preliminary X-ray analysis of human brain hexokinase. FEBS Lett. 1996 Aug 5;391(1-2):9-10.
9028305	Murakami K, Piomelli S: Identification of the cDNA for human red blood cell-specific hexokinase isozyme. Blood. 1997 Feb 1;89(3):762-6.
9493266	Aleshin AE, Zeng C, Bourenkov GP, Bartunik HD, Fromm HJ, Honzatko RB: The mechanism of regulation of hexokinase: new insights from the crystal structure of recombinant human brain hexokinase complexed with glucose and glucose-6-phosphate. Structure. 1998 Jan 15;6(1):39-50.
9531504	Ruzzo A, Andreoni F, Magnani M: Structure of the human hexokinase type I gene and nucleotide sequence of the 5' flanking region. Biochem J. 1998 Apr 15;331 ( Pt 2):607-13.
9735292	Aleshin AE, Zeng C, Bartunik HD, Fromm HJ, Honzatko RB: Regulation of hexokinase I: crystal structure of recombinant human brain hexokinase complexed with glucose and phosphate. J Mol Biol. 1998 Sep 18;282(2):345-57.

# Drug_Target_58_HGNC_ID:
HGNC:4922

# Drug_Target_58_HPRD_ID:
00809

# Drug_Target_58_ID:
1881

# Drug_Target_58_Locus:
10q22

# Drug_Target_58_Molecular_Weight:
102487

# Drug_Target_58_Name:
Hexokinase-1

# Drug_Target_58_Number_of_Residues:
917

# Drug_Target_58_PDB_ID:
1HKB

# Drug_Target_58_Pathway:
Not Available

# Drug_Target_58_Pfam_Domain_Function:
PF00349	Hexokinase_1
PF03727	Hexokinase_2

# Drug_Target_58_Protein_Sequence:
>Hexokinase-1
MIAAQLLAYYFTELKDDQVKKIDKYLYAMRLSDETLIDIMTRFRKEMKNGLSRDFNPTAT
VKMLPTFVRSIPDGSEKGDFIALDLGGSSFRILRVQVNHEKNQNVHMESEVYDTPENIVH
GSGSQLFDHVAECLGDFMEKRKIKDKKLPVGFTFSFPCQQSKIDEAILITWTKRFKASGV
EGADVVKLLNKAIKKRGDYDANIVAVVNDTVGTMMTCGYDDQHCEVGLIIGTGTNACYME
ELRHIDLVEGDEGRMCINTEWGAFGDDGSLEDIRTEFDREIDRGSLNPGKQLFEKMVSGM
YLGELVRLILVKMAKEGLLFEGRITPELLTRGKFNTSDVSAIEKNKEGLHNAKEILTRLG
VEPSDDDCVSVQHVCTIVSFRSANLVAATLGAILNRLRDNKGTPRLRTTVGVDGSLYKTH
PQYSRRFHKTLRRLVPDSDVRFLLSESGSGKGAAMVTAVAYRLAEQHRQIEETLAHFHLT
KDMLLEVKKRMRAEMELGLRKQTHNNAVVKMLPSFVRRTPDGTENGDFLALDLGGTNFRV
LLVKIRSGKKRTVEMHNKIYAIPIEIMQGTGEELFDHIVSCISDFLDYMGIKGPRMPLGF
TFSFPCQQTSLDAGILITWTKGFKATDCVGHDVVTLLRDAIKRREEFDLDVVAVVNDTVG
TMMTCAYEEPTCEVGLIVGTGSNACYMEEMKNVEMVEGDQGQMCINMEWGAFGDNGCLDD
IRTHYDRLVDEYSLNAGKQRYEKMISGMYLGEIVRNILIDFTKKGFLFRGQISETLKTRG
IFETKFLSQIESDRLALLQVRAILQQLGLNSTCDDSILVKTVCGVVSRRAAQLCGAGMAA
VVDKIRENRGLDRLNVTVGVDGTLYKLHPHFSRIMHQTVKELSPKCNVSFLLSEDGSGKG
AALITAVGVRLRTEASS

# Drug_Target_58_Reaction:
ATP + D-hexose = ADP + D-hexose 6-phosphate

# Drug_Target_58_Signals:
None

# Drug_Target_58_Specific_Function:
ATP + D-hexose = ADP + D-hexose 6-phosphate

# Drug_Target_58_SwissProt_ID:
P19367

# Drug_Target_58_SwissProt_Name:
HXK1_HUMAN

# Drug_Target_58_Synonyms:
Brain form hexokinase
EC 2.7.1.1
HK I
Hexokinase type I

# Drug_Target_58_Theoretical_pI:
6.78

# Drug_Target_58_Transmembrane_Regions:
None

# Drug_Target_59_Cellular_Location:
Cytoplasmic

# Drug_Target_59_Chromosome_Location:
Not Available

# Drug_Target_59_Drug_References:
Not Available

# Drug_Target_59_Essentiality:
Non-Essential

# Drug_Target_59_GenAtlas_ID:
Not Available

# Drug_Target_59_GenBank_ID_Gene:
AE000513

# Drug_Target_59_GenBank_ID_Protein:
Not Available

# Drug_Target_59_GeneCard_ID:
Not Available

# Drug_Target_59_Gene_Name:
treZ

# Drug_Target_59_Gene_Sequence:
>1803 bp
TCACCCCACCAACACCGCTTCCCCCGCCCCCAGCGTCAAATCCTCGCGCCCTTCGGTATG
CAGCAGCAGGCGCCTAGGCACGGTGAAGGGCAACTTGACCTCGGCGACGGCCCGCGTGTC
CTGGCCCAGGTTCCACAGCAGCACCCGCTCGCCTGCGCCGGTCACGGTACGGACCCACAG
CACGTCGCCGTCGTGGCCGGTGGTCAGGTTCTCGCGCTGGCGGTTGTGCAGCACCGGGTC
CTCGCGCCGCAGCCGCAGCAGGTCGCGGTACAGGCGCAGGGTGCGGGCGTGTTCGCCGCC
CTCGCGCTCGGCCCAGTTCAGTTTGGAGTTGAGGAAAGTCTGCTCGGCCTGCGGGTCGGG
CACGTCCTCGCCGCTGAAGCCGCTGAAGCCCCCGAATTCCTTTTTGCGGCCTTCGGATAC
GGCCTGTCCCAACTCGCCCGCGTGGTCGCTGAAAAACTGAAACGGCGTGCTGGCAGCCCA
TTCCTGGCCCTGAAACAGCAGCGGGGTCATCGGCAGCAGCAGCGCGGCGGCGCCCCGGTA
CTCGTGCAGCGTCACTCCGTCCGACTGGTGCAGCCGCTCGCCCAGGGGCCGGTTGCCGAT
CTGGTCGTGGTTCTGGATGCAGTAGACGAAGTTGGGGGCCTCCAGCGCGTCGGAGGGGTG
GCCGCGCTCGTGCTCCTCGCCCTTGACCGCCCAGAACTGCCCCTCGTAGCGCCAGCCCCG
GCGGATGGTGTAGGCGAGGGCTTCGGCGCCGCCCCGGTAGCCGGCGTAGTAGCCTTCCTG
CTCGCCGGTCAGGGTGACGCGCGTTTCGTGGTGAAAGTCGTCGGTCCAGATGCCGTCGAG
GTGGTTGACCGTCACCAGGTCGGGCAGGTTGCGGTGATCCTCGGCGAGCAGCAGGTGGGT
GCCGCCGAGTTCGTGAATTTCCTGCGCCAGCTCGGTCAGGATGTGGGTCTCGCTGTCGTC
GGTCATGTACGGCGTGGCGTCGAGCCGCAGCCCGTCGAAGTGGTAATCGCGCAGCCACAT
GCGGGCGTTGCCGGTGACGTAGCGGCGCATGTGCGGCTCGGCGTAGTCCAACCCCATGCC
CCAGGCGCTCGAAAAGCGGTCGGTAAAATAGCTCGGCGCGTAGCTGCTCAGGTAATTGCC
TGACGGCCCGAAGTGGTTGTACACCACGTCCAGAAATACGCCCAGCCCCAGTCGGTGCGC
GGCATCTACCAGGGCCATCAGGTCCTCAGGGCGGCCATACGGCGCGTAGGGCGCGTAAAA
GGCGGCGCCGTCGTAGCCCCAGCCGCGCTGCCCGTCAAAGGCGGCGAGCGGCATCACTTG
AATGGCCGTCACGCCCAGCTCTTTCAGGTACGGCAGCTTCTCGGCGGCGGCGCGGTAGGT
GCCTTCCGGGGTAAAGGTGCCCACATGCACCTCGTAGAACACGCAGTCGGCGAGTTTGAT
GCCGTGCCAGTCGGCGTCTGTCCAGTCGAAGGTGCCGAAGTCCACCACTTCCGCTTCGCC
GTGCACGCCGTCGGGCAAAAAGCGGGCGTAGGGGTCGGGGGTTGGCACGCCGTCGAGCAC
GAAAAGGTAGCGGGCGCCGGGGCCGACCGGCAGTTCCAGTTCGTAGATGCCGCCGCCGAG
CGAGGTCATGACGTGCTCGGTGCCGTTCACGCGCACGGCCACCGTGCGGGCGGTGGAGGT
CCACAGGCGAAAGCGGGTGCCCGCGCCGCCGGGCAGGGGCGTGGCGCCCAGACGGGTGCG
CGGGTCGTGCTGGGTCTGAAAAGAAGCGGGGGGGGTCGGGGTCACAGGCTGGGTCTGGGT
CAT

# Drug_Target_59_General_Function:
Involved in catalytic activity

# Drug_Target_59_General_References:
10567266	White O, Eisen JA, Heidelberg JF, Hickey EK, Peterson JD, Dodson RJ, Haft DH, Gwinn ML, Nelson WC, Richardson DL, Moffat KS, Qin H, Jiang L, Pamphile W, Crosby M, Shen M, Vamathevan JJ, Lam P, McDonald L, Utterback T, Zalewski C, Makarova KS, Aravind L, Daly MJ, Minton KW, Fleischmann RD, Ketchum KA, Nelson KE, Salzberg S, Smith HO, Venter JC, Fraser CM: Genome sequence of the radioresistant bacterium Deinococcus radiodurans R1. Science. 1999 Nov 19;286(5444):1571-7.

# Drug_Target_59_HGNC_ID:
Not Available

# Drug_Target_59_HPRD_ID:
Not Available

# Drug_Target_59_ID:
5056

# Drug_Target_59_Locus:
Not Available

# Drug_Target_59_Molecular_Weight:
66910

# Drug_Target_59_Name:
Maltooligosyltrehalose trehalohydrolase, putative

# Drug_Target_59_Number_of_Residues:
600

# Drug_Target_59_PDB_ID:
2BHU

# Drug_Target_59_Pathway:
Not Available

# Drug_Target_59_Pfam_Domain_Function:
PF00128	Alpha-amylase
PF02922	Isoamylase_N

# Drug_Target_59_Protein_Sequence:
>Maltooligosyltrehalose trehalohydrolase, putative
MTQTQPVTPTPPASFQTQHDPRTRLGATPLPGGAGTRFRLWTSTARTVAVRVNGTEHVMT
SLGGGIYELELPVGPGARYLFVLDGVPTPDPYARFLPDGVHGEAEVVDFGTFDWTDADWH
GIKLADCVFYEVHVGTFTPEGTYRAAAEKLPYLKELGVTAIQVMPLAAFDGQRGWGYDGA
AFYAPYAPYGRPEDLMALVDAAHRLGLGVFLDVVYNHFGPSGNYLSSYAPSYFTDRFSSA
WGMGLDYAEPHMRRYVTGNARMWLRDYHFDGLRLDATPYMTDDSETHILTELAQEIHELG
GTHLLLAEDHRNLPDLVTVNHLDGIWTDDFHHETRVTLTGEQEGYYAGYRGGAEALAYTI
RRGWRYEGQFWAVKGEEHERGHPSDALEAPNFVYCIQNHDQIGNRPLGERLHQSDGVTLH
EYRGAAALLLPMTPLLFQGQEWAASTPFQFFSDHAGELGQAVSEGRKKEFGGFSGFSGED
VPDPQAEQTFLNSKLNWAEREGGEHARTLRLYRDLLRLRREDPVLHNRQRENLTTGHDGD
VLWVRTVTGAGERVLLWNLGQDTRAVAEVKLPFTVPRRLLLHTEGREDLTLGAGEAVLVG

# Drug_Target_59_Reaction:
Not Available

# Drug_Target_59_Signals:
None

# Drug_Target_59_Specific_Function:
Not Available

# Drug_Target_59_SwissProt_ID:
Q9RX51

# Drug_Target_59_SwissProt_Name:
TREZ_DEIRA

# Drug_Target_59_Synonyms:
Not Available

# Drug_Target_59_Theoretical_pI:
5.26

# Drug_Target_59_Transmembrane_Regions:
None

# Drug_Target_5_Cellular_Location:
Not Available

# Drug_Target_5_Chromosome_Location:
Not Available

# Drug_Target_5_Drug_References:
Not Available

# Drug_Target_5_Essentiality:
Non-Essential

# Drug_Target_5_GenAtlas_ID:
Not Available

# Drug_Target_5_GenBank_ID_Gene:
U60828

# Drug_Target_5_GenBank_ID_Protein:
Not Available

# Drug_Target_5_GeneCard_ID:
Not Available

# Drug_Target_5_Gene_Name:
galM

# Drug_Target_5_Gene_Sequence:
>1020 bp
ATGGAAATTAAAATAAGAGATTTTGGCTTAGGAAGTGACTTAATTAGTCTAACCAATAAA
GCAGGTGTCACAATTTCTTTTACAAATCTGGGCGCTCGGATTGTTGACTGGCAAAAAGAT
GGAAAGCATCTGATTCTAGGCTTTGATTCAGCTAAAGAATATTTAGAAAAAGATGCCTAT
CCTGGTGCAACAGTTGGACCTACAGCAGGAAGAATTAAGGATGGTTTGGTCAAAATTTCT
GGAAAAGATTATATCTTAAATCAAAATGAAGGCCCTCAAACCTTACATGGTGGGGAAGAA
AGTATTCATACTAAACTTTGGACATATGAAGTTACCGATTTAGGAGCTGAAGTTCAAGTC
AAATTTTCCTTAGTTACTAATGACGGAACAAATGGTTATCCTGGTAAAATAGAAATGTCA
GTAACTCATTCTTTTGATGATTACAATAAGTGGAAAATTCATTATGAGGCCATTTCTGAT
AAAGACACTGTGTTTAATCCAACTGGGCATGTCTATTTTAATTTGAATGGTGATGCTAGT
GAATCTGTTGAAAATCATGGACTTCGACTGGCCGCTTCAAGATTTGTTCCTTTAAAAGAC
CAAACAGAAATTGTTCGTGGTGATATCGTTGATATAAAAAATACAGACTTGGATTTCCGT
CAGGAAAAACAATTATCAAATGCCTTCAATTCTAATATGGAACAAGTTCAATTAGTTAAA
GGAATTGACCATCCTTTCTTGTTAGACCAGTTAGGACTTGATAAAGAACAAGCTCGTTTA
ACGCTTGATGATACTTCAATTTCAGTCTTTACCGACCAACCAAGTATTGTGATATTTACA
GCAAATTTTGGTGATTTAGGAACTCTTTATCATGAGAAAAAGCAAGTGCACCATGGTGGA
ATTACTTTTGAATGTCAAGTATCACCTGGGTCTGAGCAAATTCCAGAGCTTGGAGATATC
AGCCTAAAAGCGGGAGAAAAATATCAAGCAACCACAATTTACAGCTTGCATACAAAATAA

# Drug_Target_5_General_Function:
Involved in isomerase activity

# Drug_Target_5_General_References:
Not Available

# Drug_Target_5_HGNC_ID:
Not Available

# Drug_Target_5_HPRD_ID:
Not Available

# Drug_Target_5_ID:
4830

# Drug_Target_5_Locus:
Not Available

# Drug_Target_5_Molecular_Weight:
37611

# Drug_Target_5_Name:
Aldose 1-epimerase

# Drug_Target_5_Number_of_Residues:
339

# Drug_Target_5_PDB_ID:
1MN0

# Drug_Target_5_Pathway:
Not Available

# Drug_Target_5_Pfam_Domain_Function:
PF01263	Aldose_epim

# Drug_Target_5_Protein_Sequence:
>Aldose 1-epimerase
MEIKIRDFGLGSDLISLTNKAGVTISFTNLGARIVDWQKDGKHLILGFDSAKEYLEKDAY
PGATVGPTAGRIKDGLVKISGKDYILNQNEGPQTLHGGEESIHTKLWTYEVTDLGAEVQV
KFSLVTNDGTNGYPGKIEMSVTHSFDDYNKWKIHYEAISDKDTVFNPTGHVYFNLNGDAS
ESVENHGLRLAASRFVPLKDQTEIVRGDIVDIKNTDLDFRQEKQLSNAFNSNMEQVQLVK
GIDHPFLLDQLGLDKEQARLTLDDTSISVFTDQPSIVIFTANFGDLGTLYHEKKQVHHGG
ITFECQVSPGSEQIPELGDISLKAGEKYQATTIYSLHTK

# Drug_Target_5_Reaction:
Not Available

# Drug_Target_5_Signals:
None

# Drug_Target_5_Specific_Function:
Not Available

# Drug_Target_5_SwissProt_ID:
Q9ZB17

# Drug_Target_5_SwissProt_Name:
Q9ZB17_9LACT

# Drug_Target_5_Synonyms:
Not Available

# Drug_Target_5_Theoretical_pI:
5.01

# Drug_Target_5_Transmembrane_Regions:
None

# Drug_Target_60_Cellular_Location:
Secreted protein

# Drug_Target_60_Chromosome_Location:
Not Available

# Drug_Target_60_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_60_Essentiality:
Non-Essential

# Drug_Target_60_GenAtlas_ID:
Not Available

# Drug_Target_60_GenBank_ID_Gene:
V00101

# Drug_Target_60_GenBank_ID_Protein:
39794

# Drug_Target_60_GeneCard_ID:
Not Available

# Drug_Target_60_Gene_Name:
amyE

# Drug_Target_60_Gene_Sequence:
>1983 bp
ATGTTTGCAAAACGATTCAAAACCTCTTTACTGCCGTTATTCGCTGGATTTTTATTGCTG
TTTCATTTGGTTCTGGCAGGACCGGCGGCTGCGAGTGCTGAAACGGCGAACAAATCGAAT
GAGCTTACAGCACCGTCGATCAAAAGCGGAACCATTCTTCATGCATGGAATTGGTCGTTC
AATACGTTAAAACACAATATGAAGGATATTCATGATGCAGGATATACAGCCATTCAGACA
TCTCCGATTAACCAAGTAAAGGAAGGGAATCAAGGAGATAAAAGCATGTCGAACTGGTAC
TGGCTGTATCAGCCGACATCGTATCAAATTGGCAACCGTTACTTAGGTACTGAACAAGAA
TTTAAAGAAATGTGTGCAGCCGCTGAAGAATATGGCATAAAGGTCATTGTTGACGCGGTC
ATCAATCATACCACCAGTGATTATGCCGCGATTTCCAATGAGGTTAAGAGTATTCCAAAC
TGGACACATGGAAACACACAAATTAAAAACTGGTCTGATCGATGGGATGTCACGCAGAAT
TCATTGCTCGGGCTGTATGACTGGAATACACAAAATACACAAGTACAGTCCTATCTGAAA
CGGTTCTTAGACAGGGCATTGAATGACGGGGCAGACGGTTTTCGATTTGATGCCGCCAAA
CATATAGAGCTTCCAGATGATGGCAGTTACGGCAGTCAATTTTGGCCGAATATCACAAAT
ACATCTGCAGAGTTCCAATACGGAGAAATCCTGCAGGATAGTGCCTCCAGAGATGCTGCA
TATGCGAATTATATGGATGTGACAGCGTCTAACTATGGGCATTCCATAAGGTCCGCTTTA
AAGAATCGTAATCTGGGCGTGTCGAATATCTCCCACTATGCATCTGATGTGTCTGCGGAC
AAGCTAGTGACATGGGTAGAGTCGCATGATACGTATGCCAATGATGATGAAGAGTCGACA
TGGATGAGCGATGATGATATCCGTTTAGGCTGGGCGGTGATAGCTTCTCGTTCAGGCAGT
ACGCCTCTTTTCTTTTCCAGACCTGAGGGAGGCGGAAATGGTGTGAGGTTCCCGGGGAAA
AGCCAAATAGGCGATCGCGGGAGTGCTTTATTTGAAGATCAGGCTATCACTGCGGTCAAT
AGATTTCACAATGTGATGGCTGGACAGCCTGAGGAACTCTCGAACCCGAATGGAAACAAC
CAGATATTTATGAATCAGCGCGGCTCACATGGCGTTGTGCTGGCAAATGCAGGTTCATCC
TCTGTCTCTATCAATACGGCAACAAAATTGCCTGATGGCAGGTATGACAATAAAGCTGGA
GCGGGTTCATTTCAAGTGAACGATGGTAAACTGACAGGCACGATCAATGCCAGGTCTGTA
GCTGTGCTTTATCCTGATGATATTGCAAAAGCGCCTCATGTTTTCCTTGAGAATTACAAA
ACAGGTGTAACACATTCTTTCAATGATCAACTGACGATTACCTTGCGTGCAGATGCGAAT
ACAACAAAAGCCGTTTATCAAATCAATAATGGACCAGACGACAGGCGTTTAAGGATGGAG
ATCAATTCACAATCGGAAAAGGAGATCCAATTTGGCAAAACATACACCATCATGTTAAAA
GGAACGAACAGTGATGGTGTAACGAGGACCGAGAAATACAGTTTTGTTAAAAGAGATCCA
GCGTCGGCCAAAACCATCGGCTATCAAAATCCGAATCATTGGAGCCAGGTAAATGCTTAT
ATCTATAAACATGATGGGAGCCGAGTAATTGAATTGACCGGATCTTGGCCTGGAAAACCA
ATGACTAAAAATGCAGACGGAATTTACACGCTGACGCTGCCTGCGGACACGGATACAACC
AACGCAAAAGTGATTTTTAATAATGGCAGCGCCCAAGTGCCCGGTCAGAATCAGCCTGGC
TTTGATTACGTGCTAAATGGTTTATATAATGACTCGGGCTTAAGCGGTTCTCTTCCCCAT
TGA

# Drug_Target_60_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_60_General_References:
112102	Mantsala P, Zalkin H: Membrane-bound and soluble extracellular alpha-amylase from Bacillus subtilis. J Biol Chem. 1979 Sep 10;254(17):8540-7.
6099357	Yamane K, Hirata Y, Furusato T, Yamazaki H, Nakayama A: Changes in the properties and molecular weights of Bacillus subtilis M-type and N-type alpha-amylases resulting from a spontaneous deletion. J Biochem (Tokyo). 1984 Dec;96(6):1849-58.
6186986	Yang M, Galizzi A, Henner D: Nucleotide sequence of the amylase gene from Bacillus subtilis. Nucleic Acids Res. 1983 Jan 25;11(2):237-49.
6189486	Ohmura K, Yamazaki H, Takeichi Y, Nakayama A, Otozai K, Yamane K, Yamasaki M, Tamura G: Nucleotide sequence of the promoter and NH2-terminal signal peptide region of Bacillus subtilis alpha-amylase gene cloned in pUB110. Biochem Biophys Res Commun. 1983 Apr 29;112(2):678-83.
6413492	Yamazaki H, Ohmura K, Nakayama A, Takeichi Y, Otozai K, Yamasaki M, Tamura G, Yamane K: Alpha-amylase genes (amyR2 and amyE+) from an alpha-amylase-hyperproducing Bacillus subtilis strain: molecular cloning and nucleotide sequences. J Bacteriol. 1983 Oct;156(1):327-37.
8969502	Yamane K, Kumano M, Kurita K: The 25 degrees-36 degrees region of the Bacillus subtilis chromosome: determination of the sequence of a 146 kb segment and identification of 113 genes. Microbiology. 1996 Nov;142 ( Pt 11):3047-56.
9384377	Kunst F, Ogasawara N, Moszer I, Albertini AM, Alloni G, Azevedo V, Bertero MG, Bessieres P, Bolotin A, Borchert S, Borriss R, Boursier L, Brans A, Braun M, Brignell SC, Bron S, Brouillet S, Bruschi CV, Caldwell B, Capuano V, Carter NM, Choi SK, Codani JJ, Connerton IF, Danchin A, et al.: The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature. 1997 Nov 20;390(6657):249-56.
9514750	Fujimoto Z, Takase K, Doui N, Momma M, Matsumoto T, Mizuno H: Crystal structure of a catalytic-site mutant alpha-amylase from Bacillus subtilis complexed with maltopentaose. J Mol Biol. 1998 Mar 27;277(2):393-407.

# Drug_Target_60_HGNC_ID:
Not Available

# Drug_Target_60_HPRD_ID:
Not Available

# Drug_Target_60_ID:
2531

# Drug_Target_60_Locus:
Not Available

# Drug_Target_60_Molecular_Weight:
72800

# Drug_Target_60_Name:
Alpha-amylase

# Drug_Target_60_Number_of_Residues:
660

# Drug_Target_60_PDB_ID:
1BAG

# Drug_Target_60_Pathway:
Not Available

# Drug_Target_60_Pfam_Domain_Function:
PF00128	Alpha-amylase
PF02806	Alpha-amylase_C

# Drug_Target_60_Protein_Sequence:
>Alpha-amylase precursor
MFAKRFKTSLLPLFAGFLLLFHLVLAGPAAASAETANKSNELTAPSIKSGTILHAWNWSF
NTLKHNMKDIHDAGYTAIQTSPINQVKEGNQGDKSMSNWYWLYQPTSYQIGNRYLGTEQE
FKEMCAAAEEYGIKVIVDAVINHTTSDYAAISNEVKSIPNWTHGNTQIKNWSDRWDVTQN
SLLGLYDWNTQNTQVQSYLKRFLDRALNDGADGFRFDAAKHIELPDDGSYGSQFWPNITN
TSAEFQYGEILQDSASRDAAYANYMDVTASNYGHSIRSALKNRNLGVSNISHYASDVSAD
KLVTWVESHDTYANDDEESTWMSDDDIRLGWAVIASRSGSTPLFFSRPEGGGNGVRFPGK
SQIGDRGSALFEDQAITAVNRFHNVMAGQPEELSNPNGNNQIFMNQRGSHGVVLANAGSS
SVSINTATKLPDGRYDNKAGAGSFQVNDGKLTGTINARSVAVLYPDDIAKAPHVFLENYK
TGVTHSFNDQLTITLRADANTTKAVYQINNGPDDRRLRMEINSQSEKEIQFGKTYTIMLK
GTNSDGVTRTEKYSFVKRDPASAKTIGYQNPNHWSQVNAYIYKHDGSRVIELTGSWPGKP
MTKNADGIYTLTLPADTDTTNAKVIFNNGSAQVPGQNQPGFDYVLNGLYNDSGLSGSLPH

# Drug_Target_60_Reaction:
Endohydrolysis of 1,4-alpha-D-glucosidic linkages in polysaccharides containing three or more 1,4-alpha-linked D-glucose units ALL_REAC (other) R02108 R06209(G)

# Drug_Target_60_Signals:
1-27

# Drug_Target_60_Specific_Function:
Endohydrolysis of 1,4-alpha-D-glucosidic linkages in oligosaccharides and polysaccharides

# Drug_Target_60_SwissProt_ID:
P00691

# Drug_Target_60_SwissProt_Name:
AMY_BACSU

# Drug_Target_60_Synonyms:
1,4-alpha-D-glucan glucanohydrolase
Alpha-amylase precursor
EC 3.2.1.1

# Drug_Target_60_Theoretical_pI:
6.27

# Drug_Target_60_Transmembrane_Regions:
None

# Drug_Target_61_Cellular_Location:
Not Available

# Drug_Target_61_Chromosome_Location:
Not Available

# Drug_Target_61_Drug_References:
Not Available

# Drug_Target_61_Essentiality:
Non-Essential

# Drug_Target_61_GenAtlas_ID:
Not Available

# Drug_Target_61_GenBank_ID_Gene:
AB096174

# Drug_Target_61_GenBank_ID_Protein:
Not Available

# Drug_Target_61_GeneCard_ID:
Not Available

# Drug_Target_61_Gene_Name:
ppgmk

# Drug_Target_61_Gene_Sequence:
>804 bp
ATGGCCAAGAAGGACGAAAAGTCGCACAAGAACGCCCCGCTGATCGGCATCGACATCGGA
GGTACCGGAATCAAGGGCGGCATTGTCGACCTGAAGAAGGGCAAACTGCTGGGGGAACGG
TTCCGTGTCCCCACTCCTCAGCCCGCCACGCCTGAATCAGTTGCCGAAGCCGTGGCGCTG
GTGGTTGCCGAGCTGTCCGCCCGCCCCGAAGCGCCTGCTGCCGGCTCCCCCGTCGGCGTG
ACCTTCCCCGGCATCATCCAGCACGGCGTGGTCCACTCCGCGGCCAACGTGGACAAGAGC
TGGCTCAACACGGACATCGATGCGCTCCTGACTGCCCGCCTTGGCCGGCCCGTTGAGGTC
ATCAACGACGCCGACGCCGCGGGCCTGGCCGAGGCGCGCTACGGCGCCGGTGCCGGTGTC
AAGGGCACGGTCCTGGTCATCACGCTCGGCACCGGAATCGGCTCGGCCTTCATCTTCGAC
GGCAAGCTCGTCCCCAATGCTGAACTTGGCCACCTCGAAATCGACGGCCACGACGCCGAG
ACCAAGGCTTCCGCGGTGGCCCGCGAACGCGACGGCCTGTCCTGGGACGAGTACAGCGTG
CTGCTGCAGCGCTACTTTTCCCACGTCGAATTCCTGTTCTCGCCCGAACTGTTTATTGTG
GGCGGCGGCATTTCCAAGCGCGCTGACGAGTACCTGCCCAACCTGCGGCTGCGCACGCCG
ATCGTGCCGGCGGTCCTCCGCAACGAGGCCGGCATCGTGGGCGCCGCGATCGAAATCGCC
CTGCAGCACAAGCTCGCCAAGTAG

# Drug_Target_61_General_Function:
Transcription

# Drug_Target_61_General_References:
12839753	Mukai T, Kawai S, Matsukawa H, Matuo Y, Murata K: Characterization and molecular cloning of a novel enzyme, inorganic polyphosphate/ATP-glucomannokinase, of Arthrobacter sp. strain KM. Appl Environ Microbiol. 2003 Jul;69(7):3849-57.

# Drug_Target_61_HGNC_ID:
Not Available

# Drug_Target_61_HPRD_ID:
Not Available

# Drug_Target_61_ID:
5565

# Drug_Target_61_Locus:
Not Available

# Drug_Target_61_Molecular_Weight:
27996

# Drug_Target_61_Name:
Inorganic polyphosphate/ATP-glucomannokinase

# Drug_Target_61_Number_of_Residues:
267

# Drug_Target_61_PDB_ID:
1WOQ

# Drug_Target_61_Pathway:
Not Available

# Drug_Target_61_Pfam_Domain_Function:
PF00480	ROK

# Drug_Target_61_Protein_Sequence:
>Inorganic polyphosphate/ATP-glucomannokinase
MAKKDEKSHKNAPLIGIDIGGTGIKGGIVDLKKGKLLGERFRVPTPQPATPESVAEAVAL
VVAELSARPEAPAAGSPVGVTFPGIIQHGVVHSAANVDKSWLNTDIDALLTARLGRPVEV
INDADAAGLAEARYGAGAGVKGTVLVITLGTGIGSAFIFDGKLVPNAELGHLEIDGHDAE
TKASAVARERDGLSWDEYSVLLQRYFSHVEFLFSPELFIVGGGISKRADEYLPNLRLRTP
IVPAVLRNEAGIVGAAIEIALQHKLAK

# Drug_Target_61_Reaction:
Not Available

# Drug_Target_61_Signals:
None

# Drug_Target_61_Specific_Function:
Not Available

# Drug_Target_61_SwissProt_ID:
Q7WT42

# Drug_Target_61_SwissProt_Name:
Q7WT42_ARTSK

# Drug_Target_61_Synonyms:
Not Available

# Drug_Target_61_Theoretical_pI:
6.41

# Drug_Target_61_Transmembrane_Regions:
None

# Drug_Target_62_Cellular_Location:
Cytoplasmic

# Drug_Target_62_Chromosome_Location:
Not Available

# Drug_Target_62_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_62_Essentiality:
Non-Essential

# Drug_Target_62_GenAtlas_ID:
Not Available

# Drug_Target_62_GenBank_ID_Gene:
M15824

# Drug_Target_62_GenBank_ID_Protein:
144425

# Drug_Target_62_GeneCard_ID:
Not Available

# Drug_Target_62_Gene_Name:
cex

# Drug_Target_62_Gene_Sequence:
>1455 bp
ATGCCTAGGACCACGCCCGCACCCGGCCACCCGGCCCGCGGCGCCCGCACCGCTCTGCGC
ACGACGCGCCGCCGCGCGGCGACGCTCGTCGTCGGCGCCACGGTCGTGCTGCCCGCCCAG
GCCGCGACCACGCTCAAGGAGGCCGCCGACGGCGCCGGCCGGGACTTCGGCTTCGCGCTC
GACCCCAACCGGCTCTCGGAGGCGCAGTACAAGGCGATCGCCGACAGCGAGTTCAACCTC
GTCGTCGCCGAGAACGCGATGAAGTGGGACGCCACCGAGCCCTCGCAGAACAGCTTCTCC
TTCGGCGCGGGCGACCGCGTCGCGAGCTACGCCGCCGACACCGGCAAGGAGCTGTACGGC
CACACGCTCGTCTGGCACTCGCAGCTGCCCGACTGGGCGAAGAACCTCAACGGCTCCGCG
TTCGAGAGCGCGATGGTCAACCACGTGACGAAGGTCGCCGACCACTTCGAGGGCAAGGTC
GCGTCGTGGGACGTCGTCAACGAGGCGTTCGCCGACGGCGACGGCCCGCCGCAGGACTCG
GCGTTCCAGCAGAAGCTCGGCAACGGCTACATCGAGACCGCGTTCCGGGCGGCACGTGCG
GCGGACCCGACCGCCAAGCTGTGCATCAACGACTACAACGTCGAGGGCATCAACGCGAAG
AGCAACTCGCTCTACGACCTCGTCAAGGACTTCAAGGCGCGCGGCGTCCCGCTCGACTGC
GTCGGGTTCCAGTCGCACCTCATCGTCGGCCAGGTGCCGGGCGACTTCCGGCAGAACCTG
CAGCGGTTCGCGGACCTGGGCGTGGACGTGCGCATCACCGAGCTCGACATCCGCATGCGG
ACGCCCTCCGACGCGACCAAGCTCGCGACCCAGGCGGCCGACTACAAGAAGGTCGTGCAG
GCCTGCATGCAGGTGACCCGCTGCCAGGGCGTGACCGTCTGGGGCATCACCGACAAGTAC
TCGTGGGTGCCGGACGTCTTCCCGGGCGAGGGGGCCGCGCTGGTGTGGGACGCGAGCTAC
GCCAAGAAGCCGGCCTACGCCGCCGTGATGGAGGCCTTCGGCGCGAGCCCGACGCCGACG
CCCACCACGCCGACCCCGACGCCCACGACGCCGACGCCGACCCCGACGTCCGGTCCGGCC
GGGTGCCAGGTGCTGTGGGGCGTCAACCAGTGGAACACCGGCTTCACCGCGAACGTCACC
GTGAAGAACACGTCCTCCGCTCCGGTCGACGGCTGGACGCTCACGTTCAGCTTCCCGTCC
GGCCAGCAGGTCACCCAGGCGTGGAGCTCGACGGTCACGCAGTCCGGCTCGGCCGTGACG
GTCCGCAACGCCCCGTGGAACGGCTCGATCCCGGCGGGCGGCACCGCGCAGTTCGGCTTC
AACGGCTCGCACACGGGCACCAACGCCGCGCCGACGGCGTTCTCGCTCAACGGCACGCCC
TGCACGGTCGGCTGA

# Drug_Target_62_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_62_General_References:
1678739	Tull D, Withers SG, Gilkes NR, Kilburn DG, Warren RA, Aebersold R: Glutamic acid 274 is the nucleophile in the active site of a "retaining" exoglucanase from Cellulomonas fimi. J Biol Chem. 1991 Aug 25;266(24):15621-5.
1761039	Gilkes NR, Claeyssens M, Aebersold R, Henrissat B, Meinke A, Morrison HD, Kilburn DG, Warren RA, Miller RC Jr: Structural and functional relationships in two families of beta-1,4-glycanases. Eur J Biochem. 1991 Dec 5;202(2):367-77.
3096818	O'Neill G, Goh SH, Warren RA, Kilburn DG, Miller RC Jr: Structure of the gene encoding the exoglucanase of Cellulomonas fimi. Gene. 1986;44(2-3):325-30.
7766609	Xu GY, Ong E, Gilkes NR, Kilburn DG, Muhandiram DR, Harris-Brandts M, Carver JP, Kay LE, Harvey TS: Solution structure of a cellulose-binding domain from Cellulomonas fimi by nuclear magnetic resonance spectroscopy. Biochemistry. 1995 May 30;34(21):6993-7009.
7910761	MacLeod AM, Lindhorst T, Withers SG, Warren RA: The acid/base catalyst in the exoglucanase/xylanase from Cellulomonas fimi is glutamic acid 127: evidence from detailed kinetic studies of mutants. Biochemistry. 1994 May 24;33(20):6371-6.
7918478	White A, Withers SG, Gilkes NR, Rose DR: Crystal structure of the catalytic domain of the beta-1,4-glycanase cex from Cellulomonas fimi. Biochemistry. 1994 Oct 25;33(42):12546-52.
8564541	White A, Tull D, Johns K, Withers SG, Rose DR: Crystallographic observation of a covalent catalytic intermediate in a beta-glycosidase. Nat Struct Biol. 1996 Feb;3(2):149-54.
9537990	Notenboom V, Birsan C, Warren RA, Withers SG, Rose DR: Exploring the cellulose/xylan specificity of the beta-1,4-glycanase cex from Cellulomonas fimi through crystallography and mutation. Biochemistry. 1998 Apr 7;37(14):4751-8.
9731776	Notenboom V, Birsan C, Nitz M, Rose DR, Warren RA, Withers SG: Insights into transition state stabilization of the beta-1,4-glycosidase Cex by covalent intermediate accumulation in active site mutants. Nat Struct Biol. 1998 Sep;5(9):812-8.

# Drug_Target_62_HGNC_ID:
Not Available

# Drug_Target_62_HPRD_ID:
Not Available

# Drug_Target_62_ID:
2448

# Drug_Target_62_Locus:
Not Available

# Drug_Target_62_Molecular_Weight:
51291

# Drug_Target_62_Name:
Exoglucanase/xylanase [Includes: Exoglucanase

# Drug_Target_62_Number_of_Residues:
484

# Drug_Target_62_PDB_ID:
1J01

# Drug_Target_62_Pathway:
Not Available

# Drug_Target_62_Pfam_Domain_Function:
PF00331	Glyco_hydro_10
PF00553	CBM_2

# Drug_Target_62_Protein_Sequence:
>Exoglucanase/xylanase precursor [Includes: Exoglucanase
MPRTTPAPGHPARGARTALRTTRRRAATLVVGATVVLPAQAATTLKEAADGAGRDFGFAL
DPNRLSEAQYKAIADSEFNLVVAENAMKWDATEPSQNSFSFGAGDRVASYAADTGKELYG
HTLVWHSQLPDWAKNLNGSAFESAMVNHVTKVADHFEGKVASWDVVNEAFADGDGPPQDS
AFQQKLGNGYIETAFRAARAADPTAKLCINDYNVEGINAKSNSLYDLVKDFKARGVPLDC
VGFQSHLIVGQVPGDFRQNLQRFADLGVDVRITELDIRMRTPSDATKLATQAADYKKVVQ
ACMQVTRCQGVTVWGITDKYSWVPDVFPGEGAALVWDASYAKKPAYAAVMEAFGASPTPT
PTTPTPTPTTPTPTPTSGPAGCQVLWGVNQWNTGFTANVTVKNTSSAPVDGWTLTFSFPS
GQQVTQAWSSTVTQSGSAVTVRNAPWNGSIPAGGTAQFGFNGSHTGTNAAPTAFSLNGTP
CTVG

# Drug_Target_62_Reaction:
Endohydrolysis of 1,4-beta-D-xylosidic linkages in xylans REFERENCE 1 [PMID:14403433] AUTHORS HOWARD BH, JONES G, PURDOM MR. TITLE The pentosanases of some rumen bacteria. JOURNAL Biochem. J. 74 (1960) 173-80. ORGANISM Triticum aestivum [GN:etae]

# Drug_Target_62_Signals:
1-41

# Drug_Target_62_Specific_Function:
The biological conversion of cellulose to glucose generally requires three types of hydrolytic enzymes:(1) Endoglucanases which cut internal beta-1,4-glucosidic bonds; (2) Exocellobiohydrolases that cut the dissaccharide cellobiose from the nonreducing end of the cellulose polymer chain; (3) Beta-1,4- glucosidases which hydrolyze the cellobiose and other short cello- oligosaccharides to glucose

# Drug_Target_62_SwissProt_ID:
P07986

# Drug_Target_62_SwissProt_Name:
GUX_CELFI

# Drug_Target_62_Synonyms:
1,4-beta-cellobiohydrolase
Beta-1,4- glycanase CEX
EC 3.2.1.8
EC 3.2.1.91
Endo-1,4-beta-xylanase B
Exocellobiohydrolase
Exoglucanase/xylanase

# Drug_Target_62_Theoretical_pI:
6.62

# Drug_Target_62_Transmembrane_Regions:
None

# Drug_Target_63_Cellular_Location:
Not Available

# Drug_Target_63_Chromosome_Location:
Not Available

# Drug_Target_63_Drug_References:
Not Available

# Drug_Target_63_Essentiality:
Non-Essential

# Drug_Target_63_GenAtlas_ID:
Not Available

# Drug_Target_63_GenBank_ID_Gene:
D86412

# Drug_Target_63_GenBank_ID_Protein:
Not Available

# Drug_Target_63_GeneCard_ID:
Not Available

# Drug_Target_63_Gene_Name:
budC

# Drug_Target_63_Gene_Sequence:
>771 bp
ATGAAAAAAGTCGCACTTGTTACCGGCGCCGGCCAGGGGATTGGTAAAGCTATCGCCCTT
CGTCTGGTGAAGGATGGATTTGCCGTGGCCATTGCCGATTATAACGACGCCACCGCCAAA
GCGGTCGCCTCGGAAATCAACCAGGCCGGCGGACACGCCGTGGCGGTGAAAGTGGATGTC
TCCGACCGCGATCAGGTATTTGCCGCCGTTGAACAGGCGCGCAAAACGCTGGGCGGCTTC
GACGTCATCGTCAATAACGCCGGTGTGGCACCGTCTACGCCGATCGAGTCCATTACCCCG
GAGATTGTCGACAAAGTCTACAACATCAACGTCAAAGGGGTGATCTGGGGTATTCAGGCG
GCGGTCGAGGCCTTTAAGAAAGAGGGGCACGGCGGGAAAATCATCAACGCCTGTTCCCAG
GCCGGCCACGTCGGCAACCCGGAGCTGGCGGTGTATAGCTCCAGTAAATTCGCGGTACGC
GGCTTAACCCAGACCGCCGCTCGCGACCTCGCGCCGCTGGGCATCACGGTCAACGGCTAC
TGCCCGGGGATTGTCAAAACGCCAATGTGGGCCGAAATTGACCGCCAGGTGTCCGAAGCC
GCCGGTAAACCGCTGGGCTACGGTACCGCCGAGTTCGCCAAACGCATCACTCTCGGTCGT
CTGTCCGAGCCGGAAGATGTCGCCGCCTGCGTCTCCTATCTTGCCAGCCCGGATTCTGAT
TACATGACCGGTCAGTCGTTGCTGATCGACGGCGGGATGGTATTTAACTAA

# Drug_Target_63_General_Function:
Involved in oxidoreductase activity

# Drug_Target_63_General_References:
11173520	Otagiri M, Kurisu G, Ui S, Takusagawa Y, Ohkuma M, Kudo T, Kusunoki M: Crystal structure of meso-2,3-butanediol dehydrogenase in a complex with NAD+ and inhibitor mercaptoethanol at 1.7 A resolution for understanding of chiral substrate recognition mechanisms. J Biochem. 2001 Feb;129(2):205-8.

# Drug_Target_63_HGNC_ID:
Not Available

# Drug_Target_63_HPRD_ID:
Not Available

# Drug_Target_63_ID:
4509

# Drug_Target_63_Locus:
Not Available

# Drug_Target_63_Molecular_Weight:
26643

# Drug_Target_63_Name:
Acetoin(diacetyl) reductase

# Drug_Target_63_Number_of_Residues:
256

# Drug_Target_63_PDB_ID:
1GEG

# Drug_Target_63_Pathway:
Not Available

# Drug_Target_63_Pfam_Domain_Function:
PF00106	adh_short

# Drug_Target_63_Protein_Sequence:
>Acetoin(diacetyl) reductase
MKKVALVTGAGQGIGKAIALRLVKDGFAVAIADYNDATAKAVASEINQAGGRAMAVKVDV
SDRDQVFAAVEQARKTLGGFDVIVNNAGVAPSTPIESITPEIVDKVYNINVKGVIWGIQA
AVEAFKKEGHGGKIINACSQAGHVGNPELAVYSSSKFAVRGLTQTAARDLAPLGITVNGY
CPGIVKTPMWAEIDRQVSEAAGKPLGYGTAEFAKRITLGRLSEPEDVAACVSYLASPDSD
YMTGQSLLIDGGMVFN

# Drug_Target_63_Reaction:
Not Available

# Drug_Target_63_Signals:
None

# Drug_Target_63_Specific_Function:
Catalyzes the reversible reduction of acetoin to 2,3- butanediol in the presence of NADH

# Drug_Target_63_SwissProt_ID:
Q48436

# Drug_Target_63_SwissProt_Name:
BUDC_KLEPN

# Drug_Target_63_Synonyms:
AR
Acetoin dehydrogenase
EC 1.1.1.5
Meso-2,3-butanediol dehydrogenase

# Drug_Target_63_Theoretical_pI:
6.53

# Drug_Target_63_Transmembrane_Regions:
None

# Drug_Target_64_Cellular_Location:
Cytoplasmic

# Drug_Target_64_Chromosome_Location:
Not Available

# Drug_Target_64_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_64_Essentiality:
Non-Essential

# Drug_Target_64_GenAtlas_ID:
Not Available

# Drug_Target_64_GenBank_ID_Gene:
M17366

# Drug_Target_64_GenBank_ID_Protein:
142676

# Drug_Target_64_GeneCard_ID:
Not Available

# Drug_Target_64_Gene_Name:
cgt

# Drug_Target_64_Gene_Sequence:
>2142 bp
ATGAAAAGATTTATGAAACTAACAGCCGTATGGACACTCTGGTTATCCCTCACGCTGGGC
CTCTTGAGCCCGGTCCACGCAGCCCCGGATACCTCGGTATCCAACAAGCAGAATTTCAGC
ACGGATGTCATATATCAGATCTTCACCGACCGGTTCTCGGACGGCAATCCGGCCAACAAT
CCGACCGGCGCGGCATTTGACGGATCATGTACGAATCTTCGCTTATACTGCGGCGGCGAC
TGGCAAGGCATCATCAACAAAATCAACGACGGTTATTTGACCGGCATGGGCATTACGGCC
ATCTGGATTTCACAGCCTGTCGAGAATATCTACAGCGTGATCAACTACTCCGGCGTCAAT
AATACGGCTTATCACGGCTACTGGGCCCGGGACTTCAAGAAGACCAATCCGGCCTACGGG
ACGATGCAGGACTTCAAAAACCTGATCGACACCGCGCATGCGCATAACATAAAAGTCATC
ATCGACTTTGCACCGAACCATACATCTCCGGCTTCTTCGGATGATCCTTCTTTTGCAGAG
AACGGCCGCTTGTACGATAACGGCAACCTGCTCGGCGGATACACCAACGATACCCAAAAT
CTGTTCCACCATTATGGCGGCACGGATTTCTCCACCATTGAGAACGGCATTTATAAAAAC
CTGTACGATCTGGCTGACCTGAATCATAACAACAGCAGCGTCGATGTGTATCTGAAGGAT
GCCATCAAAATGTGGCTCGACCTCGGGGTGGACGGCATTCGCGTGGACGCGGTCAAGCAT
ATGCCATTCGGCTGGCAGAAGAGCTTTATGGCCACCATTAACAACTACAAGCCGGTCTTC
ACCTTCGGCGAATGGTTCCTAGGCGTCAATGAGATCAGTCCGGAATACCATCAATTCGCT
AACGAGTCCGGGATGAGCCTGCTCGATTTCCGCTTTGCCCAGAAGGCTCGGCAAGTGTTC
AGGGACAACACCGACAATATGTACGGCCTGAAGGCGATGCTGGAGGGCTCTGAAGTAGAC
TATGCCCAGGTGAATGACCAGGTGACCTTCATCGACAATCATGACATGGAGCGTTTCCAC
ACCAGCAATGGCGACAGACGGAAGCTGGAGCAGGCGCTGGCCTTTACCCTGACTTCACGC
GGTGTGCCTGCCATCTATTACGGCAGCGAGCAGTATATGTCTGGCGGGAATGATCCGGAC
AACCGTGCACGACTTCCTTCCTTCTCCACGACGACGACCGCATATCAAGTCATCCAAAAG
CTCGCTCCGCTCCGCAAATCCAACCCGGCCATCGCTTACGGTTCCACACATGAGCGCTGG
ATCAACAACGATGTGATCATCTATGAACGCAAATTCGGCAATAACGTGGCCGTTGTTGCC
ATTAACCGCAATATGAACACACCGGCTTCAATTACCGGCCTTGTCACTTCCCTCCGCAGG
GCCAGCTATAACGATGTGCTCGGCGGAATTCTGAACGGCAATACGCTAACCGTGGGTGCT
GGCGGTGCAGCTTCCAACTTTACCCTGGCTCCTGGCGGCACTGCTGTATGGCAGTACACA
ACCGATGCCACAACTCCGATCATCGGCAATGTCGGTCCGATGATGGCAAAGCCAGGGGTC
ACGATTACGATTGACGGCCGCGGCTTCGGCTCCGGCAAGGGAACGGTTTACTTCGGTACA
ACGGCAGTCACTGGCGCGGACATCGTAGCTTGGGAAGATACACAGATTCAGGTGAAAATC
CCTGCGGTCCCTGGCGGCATCTATGATATCAGAGTTGCCAACGCAGCCGGAGCAGCCAGC
AACATCTACGACAATTTCGAGGTGCTGACCGGAGACCAGGTCACCGTTCGGTTCGTAATC
AACAATGCCACGACGGCGCTGGGACAGAATGTGTTCCTCACGGGCAATGTCAGCGAGCTG
GGCAACTGGGATCCGAACAACGCGATCGGCCCGATGTATAATCAGGTCGTCTACCAATAC
CCGACTTGGTATTATGATGTGAGCGTTCCGGCAGGCCAAACGATTGAATTTAAATTCCTG
AAAAAGCAAGGCTCCACCGTCACATGGGAAGGCGGCGCGAATCGCACCTTCACCACCCCA
ACCAGCGGCACGGCAACGGTGAATGTGAACTGGCAGCCTTAA

# Drug_Target_64_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_64_General_References:
2957361	Kimura K, Kataoka S, Ishii Y, Takano T, Yamane K: Nucleotide sequence of the beta-cyclodextrin glucanotransferase gene of alkalophilic Bacillus sp. strain 1011 and similarity of its amino acid sequence to those of alpha-amylases. J Bacteriol. 1987 Sep;169(9):4399-402.

# Drug_Target_64_HGNC_ID:
Not Available

# Drug_Target_64_HPRD_ID:
Not Available

# Drug_Target_64_ID:
2508

# Drug_Target_64_Locus:
Not Available

# Drug_Target_64_Molecular_Weight:
78341

# Drug_Target_64_Name:
Cyclomaltodextrin glucanotransferase

# Drug_Target_64_Number_of_Residues:
713

# Drug_Target_64_PDB_ID:
1UKQ

# Drug_Target_64_Pathway:
Not Available

# Drug_Target_64_Pfam_Domain_Function:
PF00128	Alpha-amylase
PF00686	CBM_20
PF01833	TIG
PF02806	Alpha-amylase_C

# Drug_Target_64_Protein_Sequence:
>Cyclomaltodextrin glucanotransferase precursor
MKRFMKLTAVWTLWLSLTLGLLSPVHAAPDTSVSNKQNFSTDVIYQIFTDRFSDGNPANN
PTGAAFDGSCTNLRLYCGGDWQGIINKINDGYLTGMGITAIWISQPVENIYSVINYSGVN
NTAYHGYWARDFKKTNPAYGTMQDFKNLIDTAHAHNIKVIIDFAPNHTSPASSDDPSFAE
NGRLYDNGNLLGGYTNDTQNLFHHYGGTDFSTIENGIYKNLYDLADLNHNNSSVDVYLKD
AIKMWLDLGVDGIRVDAVKHMPFGWQKSFMATINNYKPVFTFGEWFLGVNEISPEYHQFA
NESGMSLLDFRFAQKARQVFRDNTDNMYGLKAMLEGSEVDYAQVNDQVTFIDNHDMERFH
TSNGDRRKLEQALAFTLTSRGVPAIYYGSEQYMSGGNDPDNRARLPSFSTTTTAYQVIQK
LAPLRKSNPAIAYGSTHERWINNDVIIYERKFGNNVAVVAINRNMNTPASITGLVTSLRR
ASYNDVLGGILNGNTLTVGAGGAASNFTLAPGGTAVWQYTTDATTPIIGNVGPMMAKPGV
TITIDGRGFGSGKGTVYFGTTAVTGADIVAWEDTQIQVKIPAVPGGIYDIRVANAAGAAS
NIYDNFEVLTGDQVTVRFVINNATTALGQNVFLTGNVSELGNWDPNNAIGPMYNQVVYQY
PTWYYDVSVPAGQTIEFKFLKKQGSTVTWEGGANRTFTTPTSGTATVNVNWQP

# Drug_Target_64_Reaction:
Cyclizes part of a 1,4-alpha-D-glucan chain by formation of a 1,4-alpha-D-glucosidic bond

# Drug_Target_64_Signals:
1-27

# Drug_Target_64_Specific_Function:
Cyclizes part of a 1,4-alpha-D-glucan chain by formation of a 1,4-alpha-D-glucosidic bond

# Drug_Target_64_SwissProt_ID:
P05618

# Drug_Target_64_SwissProt_Name:
CDGT_BACS0

# Drug_Target_64_Synonyms:
CGTase
Cyclodextrin-glycosyltransferase
Cyclomaltodextrin glucanotransferase precursor
EC 2.4.1.19

# Drug_Target_64_Theoretical_pI:
5.76

# Drug_Target_64_Transmembrane_Regions:
None

# Drug_Target_65_Cellular_Location:
Not Available

# Drug_Target_65_Chromosome_Location:
Not Available

# Drug_Target_65_Drug_References:
Not Available

# Drug_Target_65_Essentiality:
Non-Essential

# Drug_Target_65_GenAtlas_ID:
Not Available

# Drug_Target_65_GenBank_ID_Gene:
M34958

# Drug_Target_65_GenBank_ID_Protein:
Not Available

# Drug_Target_65_GeneCard_ID:
Not Available

# Drug_Target_65_Gene_Name:
Not Available

# Drug_Target_65_Gene_Sequence:
>1155 bp
ATGGCCCCCAAAAGAAAAAGCGGCGTCTCTAAATGCGAGACAAAATGTACAAAGGCCTGT
CCAAGACCCGCACCCGTTCCCAAACTGCTTATTAAAGGGGGTATGGAGGTGCTGGACCTT
GTGACAGGGCCAGACAGTGTGACAGAAATAGAAGCTTTTCTGAACCCCAGAATGGGGCAG
CCACCCACCCCTGAAAGCCTAACAGAGGGAGGGCAATACTATGGTTGGAGCAGAGGGATT
AATTTGGCTACATCAGATACAGAGGATTCCCCAGGAAATAATACACTTCCCACATGGAGT
ATGGCAAAGCTCCAGCTTCCCATGCTCAATGAGGACCTCACCTGTGACACCCTACAAATG
TGGGAGGCAGTCTCAGTGAAAACCGAGGTGGTGGGCTCTGGCTCACTGTTAGATGTGCAT
GGGTTCAACAAACCCACAGATACAGTAAACACAAAAGGAATTTCCACTCCAGTGGAAGGC
AGCCAATATCATGTGTTTGCTGTGGGCGGGGAACCGCTTGACCTCCAGGGACTTGTGACA
GATGCCAGAACAAAATACAAGGAAGAAGGGGTAGTAACAATCAAAACAATCACAAAGAAG
GACATGGTCAACAAAGACCAAGTCCTGAATCCAATTAGCAAGGCCAAGCTGGATAAGGAC
GGAATGTATCCAGTTGAAATCTGGCATCCAGATCCAGCAAAAAATGAGAACACAAGGTAC
TTTGGCAATTACACTGGAGGCACAACAACTCCACCCGTCCTGCAGTTCACAAACACCCTG
ACAACTGTGCTCCTAGATGAAAATGGAGTTGGGCCCCTCTGTAAAGGAGAGGGCCTATAC
CTCTCCTGTGTAGATATAATGGGCTGGAGAGTTACAAGAAACTATGATGTCCATCACTGG
AGAGGGCTTCCCAGATATTTCAAAATCACCCTGAGAAAAAGATGGGTCAAAAATCCCTAT
CCCATGGCCTCCCTCATAAGTTCCCTTTTCAACAACATGCTCCCCCAAGTGCAGGGCCAA
CCCATGGAAGGGGAGAACACCCAGGTAGAGGAGGTTAGAGTGTATGATGGGACTGAACCT
GTACCGGGGGACCCTGATATGACGCGCTATGTTGACCGCTTTGGAAAAACAAAGACTGTA
TTTCCTGGAAATTAA

# Drug_Target_65_General_Function:
Involved in structural molecule activity

# Drug_Target_65_General_References:
1845896	Freund R, Garcea RL, Sahli R, Benjamin TL: A single-amino-acid substitution in polyomavirus VP1 correlates with plaque size and hemagglutination behavior. J Virol. 1991 Jan;65(1):350-5.
8177322	Stehle T, Yan Y, Benjamin TL, Harrison SC: Structure of murine polyomavirus complexed with an oligosaccharide receptor fragment. Nature. 1994 May 12;369(6476):160-3.
8805524	Stehle T, Harrison SC: Crystal structures of murine polyomavirus in complex with straight-chain and branched-chain sialyloligosaccharide receptor fragments. Structure. 1996 Feb 15;4(2):183-94.
9305654	Stehle T, Harrison SC: High-resolution structure of a polyomavirus VP1-oligosaccharide complex: implications for assembly and receptor binding. EMBO J. 1997 Aug 15;16(16):5139-48.

# Drug_Target_65_HGNC_ID:
Not Available

# Drug_Target_65_HPRD_ID:
Not Available

# Drug_Target_65_ID:
5416

# Drug_Target_65_Locus:
Not Available

# Drug_Target_65_Molecular_Weight:
42506

# Drug_Target_65_Name:
Coat protein VP1

# Drug_Target_65_Number_of_Residues:
384

# Drug_Target_65_PDB_ID:
1SIE

# Drug_Target_65_Pathway:
Not Available

# Drug_Target_65_Pfam_Domain_Function:
PF00718	Polyoma_coat

# Drug_Target_65_Protein_Sequence:
>Coat protein VP1
MAPKRKSGVSKCETKCTKACPRPAPVPKLLIKGGMEVLDLVTGPDSVTEIEAFLNPRMGQ
PPTPESLTEGGQYYGWSRGINLATSDTEDSPGNNTLPTWSMAKLQLPMLNEDLTCDTLQM
WEAVSVKTEVVGSGSLLDVHGFNKPTDTVNTKGISTPVEGSQYHVFAVGGEPLDLQGLVT
DARTKYKEEGVVTIKTITKKDMVNKDQVLNPISKAKLDKDGMYPVEIWHPDPAKNENTRY
FGNYTGGTTTPPVLQFTNTLTTVLLDENGVGPLCKGEGLYLSCVDIMGWRVTRNYDVHHW
RGLPRYFKITLRKRWVKNPYPMASLISSLFNNMLPQVQGQPMEGENTQVEEVRVYDGTEP
VPGDPDMTRYVDRFGKTKTVFPGN

# Drug_Target_65_Reaction:
Not Available

# Drug_Target_65_Signals:
None

# Drug_Target_65_Specific_Function:
Not Available

# Drug_Target_65_SwissProt_ID:
P49302

# Drug_Target_65_SwissProt_Name:
VP1_POVMP

# Drug_Target_65_Synonyms:
Not Available

# Drug_Target_65_Theoretical_pI:
6.38

# Drug_Target_65_Transmembrane_Regions:
None

# Drug_Target_66_Cellular_Location:
Cytoplasmic

# Drug_Target_66_Chromosome_Location:
Not Available

# Drug_Target_66_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_66_Essentiality:
Non-Essential

# Drug_Target_66_GenAtlas_ID:
Not Available

# Drug_Target_66_GenBank_ID_Gene:
M87018

# Drug_Target_66_GenBank_ID_Protein:
551774

# Drug_Target_66_GeneCard_ID:
Not Available

# Drug_Target_66_Gene_Name:
celCCG

# Drug_Target_66_Gene_Sequence:
>2178 bp
TTGCTTAAGACTAAAAGAAAATTGACAAAAGCAATCGGTGTTGCATTATCGATTTCAATA
TTATCTTCGCTAGTATCGTTTATACCTCAAACAAATACATATGCAGCAGGAACATATAAC
TATGGAGAAGCATTACAGAAATCAATAATGTTCTATGAATTCCAGCGTTCGGGAGATCTT
CCGGCTGATAAACGTGACAACTGGAGAGACGATTCCGGTATGAAAGACGGTTCTGATGTA
GGAGTTGATCTTACAGGAGGATGGTACGATGCAGGTGACCATGTGAAATTTAATCTACCT
ATGTCATATACATCTGCAATGCTTGCATGGTCCTTATATGAGGATAAGGATGCTTATGAT
AAGAGCGGTCAGACAAAATATATAATGGACGGTATAAAATGGGCTAATGATTATTTTATT
AAATGTAATCCGACACCCGGTGTATATTATTACCAAGTAGGAGACGGCGGAAAGGACCAC
TCTTGGTGGGGCCCTGCGGAAGTAATGCAGATGGAAAGACCGTCTTTTAAGGTTGACGCT
TCTAAGCCCGGTTCTGCAGTATGTGCTTCCACTGCAGCTTCTCTGGCATCTGCAGCAGTA
GTCTTTAAATCCAGTGATCCTACTTATGCAGAAAAGTGCATAAGCCATGCAAAGAACCTG
TTTGATATGGCTGACAAAGCAAAGAGTGATGCTGGTTATACTGCGGCTTCAGGCTACTAC
AGCTCAAGCTCATTTTACGATGATCTCTCATGGGCTGCAGTATGGTTATATCTTGCTACA
AATGACAGTACATATTTAGACAAAGCAGAATCCTATGTACCGAATTGGGGTAAAGAACAG
CAGACAGATATTATCGCCTACAAGTGGGGACAGTGCTGGGATGATGTTCATTATGGTGCT
GAGCTTCTTCTTGCAAAGCTTACAAACAAACAATTGTATAAGGATAGTATAGAAATGAAC
CTTGACTTCTGGACAACTGGTGTTAACGGAACACGTGTTTCTTACACGCCAAAGGGTTTG
GCGTGGCTATTCCAATGGGGTTCATTAAGACATGCTACAACTCAGGCTTTTTTAGCCGGT
GTTTATGCAGAGTGGGAAGGCTGTACGCCATCCAAAGTATCTGTATATAAGGATTTCCTC
AAGAGTCAAATTGATTATGCACTTGGCAGTACCGGAAGAAGTTTTGTTGTCGGATATGGA
GTAAATCCTCCTCAACATCCTCATCACAGAACTGCTCACGGTTCATGGACAGATCAAATG
ACTTCACCAACATACCACAGGCATACTATTTATGGTGCGTTGGTAGGAGGACCGGATAAT
GCAGATGGCTATACTGATGAAATAAACAATTATGTCAATAATGAAATAGCCTGCGATTAT
AATGCCGGATTTACAGGTGCACTTGCAAAAATGTACAAGCATTCTGGCGGAGATCCGATT
CCAAACTTCAAGGCTATCGAAAAAATAACCAACGATGAAGTTATTATAAAGGCAGGTTTG
AATTCAACTGGCCCTAACTACACTGAAATCAAGGCTGTTGTTTATAACCAGACAGGATGG
CCTGCAAGAGTTACGGACAAGATATCATTTAAATATTTTATGGACTTGTCTGAAATTGTA
GCAGCAGGAATTGATCCTTTAAGCCTTGTAACAAGTTCAAATTATTCTGAAGGTAAGAAT
ACTAAGGTTTCCGGTGTGTTGCCATGGGATGTTTCAAATAATGTTTACTATGTAAATGTT
GATTTGACAGGAGAAAATATCTACCCAGGCGGTCAGTCTGCGTGCAGACGAGAAGTTCAG
TTCAGAATTGCCGCACCACAGGGAAGAAGATATTGGAATCCGAAAAATGATTTCTCATAT
GATGGATTACCAACCACCAGTACTGTAAATACGGTTACCAACATACCTGTTTATGATAAC
GGCGTAAAAGTATTTGGTAACGAACCCGCAGGTGGATCGGAAAACCCTGATCCTGAAATC
TTGTATGGAGACGTAAACAGCGACAAAAATGTAGATGCATTGGACTTTGCTGCATTGAAG
AAATATTTACTTGGAGGCACTTCCAGCATAGATGTTAAGGCTGCAGATACATACAAGGAT
GGGAATATTGACGCTATAGATATGGCTACCTTGAAGAAGTATTTATTGGGAACAATCACC
CAATTACCTCAAGGCTAA

# Drug_Target_66_General_Function:
Involved in endoglucanase activity

# Drug_Target_66_General_References:
1398087	Bagnara-Tardif C, Gaudin C, Belaich A, Hoest P, Citard T, Belaich JP: Sequence analysis of a gene cluster encoding cellulases from Clostridium cellulolyticum. Gene. 1992 Sep 21;119(1):17-28.

# Drug_Target_66_HGNC_ID:
Not Available

# Drug_Target_66_HPRD_ID:
Not Available

# Drug_Target_66_ID:
2802

# Drug_Target_66_Locus:
Not Available

# Drug_Target_66_Molecular_Weight:
79886

# Drug_Target_66_Name:
Endoglucanase G

# Drug_Target_66_Number_of_Residues:
725

# Drug_Target_66_PDB_ID:
1KFG

# Drug_Target_66_Pathway:
Not Available

# Drug_Target_66_Pfam_Domain_Function:
PF00404	Dockerin_1
PF00759	Glyco_hydro_9
PF00942	CBM_3

# Drug_Target_66_Protein_Sequence:
>Endoglucanase G precursor
MLKTKRKLTKAIGVALSISILSSLVSFIPQTNTYAAGTYNYGEALQKSIMFYEFQRSGDL
PADKRDNWRDDSGMKDGSDVGVDLTGGWYDAGDHVKFNLPMSYTSAMLAWSLYEDKDAYD
KSGQTKYIMDGIKWANDYFIKCNPTPGVYYYQVGDGGKDHSWWGPAEVMQMERPSFKVDA
SKPGSAVCASTAASLASAAVVFKSSDPTYAEKCISHAKNLFDMADKAKSDAGYTAASGYY
SSSSFYDDLSWAAVWLYLATNDSTYLDKAESYVPNWGKEQQTDIIAYKWGQCWDDVHYGA
ELLLAKLTNKQLYKDSIEMNLDFWTTGVNGTRVSYTPKGLAWLFQWGSLRHATTQAFLAG
VYAEWEGCTPSKVSVYKDFLKSQIDYALGSTGRSFVVGYGVNPPQHPHHRTAHGSWTDQM
TSPTYHRHTIYGALVGGPDNADGYTDEINNYVNNEIACDYNAGFTGALAKMYKHSGGDPI
PNFKAIEKITNDEVIIKAGLNSTGPNYTEIKAVVYNQTGWPARVTDKISFKYFMDLSEIV
AAGIDPLSLVTSSNYSEGKNTKVSGVLPWDVSNNVYYVNVDLTGENIYPGGQSACRREVQ
FRIAAPQGRRYWNPKNDFSYDGLPTTSTVNTVTNIPVYDNGVKVFGNEPAGGSENPDPEI
LYGDVNSDKNVDALDFAALKKYLLGGTSSIDVKAADTYKDGNIDAIDMATLKKYLLGTIT
QLPQG

# Drug_Target_66_Reaction:
Endohydrolysis of 1,4-beta-D-glucosidic linkages in cellulose, lichenin and cereal beta-D-glucans ALL_REAC (other) R02886 R06200(G)

# Drug_Target_66_Signals:
1-35

# Drug_Target_66_Specific_Function:
The biological conversion of cellulose to glucose generally requires three types of hydrolytic enzymes:(1) Endoglucanases which cut internal beta-1,4-glucosidic bonds; (2) Exocellobiohydrolases that cut the dissaccharide cellobiose from the nonreducing end of the cellulose polymer chain; (3) Beta-1,4- glucosidases which hydrolyze the cellobiose and other short cello- oligosaccharides to glucose

# Drug_Target_66_SwissProt_ID:
P37700

# Drug_Target_66_SwissProt_Name:
GUNG_CLOCE

# Drug_Target_66_Synonyms:
Cellulase G
EC 3.2.1.4
EGCCG
Endo-1,4-beta-glucanase G
Endoglucanase G precursor

# Drug_Target_66_Theoretical_pI:
5.20

# Drug_Target_66_Transmembrane_Regions:
None

# Drug_Target_67_Cellular_Location:
Cytoplasmic

# Drug_Target_67_Chromosome_Location:
Not Available

# Drug_Target_67_Drug_References:
Not Available

# Drug_Target_67_Essentiality:
Non-Essential

# Drug_Target_67_GenAtlas_ID:
Not Available

# Drug_Target_67_GenBank_ID_Gene:
Not Available

# Drug_Target_67_GenBank_ID_Protein:
Not Available

# Drug_Target_67_GeneCard_ID:
Not Available

# Drug_Target_67_Gene_Name:
Not Available

# Drug_Target_67_Gene_Sequence:
Not Available

# Drug_Target_67_General_Function:
Involved in hydrolase activity, hydrolyzing O-glycosyl compounds

# Drug_Target_67_General_References:
10571062	Kaneko S, Kuno A, Fujimoto Z, Shimizu D, Machida S, Sato Y, Yura K, Go M, Mizuno H, Taira K, Kusakabe I, Hayashi K: An investigation of the nature and function of module 10 in a family F/10 xylanase FXYN of Streptomyces olivaceoviridis E-86 by module shuffling with the Cex of Cellulomonas fimi and by site-directed mutagenesis. FEBS Lett. 1999 Oct 22;460(1):61-6.
11829503	Fujimoto Z, Kuno A, Kaneko S, Kobayashi H, Kusakabe I, Mizuno H: Crystal structures of the sugar complexes of Streptomyces olivaceoviridis E-86 xylanase: sugar binding structure of the family 13 carbohydrate binding module. J Mol Biol. 2002 Feb 8;316(1):65-78.

# Drug_Target_67_HGNC_ID:
Not Available

# Drug_Target_67_HPRD_ID:
Not Available

# Drug_Target_67_ID:
5249

# Drug_Target_67_Locus:
Not Available

# Drug_Target_67_Molecular_Weight:
46750

# Drug_Target_67_Name:
Hydrolase

# Drug_Target_67_Number_of_Residues:
436

# Drug_Target_67_PDB_ID:
1V6X

# Drug_Target_67_Pathway:
Not Available

# Drug_Target_67_Pfam_Domain_Function:
PF00331	Glyco_hydro_10
PF00652	Ricin_B_lectin

# Drug_Target_67_Protein_Sequence:
>Hydrolase
AESTLGAAAAQSGRYFGTAIASGKLGDSAYTTIASREFNMVTAENEMKIDATEPQRGQFN
FSAGDRVYNWAVQNGKQVRGHTLAWHSQQPGWMQSLSGSTLRQAMIDHINGVMGHYKGKI
AQWDVVNEAFSDDGSGGRRDSNLQRTGNDWIEVAFRTARAADPAAKLCYNDYNIENWTWA
KTQGVYNMVRDFKQRGVPIDCVGFQSHFNSGSPYNSNFRTTLQNFAALGVDVAITELDIQ
GASSSTYAAVTNDCLAVSRCLGITVWGVRDTDSWRSGDTPLLFNGDGSKKAAYTAVLNAL
NGGSSTPPPSGGGQIKGVGSGRCLDVPNASTTDGTQVQLYDCHSATNQQWTYTDAGELRV
YGDKCLDAAGTGNGTKVQIYSCWGGDNQKWRLNSDGSIVGVQSGLCLDAVGGGTANGTLI
QLYSCSNGSNQRWTRT

# Drug_Target_67_Reaction:
Not Available

# Drug_Target_67_Signals:
None

# Drug_Target_67_Specific_Function:
Not Available

# Drug_Target_67_SwissProt_ID:
Q7SI98

# Drug_Target_67_SwissProt_Name:
Q7SI98_STROI

# Drug_Target_67_Synonyms:
Not Available

# Drug_Target_67_Theoretical_pI:
6.50

# Drug_Target_67_Transmembrane_Regions:
None

# Drug_Target_68_Cellular_Location:
Cytoplasm. Nucleus. Secreted protein (Potential). Note=May be secreted by a non-classical secretory

# Drug_Target_68_Chromosome_Location:
Not Available

# Drug_Target_68_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_68_Essentiality:
Non-Essential

# Drug_Target_68_GenAtlas_ID:
LGALS7

# Drug_Target_68_GenBank_ID_Gene:
L07769

# Drug_Target_68_GenBank_ID_Protein:
182132

# Drug_Target_68_GeneCard_ID:
LGALS7

# Drug_Target_68_Gene_Name:
LGALS7

# Drug_Target_68_Gene_Sequence:
>411 bp
ATGTCCAACGTCCCCCACAAGTCCTCGCTGCCCGAGGGCATCCGCCCTGGCACGGTGCTG
AGAATTCGCGGCTTGGTTCCTCCCAATGCCAGCAGGTTCCATGTAAACCTGCTGTGCGGG
GAGGAGCAGGGCTCCGATGCCGCCCTGCATTTCAACCCCCGGCTGGACACGTCGGAGGTG
GTCTTCAACAGCAAGGAGCAAGGCTCCTGGGGCCGCGAGGAGCGCGGGCCGGGCGTTCCT
TTCCAGCGCGGGCAGCCCTTCGAGGTGCTCATCATCGCGTCAGACGACGGCTTCAAGGCC
GTGGTTGGGGACGCCCAGTACCACCACTTCCGCCACCGCCTGCCGCTGGCGCGCGTGCGC
CTGGTGGAGGTGGGCGGGGACGTGCAGCTGGACTCCGTGAGGATCTTCTGA

# Drug_Target_68_General_Function:
Involved in sugar binding

# Drug_Target_68_General_References:
11706006	Kuwabara I, Kuwabara Y, Yang RY, Schuler M, Green DR, Zuraw BL, Hsu DK, Liu FT: Galectin-7 (PIG1) exhibits pro-apoptotic function through JNK activation and mitochondrial cytochrome c release. J Biol Chem. 2002 Feb 1;277(5):3487-97. Epub 2001 Nov 8.
7534301	Madsen P, Rasmussen HH, Flint T, Gromov P, Kruse TA, Honore B, Vorum H, Celis JE: Cloning, expression, and chromosome mapping of human galectin-7. J Biol Chem. 1995 Mar 17;270(11):5823-9.
7729568	Magnaldo T, Bernerd F, Darmon M: Galectin-7, a human 14-kDa S-lectin, specifically expressed in keratinocytes and sensitive to retinoic acid. Dev Biol. 1995 Apr;168(2):259-71.
9760227	Leonidas DD, Vatzaki EH, Vorum H, Celis JE, Madsen P, Acharya KR: Structural basis for the recognition of carbohydrates by human galectin-7. Biochemistry. 1998 Oct 6;37(40):13930-40.

# Drug_Target_68_HGNC_ID:
HGNC:6568

# Drug_Target_68_HPRD_ID:
09002

# Drug_Target_68_ID:
1503

# Drug_Target_68_Locus:
19q13.2

# Drug_Target_68_Molecular_Weight:
15075

# Drug_Target_68_Name:
Galectin-7

# Drug_Target_68_Number_of_Residues:
136

# Drug_Target_68_PDB_ID:
5GAL

# Drug_Target_68_Pathway:
Not Available

# Drug_Target_68_Pfam_Domain_Function:
PF00337	Gal-bind_lectin

# Drug_Target_68_Protein_Sequence:
>Galectin-7
MSNVPHKSSLPEGIRPGTVLRIRGLVPPNASRFHVNLLCGEEQGSDAALHFNPRLDTSEV
VFNSKEQGSWGREERGPGVPFQRGQPFEVLIIASDDGFKAVVGDAQYHHFRHRLPLARVR
LVEVGGDVQLDSVRIF

# Drug_Target_68_Reaction:
Not Available

# Drug_Target_68_Signals:
None

# Drug_Target_68_Specific_Function:
Could be involved in cell-cell and/or cell-matrix interactions necessary for normal growth control. Pro-apoptotic protein that functions intracellularly upstream of JNK activation and cytochrome c release

# Drug_Target_68_SwissProt_ID:
P47929

# Drug_Target_68_SwissProt_Name:
LEG7_HUMAN

# Drug_Target_68_Synonyms:
Gal-7
HKL-14
PI7
p53-induced protein 1

# Drug_Target_68_Theoretical_pI:
7.79

# Drug_Target_68_Transmembrane_Regions:
None

# Drug_Target_69_Cellular_Location:
Not Available

# Drug_Target_69_Chromosome_Location:
Not Available

# Drug_Target_69_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_69_Essentiality:
Non-Essential

# Drug_Target_69_GenAtlas_ID:
Not Available

# Drug_Target_69_GenBank_ID_Gene:
X00171

# Drug_Target_69_GenBank_ID_Protein:
48348

# Drug_Target_69_GeneCard_ID:
Not Available

# Drug_Target_69_Gene_Name:
ctxB

# Drug_Target_69_Gene_Sequence:
>375 bp
ATGATTAAATTAAAATTTGGTGTTTTTTTTACAGTTTTACTATCTTCAGCATATGCACAT
GGAACACCTCAAAATATTACTGATTTGTGTGCAGAATCACACAACACACAAATATATACG
CTAAATGATAAGATATTTTCGTATACAGAATCTCTAGCTGGAAAAAGAGAGATGGCTATC
ATTACTTTTAAGAATGGTGCAATTTTTCAAGTAGAAGTACCAAGTAGTCAACATATAGAT
TCACAAAAAAAAGCGATTGAAAGGATGAAGGATACCCTGAGGATTGCATATCTTACTGAA
GCTAAAGTCGAAAAGTTATGTGTATGGAATAATAAAACGCCTCATGCGATTGCCGCAATT
AGTATGGCAAATTAA

# Drug_Target_69_General_Function:
Not Available

# Drug_Target_69_General_References:
10952301	Heidelberg JF, Eisen JA, Nelson WC, Clayton RA, Gwinn ML, Dodson RJ, Haft DH, Hickey EK, Peterson JD, Umayam L, Gill SR, Nelson KE, Read TD, Tettelin H, Richardson D, Ermolaeva MD, Vamathevan J, Bass S, Qin H, Dragoi I, Sellers P, McDonald L, Utterback T, Fleishmann RD, Nierman WC, White O, Salzberg SL, Smith HO, Colwell RR, Mekalanos JJ, Venter JC, Fraser CM: DNA sequence of both chromosomes of the cholera pathogen Vibrio cholerae. Nature. 2000 Aug 3;406(6795):477-83.
11447291	Aman AT, Fraser S, Merritt EA, Rodigherio C, Kenny M, Ahn M, Hol WG, Williams NA, Lencer WI, Hirst TR: A mutant cholera toxin B subunit that binds GM1- ganglioside but lacks immunomodulatory or toxic activity. Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8536-41. Epub 2001 Jul 10.
11880036	Pickens JC, Merritt EA, Ahn M, Verlinde CL, Hol WG, Fan E: Anchor-based design of improved cholera toxin and E. coli heat-labile enterotoxin receptor binding antagonists that display multiple binding modes. Chem Biol. 2002 Feb;9(2):215-24.
12405825	Zhang Z, Merritt EA, Ahn M, Roach C, Hou Z, Verlinde CL, Hol WG, Fan E: Solution and crystallographic studies of branched multivalent ligands that inhibit the receptor-binding of cholera toxin. J Am Chem Soc. 2002 Nov 6;124(44):12991-8.
13679513	Fujinaga Y, Wolf AA, Rodighiero C, Wheeler H, Tsai B, Allen L, Jobling MG, Rapoport T, Holmes RK, Lencer WI: Gangliosides that associate with lipid rafts mediate transport of cholera and related toxins from the plasma membrane to endoplasmic reticulm. Mol Biol Cell. 2003 Dec;14(12):4783-93. Epub 2003 Sep 17.
3214	Gill DM: The arrangement of subunits in cholera toxin. Biochemistry. 1976 Mar 23;15(6):1242-8.
6315707	Lockman H, Kaper JB: Nucleotide sequence analysis of the A2 and B subunits of Vibrio cholerae enterotoxin. J Biol Chem. 1983 Nov 25;258(22):13722-6.
6646234	Mekalanos JJ, Swartz DJ, Pearson GD, Harford N, Groyne F, de Wilde M: Cholera toxin genes: nucleotide sequence, deletion analysis and vaccine development. Nature. 1983 Dec 8-14;306(5943):551-7.
7658472	Zhang RG, Westbrook ML, Westbrook EM, Scott DL, Otwinowski Z, Maulik PR, Reed RA, Shipley GG: The 2.4 A crystal structure of cholera toxin B subunit pentamer: choleragenoid. J Mol Biol. 1995 Aug 25;251(4):550-62.
8003954	Merritt EA, Sarfaty S, van den Akker F, L'Hoir C, Martial JA, Hol WG: Crystal structure of cholera toxin B-pentamer bound to receptor GM1 pentasaccharide. Protein Sci. 1994 Feb;3(2):166-75.
8181723	Lebens M, Holmgren J: Structure and arrangement of the cholera toxin genes in Vibrio cholerae O139. FEMS Microbiol Lett. 1994 Apr 1;117(2):197-202.
903362	Lai CY: Determination of the primary structure of cholera toxin B subunit. J Biol Chem. 1977 Oct 25;252(20):7249-56.
903363	Kurosky A, Markel DE, Peterson JW: Covalent structure of the beta chain of cholera enterotoxin. J Biol Chem. 1977 Oct 25;252(20):7257-64.
9232653	Merritt EA, Sarfaty S, Jobling MG, Chang T, Holmes RK, Hirst TR, Hol WG: Structural studies of receptor binding by cholera toxin mutants. Protein Sci. 1997 Jul;6(7):1516-28.

# Drug_Target_69_HGNC_ID:
Not Available

# Drug_Target_69_HPRD_ID:
Not Available

# Drug_Target_69_ID:
2723

# Drug_Target_69_Locus:
Not Available

# Drug_Target_69_Molecular_Weight:
13957

# Drug_Target_69_Name:
Cholera enterotoxin subunit B

# Drug_Target_69_Number_of_Residues:
124

# Drug_Target_69_PDB_ID:
1S5F

# Drug_Target_69_Pathway:
Not Available

# Drug_Target_69_Pfam_Domain_Function:
PF01376	Enterotoxin_b

# Drug_Target_69_Protein_Sequence:
>Cholera enterotoxin subunit B precursor
MIKLKFGVFFTVLLSSAYAHGTPQNITDLCAEYHNTQIYTLNDKIFSYTESLAGKREMAI
ITFKNGAIFQVEVPGSQHIDSQKKAIERMKDTLRIAYLTEAKVEKLCVWNNKTPHAIAAI
SMAN

# Drug_Target_69_Reaction:
Not Available

# Drug_Target_69_Signals:
1-21

# Drug_Target_69_Specific_Function:
The B subunit pentameric ring directs the A subunit to its target by binding to the GM1 gangliosides present on the surface of the intestinal epithelial cells. It can bind five GM1 gangliosides. It has no toxic activity by itself

# Drug_Target_69_SwissProt_ID:
P01556

# Drug_Target_69_SwissProt_Name:
CHTB_VIBCH

# Drug_Target_69_Synonyms:
Cholera enterotoxin B chain
Cholera enterotoxin gamma chain
Cholera enterotoxin subunit B precursor
Choleragenoid

# Drug_Target_69_Theoretical_pI:
9.09

# Drug_Target_69_Transmembrane_Regions:
None

# Drug_Target_6_Cellular_Location:
Cytoplasmic

# Drug_Target_6_Chromosome_Location:
Not Available

# Drug_Target_6_Drug_References:
Not Available

# Drug_Target_6_Essentiality:
Non-Essential

# Drug_Target_6_GenAtlas_ID:
Not Available

# Drug_Target_6_GenBank_ID_Gene:
BX842572

# Drug_Target_6_GenBank_ID_Protein:
Not Available

# Drug_Target_6_GeneCard_ID:
Not Available

# Drug_Target_6_Gene_Name:
celA1

# Drug_Target_6_Gene_Sequence:
>1143 bp
ATGACGCGTCGGACTGGGCAGCGATGGCGCGGGACTCTGCCCGGGCGCCGGCCTTGGACA
CGGCCAGCGCCCGCCACCTGTCGTCGGCATTTGGCGTTTGTCGAATTGCGGCATTATTTT
GCTCGGGTGATGTCATCAGCTATTGGTTCGGTCGCGCGGTGGATAGTCCCCCTCCTGGGG
GTTGCAGCCGTTGCTTCCATCGGTGTTATCGCGGACCCGGTGCGGGTCGTTCGGGCCCCG
GCGTTGATCCTGGTCGATGCGGCAAACCCGCTGGCCGGAAAGCCCTTCTACGTCGATCCC
GCCTCGGCGGCCATGGTCGCCGCGCGCAACGCCAACCCGCCGAACGCCGAGCTGACCTCC
GTCGCCAACACCCCGCAGTCCTACTGGCTCGACCAGGCATTCCCGCCGGCGACCGTCGGC
GGCACGGTTGCCAGGTACACCGGAGCGGCGCAGGCGGCCGGCGCCATGCCGGTTCTGACG
CTGTATGGAATCCCCCATCGCGACTGCGGTAGCTACGCATCCGGTGGGTTCGCGACGGGC
ACTGATTACCGCGGGTGGATCGACGCTGTCGCATCCGGCCTGGGCTCATCGCCGGCGACG
ATCATCGTCGAACCCGATGCGCTGGCCATGGCCGACTGCCTGTCGCCTGACCAGCGCCAG
GAACGTTTCGACTTGGTGCGCTACGCCGTCGACACGCTGACCCGCGACCCGGCCGCTGCC
GTGTACGTCGATGCGGGGCATTCGCGCTGGCTGAGCGCCGAGGCAATGGCCGCCAGGCTC
AACGATGTCGGTGTGGGCCGCGCGCGCGGGTTTAGCCTCAACGTCTCGAACTTCTACACC
ACCGATGAGGAAATCGGCTATGGCGAGGCGATTTCGGGGCTCACGAACGGTTCGCATTAC
GTGATCGACACGTCGCGCAACGGCGCCGGACCCGCGCCCGACGCCCCGCTCAACTGGTGT
AACCCCAGCGGCCGCGCCCTGGGCGCACCGCCCACCACGGCGACCGCGGGCGCGCACGCC
GACGCTTACCTGTGGATCAAACGTCCCGGGGAATCGGACGGAACCTGCGGTCGCGGGGAG
CCTCAGGCGGGTCGGTTCGTTAGCCAGTACGCCATCGATCTGGCCCACAACGCCGGCCAG
TAG

# Drug_Target_6_General_Function:
Involved in hydrolase activity, hydrolyzing O-glycosyl compounds

# Drug_Target_6_General_References:
9634230	Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE 3rd, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998 Jun 11;393(6685):537-44.

# Drug_Target_6_HGNC_ID:
Not Available

# Drug_Target_6_HPRD_ID:
Not Available

# Drug_Target_6_ID:
4272

# Drug_Target_6_Locus:
Not Available

# Drug_Target_6_Molecular_Weight:
39974

# Drug_Target_6_Name:
POSSIBLE CELLULASE CELA1

# Drug_Target_6_Number_of_Residues:
380

# Drug_Target_6_PDB_ID:
1UP3

# Drug_Target_6_Pathway:
Not Available

# Drug_Target_6_Pfam_Domain_Function:
PF01341	Glyco_hydro_6

# Drug_Target_6_Protein_Sequence:
>POSSIBLE CELLULASE CELA1
MTRRTGQRWRGTLPGRRPWTRPAPATCRRHLAFVELRHYFARVMSSAIGSVARWIVPLLG
VAAVASIGVIADPVRVVRAPALILVDAANPLAGKPFYVDPASAAMVAARNANPPNAELTS
VANTPQSYWLDQAFPPATVGGTVARYTGAAQAAGAMPVLTLYGIPHRDCGSYASGGFATG
TDYRGWIDAVASGLGSSPATIIVEPDALAMADCLSPDQRQERFDLVRYAVDTLTRDPAAA
VYVDAGHSRWLSAEAMAARLNDVGVGRARGFSLNVSNFYTTDEEIGYGEAISGLTNGSHY
VIDTSRNGAGPAPDAPLNWCNPSGRALGAPPTTATAGAHADAYLWIKRPGESDGTCGRGE
PQAGRFVSQYAIDLAHNAGQ

# Drug_Target_6_Reaction:
Not Available

# Drug_Target_6_Signals:
None

# Drug_Target_6_Specific_Function:
Not Available

# Drug_Target_6_SwissProt_ID:
Q79G13

# Drug_Target_6_SwissProt_Name:
Q79G13_MYCTU

# Drug_Target_6_Synonyms:
CARBOXYMETHYL CELLULASE
EC 3.2.1.4
ENDO-1,4-BETA-GLUCANASE
ENDOGLUCANASE
FI-CMCASE

# Drug_Target_6_Theoretical_pI:
8.20

# Drug_Target_6_Transmembrane_Regions:
None

# Drug_Target_70_Cellular_Location:
Not Available

# Drug_Target_70_Chromosome_Location:
Not Available

# Drug_Target_70_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_70_Essentiality:
Non-Essential

# Drug_Target_70_GenAtlas_ID:
Not Available

# Drug_Target_70_GenBank_ID_Gene:
Not Available

# Drug_Target_70_GenBank_ID_Protein:
Not Available

# Drug_Target_70_GeneCard_ID:
Not Available

# Drug_Target_70_Gene_Name:
KRTAP5-3

# Drug_Target_70_Gene_Sequence:
Not Available

# Drug_Target_70_General_Function:
Not Available

# Drug_Target_70_General_References:
Not Available

# Drug_Target_70_HGNC_ID:
Not Available

# Drug_Target_70_HPRD_ID:
Not Available

# Drug_Target_70_ID:
6982

# Drug_Target_70_Locus:
Not Available

# Drug_Target_70_Molecular_Weight:
Not Available

# Drug_Target_70_Name:
Keratin-associated protein 5-3

# Drug_Target_70_Number_of_Residues:
0

# Drug_Target_70_PDB_ID:
Not Available

# Drug_Target_70_Pathway:
Not Available

# Drug_Target_70_Pfam_Domain_Function:
Not Available

# Drug_Target_70_Protein_Sequence:
Not Available

# Drug_Target_70_Reaction:
Not Available

# Drug_Target_70_Signals:
Not Available

# Drug_Target_70_Specific_Function:
Not Available

# Drug_Target_70_SwissProt_ID:
Q6L8H2

# Drug_Target_70_SwissProt_Name:
KRA53_HUMAN

# Drug_Target_70_Synonyms:
Not Available

# Drug_Target_70_Theoretical_pI:
Not Available

# Drug_Target_70_Transmembrane_Regions:
Not Available

# Drug_Target_71_Cellular_Location:
Periplasm

# Drug_Target_71_Chromosome_Location:
Not Available

# Drug_Target_71_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_71_Essentiality:
Non-Essential

# Drug_Target_71_GenAtlas_ID:
Not Available

# Drug_Target_71_GenBank_ID_Gene:
L46851

# Drug_Target_71_GenBank_ID_Protein:
1161236

# Drug_Target_71_GeneCard_ID:
Not Available

# Drug_Target_71_Gene_Name:
dmsA

# Drug_Target_71_Gene_Sequence:
>2469 bp
ATGACGAAGTTGTCAGGTCAGGAGCTGCATGCCGAACTCTCGCGGCGCGCCTTCCTGAGC
TATACGGCGGCGGTGGGGGCTCTCGGTCTCTGCGGCACCTCGCTCCTCGCGCAGGGGGCC
CGCGCGGAAGGTCTCGCCAATGGCGAGGTCATGTCGGGCTGCCACTGGGGCGTGTTCAAG
GCCCGGGTCGAGAACGGCCGCGCCGTGGCCTTCGAGCCCTGGGACAAGGATCCCGCGCCG
TCGCACCAGCTGCCGGGCGTGCTCGATTCGATCTATTCGCCCACGCGGATCAAATATCCG
ATGGTGCGCCGCGAGTTCCTCGAGAAGGGCGTGAACGCCGATCGCTCGACCCGCGGCAAC
GGCGATTTCGTCCGCGTCACCTGGGATGAGGCGCTCGACCTCGTGGCCCGCGAGCTGAAG
CGCGTTCAGGAGAGCTACGGCCCCACCGGCACCTTCGGCGGCTCCTACGGCTGGAAGAGC
CCGGGCCGGCTGCACAATTGTCAGGTCCTCATGCGCCGCGCGCTGAATCTGGCGGGCGGG
TTCGTGAACTCGTCGGGCGACTATTCGACGGCGGCCGCGCAGATCATCATGCCGCATGTC
ATGGGCACGCTCGAGGTCTACGAGCAGCAGACCGCCTGGCCCGTGGTGGTGGAGAACACC
GATCTTATGGTCTTCTGGGCCGCCGACCCGATGAAGACCAACGAGATCGGCTGGGTGATC
CCCGACCATGGCGCCTATGCCGGCATGAAGGCCCTGAAGGAGAAGGGCACCAGGGTCATC
TGCATCAACCCCGTGCGCACCGAGACGGCCGACTATTTCGGCGCCGACGTCGTGTCGCCC
CGGCCGCAGACCGACGTGGCGCTGATGCTCGGCATGGCGCACACGCTCTACAGCGAAGAC
CTGCACGACAAGGACTTCCTCGAGAACTGCACCACGGGCTTCGACCTCTTCGCGGCCTAC
CTGACCGGCGAGAGCGACGGCACGCCCAAGACGGCCGAATGGGCCGCCGAGATCTGCGGC
CTGCCGGCCGAGCAGATCAGGGAGCTCGCCCGCAGCTTCGTGGCCGGCCGGACGATGCTC
GCCGCGGGCTGGTCGATCCAGCGGATGCACCATGGCGAACAGGCGCACTGGATGCTCGTG
ACTCTGGCCTCGATGATCGGCCAGATCGGTCTGCCGGGCGGCGGCTTCGGCCTCAGCTAC
CACTATTCGAACGGCGGCTCGCCCACGAGCGACGGCCCGGCGCTGGGCGGGATCTCGGAC
GGCGGCAAGGCGGTCGAAGGCGCGGCCTGGCTGTCGGAGAGCGGCGCGACCTCGATCCCC
TGCGCCCGCGTGGTAGACATGCTGCTCAATCCGGGCGGCGAGTTCCAGTTCAACGGCGCC
ACGGCGACCTATCCCGACGTGAAGCTGGCCTACTGGGCGGGCGGCAACCCCTTCGCGCAC
CACCAGGACCGCAACCGGATGCTCAAGGCCTGGGAAAAGCTCGAGACCTTCATCGTGCAG
GACTTCCAGTGGACCGCAACCGCGCGCCACGCCGACATCGTCCTGCCGGCGACGACCTCC
TACGAGCGCAACGACATCGAGTCGGTGGGCGACTATTCGAACCGCGCCATCCTCGCGATG
AAGAAGGTGGTCGATCCGCTCTACGAGGCCCGGTCGGACTACGACATCTTCGCAGCCCTG
GCCGAGCGCCTGGGCAAGGGCGCCGAATTCACCGAAGGGCGCGACGAGATGGGGTGGATC
AGCTCGTTCTACGAGGCTGCGGTGAAGCAGGCGGAGTTCAAGAACGTGGCGATGCCGTCG
TTCGAGGATTTCTGGTCGGAAGGGATCGTCGAATTCCCGATCACCGAGGGCGCGAACTTC
GTCCGCTATGCCGACTTCCGCGAGGATCCGCTGTTCAACCCGCTCGGCACGCCCTCGGGC
CTGATCGAGATCTACTCGAAGAACATCGAGAAGATGGGCTATGACGATTGCCCGGCCCAT
CCGACCTGGATGGAACCGGCCGAGCGTCTCGGCGGGGCAGGGGCGAAATATCCGCTCCAT
GTCGTGGCGAGCCATCCGAAGTCGCGGCTGCACTCGCAGCTGAACGGCACCTCGCTGCGC
GACCTCTATGCGGTGGCGGGGCACGAACCCTGCCTCATCAACCCCGCCGATGCGGCCGCG
CGCGGCATCGCGGACGGCGATGTGCTGCGGGTGTTCAACGACCGCGGGCAGATCCTCGTG
GGGGCGAAGGTCAGCGACGCGGTGATGCCGGGCGCGATCCAGATCTACGAGGGCGGCTGG
TACGACCCGCTCGATCCCTCGGAGGAGGGCACGCTCGACAAGTACGGCGACGTGAACGTG
CTGTCGCTCGATGTCGGCACCTCGAAGCTGGCGCAGGGCAACTGCGGCCAGACCATCCTC
GCGGATGTCGAGAAATATGCGGGCGCGCCGGTGACGGTGACCGTGTTCGACACGCCGAAG
GGCGCCTGA

# Drug_Target_71_General_Function:
Energy production and conversion

# Drug_Target_71_General_References:
7625833	Barber MJ, Van Valkenburgh H, Trimboli AJ, Pollock VV, Neame PJ, Bastian NR: The amino acid sequence of Rhodobacter sphaeroides dimethyl sulfoxide reductase. Arch Biochem Biophys. 1995 Jul 10;320(2):266-75.
8534974	Yamamoto I, Wada N, Ujiiye T, Tachibana M, Matsuzaki M, Kajiwara H, Watanabe Y, Hirano H, Okubo A, Satoh T, et al.: Cloning and nucleotide sequence of the gene encoding dimethyl sulfoxide reductase from Rhodobacter sphaeroides f. sp. denitrificans. Biosci Biotechnol Biochem. 1995 Oct;59(10):1850-5.
8645727	Hilton JC, Rajagopalan KV: Molecular cloning of dimethyl sulfoxide reductase from Rhodobacter sphaeroides. Biochim Biophys Acta. 1996 May 23;1294(2):111-4.
8658134	Schindelin H, Kisker C, Hilton J, Rajagopalan KV, Rees DC: Crystal structure of DMSO reductase: redox-linked changes in molybdopterin coordination. Science. 1996 Jun 14;272(5268):1615-21.

# Drug_Target_71_HGNC_ID:
Not Available

# Drug_Target_71_HPRD_ID:
Not Available

# Drug_Target_71_ID:
2705

# Drug_Target_71_Locus:
Not Available

# Drug_Target_71_Molecular_Weight:
89208

# Drug_Target_71_Name:
Dimethyl sulfoxide reductase

# Drug_Target_71_Number_of_Residues:
822

# Drug_Target_71_PDB_ID:
1EU1

# Drug_Target_71_Pathway:
Not Available

# Drug_Target_71_Pfam_Domain_Function:
PF00384	Molybdopterin
PF01568	Molydop_binding

# Drug_Target_71_Protein_Sequence:
>Dimethyl sulfoxide reductase precursor
MTKLSGQELHAELSRRAFLSYTAAVGALGLCGTSLLAQGARAEGLANGEVMSGCHWGVFK
ARVENGRAVAFEPWDKDPAPSHQLPGVLDSIYSPTRIKYPMVRREFLEKGVNADRSTRGN
GDFVRVTWDEALDLVARELKRVQESYGPTGTFGGSYGWKSPGRLHNCQVLMRRALNLAGG
FVNSSGDYSTAAAQIIMPHVMGTLEVYEQQTAWPVVVENTDLMVFWAADPMKTNEIGWVI
PDHGAYAGMKALKEKGTRVICINPVRTETADYFGADVVSPRPQTDVALMLGMAHTLYSED
LHDKDFLENCTTGFDLFAAYLTGESDGTPKTAEWAAEICGLPAEQIRELARSFVAGRTML
AAGWSIQRMHHGEQAHWMLVTLASMIGQIGLPGGGFGLSYHYSNGGSPTSDGPALGGISD
GGKAVEGAAWLSESGATSIPCARVVDMLLNPGGEFQFNGATATYPDVKLAYWAGGNPFAH
HQDRNRMLKAWEKLETFIVQDFQWTATARHADIVLPATTSYERNDIESVGDYSNRAILAM
KKVVDPLYEARSDYDIFAALAERLGKGAEFTEGRDEMGWISSFYEAAVKQAEFKNVAMPS
FEDFWSEGIVEFPITEGANFVRYADFREDPLFNPLGTPSGLIEIYSKNIEKMGYDDCPAH
PTWMEPAERLGGAGAKYPLHVVASHPKSRLHSQLNGTSLRDLYAVAGHEPCLINPADAAA
RGIADGDVLRVFNDRGQILVGAKVSDAVMPGAIQIYEGGWYDPLDPSEEGTLDKYGDVNV
LSLDVGTSKLAQGNCGQTILADVEKYAGAPVTVTVFDTPKGA

# Drug_Target_71_Reaction:
Not Available

# Drug_Target_71_Signals:
1-42

# Drug_Target_71_Specific_Function:
Terminal reductase during anaerobic growth on various sulfoxide and N-oxide compounds

# Drug_Target_71_SwissProt_ID:
Q57366

# Drug_Target_71_SwissProt_Name:
DMSA_RHOSH

# Drug_Target_71_Synonyms:
DMSO reductase
DMSOR
Dimethyl sulfoxide reductase precursor
EC 1.8.99.-

# Drug_Target_71_Theoretical_pI:
4.87

# Drug_Target_71_Transmembrane_Regions:
None

# Drug_Target_72_Cellular_Location:
Cytoplasmic

# Drug_Target_72_Chromosome_Location:
Not Available

# Drug_Target_72_Drug_References:
Not Available

# Drug_Target_72_Essentiality:
Non-Essential

# Drug_Target_72_GenAtlas_ID:
Not Available

# Drug_Target_72_GenBank_ID_Gene:
D00945

# Drug_Target_72_GenBank_ID_Protein:
Not Available

# Drug_Target_72_GeneCard_ID:
Not Available

# Drug_Target_72_Gene_Name:
celC307

# Drug_Target_72_Gene_Sequence:
>1032 bp
ATGGTGAGTTTTAAAGCAGGTATAAATTTAGGCGGATGGATATCACAATATCAAGTTTTC
AGCAAAGAGCATTTCGATACATTCATTACGGAGAAGGACATTGAAACTATTGCAGAAGCA
GGGTTTGACCATGTCAGACTGCCTTTTGATTATCCAATTATCGAGTCTGATGACAATGTG
GGAGAATATAAAGAAGATGGGCTTTCTTATATTGACCGGTGCCTTGAGTGGTGTAAAAAA
TACAATTTGGGGCTTGTGTTGGATATGCATCACGCTCCCGGGTACCGCTTTCAAGATTTT
AAGACAAGCACCTTGTTTGAAGATCCGAACCAGCAAAAGAGATTTGTTGACATATGGAGA
TTTTTAGCCAAGCGTTACATAAATGAACGGGAACATATTGCCTTTGAACTGTTAAATGAA
GTTGTTGAGCCTGACAGTACCCGCTGGAACAAGTTGATGCTTGAGTGTGTAAAAGCAATC
AGGGAAATTGATTCCACCAGGTGGCTTTACATTGGGGGCAATAACTATAACAGTCCTGAT
GAGCTTAAAAACCTTGCAGATATTGATGATGATTACATAGTTTACAATTTCCATTTTTAC
AATCCTTTTTTCTTTACGCATCAGAAAGCCCACTGGTCGGAAAGTGCCATGGCGTACAAC
AGGACTGTAAAATATCCGGGACAATATGAGGGAATTGAAGAGTTTGTGAAAAATAATCCT
AAGTACAGTTTTATGATGGAATTGAATAACCTGAAGCTGAATAAAGAGCTTTTGCGCAAA
GATTTAAAACCAGCAATTGAGTTCAGGGAAAAGAAAAAATGCAAACTATATTGCGGGGAG
TTTGGCGTAATTGCCATTGCTGACCTGGAGTCCAGGATAAAATGGCATGAAGATTATATA
AGTCTTCTGGAGGAGTATGATATCGGCGGCGCGGTGTGGAACTACAAAAAAATGGATTTT
GAAATTTATAATGAGGATAGAAAACCTGTCTCGCAAGAATTGGTAAATATACTGGCGAGA
AGAAAAACTTGA

# Drug_Target_72_General_Function:
Involved in hydrolase activity, hydrolyzing O-glycosyl compounds

# Drug_Target_72_General_References:
1368690	Sakka K, Shimanuki T, Shimada K: Nucleotide sequence of celC307 encoding endoglucanase C307 of Clostridium sp. strain F1. Agric Biol Chem. 1991 Feb;55(2):347-50.

# Drug_Target_72_HGNC_ID:
Not Available

# Drug_Target_72_HPRD_ID:
Not Available

# Drug_Target_72_ID:
5568

# Drug_Target_72_Locus:
Not Available

# Drug_Target_72_Molecular_Weight:
40906

# Drug_Target_72_Name:
Endoglucanase C307

# Drug_Target_72_Number_of_Residues:
343

# Drug_Target_72_PDB_ID:
1CEC

# Drug_Target_72_Pathway:
Not Available

# Drug_Target_72_Pfam_Domain_Function:
PF00150	Cellulase

# Drug_Target_72_Protein_Sequence:
>Endoglucanase C307
MVSFKAGINLGGWISQYQVFSKEHFDTFITEKDIETIAEAGFDHVRLPFDYPIIESDDNV
GEYKEDGLSYIDRCLEWCKKYNLGLVLDMHHAPGYRFQDFKTSTLFEDPNQQKRFVDIWR
FLAKRYINEREHIAFELLNEVVEPDSTRWNKLMLECVKAIREIDSTRWLYIGGNNYNSPD
ELKNLADIDDDYIVYNFHFYNPFFFTHQKAHWSESAMAYNRTVKYPGQYEGIEEFVKNNP
KYSFMMELNNLKLNKELLRKDLKPAIEFREKKKCKLYCGEFGVIAIADLESRIKWHEDYI
SLLEEYDIGGAVWNYKKMDFEIYNEDRKPVSQELVNILARRKT

# Drug_Target_72_Reaction:
Not Available

# Drug_Target_72_Signals:
1-21

# Drug_Target_72_Specific_Function:
This enzyme catalyzes the endohydrolysis of 1,4-beta- glucosidic linkages in cellulose, lichenin and cereal beta-D- glucans

# Drug_Target_72_SwissProt_ID:
P23340

# Drug_Target_72_SwissProt_Name:
GUNC_CLOSF

# Drug_Target_72_Synonyms:
Cellulase C307
EC 3.2.1.4
Endo-1,4-beta-glucanase C307
Endoglucanase C307 precursor

# Drug_Target_72_Theoretical_pI:
5.23

# Drug_Target_72_Transmembrane_Regions:
None

# Drug_Target_73_Cellular_Location:
Not Available

# Drug_Target_73_Chromosome_Location:
Not Available

# Drug_Target_73_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_73_Essentiality:
Non-Essential

# Drug_Target_73_GenAtlas_ID:
Not Available

# Drug_Target_73_GenBank_ID_Gene:
Not Available

# Drug_Target_73_GenBank_ID_Protein:
Not Available

# Drug_Target_73_GeneCard_ID:
Not Available

# Drug_Target_73_Gene_Name:
AMY2B

# Drug_Target_73_Gene_Sequence:
Not Available

# Drug_Target_73_General_Function:
Not Available

# Drug_Target_73_General_References:
Not Available

# Drug_Target_73_HGNC_ID:
Not Available

# Drug_Target_73_HPRD_ID:
Not Available

# Drug_Target_73_ID:
6967

# Drug_Target_73_Locus:
Not Available

# Drug_Target_73_Molecular_Weight:
Not Available

# Drug_Target_73_Name:
Alpha-amylase 2B

# Drug_Target_73_Number_of_Residues:
0

# Drug_Target_73_PDB_ID:
Not Available

# Drug_Target_73_Pathway:
Not Available

# Drug_Target_73_Pfam_Domain_Function:
Not Available

# Drug_Target_73_Protein_Sequence:
Not Available

# Drug_Target_73_Reaction:
Not Available

# Drug_Target_73_Signals:
Not Available

# Drug_Target_73_Specific_Function:
Not Available

# Drug_Target_73_SwissProt_ID:
P19961

# Drug_Target_73_SwissProt_Name:
AMY2B_HUMAN

# Drug_Target_73_Synonyms:
Not Available

# Drug_Target_73_Theoretical_pI:
Not Available

# Drug_Target_73_Transmembrane_Regions:
Not Available

# Drug_Target_74_Cellular_Location:
Cytoplasmic

# Drug_Target_74_Chromosome_Location:
Not Available

# Drug_Target_74_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_74_Essentiality:
Non-Essential

# Drug_Target_74_GenAtlas_ID:
Not Available

# Drug_Target_74_GenBank_ID_Gene:
X68326

# Drug_Target_74_GenBank_ID_Protein:
39420

# Drug_Target_74_GeneCard_ID:
Not Available

# Drug_Target_74_Gene_Name:
Not Available

# Drug_Target_74_Gene_Sequence:
>2157 bp
ATGTTTCAAATGGCCAAACGCGCATTCCTCAGCACCACACTGACCCTCGGCTTGCTTGCC
GGCAGCGCCCTGCCGTTCTTGCCAGCTTCCGCTGTATACGCCGATCCGGACACTGCTGTG
ACCAACAAACAGAGCTTCAGTACAGATGTGATCTACCAAGTATTTACGGATCGCTTTTTG
GACGGCAATCCCTCCAACAACCCCACCGGAGCCGCTTATGATGCCACATGCAGCAATTTG
AAGCTGTACTGCGGCGGAGACTGGCAAGGGTTAATCAACAAAATCAACGATAACTATTTC
AGTGATCTGGGTGTCACAGCGTTGTGGATCTCCCAGCCTGTCGAAAATATTTTTGCGACG
ATCAACTATAGCGGTGTAACCAATACTGCCTACCACGGCTACTGGGCTCGAGACTTCAAA
AAGACCAATCCGTACTTCGGCACGATGGCGGACTTTCAGAACCTGATTACGACGGCTCAT
GCCAAAGGCATCAAGATTGTCATTGACTTTGCACCGAATCACACCTCTCCAGCGATGGAA
ACCGACACCTCTTTTGCCGAAAATGGCAGACTGTACGATAACGGTACACTGGTAGGCGGT
TATACCAATGATACCAACGGGTACTTCCATCACAATGGCGGCTCCGACTTCTCTTCCCTG
GAGAACGGCATCTACAAAAACCTGTATGACCTGGCCGACTTCAACCACAATAATGCGACC
ATCGACAAATACTTCAAAGATGCGATCAAACTGTGGCTTGATATGGGCGTTGACGGTATT
CGGGTGGATGCGGTGAAACATATGCCTCTCGGTTGGCAAAAGAGCTGGATGTCCTCCATC
TACGCACACAAACCCGTGTTCACTTTTGGAGAATGGTTCTTGGGATCAGCTGCATCCGAT
GCAGATAACACGGATTTTGCTAACAAGTCTGGTATGAGCCTGCTCGACTTCCGCTTTAAC
TCTGCGGTGCGTAATGTGTTCCGTGACAACACGTCCAACATGTACGCTCTGGATTCCATG
ATTAACAGCACAGCTACGGACTACAACCAAGTGAACGATCAGGTGACGTTCATCGACAAC
CATGATATGGATCGTTTCAAAACAAGTGCGGTCAACAATCGCCGTCTGGAACAGGCTTTG
GCCTTCACATTGACTTCACGTGGTGTACCTGCCATCTACTATGGTACTGAACAGTATTTG
ACGGGGAATGGCGATCCAGATAACCGGGCCAAAATGCCTTCGTTCTCCAAATCCACTACA
GCTTTTAACGTCATAAGTAAACTCGCGCCTCTGCGCAAATCCAATCCGGCCATTGCCTAC
GGTTCCACACAGCAGCGCTGGATTAATAATGATGTATATGTTTATGAGCGTAAATTCGGC
AAGAGCGTAGCCGTTGTCGCGGTAAACCGCAATCTTTCCACGTCTGCAAGCATTACAGGG
TTAAGCACTTCCCTGCCTACAGGCTCATACACGGATGTGCTTGGCGGGGTGCTGAACGGA
AATAACATCACCTCCACGAATGGTAGCATTAACAACTTCACCCTTGCTGCGGGTGCAACG
GCAGTATGGCAATACACAACTGCCGAAACAACACCAACCATCGGTCATGTTGGTCCGGTT
ATGGGGAAACCCGGTAATGTGGTGACAATTGATGGCCGTGGATTCGGCTCGACGAAAGGC
ACGGTCTACTTCGGCACTACAGCGGTTACCGGAGCAGCGATTACGTCTTGGGAAGATACA
CAGATTAAAGTAACCATCCCTTCCGTTGCCGCTGGCAACTATGCAGTCAAAGTTGCGGCA
AGCGGGGTAAACAGCAATGCATACAACAACTTCACCATCCTGACTGGCGATCAGGTCACC
GTTCGCTTCGTCGTAAACAATGCGTCCACAACGCTTGGACAGAACCTCTATTTGACAGGC
AACGTAGCCGAGCTTGGCAACTGGAGCACCGGTTCGACTGCCATTGGACCCGCATTCAAT
CAGGTCATTCATCAATACCCAACCTGGTACTATGATGTCAGCGTACCGGCAGGCAAACAG
CTGGAGTTCAAATTTTTCAAGAAAAACGGTTCAACGATTACATGGGAAAGCGGTTCTAAC
CACACATTCACTACACCAGCGAGCGGAACAGCCACCGTTACGGTGAACTGGCAGTAA

# Drug_Target_74_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_74_General_References:
1368573	Nitschke L, Heeger K, Bender H, Schulz GE: Molecular cloning, nucleotide sequence and expression in Escherichia coli of the beta-cyclodextrin glycosyltransferase gene from Bacillus circulans strain no. 8. Appl Microbiol Biotechnol. 1990 Aug;33(5):542-6.
1826034	Klein C, Schulz GE: Structure of cyclodextrin glycosyltransferase refined at 2.0 A resolution. J Mol Biol. 1991 Feb 20;217(4):737-50.
2531228	Hofmann BE, Bender H, Schulz GE: Three-dimensional structure of cyclodextrin glycosyltransferase from Bacillus circulans at 3.4 A resolution. J Mol Biol. 1989 Oct 20;209(4):793-800.
9558324	Schmidt AK, Cottaz S, Driguez H, Schulz GE: Structure of cyclodextrin glycosyltransferase complexed with a derivative of its main product beta-cyclodextrin. Biochemistry. 1998 Apr 28;37(17):5909-15.
9738912	Parsiegla G, Schmidt AK, Schulz GE: Substrate binding to a cyclodextrin glycosyltransferase and mutations increasing the gamma-cyclodextrin production. Eur J Biochem. 1998 Aug 1;255(3):710-7.

# Drug_Target_74_HGNC_ID:
Not Available

# Drug_Target_74_HPRD_ID:
Not Available

# Drug_Target_74_ID:
2293

# Drug_Target_74_Locus:
Not Available

# Drug_Target_74_Molecular_Weight:
78047

# Drug_Target_74_Name:
Cyclomaltodextrin glucanotransferase

# Drug_Target_74_Number_of_Residues:
718

# Drug_Target_74_PDB_ID:
1CGT

# Drug_Target_74_Pathway:
Not Available

# Drug_Target_74_Pfam_Domain_Function:
PF00128	Alpha-amylase
PF00686	CBM_20
PF01833	TIG
PF02806	Alpha-amylase_C

# Drug_Target_74_Protein_Sequence:
>Cyclomaltodextrin glucanotransferase precursor
MFQMAKRAFLSTTLTLGLLAGSALPFLPASAVYADPDTAVTNKQSFSTDVIYQVFTDRFL
DGNPSNNPTGAAYDATCSNLKLYCGGDWQGLINKINDNYFSDLGVTALWISQPVENIFAT
INYSGVTNTAYHGYWARDFKKTNPYFGTMADFQNLITTAHAKGIKIVIDFAPNHTSPAME
TDTSFAENGRLYDNGTLVGGYTNDTNGYFHHNGGSDFSSLENGIYKNLYDLADFNHNNAT
IDKYFKDAIKLWLDMGVDGIRVDAVKHMPLGWQKSWMSSIYAHKPVFTFGEWFLGSAASD
ADNTDFANKSGMSLLDFRFNSAVRNVFRDNTSNMYALDSMINSTATDYNQVNDQVTFIDN
HDMDRFKTSAVNNRRLEQALAFTLTSRGVPAIYYGTEQYLTGNGDPDNRAKMPSFSKSTT
AFNVISKLAPLRKSNPAIAYGSTQQRWINNDVYVYERKFGKSVAVVAVNRNLSTSASITG
LSTSLPTGSYTDVLGGVLNGNNITSTNGSINNFTLAAGATAVWQYTTAETTPTIGHVGPV
MGKPGNVVTIDGRGFGSTKGTVYFGTTAVTGAAITSWEDTQIKVTIPSVAAGNYAVKVAA
SGVNSNAYNNFTILTGDQVTVRFVVNNASTTLGQNLYLTGNVAELGNWSTGSTAIGPAFN
QVIHQYPTWYYDVSVPAGKQLEFKFFKKNGSTITWESGSNHTFTTPASGTATVTVNWQ

# Drug_Target_74_Reaction:
Cyclizes part of a 1,4-alpha-D-glucan chain by formation of a 1,4-alpha-D-glucosidic bond

# Drug_Target_74_Signals:
1-34

# Drug_Target_74_Specific_Function:
Cyclizes part of a 1,4-alpha-D-glucan chain by formation of a 1,4-alpha-D-glucosidic bond

# Drug_Target_74_SwissProt_ID:
P30920

# Drug_Target_74_SwissProt_Name:
CDGT1_BACCI

# Drug_Target_74_Synonyms:
CGTase
Cyclodextrin-glycosyltransferase
Cyclomaltodextrin glucanotransferase precursor
EC 2.4.1.19

# Drug_Target_74_Theoretical_pI:
6.65

# Drug_Target_74_Transmembrane_Regions:
None

# Drug_Target_75_Cellular_Location:
Cytoplasmic

# Drug_Target_75_Chromosome_Location:
Not Available

# Drug_Target_75_Drug_References:
Not Available

# Drug_Target_75_Essentiality:
Non-Essential

# Drug_Target_75_GenAtlas_ID:
Not Available

# Drug_Target_75_GenBank_ID_Gene:
U37056

# Drug_Target_75_GenBank_ID_Protein:
Not Available

# Drug_Target_75_GeneCard_ID:
Not Available

# Drug_Target_75_Gene_Name:
engF

# Drug_Target_75_Gene_Sequence:
>1674 bp
ATGTTTAATAATGTAAAAAAGAAGATACTTTCTATTGTTGCAGCCGGTGCTATGTTGATG
GCATTAGTCCCAAATATAAATGTTGCAGCAGAAACAACTTATTCTAATTTAACTGGAAAT
GCTAATGTTAAAAAACCTTCTGTTGGAGGTAAATTACAACTACTAAACAAAAATGGTATA
AAAACTCTATGTGATAAAGATGGAAATCCAATTCAATTGAGAGGTATGAGTACCCATGGT
CTACAATGGTTTCCTGGGGTAGTTAATAATAATGCTTTTGCAGCCCTTTCTAATGATTGG
AATTCTAATGTAATTCGTCTTGCTATGTATGTTGCTGAAGGGGGATATGCAACAAACCCA
TCAGTTAAACAAACTGTCATCAACGGAATAAACTATGCAATTGCAAATGATATGTACGTT
ATTGTAGATTGGCATATGATGAATCCGGGAGATCCAAATGCTAGCGTATATTCAGGCGCG
CAAAGCTTCTTTAATGATATTTCTACACTATATCCAAATAATAAAAATATAATTTATGAG
TTGTGTAATGAACCTAATGGTGAAAATGGTGGAGTAACGAATGATGCAACTGGTTGGGCT
CAGGTAAAATCATATGCAACTCCTATAGTACAATTACTTAGAAACAAGGGAAATGAGAAT
CTTATCATCGTAGGAAATCCATTCTGGAGTCAAAGACCTGATTTAGCTGCAGATAATCCT
ATTAATGACTCAAATACAATGTATTCTGTACATTTTTATAGTGGTACTAATCCAATATCA
ACTGTAGACACTAATAGAGATAATGCTATGAGCAATGTAAGATATGCTCTTAACCATGGA
GCTGCTGTTTTTGCAACAGAATGGGGAACTAGTTTAGCTACTGGTACTACTGGACCTTAC
CTAGCTAAAGCAGATGCGTGGCTAGATTTCTTAAATGGAAACAACATAAGCTGGTGTAAC
TTTTCAATAAGTAACAAGGATGAAAAAGCAGCTGCACTTAATAGTTTAACAAGTCTTGAT
CCAGGTTCTGATAAGTTATGGGCAGATAATGAATTAACCACTTCAGGTCAATATGTACGT
GCTCGTATTAAGGGAGCTTATTATGCTACACCAGTTGATCCTGTAACAAACCAACCAACA
GCACCGAAAGACTTTTCTTCAGGCTTTTGGGACTTTAATGACGGTACTACACAAGGTTTT
GGTGTAAATCCAGATAGTCCAATAACTGCTATTAATGTTGAAAATGCTAACAATGCTTTA
AAAATCAGCAATCTTAATAGTAAGGGTAGTAATGATTTATCTGAAGGAAACTTTTGGGCC
AATGTCCGCATTTCAGCTGATATCTGGGGACAAAGTATAAATATATATGGAGACACAAAA
CTAACAATGGATGTTATAGCTCCAACACCTGTAAATGTATCAATCGCAGCTATCCCACAA
AGTAGTACTCACGGTTGGGGAAATCCTACAAGAGCTATACGTGTTTGGACAAACAACTTT
GTAGCACAAACTGATGGAACCTATAAAGCAACTTTGACCATTTCTACAAACGATAGTCCA
AATTTCAATACTATAGCTACAGATGCTGCTGATAGTGTAGTAACAAATATGATTCTATTT
GTTGGTTCAAATTCAGATAATATTTCTTTAGACAATATAAAGTTTACTAAATAA

# Drug_Target_75_General_Function:
Involved in hydrolase activity, hydrolyzing O-glycosyl compounds

# Drug_Target_75_General_References:
11733998	Notenboom V, Boraston AB, Chiu P, Freelove AC, Kilburn DG, Rose DR: Recognition of cello-oligosaccharides by a family 17 carbohydrate-binding module: an X-ray crystallographic, thermodynamic and mutagenic study. J Mol Biol. 2001 Dec 7;314(4):797-806.
8982083	Sheweita SA, Ichi-ishi A, Park JS, Liu C, Malburg LM Jr, Doi RH: Characterization of engF, a gene for a non-cellulosomal Clostridium cellulovorans endoglucanase. Gene. 1996 Dec 5;182(1-2):163-7.

# Drug_Target_75_HGNC_ID:
Not Available

# Drug_Target_75_HPRD_ID:
Not Available

# Drug_Target_75_ID:
5569

# Drug_Target_75_Locus:
Not Available

# Drug_Target_75_Molecular_Weight:
60131

# Drug_Target_75_Name:
Endo-1,4-beta glucanase EngF

# Drug_Target_75_Number_of_Residues:
557

# Drug_Target_75_PDB_ID:
Not Available

# Drug_Target_75_Pathway:
Not Available

# Drug_Target_75_Pfam_Domain_Function:
PF00150	Cellulase
PF03424	CBM_17_28

# Drug_Target_75_Protein_Sequence:
>Endo-1,4-beta glucanase EngF
MFNNVKKKILSIVAAGAMLMALVPNINVAAETTYSNLTGNANVKKPSVGGKLQLLNKNGI
KTLCDKDGNPIQLRGMSTHGLQWFPGVVNNNAFAALSNDWNSNVIRLAMYVAEGGYATNP
SVKQTVINGINYAIANDMYVIVDWHMMNPGDPNASVYSGAQSFFNDISTLYPNNKNIIYE
LCNEPNGENGGVTNDATGWAQVKSYATPIVQLLRNKGNENLIIVGNPFWSQRPDLAADNP
INDSNTMYSVHFYSGTNPISTVDTNRDNAMSNVRYALNHGAAVFATEWGTSLATGTTGPY
LAKADAWLDFLNGNNISWCNFSISNKDEKAAALNSLTSLDPGSDKLWADNELTTSGQYVR
ARIKGAYYATPVDPVTNQPTAPKDFSSGFWDFNDGTTQGFGVNPDSPITAINVENANNAL
KISNLNSKGSNDLSEGNFWANVRISADIWGQSINIYGDTKLTMDVIAPTPVNVSIAAIPQ
SSTHGWGNPTRAIRVWTNNFVAQTDGTYKATLTISTNDSPNFNTIATDAADSVVTNMILF
VGSNSDNISLDNIKFTK

# Drug_Target_75_Reaction:
Not Available

# Drug_Target_75_Signals:
None

# Drug_Target_75_Specific_Function:
Endohydrolysis of 1,4-beta-D-glucosidic linkages in cellulose, lichenin and cereal beta-D-glucans

# Drug_Target_75_SwissProt_ID:
P94622

# Drug_Target_75_SwissProt_Name:
P94622_CLOCL

# Drug_Target_75_Synonyms:
EC 3.2.1.4

# Drug_Target_75_Theoretical_pI:
4.96

# Drug_Target_75_Transmembrane_Regions:
None

# Drug_Target_76_Cellular_Location:
Cytoplasmic

# Drug_Target_76_Chromosome_Location:
Not Available

# Drug_Target_76_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_76_Essentiality:
Non-Essential

# Drug_Target_76_GenAtlas_ID:
Not Available

# Drug_Target_76_GenBank_ID_Gene:
D13178

# Drug_Target_76_GenBank_ID_Protein:
398125

# Drug_Target_76_GeneCard_ID:
Not Available

# Drug_Target_76_Gene_Name:
tvaII

# Drug_Target_76_Gene_Sequence:
>1758 bp
ATGCTGTTGGAAGCGATTTTTCATGAAGCGAAAGGAAGCTATGCTTACCCGATTTCGGAA
ACGCAACTGCGGGTGAGATTGCGGGCGAAAAAAGGGGACGTGGTGAGATGCGAGGTGCTC
TATGCGGACCGCTATGCTTCGCCGGAGGAAGAACTGGCACATGCACTTGCGGGCAAAGCA
GGGTCCGATGAGCGATTTGATTATTTTGAGGCTTTACTGGAATGTTCCACCAAACGGGTG
AAATACGTGTTTTTGTTGACAGGCCCACAAGGGGAGGCTGTTTATTTTGGCGAGACCGGT
TTTTCCGCCGAACGGTCTAAAGCGGGGGTGTTCCAATATGCTTACATCCACCGGAGCGAA
GTGTTTACGACACCGGAATGGGCAAAGGAGGCGGTGATCTACCAGATCTTTCCCGAACGT
TTTGCCAATGGGGATCCCAGCAATGATCCGCCGGGAACGGAACAATGGGCCAAAGACGCC
AGACCTCGGCACGACAGTTTTTACGGCGGAGATTTAAAGGGGGTGATCGACCGTTTGCCA
TATTTGGAGGAGTTGGGAGTGACGGCGCTTTATTTTACTCCCATTTTTGCTTCGCCGTCC
CATCACAAATATGATACAGCTGATTATTTGGCGATTGATCCGCAATTTGGGGATTTGCCC
ACCTTTCGGCGTTTGGTGGATGAAGCTCACCGGCGCGGGATCAAAATCATTTTGGATGCC
GTGTTTAACCATGCCGGAGATCAGTTTTTTGCGTTTCGGGATGTTCTGCAAAAGGGAGAA
CAGTCGCGATATAAGGATTGGTTTTTCATCGAGGATTTTCCCGTTTCCAAGACGTCAAGA
ACCAATTATGAAACCTTTGCCGTCCAAGTGCCGGCCATGCCCAAATTGCGGACGGAAAAT
CCGGAAGTGAAGGAATATTTGTTTGATGTCGCGCGATTTTGGATGGAGCAGGGGATCGAC
GGATGGAGACTGGATGTGGCCAATGAGGTGGATCACGCCTTTTGGCGCGAGTTTCGCCGC
CTTGTCAAATCCCTCAATCCCGACGCCTTGATTGTCGGAGAGATTTGGCATGACGCTTCC
GGCTGGCTGATGGGAGACCAATTTGATTCGGTGATGAATTATTTGTTTCGCGAGAGTGTG
ATCCGTTTTTTTGCCACGGGGGAGATCCATGCCGAAAGATTTGACGCCGAACTTACCCGG
GCCAGGATGCTTTATCCGGAACAGGCGGCACAAGGGTTATGGAACCTCCTCGACTCACAC
GATACGGAACGTTTTTTGACATCGTGTGGGGGGAATGAGGCGAAATTCCGCCTGGCTGTT
TTGTTTCAGATGACATACCTGGGGACGCCGCTGATTTATTACGGTGATGAGATCGGGATG
GCCGGAGCGACGGACCCGGATTGCCGGCGCCCGATGATATGGGAGGAAAAAGAGCAGAAC
CGCGGCTTGTTTGAGTTTTATAAGGAATTGATTCGCTTGCGCCATCGGCTGGCATCGCTC
ACCAGGGGAAATGTCCGGTCTTGGCATGCCGACAAACAAGCCAATCTTTATGCTTTTGTG
CGCACGGTTCAAGACCAACATGTCGGTGTGGTTCTCAATAATCGTGGCGAGAAGCAAACC
GTTTTGCTACAGGTGCCGGAATCGGGCGGAAAAACTTGGCTGGATTGTTTGACCGGAGAA
GAAGTGCATGGCAAACAAGGGCAACTGAAGCTGACACTTCGCCCTTACCAGGGAATGATT
CTCTGGAATGGCCGGTAG

# Drug_Target_76_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_76_General_References:
10222200	Kamitori S, Kondo S, Okuyama K, Yokota T, Shimura Y, Tonozuka T, Sakano Y: Crystal structure of Thermoactinomyces vulgaris R-47 alpha-amylase II (TVAII) hydrolyzing cyclodextrins and pullulan at 2.6 A resolution. J Mol Biol. 1999 Apr 16;287(5):907-21.
12051850	Kamitori S, Abe A, Ohtaki A, Kaji A, Tonozuka T, Sakano Y: Crystal structures and structural comparison of Thermoactinomyces vulgaris R-47 alpha-amylase 1 (TVAI) at 1.6 A resolution and alpha-amylase 2 (TVAII) at 2.3 A resolution. J Mol Biol. 2002 Apr 26;318(2):443-53.
7763540	Tonozuka T, Ohtsuka M, Mogi S, Sakai H, Ohta T, Sakano Y: A neopullulanase-type alpha-amylase gene from Thermoactinomyces vulgaris R-47. Biosci Biotechnol Biochem. 1993 Mar;57(3):395-401.

# Drug_Target_76_HGNC_ID:
Not Available

# Drug_Target_76_HPRD_ID:
Not Available

# Drug_Target_76_ID:
2606

# Drug_Target_76_Locus:
Not Available

# Drug_Target_76_Molecular_Weight:
67468

# Drug_Target_76_Name:
Neopullulanase 2

# Drug_Target_76_Number_of_Residues:
585

# Drug_Target_76_PDB_ID:
1VFK

# Drug_Target_76_Pathway:
Not Available

# Drug_Target_76_Pfam_Domain_Function:
PF00128	Alpha-amylase
PF02903	Alpha-amylase_N

# Drug_Target_76_Protein_Sequence:
>Neopullulanase 2
MLLEAIFHEAKGSYAYPISETQLRVRLRAKKGDVVRCEVLYADRYASPEEELAHALAGKA
GSDERFDYFEALLECSTKRVKYVFLLTGPQGEAVYFGETGFSAERSKAGVFQYAYIHRSE
VFTTPEWAKEAVIYQIFPERFANGDPSNDPPGTEQWAKDARPRHDSFYGGDLKGVIDRLP
YLEELGVTALYFTPIFASPSHHKYDTADYLAIDPQFGDLPTFRRLVDEAHRRGIKIILDA
VFNHAGDQFFAFRDVLQKGEQSRYKDWFFIEDFPVSKTSRTNYETFAVQVPAMPKLRTEN
PEVKEYLFDVARFWMEQGIDGWRLDVANEVDHAFWREFRRLVKSLNPDALIVGEIWHDAS
GWLMGDQFDSVMNYLFRESVIRFFATGEIHAERFDAELTRARMLYPEQAAQGLWNLLDSH
DTERFLTSCGGNEAKFRLAVLFQMTYLGTPLIYYGDEIGMAGATDPDCRRPMIWEEKEQN
RGLFEFYKELIRLRHRLASLTRGNVRSWHADKQANLYAFVRTVQDQHVGVVLNNRGEKQT
VLLQVPESGGKTWLDCLTGEEVHGKQGQLKLTLRPYQGMILWNGR

# Drug_Target_76_Reaction:
Hydrolysis of pullulan to panose (6-alpha-D-glucosylmaltose)

# Drug_Target_76_Signals:
None

# Drug_Target_76_Specific_Function:
Hydrolyzes pullulan efficiently but only a small amount of starch. Endohydrolysis of 1,4-alpha-glucosidic linkages in pullulan to form panose. Cleaves also (1-6)-alpha-glucosidic linkages to form maltotriose

# Drug_Target_76_SwissProt_ID:
Q08751

# Drug_Target_76_SwissProt_Name:
NEPU2_THEVU

# Drug_Target_76_Synonyms:
Alpha-amylase II
EC 3.2.1.135
TVA II

# Drug_Target_76_Theoretical_pI:
5.89

# Drug_Target_76_Transmembrane_Regions:
None

# Drug_Target_77_Cellular_Location:
Cytoplasmic

# Drug_Target_77_Chromosome_Location:
Not Available

# Drug_Target_77_Drug_References:
Not Available

# Drug_Target_77_Essentiality:
Non-Essential

# Drug_Target_77_GenAtlas_ID:
Not Available

# Drug_Target_77_GenBank_ID_Gene:
L20093

# Drug_Target_77_GenBank_ID_Protein:
Not Available

# Drug_Target_77_GeneCard_ID:
Not Available

# Drug_Target_77_Gene_Name:
celD

# Drug_Target_77_Gene_Sequence:
>2643 bp
ATGTCCGTCACTGAACCTCCTCCCCGCCGACGCGGCCGTCACAGCCGGGCGCGCCGCTTC
CTCACTTCCCTGGGAGCTACCGCGGCCCTCACCGCGGGCATGCTGGGCGTCCCCTTGGCC
ACGGGAACCGCCCACGCCGAACCGGCGTTCAACTACGCCGAAGCCCTCCAGAAGTCGATG
TTCTTCTACGAGGCCCAACGCTCCGGGAAACTCCCGGAGAACAACCGGGTCTCCTGGCGC
GGCGACTCCGGGCTCAACGACGGCGCGGACGTGGGACTCGACCTCACCGGCGGCTGGTAC
GACGCCGGCGACCACGTGAAATTCGGCTTCCCCATGGCCTTCACCGCGACCATGCTCGCC
TGGGGCGCCATCGAAAGCCCGGAAGGCTACATCCGCTCCGGCCAGATGCCCTACCTCAAG
GACAACCTGCGCTGGGTCAACGACTACTTCATCAAAGCCCACCCCTCGCCCAACGTGCTG
TACGTGCAGGTCGGCGACGGCGACGCCGACCACAAGTGGTGGGGTCCGGCCGAAGTCATG
CCGATGGAGCGGCCCAGCTTCAAAGTGGACCCCTCCTGCCCGGGCAGCGACGTCGCAGCC
GAAACCGCCGCGGCCATGGCCGCGTCCTCCATCGTGTTCGCCGACGACGACCCTGCGTAC
GCGGCCACCCTCGTGCAGCACGCCAAGCAGCTCTACACGTTCGCCGACACCTACCGCGGC
GTGTACTCCGACTGCGTGCCCGCCGGAGCGTTCTACAACTCCTGGTCGGGCTACCAGGAC
GAGCTCGTCTGGGGCGCCTACTGGCTGTACAAGGCCACCGGGGACGACTCCTACTTGGCG
AAGGCCGAGTACGAGTACGACTTCCTCTCCACCGAGCAGCAGACCGACCTCCGCAGCTAC
CGGTGGACCATCGCCTGGGACGACAAGTCCTACGGCACCTACGTGCTGCTCGCCAAGGAA
ACCGGCAAGCAAAAATACATCGACGACGCCAACCGGTGGCTCGACTACTGGACGGTCGGC
GTCAACGGCCAGCGCGTGCCCTACTCCCCCGGCGGGATGGCTGTGCTCGACACCTGGGGA
GCCCTGCGCTACGCCGCTAACACCGCGTTCGTCGCCCTCGTCTACGCCAAGGTGATCGAC
GACCCCGTCCGCAAGCAGCGGTACCACGACTTCGCGGTGCGGCAGATCAACTACGCGCTC
GGCGACAACCCGCGGAACTCCAGCTACGTGGTGGGCTTCGGCAACAACCCGCCGCGCAAC
CCCCACCACCGCACCGCGCACGGGTCGTGGACCGACAGCATCGCCTCGCCCGCGGAGAAC
CGGCACGTCCTCTACGGCGCCCTCGTCGGCGGTCCCGGCTCCCCGAACGACGCCTACACC
GACGACCGGCAGGACTACGTCGCCAACGAAGTCGCCACCGACTACAACGCCGGATTCTCC
AGCGCGCTGGCCATGCTGGTCGAAGAGTACGGCGGCACCCCGCTGGCGGACTTCCCGCCC
ACCGAGGAGCCCGACGGACCGGAGATCTTCGTGGAAGCCCAGATCAACACGCCGGGCACC
ACGTTCACCGAGATCAAAGCCATGATCCGCAACCAGTCGGGCTGGCCGGCCCGGATGCTG
GACAAGGGCACCTTCCGGTACTGGTTCACCCTCGATGAAGGCGTGGACCCCGCGGACATC
ACGGTGAGCTCCGCCTACAACCAGTGCGCCACCCCGGAGGACGTCCACCACGTCTCCGGC
GACCTGTACTACGTGGAGATCGACTGCACCGGGGAGAAGATCTTCCCCGGCGGCCAGTCG
GAGCACCGCCGCGAAGTCCAGTTCCGCATCGCCGGCGGCCCCGGATGGGACCCCTCCAAC
GACTGGTCCTTCCAAGGCATCGGCAACGAACTCGCCCCCGCCCCGTACATCGTGCTCTAC
GACGACGGTGTACCGGTGTGGGGCACCGCCCCCGAGGAAGGGGAAGAGCCCGGCGGCGGA
GAAGGACCGGGAGGCGGCGAAGAACCCGGCGAGGACGTGACCCCGCCGAGCGCGCCCGGC
TCCCCCGCGGTCCGGGACGTCACCTCCACCAGCGCCGTGCTCACCTGGTCCGCGTCCAGC
GACACCGGCGGCAGCGGCGTAGCCGGGTACGACGTCTTCCTCCGCGCCGGCACAGGCCAG
GAGCAGAAGGTGGGATCCACCACCCGGACCAGCTTCACCTTGACCGGTCTAGAACCCGAC
ACCACCTACATCGCGGCTGTCGTGGCCCGGGACAACGCGGGCAACGTCTCCCAGCGGAGT
ACCGTCTCCTTCACCACGCTGGCCGAGAACGGCGGCGGGCCTGACGCCTCCTGCACGGTG
GGCTACAGCACCAACGACTGGGACTCCGGATTCACCGCTTCGATCCGGATCACCTACCAC
GGCACGGCCCCGCTCTCCAGCTGGGAGCTCTCCTTCACCTTCCCCGCTGGCCAGCAGGTC
ACCCACGGGTGGAACGCCACGTGGCGCCAGGACGGGGCCGCCGTGACCGCCACCCCCATG
TCCTGGAACAGCTCCCTGGCGCCTGGAGCCACCGTCGAGGTCGGCTTCAACGGCTCCTGG
AGCGGCAGCAACACACCTCCCACCGATTTCACCCTCAACGGCGAGCCCTGCGCCCTCGCC
TAA

# Drug_Target_77_General_Function:
Involved in catalytic activity

# Drug_Target_77_General_References:
1904434	Lao G, Ghangas GS, Jung ED, Wilson DB: DNA sequences of three beta-1,4-endoglucanase genes from Thermomonospora fusca. J Bacteriol. 1991 Jun;173(11):3397-407.
8215374	Jung ED, Lao G, Irwin D, Barr BK, Benjamin A, Wilson DB: DNA sequences and expression in Streptomyces lividans of an exoglucanase gene and an endoglucanase gene from Thermomonospora fusca. Appl Environ Microbiol. 1993 Sep;59(9):3032-43.
9334746	Sakon J, Irwin D, Wilson DB, Karplus PA: Structure and mechanism of endo/exocellulase E4 from Thermomonospora fusca. Nat Struct Biol. 1997 Oct;4(10):810-8.

# Drug_Target_77_HGNC_ID:
Not Available

# Drug_Target_77_HPRD_ID:
Not Available

# Drug_Target_77_ID:
5570

# Drug_Target_77_Locus:
Not Available

# Drug_Target_77_Molecular_Weight:
95203

# Drug_Target_77_Name:
Endoglucanase E-4

# Drug_Target_77_Number_of_Residues:
880

# Drug_Target_77_PDB_ID:
4TF4

# Drug_Target_77_Pathway:
Not Available

# Drug_Target_77_Pfam_Domain_Function:
PF00041	fn3
PF00553	CBM_2
PF00759	Glyco_hydro_9
PF00942	CBM_3

# Drug_Target_77_Protein_Sequence:
>Endoglucanase E-4
MSVTEPPPRRRGRHSRARRFLTSLGATAALTAGMLGVPLATGTAHAEPAFNYAEALQKSM
FFYEAQRSGKLPENNRVSWRGDSGLNDGADVGLDLTGGWYDAGDHVKFGFPMAFTATMLA
WGAIESPEGYIRSGQMPYLKDNLRWVNDYFIKAHPSPNVLYVQVGDGDADHKWWGPAEVM
PMERPSFKVDPSCPGSDVAAETAAAMAASSIVFADDDPAYAATLVQHAKQLYTFADTYRG
VYSDCVPAGAFYNSWSGYQDELVWGAYWLYKATGDDSYLAKAEYEYDFLSTEQQTDLRSY
RWTIAWDDKSYGTYVLLAKETGKQKYIDDANRWLDYWTVGVNGQRVPYSPGGMAVLDTWG
ALRYAANTAFVALVYAKVIDDPVRKQRYHDFAVRQINYALGDNPRNSSYVVGFGNNPPRN
PHHRTAHGSWTDSIASPAENRHVLYGALVGGPGSPNDAYTDDRQDYVANEVATDYNAGFS
SALAMLVEEYGGTPLADFPPTEEPDGPEIFVEAQINTPGTTFTEIKAMIRNQSGWPARML
DKGTFRYWFTLDEGVDPADITVSSAYNQCATPEDVHHVSGDLYYVEIDCTGEKIFPGGQS
EHRREVQFRIAGGPGWDPSNDWSFQGIGNELAPAPYIVLYDDGVPVWGTAPEEGEEPGGG
EGPGGGEEPGEDVTPPSAPGSPAVRDVTSTSAVLTWSASSDTGGSGVAGYDVFLRAGTGQ
EQKVGSTTRTSFTLTGLEPDTTYIAAVVARDNAGNVSQRSTVSFTTLAENGGGPDASCTV
GYSTNDWDSGFTASIRITYHGTAPLSSWELSFTFPAGQQVTHGWNATWRQDGAAVTATPM
SWNSSLAPGATVEVGFNGSWSGSNTPPTDFTLNGEPCALA

# Drug_Target_77_Reaction:
Not Available

# Drug_Target_77_Signals:
1-46

# Drug_Target_77_Specific_Function:
Endohydrolysis of 1,4-beta-D-glucosidic linkages in cellulose, lichenin and cereal beta-D-glucans

# Drug_Target_77_SwissProt_ID:
P26221

# Drug_Target_77_SwissProt_Name:
GUN4_THEFU

# Drug_Target_77_Synonyms:
Cellulase E-4
Cellulase E4
EC 3.2.1.4
Endo-1,4-beta-glucanase E-4
Endoglucanase E-4 precursor

# Drug_Target_77_Theoretical_pI:
4.36

# Drug_Target_77_Transmembrane_Regions:
None

# Drug_Target_78_Cellular_Location:
Secreted protein

# Drug_Target_78_Chromosome_Location:
Not Available

# Drug_Target_78_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_78_Essentiality:
Non-Essential

# Drug_Target_78_GenAtlas_ID:
Not Available

# Drug_Target_78_GenBank_ID_Gene:
M81186

# Drug_Target_78_GenBank_ID_Protein:
144735

# Drug_Target_78_GeneCard_ID:
Not Available

# Drug_Target_78_Gene_Name:
botB

# Drug_Target_78_Gene_Sequence:
>3876 bp
ATGCCAGTTACAATAAATAATTTTAATTATAATGATCCTATTGATAATAATAATATTATT
ATGATGGAGCCTCCATTTGCGAGAGGTACGGGGAGATATTATAAAGCTTTTAAAATCACA
GATCGTATTTGGATAATACCGGAAAGATATACTTTTGGATATAAACCTGAGGATTTTAAT
AAAAGTTCCGGTATTTTTAATAGAGATGTTTGTGAATATTATGATCCAGATTACTTAAAT
ACTAATGATAAAAAGAATATATTTTTACAAACAATGATCAAGTTATTTAATAGAATCAAA
TCAAAACCATTGGGTGAAAAGTTATTAGAGATGATTATAAATGGTATACCTTATCTTGGA
GATAGACGTGTTCCACTCGAAGAGTTTAACACAAACATTGCTAGTGTAACTGTTAATAAA
TTAATCAGTAATCCAGGAGAAGTGGAGCGAAAAAAAGGTATTTTCGCAAATTTAATAATA
TTTGGACCTGGGCCAGTTTTAAATGAAAATGAGACTATAGATATAGGTATACAAAATCAT
TTTGCATCAAGGGAAGGCTTCGGGGGTATAATGCAAATGAAGTTTTGCCCAGAATATGTA
AGCGTATTTAATAATGTTCAAGAAAACAAAGGCGCAAGTATATTTAATAGACGTGGATAT
TTTTCAGATCCAGCCTTGATATTAATGCATGAACTTATACATGTTTTACATGGATTATAT
GGCATTAAAGTAGATGATTTACCAATTGTACCAAATGAAAAAAAATTTTTTATGCAATCT
ACAGATGCTATACAGGCAGAAGAACTATATACATTTGGAGGACAAGATCCCAGCATCATA
ACTCCTTCTACGGATAAAAGTATCTATGATAAAGTTTTGCAAAATTTTAGAGGGATAGTT
GATAGACTTAACAAGGTTTTAGTTTGCATATCAGATCCTAACATTAATATTAATATATAT
AAAAATAAATTTAAAGATAAATATAAATTCGTTGAAGATTCTGAGGGAAAATATAGTATA
GATGTAGAAAGTTTTGATAAATTATATAAAAGCTTAATGTTTGGTTTTACAGAAACTAAT
ATAGCAGAAAATTATAAAATAAAAACTAGAGCTTCTTATTTTAGTGATTCCTTACCACCA
GTAAAAATAAAAAATTTATTAGATAATGAAATCTATACTATAGAGGAAGGGTTTAATATA
TCTGATAAAGATATGGAAAAAGAATATAGAGGTCAGAATAAAGCTATAAATAAACAAGCT
TATGAAGAAATTAGCAAGGAGCATTTGGCTGTATATAAGATACAAATGTGTAAAAGTGTT
AAAGCTCCAGGAATATGTATTGATGTTGATAATGAAGATTTGTTCTTTATAGCTGATAAA
AATAGTTTTTCAGATGATTTATCTAAAAACGAAAGAATAGAATATAATACACAGAGTAAT
TATATAGAAAATGACTTCCCTATAAATGAATTAATTTTAGATACTGATTTAATAAGTAAA
ATAGAATTACCAAGTGAAAATACAGAATCACTTACTGATTTTAATGTAGATGTTCCAGTA
TATGAAAAACAACCCGCTATAAAAAAAATTTTTACAGATGAAAATACCATCTTTCAATAT
TTATACTCTCAGACATTTCCTCTAGATATAAGAGATATAAGTTTAACATCTTCATTTGAT
GATGCATTATTATTTTCTAACAAAGTTTATTCATTTTTTTCTATGGATTATATTAAAACT
GCTAATAAAGTGGTAGAAGCAGGATTATTTGCAGGTTGGGTGAAACAGATAGTAAATGAT
TTTGTAATCGAAGCTAATAAAAGCAATACTATGGATAAAATTGCAGATATATCTCTAATT
GTTCCTTATATAGGATTAGCTTTAAATGTAGGAAATGAAACAGCTAAAGGAAATTTTGAA
AATGCTTTTGAGATTGCAGGAGCCAGTATTCTACTAGAATTTATACCAGAACTTTTAATA
CCTGTAGTTGGAGCCTTTTTATTAGAATCATATATTGACAATAAAAATAAAATTATTAAA
ACAATAGATAATGCTTTAACTAAAAGAAATGAAAAATGGAGTGATATGTACGGATTAATA
GTAGCGCAATGGCTCTCAACAGTTAATACTCAATTTTATACAATAAAAGAGGGAATGTAT
AAGGCTTTAAATTATCAAGCACAAGCATTGGAAGAAATAATAAAATACAGATATAATATA
TATTCTGAAAAAGAAAAGTCAAATATTAACATCGATTTTAATGATATAAATTCTAAACTT
AATGAGGGTATTAACCAAGCTATAGATAATATAAATAATTTTATAAATGGATGTTCTGTA
TCATATTTAATGAAAAAAATGATTCCATTAGCTGTAGAAAAATTACTAGACTTTGATAAT
ACTCTCAAAAAAAATTTGTTAAATTATATAGATGAAAATAAATTATATTTGATTGGAAGT
GCAGAATATGAAAAATCAAAAGTAAATAAATACTTGAAAACCATTATGCCGTTTGATCTT
TCAATATATACCAATGATACAATACTAATAGAAATGTTTAATAAATATAATAGCGAAATT
TTAAATAATATTATCTTAAATTTAAGATATAAGGATAATAATTTAATAGATTTATCAGGA
TATGGGGCAAAGGTAGAGGTATATGATGGAGTCGAGCTTAATGATAAAAATCAATTTAAA
TTAACTAGTTCAGCAAATAGTAAGATTAGAGTGACTCAAAATCAGAATATCATATTTAAT
AGTGTGTTCCTTGATTTTAGCGTTAGCTTTTGGATAAGAATACCTAAATATAAGAATGAT
GGTATACAAAATTATATTCATAATGAATATACAATAATTAATTGTATGAAAAATAATTCG
GGCTGGAAAATATCTATTAGGGGTAATAGGATAATATGGACTTTAATTGATATAAATGGA
AAAACCAAATCGGTATTTTTTGAATATAACATAAGAGAAGATATATCAGAGTATATAAAT
AGATGGTTTTTTGTAACTATTACTAATAATTTGAATAACGCTAAAATTTATATTAATGGT
AAGCTAGAATCAAATACAGATATTAAAGATATAAGAGAAGTTATTGCTAATGGTGAAATA
ATATTTAAATTAGATGGTGATATAGATAGAACACAATTTATTTGGATGAAATATTTCAGT
ATTTTTAATACGGAATTAAGTCAATCAAATATTGAAGAAAGATATAAAATTCAATCATAT
AGCGAATATTTAAAAGATTTTTGGGGAAATCCTTTAATGTACAATAAAGAATATTATATG
TTTAATGCGGGGAATAAAAATTCATATATTAAACTAAAGAAAGATTCACCTGTAGGTGAA
ATTTTAACACGTAGCAAATATAATCAAAATTCTAAATATATAAATTATAGAGATTTATAT
ATTGGAGAAAAATTTATTATAAGAAGAAAGTCAAATTCTCAATCTATAAATGATGATATA
GTTAGAAAAGAAGATTATATATATCTAGATTTTTTTAATTTAAATCAAGAGTGGAGAGTA
TATACCTATAAATATTTTAAGAAAGAGGAAGAAAAATTGTTTTTAGCTCCTATAAGTGAT
TCTGATGAGTTTTACAATACTATACAAATAAAAGAATATGATGAACAGCCAACATATAGT
TGTCAGTTGCTTTTTAAAAAAGATGAAGAAAGTACTGATGAGATAGGATTGATTGGTATT
CATCGTTTCTACGAATCTGGAATTGTATTTGAAGAGTATAAAGATTATTTTTGTATAAGT
AAATGGTACTTAAAAGAGGTAAAAAGGAAACCATATAATTTAAAATTGGGATGTAATTGG
CAGTTTATTCCTAAAGATGAAGGGTGGACTGAATAA

# Drug_Target_78_General_Function:
Involved in metalloendopeptidase activity

# Drug_Target_78_General_References:
1331807	Schiavo G, Benfenati F, Poulain B, Rossetto O, Polverino de Laureto P, DasGupta BR, Montecucco C: Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature. 1992 Oct 29;359(6398):832-5.
1429690	Schiavo G, Rossetto O, Santucci A, DasGupta BR, Montecucco C: Botulinum neurotoxins are zinc proteins. J Biol Chem. 1992 Nov 25;267(33):23479-83.
1514783	Whelan SM, Elmore MJ, Bodsworth NJ, Brehm JK, Atkinson T, Minton NP: Molecular cloning of the Clostridium botulinum structural gene encoding the type B neurotoxin and determination of its entire nucleotide sequence. Appl Environ Microbiol. 1992 Aug;58(8):2345-54.
3139097	Dasgupta BR, Datta A: Botulinum neurotoxin type B (strain 657): partial sequence and similarity with tetanus toxin. Biochimie. 1988 Jun;70(6):811-7.
3888113	Schmidt JJ, Sathyamoorthy V, DasGupta BR: Partial amino acid sequences of botulinum neurotoxins types B and E. Arch Biochem Biophys. 1985 May 1;238(2):544-8.
8408542	Campbell KD, Collins MD, East AK: Gene probes for identification of the botulinal neurotoxin gene and specific identification of neurotoxin types B, E, and F. J Clin Microbiol. 1993 Sep;31(9):2255-62.

# Drug_Target_78_HGNC_ID:
Not Available

# Drug_Target_78_HPRD_ID:
Not Available

# Drug_Target_78_ID:
2324

# Drug_Target_78_Locus:
Not Available

# Drug_Target_78_Molecular_Weight:
150804

# Drug_Target_78_Name:
Botulinum neurotoxin type B

# Drug_Target_78_Number_of_Residues:
1291

# Drug_Target_78_PDB_ID:
1S0G

# Drug_Target_78_Pathway:
Not Available

# Drug_Target_78_Pfam_Domain_Function:
PF01742	Peptidase_M27
PF07951	Toxin_R_bind_C
PF07952	Toxin_trans
PF07953	Toxin_R_bind_N

# Drug_Target_78_Protein_Sequence:
>Botulinum neurotoxin type B precursor
MPVTINNFNYNDPIDNNNIIMMEPPFARGTGRYYKAFKITDRIWIIPERYTFGYKPEDFN
KSSGIFNRDVCEYYDPDYLNTNDKKNIFLQTMIKLFNRIKSKPLGEKLLEMIINGIPYLG
DRRVPLEEFNTNIASVTVNKLISNPGEVERKKGIFANLIIFGPGPVLNENETIDIGIQNH
FASREGFGGIMQMKFCPEYVSVFNNVQENKGASIFNRRGYFSDPALILMHELIHVLHGLY
GIKVDDLPIVPNEKKFFMQSTDAIQAEELYTFGGQDPSIITPSTDKSIYDKVLQNFRGIV
DRLNKVLVCISDPNININIYKNKFKDKYKFVEDSEGKYSIDVESFDKLYKSLMFGFTETN
IAENYKIKTRASYFSDSLPPVKIKNLLDNEIYTIEEGFNISDKDMEKEYRGQNKAINKQA
YEEISKEHLAVYKIQMCKSVKAPGICIDVDNEDLFFIADKNSFSDDLSKNERIEYNTQSN
YIENDFPINELILDTDLISKIELPSENTESLTDFNVDVPVYEKQPAIKKIFTDENTIFQY
LYSQTFPLDIRDISLTSSFDDALLFSNKVYSFFSMDYIKTANKVVEAGLFAGWVKQIVND
FVIEANKSNTMDKIADISLIVPYIGLALNVGNETAKGNFENAFEIAGASILLEFIPELLI
PVVGAFLLESYIDNKNKIIKTIDNALTKRNEKWSDMYGLIVAQWLSTVNTQFYTIKEGMY
KALNYQAQALEEIIKYRYNIYSEKEKSNINIDFNDINSKLNEGINQAIDNINNFINGCSV
SYLMKKMIPLAVEKLLDFDNTLKKNLLNYIDENKLYLIGSAEYEKSKVNKYLKTIMPFDL
SIYTNDTILIEMFNKYNSEILNNIILNLRYKDNNLIDLSGYGAKVEVYDGVELNDKNQFK
LTSSANSKIRVTQNQNIIFNSVFLDFSVSFWIRIPKYKNDGIQNYIHNEYTIINCMKNNS
GWKISIRGNRIIWTLIDINGKTKSVFFEYNIREDISEYINRWFFVTITNNLNNAKIYING
KLESNTDIKDIREVIANGEIIFKLDGDIDRTQFIWMKYFSIFNTELSQSNIEERYKIQSY
SEYLKDFWGNPLMYNKEYYMFNAGNKNSYIKLKKDSPVGEILTRSKYNQNSKYINYRDLY
IGEKFIIRRKSNSQSINDDIVRKEDYIYLDFFNLNQEWRVYTYKYFKKEEEKLFLAPISD
SDEFYNTIQIKEYDEQPTYSCQLLFKKDEESTDEIGLIGIHRFYESGIVFEEYKDYFCIS
KWYLKEVKRKPYNLKLGCNWQFIPKDEGWTE

# Drug_Target_78_Reaction:
Limited hydrolysis of proteins of the neuroexocytosis apparatus, synaptobrevin (also known as neuronal vesicle-associated membrane protein, VAMP), synaptosome-associated protein of 25 kDa (SNAP25) or syntaxin. No detected action on small molecule substrates

# Drug_Target_78_Signals:
None

# Drug_Target_78_Specific_Function:
Botulinum toxin acts by inhibiting neurotransmitter release. It binds to peripheral neuronal synapses, is internalized and moves by retrograde transport up the axon into the spinal cord where it can move between postsynaptic and presynaptic neurons. It inhibits neurotransmitter release by acting as a zinc endopeptidase that cleaves the '76-Gln-|-Phe-77' bond of synaptobrevin-2

# Drug_Target_78_SwissProt_ID:
P10844

# Drug_Target_78_SwissProt_Name:
BXB_CLOBO

# Drug_Target_78_Synonyms:
BoNT/B
Bontoxilysin-B
Botulinum neurotoxin type B precursor
EC 3.4.24.69

# Drug_Target_78_Theoretical_pI:
4.97

# Drug_Target_78_Transmembrane_Regions:
None

# Drug_Target_79_Cellular_Location:
Not Available

# Drug_Target_79_Chromosome_Location:
Not Available

# Drug_Target_79_Drug_References:
Not Available

# Drug_Target_79_Essentiality:
Non-Essential

# Drug_Target_79_GenAtlas_ID:
Not Available

# Drug_Target_79_GenBank_ID_Gene:
AB252836

# Drug_Target_79_GenBank_ID_Protein:
Not Available

# Drug_Target_79_GeneCard_ID:
Not Available

# Drug_Target_79_Gene_Name:
stxB2e

# Drug_Target_79_Gene_Sequence:
>264 bp
ATGAAGAAGATGTTTATAGCGGTTTTATTTGCATTGGTTTCTGTTAATGCAATGGCGGCG
GATTGTGCTAAAGGTAAAATTGAGTTTTCCAAGTATAATGAGGATAATACCTTTACTGTG
AAGGTGTCAGGAAGAGAATACTGGACGAACAGATGGAATTTGCAGCCATTGTTACAAAGT
GCTCAGCTGACAGGGATGACTGTAACAATCATATCTAATACCTGCAGTTCAGGCTCAGGC
TTTGCCCAGGTGAAGTTTAACTGA

# Drug_Target_79_General_Function:
Not Available

# Drug_Target_79_General_References:
12089277	Reischl U, Youssef MT, Kilwinski J, Lehn N, Zhang WL, Karch H, Strockbine NA: Real-time fluorescence PCR assays for detection and characterization of Shiga toxin, intimin, and enterohemolysin genes from Shiga toxin-producing Escherichia coli. J Clin Microbiol. 2002 Jul;40(7):2555-65.
3045088	Weinstein DL, Jackson MP, Samuel JE, Holmes RK, O'Brien AD: Cloning and sequencing of a Shiga-like toxin type II variant from Escherichia coli strain responsible for edema disease of swine. J Bacteriol. 1988 Sep;170(9):4223-30.
3072464	Gyles CL, De Grandis SA, MacKenzie C, Brunton JL: Cloning and nucleotide sequence analysis of the genes determining verocytotoxin production in a porcine edema disease isolate of Escherichia coli. Microb Pathog. 1988 Dec;5(6):419-26.
8586696	Franke S, Harmsen D, Caprioli A, Pierard D, Wieler LH, Karch H: Clonal relatedness of Shiga-like toxin-producing Escherichia coli O101 strains of human and porcine origin. J Clin Microbiol. 1995 Dec;33(12):3174-8.

# Drug_Target_79_HGNC_ID:
Not Available

# Drug_Target_79_HPRD_ID:
Not Available

# Drug_Target_79_ID:
5411

# Drug_Target_79_Locus:
Not Available

# Drug_Target_79_Molecular_Weight:
9650

# Drug_Target_79_Name:
Slt-IIvB

# Drug_Target_79_Number_of_Residues:
87

# Drug_Target_79_PDB_ID:
1QOH

# Drug_Target_79_Pathway:
Not Available

# Drug_Target_79_Pfam_Domain_Function:
PF02258	SLT_beta

# Drug_Target_79_Protein_Sequence:
>Slt-IIvB
MKKMFIAVLFALVSVNAMAADCAKGKIEFSKYNEDNTFTVKVSGREYWTNRWNLQPLLQS
AQLTGMTVTIISNTCSSGSGFAQVKFN

# Drug_Target_79_Reaction:
Not Available

# Drug_Target_79_Signals:
1-19

# Drug_Target_79_Specific_Function:
Not Available

# Drug_Target_79_SwissProt_ID:
Q47644

# Drug_Target_79_SwissProt_Name:
Q47644_ECOLX

# Drug_Target_79_Synonyms:
Orf protein
SLT-IIeB
Shiga toxin 2 variant e B-subunit
Shiga toxin 2e subunit B
Shiga-like toxin 2B-subunit
Shiga-like toxin IIe variant subunit B
Slt-IIvB precursor

# Drug_Target_79_Theoretical_pI:
9.74

# Drug_Target_79_Transmembrane_Regions:
None

# Drug_Target_7_Cellular_Location:
Cytoplasm

# Drug_Target_7_Chromosome_Location:
Not Available

# Drug_Target_7_Drug_References:
Not Available

# Drug_Target_7_Essentiality:
Non-Essential

# Drug_Target_7_GenAtlas_ID:
Not Available

# Drug_Target_7_GenBank_ID_Gene:
U22490

# Drug_Target_7_GenBank_ID_Protein:
Not Available

# Drug_Target_7_GeneCard_ID:
Not Available

# Drug_Target_7_Gene_Name:
glk

# Drug_Target_7_Gene_Sequence:
>966 bp
ATGACAAAGTATGCATTAGTCGGTGATGTGGGCGGCACCAACGCACGTCTTGCTCTGTGT
GATATTGCCAGTGGTGAAATCTCGCAGGCTAAGACCTATTCAGGGCTTGATTACCCCAGC
CTCGAAGCGGTCATTCGCGTTTATCTTGAAGAACATAAGGTCGAGGTGAAAGACGGCTGT
ATTGCCATCGCTTGCCCAATTACCGGTGACTGGGTGGCGATGACCAACCATACCTGGGCG
TTCTCAATTGCCGAAATGAAAAAGAATCTCGGTTTTAGCCATCTGGAAATTATTAACGAT
TTTACCGCTGTATCGATGGCGAACCCGATGCTGAAAAAAGAGCATCTGATTCAGTTTGGT
GGCGCAGAACCGGTCGAAGGTAAGCCTATTGCGGTTTACGGTGCCGGAACGGGGCTTGGG
GTTGCGCATCTGGTCCATGTCGATAAGCGTTGGGTAAGCTTGCCAGGCGAAGGCGGTCAC
GTTGATTTTGCGCCGAATAGTGAAGAAGAGGCCATTATCCTCGAAATATTGCGTGCGGAA
ATTGGTCATGTTTCGGCGGAGGCGTGCCTTTCTGGCCCTGGGCTGGTGAATTTGTATCGC
GCAATTGTGAAAGCTGACAACCGCCTGCCAGAAAATCTCAAGCCAAAAGATATTACCGAA
CGCGCGCTGGCTGACAGCTGCACCGATTGCCGCCGCGCATTGTCGCTGTTTTGCGTCATT
ATGGGCCGTTTTGGCGGCAATCTGGCGCTCAATCTCGGGACATTTGGCGGCGTGTTTATT
GCGGGCGGTATCGTGCCGCGCTTCCTTGAGTTCTTCAAAGGCTCCGGTTTCCGTGCCGCA
TTTGAAGATAAAGGGCGCTTTAAAGAATATGTCCATGATATTCCGGTGTATCTCATCGTC
CATGACAATCCGGGCCTTCTCGGTTCCGGTGCACATTTACGCCAGACCTTAGGTCACATT
CTGTAA

# Drug_Target_7_General_Function:
Involved in glucokinase activity

# Drug_Target_7_General_References:
9023215	Meyer D, Schneider-Fresenius C, Horlacher R, Peist R, Boos W: Molecular characterization of glucokinase from Escherichia coli K-12. J Bacteriol. 1997 Feb;179(4):1298-306.
9205837	Yamamoto Y, Aiba H, Baba T, Hayashi K, Inada T, Isono K, Itoh T, Kimura S, Kitagawa M, Makino K, Miki T, Mitsuhashi N, Mizobuchi K, Mori H, Nakade S, Nakamura Y, Nashimoto H, Oshima T, Oyama S, Saito N, Sampei G, Satoh Y, Sivasundaram S, Tagami H, Horiuchi T, et al.: Construction of a contiguous 874-kb sequence of the Escherichia coli -K12 genome corresponding to 50.0-68.8 min on the linkage map and analysis of its sequence features. DNA Res. 1997 Apr 28;4(2):91-113.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_7_HGNC_ID:
Not Available

# Drug_Target_7_HPRD_ID:
Not Available

# Drug_Target_7_ID:
4662

# Drug_Target_7_Locus:
Not Available

# Drug_Target_7_Molecular_Weight:
34724

# Drug_Target_7_Name:
Glucokinase

# Drug_Target_7_Number_of_Residues:
321

# Drug_Target_7_PDB_ID:
1Q18

# Drug_Target_7_Pathway:
Not Available

# Drug_Target_7_Pfam_Domain_Function:
PF02685	Glucokinase

# Drug_Target_7_Protein_Sequence:
>Glucokinase
MTKYALVGDVGGTNARLALCDIASGEISQAKTYSGLDYPSLEAVIRVYLEEHKVEVKDGC
IAIACPITGDWVAMTNHTWAFSIAEMKKNLGFSHLEIINDFTAVSMAIPMLKKEHLIQFG
GAEPVEGKPIAVYGAGTGLGVAHLVHVDKRWVSLPGEGGHVDFAPNSEEEAIILEILRAE
IGHVSAERVLSGPGLVNLYRAIVKADNRLPENLKPKDITERALADSCTDCRRALSLFCVI
MGRFGGNLALNLGTFGGVFIAGGIVPRFLEFFKASGFRAAFEDKGRFKEYVHDIPVYLIV
HDNPGLLGSGAHLRQTLGHIL

# Drug_Target_7_Reaction:
Not Available

# Drug_Target_7_Signals:
None

# Drug_Target_7_Specific_Function:
Not highly important in E.coli as glucose is transported into the cell by the pts system already as glucose 6-phosphate

# Drug_Target_7_SwissProt_ID:
P0A6V8

# Drug_Target_7_SwissProt_Name:
GLK_ECOLI

# Drug_Target_7_Synonyms:
EC 2.7.1.2
Glucose kinase

# Drug_Target_7_Theoretical_pI:
6.51

# Drug_Target_7_Transmembrane_Regions:
None

# Drug_Target_80_Cellular_Location:
Cytoplasmic

# Drug_Target_80_Chromosome_Location:
Not Available

# Drug_Target_80_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_80_Essentiality:
Non-Essential

# Drug_Target_80_GenAtlas_ID:
Not Available

# Drug_Target_80_GenBank_ID_Gene:
X04436

# Drug_Target_80_GenBank_ID_Protein:
40770

# Drug_Target_80_GeneCard_ID:
Not Available

# Drug_Target_80_Gene_Name:
tetX

# Drug_Target_80_Gene_Sequence:
>3948 bp
ATGCCAATAACCATAAATAATTTTAGATATAGTGATCCTGTTAATAATGATACAATTATT
ATGATGGAGCCACCATACTGTAAGGGTCTAGATATCTATTATAAGGCTTTCAAAATAACA
GATCGTATTTGGATAGTGCCGGAAAGGTATGAATTTGGGACAAAACCTGAAGATTTTAAC
CCACCATCTTCATTAATAGAAGGTGCATCTGAGTATTACGATCCAAATTATTTAAGGACT
GATTCTGATAAAGATAGATTTTTACAAACCATGGTAAAACTGTTTAACAGAATTAAAAAC
AATGTAGCAGGTGAAGCCTTATTAGATAAGATAATAAATGCCATACCTTACCTTGGAAAT
TCATATTCCTTACTAGACAAGTTTGATACAAACTCTAATTCAGTATCTTTTAATTTATTA
GAACAAGACCCCAGTGGAGCAACTACAAAATCAGCAATGCTGACAAATTTAATAATATTT
GGACCTGGGCCTGTTTTAAATAAAAATGAGGTTAGAGGTATTGTATTGAGGGTAGATAAT
AAAAATTACTTCCCATGTAGAGATGGTTTTGGCTCAATAATGCAAATGGCATTTTGCCCA
GAATATGTACCTACCTTTGATAATGTAATAGAAAATATTACGTCACTCACTATTGGCAAA
AGCAAATATTTTCAAGATCCAGCATTACTATTAATGCACGAACTTATACATGTACTACAT
GGTTTATACGGAATGCAGGTATCAAGCCATGAAATTATTCCATCCAAACAAGAAATTTAT
ATGCAGCATACATATCCAATAAGTGCTGAAGAACTATTCACTTTTGGCGGACAGGATGCT
AATCTTATAAGTATTGATATAAAAAACGATTTATATGAAAAAACTTTAAATGATTATAAA
GCTATAGCTAACAAACTTAGTCAAGTCACTAGCTGCAATGATCCCAACATTGATATTGAT
AGCTACAAACAAATATATCAACAAAAATATCAATTCGATAAAGATAGCAATGGACAATAT
ATTGTAAATGAGGATAAATTTCAGATACTATATAATAGCATAATGTATGGTTTTACAGAG
ATTGAATTGGGAAAAAAATTTAATATAAAAACTAGACTTTCTTATTTTAGTATGAATCAT
GACCCTGTAAAAATTCCAAATTTATTAGATGATACAATTTACAATGATACAGAAGGATTT
AATATAGAAAGCAAAGATCTGAAATCTGAATATAAAGGACAAAATATGAGGGTAAATACA
AATGCTTTTAGAAATGTTGATGGATCAGGCCTAGTTTCAAAACTTATTGGCTTATGTAAA
AAAATTATACCACCAACAAATATAAGAGAAAATTTATATAATAGAACTGCATCATTAACA
GATTTAGGAGGAGAATTATGTATAAAAATTAAAAATGAAGATTTAACTTTTATAGCTGAA
AAAAATAGCTTTTCAGAAGAACCATTTCAAGATGAAATAGTTAGTTATAATACAAAAAAT
AAACCATTAAATTTTAATTATTCGCTAGATAAAATTATTGTAGATTATAATCTACAAAGT
AAAATTACATTACCTAATGATAGGACAACCCCAGTTACAAAAGGAATTCCATATGCTCCA
GAATATAAAAGTAATGCTGCAAGTACAATAGAAATACATAATATTGATGACAATACAATA
TATCAATATTTGTATGCTCAAAAATCTCCTACAACTCTACAAAGAATAACTATGACTAAT
TCTGTTGATGACGCATTAATAAATTCCACCAAAATATATTCATATTTTCCATCTGTAATC
AGTAAAGTTAACCAAGGTGCACAAGGAATTTTATTCTTACAGTGGGTGAGAGATATAATT
GATGATTTTACCAATGAATCTTCACAAAAAACTACTATTGATAAAATTTCAGATGTATCC
ACTATTGTTCCTTATATAGGACCCGCATTAAACATTGTAAAACAAGGCTATGAGGGAAAC
TTTATAGGCGCTTTAGAAACTACCGGAGTGGTTTTATTATTAGAATATATTCCAGAAATT
ACTTTACCAGTAATTGCAGCTTTATCTATAGCAGAAAGTAGCACACAAAAAGAAAAGATA
ATAAAAACAATAGATAACTTTTTAGAAAAAAGATATGAAAAATGGATTGAAGTATATAAA
CTAGTAAAAGCAAAATGGTTAGGCACAGTTAATACGCAATTCCAAAAAAGAAGTTATCAA
ATGTATAGATCTTTAGAATATCAAGTAGATGCAATAAAAAAAATAATAGACTATGAATAT
AAAATATATTCAGGACCTGATAAGGAACAAATTGCCGACGAAATTAATAATCTGAAAAAC
AAACTTGAAGAAAAGGCTAATAAAGCAATGATAAACATAAATATATTTATGAGGGAAAGT
TCTAGATCATTTTTAGTTAATCAAATGATTAACGAAGCTAAAAAGCAGTTATTAGAGTTT
GATACTCAAAGCAAAAATATTTTAATGCAGTATATAAAAGCAAATTCTAAATTTATAGGT
ATAACTGAACTAAAAAAATTAGAATCAAAAATAAACAAAGTTTTTTCAACACCAATTCCA
TTTTCTTATTCTAAAAATCTGGATTGTTGGGTTGATAATGAAGAAGATATAGATGTTATA
TTAAAAAAGAGTACAATTTTAAATTTAGATATTAATAATGATATTATATCAGATATATCT
GGGTTTAATTCATCTGTAATAACATATCCAGATGCTCAATTGGTGCCCGGAATAAATGGC
AAAGCAATACATTTAGTAAACAATGAATCTTCTGAAGTTATAGTGCATAAAGCTATGGAT
ATTGAATATAATGATATGTTTAATAATTTTACCGTTAGCTTTTGGTTGAGGGTTCCTAAA
GTATCTGCTAGTCATTTAGAACAATATGGCACAAATGAGTATTCAATAATTAGCTCTATG
AAAAAACATAGTCTATCAATAGGATCTGGTTGGAGTGTATCACTTAAAGGTAATAACTTA
ATATGGACTTTAAAAGATTCCGCGGGAGAAGTTAGACAAATAACTTTTAGGGATTTACCT
GATAAATTTAATGCTTATTTAGCAAATAAATGGGTTTTTATAACTATTACTAATGATAGA
TTATCTTCTGCTAATTTGTATATAAATGGAGTACTTATGGGAAGTGCAGAAATTACTGGT
TTAGGAGCTATTAGAGAGGATAATAATATAACATTAAAACTAGATAGATGTAATAATAAT
AATCAATACGTTTCTATTGATAAATTTAGGATATTTTGCAAAGCATTAAATCCAAAAGAG
ATTGAAAAATTATACACAAGTTATTTATCTATAACCTTTTTAAGAGACTTCTGGGGAAAC
CCTTTACGATATGATACAGAATATTATTTAATACCAGTAGCTTCTAGTTCTAAAGATGTT
CAATTGAAAAATATAACAGATTATATGTATTTGACAAATGCGCCATCGTATACTAACGGA
AAATTGAATATATATTATAGAAGGTTATATAATGGACTAAAATTTATTATAAAAAGATAT
ACACCTAATAATGAAATAGATTCTTTTGTTAAATCAGGTGATTTTATTAAATTATATGTA
TCATATAACAATAATGAGCACATTGTAGGTTATCCGAAAGATGGAAATGCCTTTAATAAT
CTTGATAGAATTCTAAGAGTAGGTTATAATGCCCCAGGTATCCCTCTTTATAAAAAAATG
GAAGCAGTAAAATTGCGTGATTTAAAAACCTATTCTGTACAACTTAAATTATATGATGAT
AAAAATGCATCTTTAGGACTAGTAGGTACCCATAATGGTCAAATAGGCAACGATCCAAAT
AGGGATATATTAATTGCAAGCAACTGGTACTTTAATCATTTAAAAGATAAAATTTTAGGA
TGTGATTGGTACTTTGTACCTACAGATGAAGGATGGACAAATGATTAA

# Drug_Target_80_General_Function:
Involved in metalloendopeptidase activity

# Drug_Target_80_General_References:
12552129	Bruggemann H, Baumer S, Fricke WF, Wiezer A, Liesegang H, Decker I, Herzberg C, Martinez-Arias R, Merkl R, Henne A, Gottschalk G: The genome sequence of Clostridium tetani, the causative agent of tetanus disease. Proc Natl Acad Sci U S A. 2003 Feb 4;100(3):1316-21. Epub 2003 Jan 27.
1331807	Schiavo G, Benfenati F, Poulain B, Rossetto O, Polverino de Laureto P, DasGupta BR, Montecucco C: Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature. 1992 Oct 29;359(6398):832-5.
1396558	Schiavo G, Poulain B, Rossetto O, Benfenati F, Tauc L, Montecucco C: Tetanus toxin is a zinc protein and its inhibition of neurotransmitter release and protease activity depend on zinc. EMBO J. 1992 Oct;11(10):3577-83.
1935979	Krieglstein KG, Henschen AH, Weller U, Habermann E: Limited proteolysis of tetanus toxin. Relation to activity and identification of cleavage sites. Eur J Biochem. 1991 Nov 15;202(1):41-51.
2108021	Krieglstein K, Henschen A, Weller U, Habermann E: Arrangement of disulfide bridges and positions of sulfhydryl groups in tetanus toxin. Eur J Biochem. 1990 Feb 22;188(1):39-45.
3510187	Fairweather NF, Lyness VA, Pickard DJ, Allen G, Thomson RO: Cloning, nucleotide sequencing, and expression of tetanus toxin fragment C in Escherichia coli. J Bacteriol. 1986 Jan;165(1):21-7.
3536478	Eisel U, Jarausch W, Goretzki K, Henschen A, Engels J, Weller U, Hudel M, Habermann E, Niemann H: Tetanus toxin: primary structure, expression in E. coli, and homology with botulinum toxins. EMBO J. 1986 Oct;5(10):2495-502.
3774547	Fairweather NF, Lyness VA: The complete nucleotide sequence of tetanus toxin. Nucleic Acids Res. 1986 Oct 10;14(19):7809-12.
9334741	Umland TC, Wingert LM, Swaminathan S, Furey WF, Schmidt JJ, Sax M: Structure of the receptor binding fragment HC of tetanus neurotoxin. Nat Struct Biol. 1997 Oct;4(10):788-92.

# Drug_Target_80_HGNC_ID:
Not Available

# Drug_Target_80_HPRD_ID:
Not Available

# Drug_Target_80_ID:
2570

# Drug_Target_80_Locus:
Not Available

# Drug_Target_80_Molecular_Weight:
150684

# Drug_Target_80_Name:
Tetanus toxin

# Drug_Target_80_Number_of_Residues:
1315

# Drug_Target_80_PDB_ID:
Not Available

# Drug_Target_80_Pathway:
Not Available

# Drug_Target_80_Pfam_Domain_Function:
PF01742	Peptidase_M27
PF07951	Toxin_R_bind_C
PF07952	Toxin_trans
PF07953	Toxin_R_bind_N

# Drug_Target_80_Protein_Sequence:
>Tetanus toxin precursor
MPITINNFRYSDPVNNDTIIMMEPPYCKGLDIYYKAFKITDRIWIVPERYEFGTKPEDFN
PPSSLIEGASEYYDPNYLRTDSDKDRFLQTMVKLFNRIKNNVAGEALLDKIINAIPYLGN
SYSLLDKFDTNSNSVSFNLLEQDPSGATTKSAMLTNLIIFGPGPVLNKNEVRGIVLRVDN
KNYFPCRDGFGSIMQMAFCPEYVPTFDNVIENITSLTIGKSKYFQDPALLLMHELIHVLH
GLYGMQVSSHEIIPSKQEIYMQHTYPISAEELFTFGGQDANLISIDIKNDLYEKTLNDYK
AIANKLSQVTSCNDPNIDIDSYKQIYQQKYQFDKDSNGQYIVNEDKFQILYNSIMYGFTE
IELGKKFNIKTRLSYFSMNHDPVKIPNLLDDTIYNDTEGFNIESKDLKSEYKGQNMRVNT
NAFRNVDGSGLVSKLIGLCKKIIPPTNIRENLYNRTASLTDLGGELCIKIKNEDLTFIAE
KNSFSEEPFQDEIVSYNTKNKPLNFNYSLDKIIVDYNLQSKITLPNDRTTPVTKGIPYAP
EYKSNAASTIEIHNIDDNTIYQYLYAQKSPTTLQRITMTNSVDDALINSTKIYSYFPSVI
SKVNQGAQGILFLQWVRDIIDDFTNESSQKTTIDKISDVSTIVPYIGPALNIVKQGYEGN
FIGALETTGVVLLLEYIPEITLPVIAALSIAESSTQKEKIIKTIDNFLEKRYEKWIEVYK
LVKAKWLGTVNTQFQKRSYQMYRSLEYQVDAIKKIIDYEYKIYSGPDKEQIADEINNLKN
KLEEKANKAMININIFMRESSRSFLVNQMINEAKKQLLEFDTQSKNILMQYIKANSKFIG
ITELKKLESKINKVFSTPIPFSYSKNLDCWVDNEEDIDVILKKSTILNLDINNDIISDIS
GFNSSVITYPDAQLVPGINGKAIHLVNNESSEVIVHKAMDIEYNDMFNNFTVSFWLRVPK
VSASHLEQYGTNEYSIISSMKKHSLSIGSGWSVSLKGNNLIWTLKDSAGEVRQITFRDLP
DKFNAYLANKWVFITITNDRLSSANLYINGVLMGSAEITGLGAIREDNNITLKLDRCNNN
NQYVSIDKFRIFCKALNPKEIEKLYTSYLSITFLRDFWGNPLRYDTEYYLIPVASSSKDV
QLKNITDYMYLTNAPSYTNGKLNIYYRRLYNGLKFIIKRYTPNNEIDSFVKSGDFIKLYV
SYNNNEHIVGYPKDGNAFNNLDRILRVGYNAPGIPLYKKMEAVKLRDLKTYSVQLKLYDD
KNASLGLVGTHNGQIGNDPNRDILIASNWYFNHLKDKILGCDWYFVPTDEGWTND

# Drug_Target_80_Reaction:
Hydrolysis of -Gln76!Phe- bond in synaptobrevin (also known as neuronal vesicle-associated membrane protein, VAMP)

# Drug_Target_80_Signals:
None

# Drug_Target_80_Specific_Function:
Tetanus toxin acts by inhibiting neurotransmitter release. It binds to peripheral neuronal synapses, is internalized and moves by retrograde transport up the axon into the spinal cord where it can move between postsynaptic and presynaptic neurons. It inhibits neurotransmitter release by acting as a zinc endopeptidase that catalyzes the hydrolysis of the '76-Gln-|-Phe- 77' bond of synaptobrevin-2

# Drug_Target_80_SwissProt_ID:
P04958

# Drug_Target_80_SwissProt_Name:
TETX_CLOTE

# Drug_Target_80_Synonyms:
EC 3.4.24.68
Tentoxylysin
Tetanus toxin precursor

# Drug_Target_80_Theoretical_pI:
5.91

# Drug_Target_80_Transmembrane_Regions:
None

# Drug_Target_81_Cellular_Location:
Cytoplasm

# Drug_Target_81_Chromosome_Location:
Not Available

# Drug_Target_81_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_81_Essentiality:
Non-Essential

# Drug_Target_81_GenAtlas_ID:
Not Available

# Drug_Target_81_GenBank_ID_Gene:
M73789

# Drug_Target_81_GenBank_ID_Protein:
153534

# Drug_Target_81_GeneCard_ID:
Not Available

# Drug_Target_81_Gene_Name:
xylA

# Drug_Target_81_Gene_Sequence:
>1167 bp
ATGAACTACCAGCCCACCCCCGAGGACAGGTTCACCTTCGGACTGTGGACCGTCGGCTGG
CAGGGACGGGACCCCTTCGGTGACGCCACGCGGCGCGCCCTCGACCCGGTCGAGTCGGTG
CGGCGGCTGGCCGAGCTGGGCGCCCACGGCGTCACGTTCCACGACGACGACCTCATCCCC
TTCGGCTCCAGCGACAGCGAGCGCGAGGAGCACGTCAAGCGGTTCCGGCAGGCGCTGGAC
GACACCGGCATGAAGGTGCCGATGGCCACCACCAACCTGTTCACCCACCCGGTGTTCAAG
GACGGCGGCTTCACCGCCAACGACCGCGACGTGCGCCGCTACGCCCTGCGCAAGACCATC
CGCAACATCGACCTCGCGGTCGAGCTCGGCGCCGAGACCTATGTGGCCTGGGGCGGCCGC
GAGGGTGCCGAGTCGGGTGGCGCCAAGGACGTGCGGGACGCCCTCGACCGCATGAAGGAG
GCCTTCGACCTGCTCGGCGAGTACGTCACCTCCCAGGGCTACGACATCCGCTTCGCCATC
GAGCCCAAGCCGAACGAGCCGCGCGGCGACATCCTGCTCCCCACCGTCGGCCACGCCCTG
GCGTTCATCGAGCGCCTGGAGCGACCGGAGCTGTACGGCGTGAACCCCGAGGTCGGCCAC
GAGCAGATGGCCGGGCTGAACTTCCCGCACGGCATCGCGCAGGCGCTGTGGGCGGGCAAG
CTGTTCCACATCGACCTCAACGGCCAGAACGGCATCAAGTACGACCAGGACCTCCGCTTC
GGCGCGGGCGACCTGCGGGCCGCGTTCTGGCTGGTGGACCTGCTGGAGTCGGCCGGCTAC
AGCGGCCCGCGGCACTTCGACTTCAAGCCGCCGCGGACCGAGGACTTCGACGGGGTGTGG
GCCTCGGCGGCCGGCTGCATGCGCAACTACCTGATCCTCAAGGAGCGTGCGGCGGCCTTC
CGCGCCGACCCCGAGGTGCAGGAGGCGCTGCGCGCGTCCCGTCTGGACGAGCTGGCCCGG
CCCACGGCGGCCGACGGTCTGCAGGCCCTGCTCGACGACCGGTCCGCCTTCGAGGAGTTC
GACGTCGACGCGGCGGCGGCCCGTGGGATGGCCTTCGAGCGCCTGGACCAGCTGGCGATG
GACCACCTGCTGGGCGCCCGGGGCTGA

# Drug_Target_81_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_81_General_References:
1657868	Wong HC, Ting Y, Lin HC, Reichert F, Myambo K, Watt KW, Toy PL, Drummond RJ: Genetic organization and regulation of the xylose degradation genes in Streptomyces rubiginosus. J Bacteriol. 1991 Nov;173(21):6849-58.
2006134	Whitlow M, Howard AJ, Finzel BC, Poulos TL, Winborne E, Gilliland GL: A metal-mediated hydride shift mechanism for xylose isomerase based on the 1.6 A Streptomyces rubiginosus structures with xylitol and D-xylose. Proteins. 1991;9(3):153-73.
2734296	Carrell HL, Glusker JP, Burger V, Manfre F, Tritsch D, Biellmann JF: X-ray analysis of D-xylose isomerase at 1.9 A: native enzyme in complex with substrate and with a mechanism-designed inactivator. Proc Natl Acad Sci U S A. 1989 Jun;86(12):4440-4.

# Drug_Target_81_HGNC_ID:
Not Available

# Drug_Target_81_HPRD_ID:
Not Available

# Drug_Target_81_ID:
2260

# Drug_Target_81_Locus:
Not Available

# Drug_Target_81_Molecular_Weight:
43228

# Drug_Target_81_Name:
Xylose isomerase

# Drug_Target_81_Number_of_Residues:
388

# Drug_Target_81_PDB_ID:
1MNZ

# Drug_Target_81_Pathway:
Not Available

# Drug_Target_81_Pfam_Domain_Function:
PF01261	AP_endonuc_2

# Drug_Target_81_Protein_Sequence:
>Xylose isomerase
MNYQPTPEDRFTFGLWTVGWQGRDPFGDATRRALDPVESVRRLAELGAHGVTFHDDDLIP
FGSSDSEREEHVKRFRQALDDTGMKVPMATTNLFTHPVFKDGGFTANDRDVRRYALRKTI
RNIDLAVELGAETYVAWGGREGAESGGAKDVRDALDRMKEAFDLLGEYVTSQGYDIRFAI
EPKPNEPRGDILLPTVGHALAFIERLERPELYGVNPEVGHEQMAGLNFPHGIAQALWAGK
LFHIDLNGQNGIKYDQDLRFGAGDLRAAFWLVDLLESAGYSGPRHFDFKPPRTEDFDGVW
ASAAGCMRNYLILKERAAAFRADPEVQEALRASRLDELARPTAADGLQALLDDRSAFEEF
DVDAAAARGMAFERLDQLAMDHLLGARG

# Drug_Target_81_Reaction:
D-xylose = D-xylulose

# Drug_Target_81_Signals:
None

# Drug_Target_81_Specific_Function:
Involved in D-xylose catabolism

# Drug_Target_81_SwissProt_ID:
P24300

# Drug_Target_81_SwissProt_Name:
XYLA_STRRU

# Drug_Target_81_Synonyms:
EC 5.3.1.5

# Drug_Target_81_Theoretical_pI:
4.78

# Drug_Target_81_Transmembrane_Regions:
None

# Drug_Target_82_Cellular_Location:
Secreted protein

# Drug_Target_82_Chromosome_Location:
Not Available

# Drug_Target_82_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_82_Essentiality:
Non-Essential

# Drug_Target_82_GenAtlas_ID:
Not Available

# Drug_Target_82_GenBank_ID_Gene:
M18862

# Drug_Target_82_GenBank_ID_Protein:
142497

# Drug_Target_82_GeneCard_ID:
Not Available

# Drug_Target_82_Gene_Name:
Not Available

# Drug_Target_82_Gene_Sequence:
>1557 bp
ATGAAAATGAGAACAGGAAAAAAGGGTTTTTTAAGTATTTTATTAGCGTTCTTATTGGTG
ATTACTTCAATACCGTTTACTTTAGTAGATGTAGAAGCACATCATAACGGTACGAACGGG
ACAATGATGCAATACTTTGAATGGTATCTACCTAATGACGGAAATCATTGGAATCGATTA
AACTCTGATGCGAGTAACCTTAAAAGCAAAGGGATTACAGCGGTGTGGATTCCTCCAGCA
TGGAAGGGCGCTTCTCAAAATGACGTAGGATACGGAGCCTATGACCTGTATGATCTGGGA
GAATTTAATCAAAAAGGTACCGTCCGTACAAAATATGGAACACGTAGTCAGTTACAAGCT
GCGGTAACCTCCTTAAAAAATAATGGAATTCAAGTATATGGTGACGTTGTTATGAATCAC
AAAGGTGGCGCAGACGCTACTGAAATGGTAAGGGCCGTTGAAGTGAATCCCAATAACCGT
AACCAAGAAGTGACTGGTGAATATACCATTGAAGCTTGGACTAGATTTGATTTTCCAGGG
CGAGGAAATACTCATTCTAGCTTTAAATGGAGATGGTATCATTTTGATGGTGTGGATTGG
GATCAGTCACGTAGACTGAACAATCGCATCTATAAATTTAGAGGTCATGGCAAAGCTTGG
GATTGGGAAGTTGATACGGAAAATGGTAATTATGATTATTTAATGTACGCTGATATTGAT
ATGGATCACCCAGAAGTAGTAAATGAATTAAGAAATTGGGGTGTTTGGTACACAAACACA
TTAGGACTCGATGGATTTAGAATAGATGCGGTTAAACATATAAAGTATAGCTTTACGCGC
GATTGGATTAATCACGTTAGAAGTGCAACAGGTAAAAATATGTTTGCGGTTGCTGAGTTT
TGGAAGAATGATTTAGGTGCAATTGAAAACTATCTGCAGAAAACAAACTGGAACCATTCA
GTCTTTGATGTGCCGTTACATTATAATCTTTATAATGCATCAAAAAGCGGAGGGAACTAT
GATATGCGAAACATATTTAATGGAACGGTTGTTCAACGACATCCAAGTCATGCTGTAACA
TTTGTTGATAATCATGATTCGCAGCCTGAAGAAGCATTAGAATCTTTTGTTGAAGAATGG
TTTAAACCATTAGCGTATGCGCTTACATTAACGCGTGAACAAGGATACCCTTCTGTATTT
TACGGAGATTATTATGGGATTCCAACACATGGAGTGCCAGCAATGAGATCAAAAATCGAT
CCGATTTTAGAAGCACGTCAAAAGTATGCATACGGAAAACAAAATGATTACTTAGACCAT
CATAATATCATTGGTTGGACGCGTGAAGGGAATACAGCACACCCCAATTCAGGTCTAGCT
ACCATCATGTCTGATGGAGCGGGTGGAAGTAAGTGGATGTTTGTTGGGCGTAATAAGGCT
GGTCAAGTATGGAGTGATATTACAGGAAACCGTACAGGTACGGTTACAATCAATGCAGAC
GGTTGGGGCAATTTCTCTGTGAATGGAGGGTCAGTTTCTATTTGGGTCAACAAATAA

# Drug_Target_82_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_82_General_References:
3258152	Tsukamoto A, Kimura K, Ishii Y, Takano T, Yamane K: Nucleotide sequence of the maltohexaose-producing amylase gene from an alkalophilic Bacillus sp. #707 and structural similarity to liquefying type alpha-amylases. Biochem Biophys Res Commun. 1988 Feb 29;151(1):25-31.

# Drug_Target_82_HGNC_ID:
Not Available

# Drug_Target_82_HPRD_ID:
Not Available

# Drug_Target_82_ID:
2564

# Drug_Target_82_Locus:
Not Available

# Drug_Target_82_Molecular_Weight:
59009

# Drug_Target_82_Name:
Glucan 1,4-alpha-maltohexaosidase

# Drug_Target_82_Number_of_Residues:
518

# Drug_Target_82_PDB_ID:
1WPC

# Drug_Target_82_Pathway:
Not Available

# Drug_Target_82_Pfam_Domain_Function:
PF00128	Alpha-amylase

# Drug_Target_82_Protein_Sequence:
>Glucan 1,4-alpha-maltohexaosidase precursor
MKMRTGKKGFLSILLAFLLVITSIPFTLVDVEAHHNGTNGTMMQYFEWYLPNDGNHWNRL
NSDASNLKSKGITAVWIPPAWKGASQNDVGYGAYDLYDLGEFNQKGTVRTKYGTRSQLQA
AVTSLKNNGIQVYGDVVMNHKGGADATEMVRAVEVNPNNRNQEVTGEYTIEAWTRFDFPG
RGNTHSSFKWRWYHFDGVDWDQSRRLNNRIYKFRGHGKAWDWEVDTENGNYDYLMYADID
MDHPEVVNELRNWGVWYTNTLGLDGFRIDAVKHIKYSFTRDWINHVRSATGKNMFAVAEF
WKNDLGAIENYLQKTNWNHSVFDVPLHYNLYNASKSGGNYDMRNIFNGTVVQRHPSHAVT
FVDNHDSQPEEALESFVEEWFKPLAYALTLTREQGYPSVFYGDYYGIPTHGVPAMRSKID
PILEARQKYAYGKQNDYLDHHNIIGWTREGNTAHPNSGLATIMSDGAGGSKWMFVGRNKA
GQVWSDITGNRTGTVTINADGWGNFSVNGGSVSIWVNK

# Drug_Target_82_Reaction:
Hydrolysis of 1,4-alpha-D-glucosidic linkages in amylaceous polysaccharides, to remove successive maltohexaose residues from the non-reducing chain ends

# Drug_Target_82_Signals:
1-33

# Drug_Target_82_Specific_Function:
Hydrolysis of 1,4-alpha-D-glucosidic linkages in amylaceous polysaccharides, to remove successive maltohexaose residues from the non-reducing chain ends

# Drug_Target_82_SwissProt_ID:
P19571

# Drug_Target_82_SwissProt_Name:
AMT6_BACS7

# Drug_Target_82_Synonyms:
EC 3.2.1.98
Exo-maltohexaohydrolase
G6-amylase
Glucan 1,4-alpha-maltohexaosidase precursor
Maltohexaose-producing amylase

# Drug_Target_82_Theoretical_pI:
7.07

# Drug_Target_82_Transmembrane_Regions:
None

# Drug_Target_83_Cellular_Location:
Secreted protein

# Drug_Target_83_Chromosome_Location:
Not Available

# Drug_Target_83_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_83_Essentiality:
Non-Essential

# Drug_Target_83_GenAtlas_ID:
Not Available

# Drug_Target_83_GenBank_ID_Gene:
M24516

# Drug_Target_83_GenBank_ID_Protein:
151013

# Drug_Target_83_GeneCard_ID:
Not Available

# Drug_Target_83_Gene_Name:
amyP

# Drug_Target_83_Gene_Sequence:
>1644 bp
ATGAGCCACATCCTGCGAGCCGCCGTATTGGCGGCGATGCTGTTGCCGTTGCCGTCCATG
GCCGATCAGGCCGGCAAGAGCCCCAACGCTGTGCGCTACCACGGCGGCGACGAAATCATT
CTCCAGGGCTTTCACTGGAACGTCGTCCGCGAAGCGCCCAACGACTGGTACAACATCCTG
CGCCAGCAGGCCGCGACCATCGCCGCCGACGGCTTCTCGGCGATCTGGATGCCGGTGCCC
TGGCGCGACTTCTCCAGCTGGAGCGACGGCAGCAAGTCCGGCGGCGGTGAAGGCTACTTC
TGGCACGACTTCAACAAGAACGGCCGCTATGGCAGTGACGCCCAGCTGCGTCAGGCCGCC
AGCGCGCTCGGTGGCGCCGGCGTGAAAGTGCTTTACGACGTGGTGCCCAACCACATGAAC
CGTGGCTATCCGGACAAGGAGATCAACCTCCCGGCCGGCCAGGGCTTCTGGCGCAACGAC
TGCGCCGACCCGGGCAACTACCCCAATGATTGCGACGACGGCGACCGCTTCATCGGCGGC
GATGCGGACCTCAACACCGGCCACCCGCAGGTCTACGGCATGTTCCGCGATGAATTCACC
AACCTGCGCAGTCAGTACGGTGCCGGCGGCTTCCGCTTCGACTTTGTTCGGGGCTATGCG
CCGGAGCGGGTCAACAGCTGGATGACCGATAGCGCCGACAACAGCTTCTGCGTCGGCGAA
CTGTGGAAAGGCCCCTCTGAGTACCCGAACTGGGACTGGCGCAACACCGCCAGCTGGCAG
CAGATCATCAAGGACTGGTCCGACCGGGCCAAGTGCCCGGTGTTCGACTTCGCCCTCAAG
GAACGCATGCAGAACGCTCGATCGCCGACTGGAAGCACGCCTGAACGGCAATCCCGACCC
GCGTGGCGCGAGGTGGCGGTGACCTTCGTCGACAACCACGACACCGGCTACTCGCCCGGG
CAGAACGGTGGGCAGCACCACTGGGCTCTGCAGGACGGGCTGATCCGCCAGGCCTACGCC
TACATCCTCACCAGCCCCGGTACGCCGGTGGTGTACTGGTCGCACATGTACGACTGGGGT
TACGGCGACTTCATCCGTCAGCTGATCCAGGTGCGTCGCGCCGCCGGCGTGCGCGCCGAT
TCGGCGATCAGCTTCCACAGCGGCTACAGCGGTCTGGTCGCCACCGTCAGCGGCAGCCAG
CAGACCCTGGTGGTGGCGCTCAACTCCGACCTGGGCAATCCCGGCCAGGTGGCCAGCGGC
AGCTTCAGCGAGGCGGTCAACGCCAGCAACGGCCAGGTGCGCGTGTGGCGTAGCGGCACG
GGCAGCGGTGGCGGTGAACCCGGCGCTCTGGTCAGTGTGAGTTTCCGCTGCGACAACGGC
GCGACGCAGATGGGCGACAGCGTCTACGCGGTCGGCAACGTCAGCCAGCTCGGTAACTGG
AGCCCGGCCGCGGCGTTGCGCCTGACCGACACCAGCGGCTACCCGACCTGGAAGGGCAGC
ATTGCCTTGCCTGCCGGCCAGAACGAGGAATGGAAATGCCTGATCCGCAACGAGGCCAAC
GCCACCCAGGTGCGGCAATGGCAGGGCGGGGCAAACAACAGCCTGACGCCGAGCGAGGGC
GCCACCACCGTCGGCCGGCTCTAG

# Drug_Target_83_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_83_General_References:
10556241	Hasegawa K, Kubota M, Matsuura Y: Roles of catalytic residues in alpha-amylases as evidenced by the structures of the product-complexed mutants of a maltotetraose-forming amylase. Protein Eng. 1999 Oct;12(10):819-24.
2646279	Fujita M, Torigoe K, Nakada T, Tsusaki K, Kubota M, Sakai S, Tsujisaka Y: Cloning and nucleotide sequence of the gene (amyP) for maltotetraose-forming amylase from Pseudomonas stutzeri MO-19. J Bacteriol. 1989 Mar;171(3):1333-9.
9126844	Morishita Y, Hasegawa K, Matsuura Y, Katsube Y, Kubota M, Sakai S: Crystal structure of a maltotetraose-forming exo-amylase from Pseudomonas stutzeri. J Mol Biol. 1997 Apr 4;267(3):661-72.
9281429	Yoshioka Y, Hasegawa K, Matsuura Y, Katsube Y, Kubota M: Crystal structures of a mutant maltotetraose-forming exo-amylase cocrystallized with maltopentaose. J Mol Biol. 1997 Aug 29;271(4):619-28.

# Drug_Target_83_HGNC_ID:
Not Available

# Drug_Target_83_HPRD_ID:
Not Available

# Drug_Target_83_ID:
2728

# Drug_Target_83_Locus:
Not Available

# Drug_Target_83_Molecular_Weight:
59876

# Drug_Target_83_Name:
Glucan 1,4-alpha-maltotetraohydrolase

# Drug_Target_83_Number_of_Residues:
548

# Drug_Target_83_PDB_ID:
1GCY

# Drug_Target_83_Pathway:
Not Available

# Drug_Target_83_Pfam_Domain_Function:
PF00128	Alpha-amylase
PF00686	CBM_20
PF09081	DUF1921

# Drug_Target_83_Protein_Sequence:
>Glucan 1,4-alpha-maltotetraohydrolase precursor
MSHILRAAVLAAMLLPLPSMADQAGKSPNAVRYHGGDEIILQGFHWNVVREAPNDWYNIL
RQQAATIAADGFSAIWMPVPWRDFSSWSDGSKSGGGEGYFWHDFNKNGRYGSDAQLRQAA
SALGGAGVKVLYDVVPNHMNRGYPDKEINLPAGQGFWRNDCADPGNYPNDCDDGDRFIGG
DADLNTGHPQVYGMFRDEFTNLRSQYGAGGFRFDFVRGYAPERVNSWMTDSADNSFCVGE
LWKGPSEYPNWDWRNTASWQQIIKDWSDRAKCPVFDFALKERMQNGSIADWKHGLNGNPD
PRWREVAVTFVDNHDTGYSPGQNGGQHHWALQDGLIRQAYAYILTSPGTPVVYWSHMYDW
GYGDFIRQLIQVRRAAGVRADSAISFHSGYSGLVATVSGSQQTLVVALNSDLGNPGQVAS
GSFSEAVNASNGQVRVWRSGTGSGGGEPGALVSVSFRCDNGATQMGDSVYAVGNVSQLGN
WSPAAALRLTDTSGYPTWKGSIALPAGQNEEWKCLIRNEANATQVRQWQGGANNSLTPSE
GATTVGRL

# Drug_Target_83_Reaction:
Hydrolysis of 1,4-alpha-D-glucosidic linkages in amylaceous polysaccharides, to remove successive maltotetraose residues from the non-reducing chain ends

# Drug_Target_83_Signals:
1-21

# Drug_Target_83_Specific_Function:
Hydrolysis of 1,4-alpha-D-glucosidic linkages in amylaceous polysaccharides, to remove successive maltotetraose residues from the non-reducing chain ends

# Drug_Target_83_SwissProt_ID:
P13507

# Drug_Target_83_SwissProt_Name:
AMT4_PSEST

# Drug_Target_83_Synonyms:
EC 3.2.1.60
Exo-maltotetraohydrolase
G4- amylase
Glucan 1,4-alpha-maltotetraohydrolase precursor
Maltotetraose-forming amylase
Maltotetraose-forming exo-amylase

# Drug_Target_83_Theoretical_pI:
5.93

# Drug_Target_83_Transmembrane_Regions:
None

# Drug_Target_84_Cellular_Location:
Cytoplasmic

# Drug_Target_84_Chromosome_Location:
Not Available

# Drug_Target_84_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_84_Essentiality:
Non-Essential

# Drug_Target_84_GenAtlas_ID:
Not Available

# Drug_Target_84_GenBank_ID_Gene:
U30321

# Drug_Target_84_GenBank_ID_Protein:
927292

# Drug_Target_84_GeneCard_ID:
Not Available

# Drug_Target_84_Gene_Name:
celCCF

# Drug_Target_84_Gene_Sequence:
>2169 bp
ATGAGTAAGAATTTTAAAAGAGTAGGAGCAGTTGCAGTTGCTGCTGCAATGTCATTATCT
ATAATGGCAACAACCAGCATAAATGCAGCTTCAAGTCCTGCAAACAAGGTGTACCAGGAT
CGTTTTGAATCCATGTACAGCAAGATTAAGGATCCTGCAAACGGATACTTCAGTGAACAG
GGAATTCCTTACCACTCAATTGAAACACTGATGGTCGAAGCTCCTGACTACGGACATGTT
ACAACAAGTGAAGCTATGTCCTATTATATGTGGTTGGAAGCAATGCACGGAAGATTTTCA
GGAGATTTTACAGGTTTTGATAAGTCTTGGTCTGTTACCGAACAGTATTTGATCCCAACA
GAAAAGGATCAGCCCAATACAAGTATGAGCAGATATGATGCTAACAAACCGGCTACATAC
GCTCCGGAATTTCAGGACCCAAGCAAGTATCCTTCTCCGTTGGATACTAGTCAACCTGTT
GGTAGAGATCCAATCAACTCACAATTGACTTCAGCATACGGAACAAGCATGCTGTATGGA
ATGCACTGGATACTTGACGTTGATAACTGGTATGGATTTGGAGCAAGAGCTGATGGAACC
TCCAAGCCATCATATATCAATACTTTCCAAAGAGGTGAGCAGGAGTCAACTTGGGAAACC
ATACCTCAACCATGTTGGGATGAACATAAATTTGGTGGACAGTACGGATTCCTGGATCTC
TTTACAAAGGATACAGGTACTCCGGCAAAGCAATTCAAATATACAAATGCTCCAGATGCT
GATGCTCGTGCAGTTCAAGCAACTTACTGGGCTGATCAGTGGGCAAAAGAACAAGGTAAG
AGCGTAAGTACTAGCGTAGGTAAGGCAACAAAGATGGGTGATTACCTTAGATATTCATTC
TTTGATAAGTATTTCAGAAAGATCGGACAACCTTCTCAGGCTGGTACCGGATATGATGCA
GCACATTATCTGCTTTCATGGTACTATGCATGGGGTGGTGGAATTGACTCTACCTGGTCT
TGGATAATCGGTAGCAGTCATAATCATTTCGGTTACCAGAACCCATTTGCAGCTTGGGTA
CTTTCAACAGATGCAAACTTCAAGCCTAAGTCATCAAATGGTGCATCAGACTGGGCAAAG
AGTTTGGACAGACAGCTTGAATTCTATCAGTGGTTGCAGTCAGCAGAAGGTGCTATTGCC
GGTGGAGCTACAAACTCATGGAACGGACGTTATGAAGCAGTTCCTTCAGGTACATCAACA
TTCTATGGAATGGGTTATGTAGAAAACCCTGTATATGCTGACCCAGGTAGTAACACTTGG
TTTGGTATGCAGGTATGGTCAATGCAGCGTGTAGCTGAATTGTACTATAAGACTGGCGAT
GCCAGAGCTAAGAAACTCTTAGACAAATGGGCAAAATGGATTAATGGCGAAATCAAGTTC
AATGCTGACGGAACATTCCAGATTCCTAGCACAATTGATTGGGAAGGACAGCCGGATACT
TGGAATCCAACACAGGGATACACCGGAAATGCAAACTTGCATGTTAAAGTTGTTAACTAT
GGTACTGACCTAGGTTGTGCTTCTTCACTTGCAAACACATTGACTTACTATGCTGCTAAA
TCAGGAGATGAAACTTCAAGGCAGAATGCACAGAAATTACTTGACGCTATGTGGAATAAC
TATAGCGATTCAAAGGGTATATCAACTGTTGAACAGCGTGGTGATTACCATAGATTCCTT
GATCAGGAAGTTTTTGTACCAGCTGGTTGGACTGGAAAAATGCCTAACGGCGACGTAATC
AAATCTGGTGTCAAGTTCATAGACATTCGTTCCAAGTACAAGCAGGATCCTGAATGGCAG
ACAATGGTTGCTGCATTACAGGCAGGACAGGTTCCAACTCAGAGATTACACCGTTTCTGG
GCTCAGAGTGAATTTGCAGTTGCAAATGGAGTTTATGCAATACTCTTCCCAGATCAAGGT
CCAGAAAAATTATTGGGTGATGTAAACGGTGACGAAACTGTAGACGCTATTGACCTTGCT
ATACTTAAAAAATATCTTTTAAACAGCAGTACTACAATAAATACTGCAAATGCAGATATG
AATAGTGATAATGCTATTGACGCTATTGACTATGCTCTTTTAAAGAAAGCACTTCTTTCT
ATCCAATAG

# Drug_Target_84_General_Function:
Involved in endoglucanase activity

# Drug_Target_84_General_References:
1398087	Bagnara-Tardif C, Gaudin C, Belaich A, Hoest P, Citard T, Belaich JP: Sequence analysis of a gene cluster encoding cellulases from Clostridium cellulolyticum. Gene. 1992 Sep 21;119(1):17-28.
8936327	Reverbel-Leroy C, Belaich A, Bernadac A, Gaudin C, Belaich JP, Tardif C: Molecular study and overexpression of the Clostridium cellulolyticum celF cellulase gene in Escherichia coli. Microbiology. 1996 Apr;142 ( Pt 4):1013-23.

# Drug_Target_84_HGNC_ID:
Not Available

# Drug_Target_84_HPRD_ID:
Not Available

# Drug_Target_84_ID:
2440

# Drug_Target_84_Locus:
Not Available

# Drug_Target_84_Molecular_Weight:
80545

# Drug_Target_84_Name:
Endoglucanase F

# Drug_Target_84_Number_of_Residues:
722

# Drug_Target_84_PDB_ID:
1FBO

# Drug_Target_84_Pathway:
Not Available

# Drug_Target_84_Pfam_Domain_Function:
PF00404	Dockerin_1
PF02011	Glyco_hydro_48

# Drug_Target_84_Protein_Sequence:
>Endoglucanase F precursor
MSKNFKRVGAVAVAAAMSLSIMATTSINAASSPANKVYQDRFESMYSKIKDPANGYFSEQ
GIPYHSIETLMVEAPDYGHVTTSEAMSYYMWLEAMHGRFSGDFTGFDKSWSVTEQYLIPT
EKDQPNTSMSRYDANKPATYAPEFQDPSKYPSPLDTSQPVGRDPINSQLTSAYGTSMLYG
MHWILDVDNWYGFGARADGTSKPSYINTFQRGEQESTWETIPQPCWDEHKFGGQYGFLDL
FTKDTGTPAKQFKYTNAPDADARAVQATYWADQWAKEQGKSVSTSVGKATKMGDYLRYSF
FDKYFRKIGQPSQAGTGYDAAHYLLSWYYAWGGGIDSTWSWIIGSSHNHFGYQNPFAAWV
LSTDANFKPKSSNGASDWAKSLDRQLEFYQWLQSAEGAIAGGATNSWNGRYEAVPSGTST
FYGMGYVENPVYADPGSNTWFGMQVWSMQRVAELYYKTGDARAKKLLDKWAKWINGEIKF
NADGTFQIPSTIDWEGQPDTWNPTQGYTGNANLHVKVVNYGTDLGCASSLANTLTYYAAK
SGDETSRQNAQKLLDAMWNNYSDSKGISTVEQRGDYHRFLDQEVFVPAGWTGKMPNGDVI
KSGVKFIDIRSKYKQDPEWQTMVAALQAGQVPTQRLHRFWAQSEFAVANGVYAILFPDQG
PEKLLGDVNGDETVDAIDLAILKKYLLNSSTTINTANADMNSDNAIDAIDYALLKKALLS
IQ

# Drug_Target_84_Reaction:
Endohydrolysis of 1,4-beta-D-glucosidic linkages in cellulose, lichenin and cereal beta-D-glucans ALL_REAC (other) R02886 R06200(G)

# Drug_Target_84_Signals:
1-29

# Drug_Target_84_Specific_Function:
Probable endoglucanase involved in the degradation of cellulose or related beta-glucans

# Drug_Target_84_SwissProt_ID:
P37698

# Drug_Target_84_SwissProt_Name:
GUNF_CLOCE

# Drug_Target_84_Synonyms:
Cellulase F
EC 3.2.1.4
EGCCF
Endo-1,4-beta-glucanase F
Endoglucanase F precursor

# Drug_Target_84_Theoretical_pI:
5.19

# Drug_Target_84_Transmembrane_Regions:
None

# Drug_Target_85_Cellular_Location:
Periplasm

# Drug_Target_85_Chromosome_Location:
Not Available

# Drug_Target_85_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_85_Essentiality:
Non-Essential

# Drug_Target_85_GenAtlas_ID:
Not Available

# Drug_Target_85_GenBank_ID_Gene:
M97379

# Drug_Target_85_GenBank_ID_Protein:
155588

# Drug_Target_85_GeneCard_ID:
Not Available

# Drug_Target_85_Gene_Name:
gfo

# Drug_Target_85_Gene_Sequence:
>1320 bp
ATGACGAACAAAATCTCGTCTTCAGATAATCTTTCCAATGCTGTTTCAGCAACGGATGAC
AACGCTTCCCGTACGCCAAATCTGAACCGTCGCGCTCTCGTTGGTGGTGGTGTTGGACTG
GCCGCACGTGGCGCCTTAGCCAGTGGTCTTCAGGCAGCGACGCTTCCTGCTGGTGCCAGC
CTGGTTCCGACCACGCCTGCAGGTCGCCCGATGCCTTACGCGATCCGCCCGATGCCGGAA
GATCGTCGTTTCGGTTATGCTATCGTCGGTCTGGGTAAATATGCCCTTAACCAGATTTTA
CCGGGTTTTGCCGGATGCCAGCATTCCCGCATGAAGCTTTGGTCAGCGGTAACCGAAAAA
GCTAAAATCGTTGCCGCTGAATATGGCGTCGATCCCCGTAAAATTTATGATTACAGCAAC
TTCGACAAGATCGCTAAAGATCCAAAAATCGACGCTGTTTACATCATTTTGCCAAACTCT
TTGCATGCTGAATTTGCTATCCGTTCTTTCAAAGCCGGCAAGCATGTTATGTGTGAAAAG
CCGATGGCAACCTCTGTTGCTGATTGTCAGCGGATGATCGATGCAGCCAAGGCTGCTAAT
AAAAAGCTGATGATCGGTTACCGTTGCCACTATGATCCAATGAACCGTGCAGCGGTAAAA
TTGATCCGTGAAAACCAGTTGGGTAAACTGGGCATGGTTACCACCGACAACTCAGACGTT
ATGGATCAGAACGACCTGCACAGCAGTGGCGTCTGCGTCGTGAACTCCGGTGGCGGTTCT
TTGATGGATATCGGTATTTATGGCTTGAACGGTACCCGTTACTTGCTGGGTGAAGAACCG
ATCGAAGTCCGTGCTTACACCTACAGCGATCCGAATGATGAACGTTTCGTTGAAGTCGAA
GATCGTATTATTTGGCAGATGCGCTTCAGAAGCGGTGCTCTGTCTCATGGTGCATCTTCT
TATTCGACCACGACGACTTCACGTTTCTCGGTGCAGGGCGACAAAGCTGTTCTGTTGATG
GATCCGGCTACCGGATATTATCAGAATTTGATTTCTGTCCAGACCCCAGGCCATGCTAAC
CAGTCGATGATGCCACAGTTCATCATGCCAGCGAACAACCAGTTCTCTGCACAGTTGGAT
CATCTGGCTGAAGCCGTCATCAATAACAAACCAGTTCGTAGCCCGGGTGAAGAAGGTATG
CAGGATGTGCGCCTGATTCAGGCCATTTATGAAGCAGCTCGTACCGGTCGCGCCGTCAAC
ACGGATTGGGGTTATGTGCGTCAGGTGGTTATTGATTCTGACTTAACCTATTTGGGTTAA

# Drug_Target_85_General_Function:
Involved in oxidoreductase activity

# Drug_Target_85_General_References:
1537789	Kanagasundaram V, Scopes RK: Cloning, sequence analysis, and expression of the structural gene encoding glucose-fructose oxidoreductase from Zymomonas mobilis. J Bacteriol. 1992 Mar;174(5):1439-47.
8472911	Loos H, Sahm H, Sprenger GA: Glucose-fructose oxidoreductase, a periplasmic enzyme of Zymomonas mobilis, is active in its precursor form. FEMS Microbiol Lett. 1993 Mar 1;107(2-3):293-8.
8994968	Kingston RL, Scopes RK, Baker EN: The structure of glucose-fructose oxidoreductase from Zymomonas mobilis: an osmoprotective periplasmic enzyme containing non-dissociable NADP. Structure. 1996 Dec 15;4(12):1413-28.

# Drug_Target_85_HGNC_ID:
Not Available

# Drug_Target_85_HPRD_ID:
Not Available

# Drug_Target_85_ID:
2826

# Drug_Target_85_Locus:
Not Available

# Drug_Target_85_Molecular_Weight:
47190

# Drug_Target_85_Name:
Glucose--fructose oxidoreductase

# Drug_Target_85_Number_of_Residues:
433

# Drug_Target_85_PDB_ID:
1H6A

# Drug_Target_85_Pathway:
Not Available

# Drug_Target_85_Pfam_Domain_Function:
PF01408	GFO_IDH_MocA
PF02894	GFO_IDH_MocA_C

# Drug_Target_85_Protein_Sequence:
>Glucose--fructose oxidoreductase precursor
MTNKISSSDNLSNAVSATDDNASRTPNLTRRALVGGGVGLAAAGALASGLQAATLPAGAS
QVPTTPAGRPMPYAIRPMPEDRRFGYAIVGLGKYALNQILPGFAGCQHSRIEALVSGNAE
KAKIVAAEYGVDPRKIYDYSNFDKIAKDPKIDAVYIILPNSLHAEFAIRAFKAGKHVMCE
KPMATSVADCQRMIDAAKAANKKLMIGYRCHYDPMNRAAVKLIRENQLGKLGMVTTDNSD
VMDQNDPAQQWRLRRELAGGGSLMDIGIYGLNGTRYLLGEEPIEVRAYTYSDPNDERFVE
VEDRIIWQMRFRSGALSHGASSYSTTTTSRFSVQGDKAVLLMDPATGYYQNLISVQTPGH
ANQSMMPQFIMPANNQFSAQLDHLAEAVINNKPVRSPGEEGMQDVRLIQAIYEAARTGRP
VNTDWGYVRQGGY

# Drug_Target_85_Reaction:
D-glucose + D-fructose = D-gluconolactone + D-glucitol

# Drug_Target_85_Signals:
1-52

# Drug_Target_85_Specific_Function:
D-glucose + D-fructose = D-gluconolactone + D- glucitol

# Drug_Target_85_SwissProt_ID:
Q07982

# Drug_Target_85_SwissProt_Name:
GFO_ZYMMO

# Drug_Target_85_Synonyms:
EC 1.1.99.28
GFOR
Glucose--fructose oxidoreductase precursor

# Drug_Target_85_Theoretical_pI:
8.73

# Drug_Target_85_Transmembrane_Regions:
None

# Drug_Target_86_Cellular_Location:
Not Available

# Drug_Target_86_Chromosome_Location:
Not Available

# Drug_Target_86_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_86_Essentiality:
Non-Essential

# Drug_Target_86_GenAtlas_ID:
Not Available

# Drug_Target_86_GenBank_ID_Gene:
J02473

# Drug_Target_86_GenBank_ID_Protein:
Not Available

# Drug_Target_86_GeneCard_ID:
Not Available

# Drug_Target_86_Gene_Name:
9

# Drug_Target_86_Gene_Sequence:
Not Available

# Drug_Target_86_General_Function:
Not Available

# Drug_Target_86_General_References:
11053393	Vander Byl C, Kropinski AM: Sequence of the genome of Salmonella bacteriophage P22. J Bacteriol. 2000 Nov;182(22):6472-81.
12562822	Pedulla ML, Ford ME, Karthikeyan T, Houtz JM, Hendrix RW, Hatfull GF, Poteete AR, Gilcrease EB, Winn-Stapley DA, Casjens SR: Corrected sequence of the bacteriophage p22 genome. J Bacteriol. 2003 Feb;185(4):1475-7.
6295443	Sauer RT, Krovatin W, Poteete AR, Berget PB: Phage P22 tail protein: gene and amino acid sequence. Biochemistry. 1982 Nov 9;21(23):5811-5.
8023158	Steinbacher S, Seckler R, Miller S, Steipe B, Huber R, Reinemer P: Crystal structure of P22 tailspike protein: interdigitated subunits in a thermostable trimer. Science. 1994 Jul 15;265(5170):383-6.
8855221	Steinbacher S, Baxa U, Miller S, Weintraub A, Seckler R, Huber R: Crystal structure of phage P22 tailspike protein complexed with Salmonella sp. O-antigen receptors. Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):10584-8.
9135118	Steinbacher S, Miller S, Baxa U, Budisa N, Weintraub A, Seckler R, Huber R: Phage P22 tailspike protein: crystal structure of the head-binding domain at 2.3 A, fully refined structure of the endorhamnosidase at 1.56 A resolution, and the molecular basis of O-antigen recognition and cleavage. J Mol Biol. 1997 Apr 11;267(4):865-80.

# Drug_Target_86_HGNC_ID:
Not Available

# Drug_Target_86_HPRD_ID:
Not Available

# Drug_Target_86_ID:
2372

# Drug_Target_86_Locus:
Not Available

# Drug_Target_86_Molecular_Weight:
71858

# Drug_Target_86_Name:
Bifunctional tail protein

# Drug_Target_86_Number_of_Residues:
667

# Drug_Target_86_PDB_ID:
1TSP

# Drug_Target_86_Pathway:
Not Available

# Drug_Target_86_Pfam_Domain_Function:
PF09008	Head_binding
PF09251	PhageP22-tail

# Drug_Target_86_Protein_Sequence:
>Bifunctional tail protein
MTDITANVVVSNPRPIFTESRSFKAVANGKIYIGQIDTDPVNPANQIPVYIENEDGSHVQ
ITQPLIINAAGKIVYNGQLVKIVTVQGHSMAIYDANGSQVDYIANVLKYDPDQYSIEADK
KFKYSVKLSDYPTLQDAASAAVDGLLIDRDYNFYGGETVDFGGKVLTIECKAKFIGDGNL
IFTKLGKGSRIAGVFMESTTTPWVIKPWTDDNQWLTDAAAVVATLKQSKTDGYQPTVSDY
VKFPGIETLLPPNAKGQNITSTLEIRECIGVEVHRASGLMAGFLFRGCHFCKMVDANNPS
GGKDGIITFENLSGDWGKGNYVIGGRTSYGSVSSAQFLRNNGGFERDGGVIGFTSYRAGE
SGVKTWQGTVGSTTSRNYNLQFRDSVVIYPVWDGFDLGADTDMNPELDRPGDYPITQYPL
HQLPLNHLIDNLLVRGALGVGFGMDGKGMYVSNITVEDCAGSGAYLLTHESVFTNIAIID
TNTKDFQANQIYISGACRVNGLRLIGIRSTDGQGLTIDAPNSTVSGITGMVDPSRINVAN
LAEEGLGNIRANSFGYDSAAIKLRIHKLSKTLDSGALYSHINGGAGSGSAYTQLTAISGS
TPDAVSLKVNHKDCRGAEIPFVPDIASDDFIKDSSCFLPYWENNSTSLKALVKKPNGELV
RLTLATL

# Drug_Target_86_Reaction:
Not Available

# Drug_Target_86_Signals:
None

# Drug_Target_86_Specific_Function:
Non-covalently bound to the neck of the phage capsid and essential for phage adsorption to the bacterial host. It displays endorhamnosidase enzymatic activity, hydrolyzing the alpha-1,3-O- glycosidic linkage between rhamnose and galactose of the O-antigen polysaccharide

# Drug_Target_86_SwissProt_ID:
P12528

# Drug_Target_86_SwissProt_Name:
TSPE_BPP22

# Drug_Target_86_Synonyms:
EC 3.2.1.-
Endorhamnosidase
Late protein gp9
TSP

# Drug_Target_86_Theoretical_pI:
5.25

# Drug_Target_86_Transmembrane_Regions:
None

# Drug_Target_87_Cellular_Location:
Not Available

# Drug_Target_87_Chromosome_Location:
Not Available

# Drug_Target_87_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_87_Essentiality:
Non-Essential

# Drug_Target_87_GenAtlas_ID:
PYGL

# Drug_Target_87_GenBank_ID_Gene:
M14636

# Drug_Target_87_GenBank_ID_Protein:
183353

# Drug_Target_87_GeneCard_ID:
PYGL

# Drug_Target_87_Gene_Name:
PYGL

# Drug_Target_87_Gene_Sequence:
>2544 bp
ATGGGCGAACCGCTGACAGACCAGGAGAAGCGGCGGCAGATCAGCATCCGCGGCATCGTG
GGCGTGGAGAACGTGGCAGAGCTGAAGAAGAGTTTCAACCGGCACCTGCACTTCACGCTG
GTCAAGGACCGCAACGTGGCCACCACCCGCGACTACTACTTCGCGCTGGCGCACACGGTG
CGGGACCACCTGGTGGGGCGCTGGATCCGCACGCAGCAGCACTACTACGACAAGTGCCCC
AAGAGGGAATATTACCTCTCTCTGGAATTTTACATGGGCCGAACATTACAGAACACCATG
ATCAACCTCGGTCTGCAAAATGCCTGTGATGAGGCCATTTACCAGCTTGGATTGGATATA
GAAGAGTTAGAAGAAATTGAAGAAGATGCTGGACTTGGCAATGGTGGTCTTGGGAGACTT
GCTGCCTGCTTCTTGGATTCCATGGCAACCCTGGGACTTGCAGCCTATGGATACGGCATT
CGGTATGAATATGGGATTTTCAATCAGAAGATCCGAGATGGATGGCAGGTAGAAGAAGCA
GATGATTGGCTCAGATATGGAAACCCTTGGGAGAAGTCCCGCCCAGAATTCATGCTGCCT
GTGCACTTCTATGGAAAAGTAGAACACACCAACACCGGGACCAAGTGGATTGACACTCAA
GTGGTCCTGGCTCTGCCATATGACACCCCCGAGCCCGGCTACATGAATAACACTGTCAAC
ACCATGCGCCTCTGGTCTGCTCGGGCACCAAATGACTTTAACCTCAGAGACTTTAATGTT
GGAGACTACATTCAGGCTGTGCTGGACCGAAACCTGGCCGAGAACATCTCCCGGGTCCTC
TATCCCAATGACAATTTTTTTGAAGGGAAGGAGCTAAGATTGAAGCAGGAATACTTTGTG
GTGGCTGCAACCTTGCAAGATATCATCCGCCGTTTCAAAGCCTCCAAGTTTGGCTCCACC
CGTGGTCAAGGAACTGTGTTTGATGCCTTCCCGGATCAGGTGGCCATCCAGCTGAATGAT
ACTCACCCTCGCATCGCGATCCCTGAGCTGATGAGGATTTTTGTGGATATTGAAAAACTG
CCCTGGTCCAAGGCATGGGAGCTCAACCAGAAGACCTTCGCCTACACCAACCACACAGTG
CTCCCGGAAGCCCTGGAGCGCTGGCCCGTGGACCTGGTGGAGAAGCTGCTCCCTCGACAT
TTGGAAATCATTTATGAGATAAATCAGAAGCATTTAGATAGAATTGTGGCCTTGTTTCCT
AAAGATGTGGACCCTCTGAGAAGGATGTCTCTGATAGAAGAGGAAGGAAGCAAAAGGATC
AACATGGCCCATCTCTGCATTGTCGGTTCCCATGCTGTGAATGGCGTGGCTAAAATCCAC
TCAGACATCGTGAAGACTAAAGTATTCAAGGACTTCAGTGAGCTAGAACCTGACAAGTTT
CAGAATAAAACCAATGGGATCACTCCAAGGCGCTGGCTCCTACTCTGCAACCCAGGACTT
GCAGAGCTCATAGCAGAGAAAATTGGAGAAGACTATGTGAAAGACCTGAGCCAGCTGACG
AAGCTCCACAGCTTCCTGGGTGATGATGTCTTCCTCCGGGAACTCGCCAAGGTGAAGCAG
GAGAATAAGCTGAAGTTTTCTCAGTTCCTGGAGACGGAGTACAAAGTGAAGATCAACCCA
TCCTCCATGTTTGATGTCCAGGTGAAGAGGATACATGAGTACAAGCGACAGCTCTTGAAC
TGTCTGCATGTGATCACGATGTACAACCGCATTAAGAAAGACCCTAAGAAGTTATTCGTG
CCAAGGACAGTTATCATTGGTGGTAAAGCTGCCCCAGGATATCACATGGCCAAAATGATC
ATAAAGCTGATCACTTCAGTGGCAGATGTGGTGAACAATGACCCTATGGTTGGAAGCAAG
TTGAAAGTCATCTTCTTGGAGAACTACAGAGTATCTCTTGCTGAAAAAGTCATTCCAGCC
ACAGATCTGTCAGAGCAGATTTCCACTGCAGGCACCGAAGCCTCGGGGACAGGCAATATG
AAGTTCATGCTAAATGGGGCCCTAACTATCGGGACCATGGATGGGGCCAATGTGGAAATG
GCAGAAGAAGCTGGGGAAGAGAACCTGTTCATCTTTGGCATGAGCATAGATGATGTGGCT
GCTTTGGACAAGAAAGGGTACGAGGCAAAAGAATACTATGAGGCACTTCCAGAGCTGAAG
CTGGTCATTGATCAAATTGACAATGGCTTTTTTTCTCCCAAGCAGCCTGACCTCTTCAAA
GATATCATCAACATGCTATTTTATCATGACAGGTTTAAAGTCTTTGCAGACTACGAAGCC
TATGTCAAGTGTCAAGATAAAGTGAGTCAGCTGTACATGAATCCAAAGGCCTGGAACACA
ATGGTACTCAAAAACATAGCTGCCTCGGGGAAATTCTCCAGTGACCGAACAATTAAAGAA
TATGCCCAAAACATCTGGAACGTGGAACCTTCAGATCTAAAGATTTCTCTATCCAATGAA
TCTAACAAAGTCAATGGAAATTGA

# Drug_Target_87_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_87_General_References:
10949035	Rath VL, Ammirati M, LeMotte PK, Fennell KF, Mansour MN, Danley DE, Hynes TR, Schulte GK, Wasilko DJ, Pandit J: Activation of human liver glycogen phosphorylase by alteration of the secondary structure and packing of the catalytic core. Mol Cell. 2000 Jul;6(1):139-48.
10980448	Rath VL, Ammirati M, Danley DE, Ekstrom JL, Gibbs EM, Hynes TR, Mathiowetz AM, McPherson RK, Olson TV, Treadway JL, Hoover DJ: Human liver glycogen phosphorylase inhibitors bind at a new allosteric site. Chem Biol. 2000 Sep;7(9):677-82.
12204691	Ekstrom JL, Pauly TA, Carty MD, Soeller WC, Culp J, Danley DE, Hoover DJ, Treadway JL, Gibbs EM, Fletterick RJ, Day YS, Myszka DG, Rath VL: Structure-activity analysis of the purine binding site of human liver glycogen phosphorylase. Chem Biol. 2002 Aug;9(8):915-24.
2877458	Newgard CB, Nakano K, Hwang PK, Fletterick RJ: Sequence analysis of the cDNA encoding human liver glycogen phosphorylase reveals tissue-specific codon usage. Proc Natl Acad Sci U S A. 1986 Nov;83(21):8132-6.
3509980	Gorin FA, Mullinax RL, Ignacio PC, Neve RL, Kurnit DM: McArdle's & Hers' diseases: glycogen phosphorylase transcriptional expression in human tissues. J Neurogenet. 1987 Dec;4(6):293-308.
9529348	Burwinkel B, Bakker HD, Herschkovitz E, Moses SW, Shin YS, Kilimann MW: Mutations in the liver glycogen phosphorylase gene (PYGL) underlying glycogenosis type VI. Am J Hum Genet. 1998 Apr;62(4):785-91.
9536091	Chang S, Rosenberg MJ, Morton H, Francomano CA, Biesecker LG: Identification of a mutation in liver glycogen phosphorylase in glycogen storage disease type VI. Hum Mol Genet. 1998 May;7(5):865-70.

# Drug_Target_87_HGNC_ID:
HGNC:9725

# Drug_Target_87_HPRD_ID:
01987

# Drug_Target_87_ID:
10

# Drug_Target_87_Locus:
14q21-q22

# Drug_Target_87_Molecular_Weight:
97019

# Drug_Target_87_Name:
Glycogen phosphorylase, liver form

# Drug_Target_87_Number_of_Residues:
846

# Drug_Target_87_PDB_ID:
1L7X

# Drug_Target_87_Pathway:
Not Available

# Drug_Target_87_Pfam_Domain_Function:
PF00343	Phosphorylase

# Drug_Target_87_Protein_Sequence:
>Glycogen phosphorylase, liver form
AKPLTDQEKRRQISIRGIVGVENVAELKKSFNRHLHFTLVKDRNVATTRDYYFALAHTVR
DHLVGRWIRTQQHYYDKCPKRVYYLSLEFYMGRTLQNTMINLGLQNACDEAIYQLGLDIE
ELEEIEEDAGLGNGGLGRLAACFLDSMATLGLAAYGYGIRYEYGIFNQKIRDGWQVEEAD
DWLRYGNPWEKSRPEFMLPVHFYGKVEHTNTGTKWIDTQVVLALPYDTPVPGYMNNTVNT
MRLWSARAPNDFNLRDFNVGDYIQAVLDRNLAENISRVLYPNDNFFEGKELRLKQEYFVV
AATLQDIIRRFKASKFGSTRGAGTVFDAFPDQVAIQLNDTHPALAIPELMRIFVDIEKLP
WSKAWELTQKTFAYTNHTVLPEALERWPVDLVEKLLPRHLEIIYEINQKHLDRIVALFPK
DVDRLRRMSLIEEEGSKRINMAHLCIVGSHAVNGVAKIHSDIVKTKVFKDFSELEPDKFQ
NKTNGITPRRWLLLCNPGLAELIAEKIGEDYVKDLSQLTKLHSFLGDDVFLRELAKVKQE
NKLKFSQFLETEYKVKINPSSMFDVQVKRIHEYKRQLLNCLHVITMYNRIKKDPKKLFVP
RTVIIGGKAAPGYHMAKMIIKLITSVADVVNNDPMVGSKLKVIFLENYRVSLAEKVIPAT
DLSEQISTAGTEASGTGNMKFMLNGALTIGTMDGANVEMAEEAGEENLFIFGMRIDDVAA
LDKKGYEAKEYYEALPELKLVIDQIDNGFFSPKQPDLFKDIINMLFYHDRFKVFADYEAY
VKCQDKVSQLYMNPKAWNTMVLKNIAASGKFSSDRTIKEYAQNIWNVEPSDLKISLSNES
NKVNGN

# Drug_Target_87_Reaction:
(1,4-alpha-D-glucosyl)n + phosphate = (1,4-alpha-D-glucosyl)n-1 + alpha-D-glucose 1-phosphate

# Drug_Target_87_Signals:
None

# Drug_Target_87_Specific_Function:
Phosphorylase is an important allosteric enzyme in carbohydrate metabolism. Enzymes from different sources differ in their regulatory mechanisms and in their natural substrates. However, all known phosphorylases share catalytic and structural properties

# Drug_Target_87_SwissProt_ID:
P06737

# Drug_Target_87_SwissProt_Name:
PYGL_HUMAN

# Drug_Target_87_Synonyms:
EC 2.4.1.1

# Drug_Target_87_Theoretical_pI:
7.17

# Drug_Target_87_Transmembrane_Regions:
None

# Drug_Target_88_Cellular_Location:
Secreted protein
extracellular space

# Drug_Target_88_Chromosome_Location:
Not Available

# Drug_Target_88_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_88_Essentiality:
Non-Essential

# Drug_Target_88_GenAtlas_ID:
SFTPD

# Drug_Target_88_GenBank_ID_Gene:
X65018

# Drug_Target_88_GenBank_ID_Protein:
34767

# Drug_Target_88_GeneCard_ID:
SFTPD

# Drug_Target_88_Gene_Name:
SFTPD

# Drug_Target_88_Gene_Sequence:
>1128 bp
ATGCTGCTCTTCCTCCTCTCTGCACTGGTCCTACTCACACAGCCCCTGGGCTACCTGGAA
GCAGAAATGAAGACCTACTCCCACAGAACAACGCCCAGTGCTTGCACCCTGGTCATGTGT
AGCTCAGTGGAGAGTGGCCTGCCTGGTCGCGATGGACGGGATGGGAGAGAGGGCCCTCGG
GGCGAGAAGGGGGACCCAGGTTTGCCAGGAGCTGCAGGGCAAGCAGGGATGCCTGGACAA
GCTGGCCCAGTTGGGCCCAAAGGGGACAATGGCTCTGTTGGAGAACCTGGACCAAAGGGA
GACACTGGGCCAAGTGGACCTCCAGGACCTCCCGGTGTGCCTGGTCCAGCTGGAAGAGAA
GGTCCCCTGGGGAAGCAGGGGAACATAGGACCTCAGGGCAAGCCAGGCCCAAAAGGAGAA
GCTGGGCCCAAAGGAGAAGTAGGTGCCCCAGGCATGCAGGGCTCGGCAGGGGCAAGAGGC
CTCGCAGGCCCTAAGGGAGAGCGAGGTGTCCCTGGTGAGCGTGGAGTCCCTGGAAACGCA
GGGGCAGCAGGGTCTGCTGGAGCCATGGGTCCCCAGGGAAGTCCAGGTGCCAGGGGACCC
CCGGGATTGAAGGGGGACAAAGGCATTCCTGGAGACAAAGGAGCAAAGGGAGAAAGTGGG
CTTCCAGATGTTGCTTCTCTGAGGCAGCAGGTTGAGGCCTTACAGGGACAAGTACAGCAC
CTCCAGGCTGCTTTCTCTCAGTATAAGAAAGTTGAGCTCTTCCCAAATGGCCAAAGTGTC
GGGGAGAAGATTTTCAAGACAGCAGGCTTTGTAAAACCATTTACGGAGGCACAGCTGCTG
TGCACACAGGCTGGTGGACAGTTGGCCTCTCCACGCTCTGCCGCTGAGAATGCCGCCTTG
CAACAGCTGGTCGTAGCTAAGAACGAGGCTGCTTTCCTGAGCATGACTGATTCCAAGACA
GAGGGCAAGTTCACCTACCCCACAGGAGAGTCCCTGGTCTATTCCAACTGGGCCCCAGGG
GAGCCCAACGATGATGGCGGGTCAGAGGACTGTGTGGAGATCTTCACCAATGGCAAGTGG
AATGACAGGGCTTGTGGAGAAAAGCGTCTTGTGGTCTGCGAGTTCTGA

# Drug_Target_88_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_88_General_References:
10368295	Hakansson K, Lim NK, Hoppe HJ, Reid KB: Crystal structure of the trimeric alpha-helical coiled-coil and the three lectin domains of human lung surfactant protein D. Structure. 1999 Mar 15;7(3):255-64.
1339284	Lu J, Willis AC, Reid KB: Purification, characterization and cDNA cloning of human lung surfactant protein D. Biochem J. 1992 Jun 15;284 ( Pt 3):795-802.
1898081	Rust K, Grosso L, Zhang V, Chang D, Persson A, Longmore W, Cai GZ, Crouch E: Human surfactant protein D: SP-D contains a C-type lectin carbohydrate recognition domain. Arch Biochem Biophys. 1991 Oct;290(1):116-26.
8428971	Crouch E, Rust K, Veile R, Donis-Keller H, Grosso L: Genomic organization of human surfactant protein D (SP-D). SP-D is encoded on chromosome 10q22.2-23.1. J Biol Chem. 1993 Feb 5;268(4):2976-83.

# Drug_Target_88_HGNC_ID:
HGNC:10803

# Drug_Target_88_HPRD_ID:
01522

# Drug_Target_88_ID:
1875

# Drug_Target_88_Locus:
10q22.2-q23.1

# Drug_Target_88_Molecular_Weight:
37699

# Drug_Target_88_Name:
Pulmonary surfactant-associated protein D

# Drug_Target_88_Number_of_Residues:
375

# Drug_Target_88_PDB_ID:
1PWB

# Drug_Target_88_Pathway:
Not Available

# Drug_Target_88_Pfam_Domain_Function:
PF00059	Lectin_C
PF01391	Collagen
PF09006	Surfac_D-trimer

# Drug_Target_88_Protein_Sequence:
>Pulmonary surfactant-associated protein D precursor
MLLFLLSALVLLTQPLGYLEAEMKTYSHRTMPSACTLVMCSSVESGLPGRDGRDGREGPR
GEKGDPGLPGAAGQAGMPGQAGPVGPKGDNGSVGEPGPKGDTGPSGPPGPPGVPGPAGRE
GPLGKQGNIGPQGKPGPKGEAGPKGEVGAPGMQGSAGARGLAGPKGERGVPGERGVPGNA
GAAGSAGAMGPQGSPGARGPPGLKGDKGIPGDKGAKGESGLPDVASLRQQVEALQGQVQH
LQAAFSQYKKVELFPNGQSVGEKIFKTAGFVKPFTEAQLLCTQAGGQLASPRSAAENAAL
QQLVVAKNEAAFLSMTDSKTEGKFTYPTGESLVYSNWAPGEPNDDGGSEDCVEIFTNGKW
NDRACGEKRLVVCEF

# Drug_Target_88_Reaction:
Not Available

# Drug_Target_88_Signals:
1-20

# Drug_Target_88_Specific_Function:
Contributes to the lung's defense against inhaled microorganisms. May participate in the extracellular reorganization or turnover of pulmonary surfactant. Binds strongly maltose residues and to a lesser extent other alpha-glucosyl moieties

# Drug_Target_88_SwissProt_ID:
P35247

# Drug_Target_88_SwissProt_Name:
SFTPD_HUMAN

# Drug_Target_88_Synonyms:
Lung surfactant protein D
PSP-D
Pulmonary surfactant-associated protein D precursor
SP-D

# Drug_Target_88_Theoretical_pI:
6.54

# Drug_Target_88_Transmembrane_Regions:
None

# Drug_Target_89_Cellular_Location:
Secreted protein

# Drug_Target_89_Chromosome_Location:
Not Available

# Drug_Target_89_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_89_Essentiality:
Non-Essential

# Drug_Target_89_GenAtlas_ID:
IFNB1

# Drug_Target_89_GenBank_ID_Gene:
V00534

# Drug_Target_89_GenBank_ID_Protein:
32638

# Drug_Target_89_GeneCard_ID:
IFNB1

# Drug_Target_89_Gene_Name:
IFNB1

# Drug_Target_89_Gene_Sequence:
>564 bp
ATGACCAACAAGTGTCTCCTCCAAATTGCTCTCCTGTTGTGCTTCTCCACTACAGCTCTT
TCCATGAGCTACAACTTGCTTGGATTCCTACAAAGAAGCAGCAATTTTCAGTGTCAGAAG
CTCCTGTGGCAATTGAATGGGAGGCTTGAATACTGCCTCAAGGACAGGATGAACTTTGAC
ATCCCTGAGGAGATTAAGCAGCTGCAGCAGTTCCAGAAGGAGGACGCCGCATTGACCATC
TATGAGATGCTCCAGAACATCTTTGCTATTTTCAGACAAGATTCATCTAGCACTGGCTGG
AATGAGACTATTGTTGAGAACCTCCTGGCTAATGTCTATCATCAGATAAACCATCTGAAG
ACAGTCCTGGAAGAAAAACTGGAGAAAGAAGATTTCACCAGGGGAAAACTCATGAGCAGT
CTGCACCTGAAAAGATATTATGGGAGGATTCTGCATTACCTGAAGGCCAAGGAGTACAGT
CACTGTGCCTGGACCATAGTCAGAGTGGAAATCCTAAGGAACTTTTACTTCATTAACAGA
CTTACAGGTTACCTCCGAAACTGA

# Drug_Target_89_General_Function:
Involved in hematopoietin/interferon-class (D200-domain) cytokine receptor binding

# Drug_Target_89_General_References:
2414376	May LT, Sehgal PB: On the relationship between human interferon alpha 1 and beta 1 genes. J Interferon Res. 1985 Summer;5(3):521-6.
6157094	Derynck R, Content J, DeClercq E, Volckaert G, Tavernier J, Devos R, Fiers W: Isolation and structure of a human fibroblast interferon gene. Nature. 1980 Jun 19;285(5766):542-7.
6157601	Taniguchi T, Ohno S, Fujii-Kuriyama Y, Muramatsu M: The nucleotide sequence of human fibroblast interferon cDNA. Gene. 1980 Jun;10(1):11-5.
6159580	Houghton M, Easton MA, Stewart AG, Smith JC, Doel SM, Catlin GH, Lewis HM, Patel TP, Emtage JS, Carey NH, Porter AG: The complete amino acid sequence of human fibroblast interferon as deduced using synthetic oligodeoxyribonucleotide primers of reverse transcriptase. Nucleic Acids Res. 1980 Jul 11;8(13):2885-94.
6159584	Goeddel DV, Shepard HM, Yelverton E, Leung D, Crea R, Sloma A, Pestka S: Synthesis of human fibroblast interferon by E. coli. Nucleic Acids Res. 1980 Sep 25;8(18):4057-74.
6159597	Houghton M, Stewart AG, Doel SM, Emtage JS, Eaton MA, Smith JC, Patel TP, Lewis HM, Porter AG, Birch JR, Cartwright T, Carey NH: The amino-terminal sequence of human fibroblast interferon as deduced from reverse transcripts obtained using synthetic oligonucleotide primers. Nucleic Acids Res. 1980 May 10;8(9):1913-31.
6162107	Wetzel R: Assignment of the disulphide bonds of leukocyte interferon. Nature. 1981 Feb 12;289(5798):606-7.
6164984	Lawn RM, Adelman J, Franke AE, Houck CM, Gross M, Najarian R, Goeddel DV: Human fibroblast interferon gene lacks introns. Nucleic Acids Res. 1981 Mar 11;9(5):1045-52.
6171735	Shepard HM, Leung D, Stebbing N, Goeddel DV: A single amino acid change in IFN-beta1 abolishes its antiviral activity. Nature. 1981 Dec 10;294(5841):563-5.
9342320	Karpusas M, Nolte M, Benton CB, Meier W, Lipscomb WN, Goelz S: The crystal structure of human interferon beta at 2.2-A resolution. Proc Natl Acad Sci U S A. 1997 Oct 28;94(22):11813-8.

# Drug_Target_89_HGNC_ID:
HGNC:5434

# Drug_Target_89_HPRD_ID:
00972

# Drug_Target_89_ID:
1184

# Drug_Target_89_Locus:
9p21

# Drug_Target_89_Molecular_Weight:
22294

# Drug_Target_89_Name:
Interferon beta

# Drug_Target_89_Number_of_Residues:
187

# Drug_Target_89_PDB_ID:
1AU1

# Drug_Target_89_Pathway:
Not Available

# Drug_Target_89_Pfam_Domain_Function:
PF00143	Interferon

# Drug_Target_89_Protein_Sequence:
>Interferon beta precursor
MTNKCLLQIALLLCFSTTALSMSYNLLGFLQRSSNFQCQKLLWQLNGRLEYCLKDRMNFD
IPEEIKQLQQFQKEDAALTIYEMLQNIFAIFRQDSSSTGWNETIVENLLANVYHQINHLK
TVLEEKLEKEDFTRGKLMSSLHLKRYYGRILHYLKAKEYSHCAWTIVRVEILRNFYFINR
LTGYLRN

# Drug_Target_89_Reaction:
Not Available

# Drug_Target_89_Signals:
1-21

# Drug_Target_89_Specific_Function:
Has antiviral, antibacterial and anticancer activities

# Drug_Target_89_SwissProt_ID:
P01574

# Drug_Target_89_SwissProt_Name:
IFNB_HUMAN

# Drug_Target_89_Synonyms:
Fibroblast interferon
IFN-beta
Interferon beta precursor

# Drug_Target_89_Theoretical_pI:
8.91

# Drug_Target_89_Transmembrane_Regions:
None

# Drug_Target_8_Cellular_Location:
Cytoplasmic

# Drug_Target_8_Chromosome_Location:
Not Available

# Drug_Target_8_Drug_References:
Not Available

# Drug_Target_8_Essentiality:
Non-Essential

# Drug_Target_8_GenAtlas_ID:
Not Available

# Drug_Target_8_GenBank_ID_Gene:
AB008763

# Drug_Target_8_GenBank_ID_Protein:
Not Available

# Drug_Target_8_GeneCard_ID:
Not Available

# Drug_Target_8_Gene_Name:
Not Available

# Drug_Target_8_Gene_Sequence:
>1551 bp
ATGAAACTTCATAACCGTATAATTAGCGTACTATTAACACTATTGTTAGCTGTAGCTGTT
TTGTTTCCATATATGACGGAACCAGCACAAGCCCATCATAATGGGACGAATGGGACCATG
ATGCAGTATTTTGAATGGCATTTGCCAAATGACGGGAACCACTGGAACAGGTTACGAGAT
GACGCAGCTAACTTAAAGAGTAAAGGGATTACCGCTGTTTGGATTCCTCCTGCATGGAAG
GGGACTTCGCAAAATGATGTTGGGTATGGTGCCTATGATTTGTACGATCTTGGTGAGTTT
AACCAAAAGGGAACCGTCCGTACAAAATATGGCACAAGGAGTCAGTTGCAAGGTGCCGTG
ACATCTTTGAAAAATAACGGGATTCAAGTTTATGGGGATGTCGTGATGAATCATAAAGGT
GGAGCAGACGGGACAGAGATGGTAAATGCGGTGGAAGTGAACCGAAGCAACCGAAACCAA
GAAATATCAGGTGAATACACCATTGAAGCATGGACGAAATTTGATTTCCCTGGAAGAGGA
AATACCCATTCCAACTTTAAATGGCGCTGGTATCATTTTGATGGGACAGATTGGGATCAG
TCACGTCAGCTTCAGAACAAAATATATAAATTCAGAGGTACCGGAAAGGCATGGGACTGG
GAAGTAGATATAGAGAACGGCAACTATGATTACCTTATGTATGCAGACATTGATATGGAT
CATCCAGAAGTAATCAATGAACTTAGAAATTGGGGAGTTTGGTATACAAATACACTTAAT
CTAGATGGATTTAGAATCGATGCTGTGAAACATATTAAATACAGCTATACGAGAGATTGG
CTAACACATGTGCGTAACACCACAGGTAAACCAATGTTTGCAGTTGCAGAATTTTGGAAA
AATGACCTTGCTGCAATCGAAAACTATTTAAATAAAACAAGTTGGAATCACTCCGTGTTC
GATGTTCCTCTTCATTATAATTTGTACAATGCATCTAATAGTGGTGGCTATTTTGATATG
AGAAATATTTTAAATGGTTCTGTCGTACAAAAACACCCTATACATGCAGTCACATTTGTT
GATAACCATGACTCTCAGCCAGGAGAAGCATTGGAATCCTTTGTTCAATCGTGGTTCAAA
CCACTGGCATATGCATTGATTCTGACAAGGGAGCAAGGTTACCCTTCCGTATTTTACGGT
GATTACTACGGTATACCAACTCATGGTGTTCCTTCGATGAAATCTAAAATTGATCCACTT
CTGCAGGCACGTCAAACGTATGCCTACGGAACCCAACATGATTATTTTGATCATCATGAT
ATTATCGGCTGGACGAGAGAAGGGGACAGCTCCCACCCAAATTCAGGACTTGCAACTATT
ATGTCCGATGGGCCAGGGGGTAATAAATGGATGTATGTCGGGAAACATAAAGCTGGCCAA
GTATGGAGAGATATCACCGGAAATAGGTCTGGTACCGTCACCATTAATGCAGATGGTTGG
GGGAATTTCACTGTAAACGGAGGGGCAGTTTCGGTTTGGGTGAAGCAATAA

# Drug_Target_8_General_Function:
Involved in hydrolase activity, hydrolyzing O-glycosyl compounds

# Drug_Target_8_General_References:
9675143	Igarashi K, Hatada Y, Ikawa K, Araki H, Ozawa T, Kobayashi T, Ozaki K, Ito S: Improved thermostability of a Bacillus alpha-amylase by deletion of an arginine-glycine residue is caused by enhanced calcium binding. Biochem Biophys Res Commun. 1998 Jul 20;248(2):372-7.

# Drug_Target_8_HGNC_ID:
Not Available

# Drug_Target_8_HPRD_ID:
Not Available

# Drug_Target_8_ID:
4622

# Drug_Target_8_Locus:
Not Available

# Drug_Target_8_Molecular_Weight:
58842

# Drug_Target_8_Name:
Amylase

# Drug_Target_8_Number_of_Residues:
516

# Drug_Target_8_PDB_ID:
Not Available

# Drug_Target_8_Pathway:
Not Available

# Drug_Target_8_Pfam_Domain_Function:
PF00128	Alpha-amylase

# Drug_Target_8_Protein_Sequence:
>Amylase
MKLHNRIISVLLTLLLAVAVLFPYMTEPAQAHHNGTNGTMMQYFEWHLPNDGNHWNRLRD
DAANLKSKGITAVWIPPAWKGTSQNDVGYGAYDLYDLGEFNQKGTVRTKYGTRSQLQGAV
TSLKNNGIQVYGDVVMNHKGGADGTEMVNAVEVNRSNRNQEISGEYTIEAWTKFDFPGRG
NTHSNFKWRWYHFDGTDWDQSRQLQNKIYKFRGTGKAWDWEVDIENGNYDYLMYADIDMD
HPEVINELRNWGVWYTNTLNLDGFRIDAVKHIKYSYTRDWLTHVRNTTGKPMFAVAEFWK
NDLAAIENYLNKTSWNHSVFDVPLHYNLYNASNSGGYFDMRNILNGSVVQKHPIHAVTFV
DNHDSQPGEALESFVQSWFKPLAYALILTREQGYPSVFYGDYYGIPTHGVPSMKSKIDPL
LQARQTYAYGTQHDYFDHHDIIGWTREGDSSHPNSGLATIMSDGPGGNKWMYVGKHKAGQ
VWRDITGNRSGTVTINADGWGNFTVNGGAVSVWVKQ

# Drug_Target_8_Reaction:
Not Available

# Drug_Target_8_Signals:
None

# Drug_Target_8_Specific_Function:
Not Available

# Drug_Target_8_SwissProt_ID:
O82839

# Drug_Target_8_SwissProt_Name:
O82839_BACSP

# Drug_Target_8_Synonyms:
Not Available

# Drug_Target_8_Theoretical_pI:
6.93

# Drug_Target_8_Transmembrane_Regions:
None

# Drug_Target_90_Cellular_Location:
Periplasm

# Drug_Target_90_Chromosome_Location:
Not Available

# Drug_Target_90_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_90_Essentiality:
Non-Essential

# Drug_Target_90_GenAtlas_ID:
Not Available

# Drug_Target_90_GenBank_ID_Gene:
V00303

# Drug_Target_90_GenBank_ID_Protein:
Not Available

# Drug_Target_90_GeneCard_ID:
Not Available

# Drug_Target_90_Gene_Name:
malE

# Drug_Target_90_Gene_Sequence:
Not Available

# Drug_Target_90_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_90_General_References:
1420181	Sharff AJ, Rodseth LE, Spurlino JC, Quiocho FA: Crystallographic evidence of a large ligand-induced hinge-twist motion between the two domains of the maltodextrin binding protein involved in active transport and chemotaxis. Biochemistry. 1992 Nov 10;31(44):10657-63.
2002054	Spurlino JC, Lu GY, Quiocho FA: The 2.3-A resolution structure of the maltose- or maltodextrin-binding protein, a primary receptor of bacterial active transport and chemotaxis. J Biol Chem. 1991 Mar 15;266(8):5202-19.
6088507	Duplay P, Bedouelle H, Fowler A, Zabin I, Saurin W, Hofnung M: Sequences of the malE gene and of its product, the maltose-binding protein of Escherichia coli K12. J Biol Chem. 1984 Aug 25;259(16):10606-13.
6088520	Froshauer S, Beckwith J: The nucleotide sequence of the gene for malF protein, an inner membrane component of the maltose transport system of Escherichia coli. Repeated DNA sequences are found in the malE-malF intercistronic region. J Biol Chem. 1984 Sep 10;259(17):10896-903.
6185687	Bedouelle H, Schmeissner U, Hofnung M, Rosenberg M: Promoters of the malEFG and malK-lamB operons in Escherichia coli K12. J Mol Biol. 1982 Nov 15;161(4):519-31.
6283312	Bedouelle H, Hofnung M: A DNA sequence containing the control regions of the malEFG and malK-lamB operons in Escherichia coli K12. Mol Gen Genet. 1982;185(1):82-7.
8265357	Blattner FR, Burland V, Plunkett G 3rd, Sofia HJ, Daniels DL: Analysis of the Escherichia coli genome. IV. DNA sequence of the region from 89.2 to 92.8 minutes. Nucleic Acids Res. 1993 Nov 25;21(23):5408-17.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9298646	Link AJ, Robison K, Church GM: Comparing the predicted and observed properties of proteins encoded in the genome of Escherichia coli K-12. Electrophoresis. 1997 Aug;18(8):1259-313.
9309217	Quiocho FA, Spurlino JC, Rodseth LE: Extensive features of tight oligosaccharide binding revealed in high-resolution structures of the maltodextrin transport/chemosensory receptor. Structure. 1997 Aug 15;5(8):997-1015.
9600841	Wilkins MR, Gasteiger E, Tonella L, Ou K, Tyler M, Sanchez JC, Gooley AA, Walsh BJ, Bairoch A, Appel RD, Williams KL, Hochstrasser DF: Protein identification with N and C-terminal sequence tags in proteome projects. J Mol Biol. 1998 May 8;278(3):599-608.

# Drug_Target_90_HGNC_ID:
Not Available

# Drug_Target_90_HPRD_ID:
Not Available

# Drug_Target_90_ID:
3668

# Drug_Target_90_Locus:
Not Available

# Drug_Target_90_Molecular_Weight:
43388

# Drug_Target_90_Name:
Maltose-binding periplasmic protein precursor

# Drug_Target_90_Number_of_Residues:
396

# Drug_Target_90_PDB_ID:
1LLS

# Drug_Target_90_Pathway:
Not Available

# Drug_Target_90_Pfam_Domain_Function:
PF01547	SBP_bac_1

# Drug_Target_90_Protein_Sequence:
>Maltose-binding periplasmic protein precursor
MKIKTGARILALSALTTMMFSASALAKIEEGKLVIWINGDKGYNGLAEVGKKFEKDTGIK
VTVEHPDKLEEKFPQVAATGDGPDIIFWAHDRFGGYAQSGLLAEITPDKAFQDKLYPFTW
DAVRYNGKLIAYPIAVEALSLIYNKDLLPNPPKTWEEIPALDKELKAKGKSALMFNLQEP
YFTWPLIAADGGYAFKYENGKYDIKDVGVDNAGAKAGLTFLVDLIKNKHMNADTDYSIAE
AAFNKGETAMTINGPWAWSNIDTSKVNYGVTVLPTFKGQPSKPFVGVLSAGINAASPNKE
LAKEFLENYLLTDEGLEAVNKDKPLGAVALKSYEEELAKDPRIAATMENAQKGEIMPNIP
QMSAFWYAVRTAVINAASGRQTVDEALKDAQTRITK

# Drug_Target_90_Reaction:
Not Available

# Drug_Target_90_Signals:
1-26

# Drug_Target_90_Specific_Function:
Involved in the high-affinity maltose membrane transport system malEFGK. Initial receptor for the active transport of and chemotaxis toward maltooligosaccharides

# Drug_Target_90_SwissProt_ID:
P0AEX9

# Drug_Target_90_SwissProt_Name:
MALE_ECOLI

# Drug_Target_90_Synonyms:
MMBP
Maltodextrin-binding protein

# Drug_Target_90_Theoretical_pI:
5.37

# Drug_Target_90_Transmembrane_Regions:
None

# Drug_Target_91_Cellular_Location:
Cell inner membrane
peripheral membrane protein

# Drug_Target_91_Chromosome_Location:
Not Available

# Drug_Target_91_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_91_Essentiality:
Non-Essential

# Drug_Target_91_GenAtlas_ID:
Not Available

# Drug_Target_91_GenBank_ID_Gene:
X78733

# Drug_Target_91_GenBank_ID_Protein:
587106

# Drug_Target_91_GeneCard_ID:
Not Available

# Drug_Target_91_Gene_Name:
fabI

# Drug_Target_91_Gene_Sequence:
>789 bp
ATGGGTTTTCTTTCCGGTAAGCGCATTCTGGTAACCGGTGTTGCCAGCAAACTATCCATC
GCCTACGGTATCGCTCAGGCGATGCACCGCGAAGGAGCTGAACTGGCATTCACCTACCAG
AACGACAAACTGAAAGGCCGCGTAGAAGAATTTGCCGCTCAATTGGGTTCTGACATCGTT
CTGCAGTGCGATGTTGCAGAAGATGCCAGCATCGACACCATGTTCGCTGAACTGGGGAAA
GTTTGGCCGAAATTTGACGGTTTCGTACACTCTATTGGTTTTGCACCTGGCGATCAGCTG
GATGGTGACTATGTTAACGCCGTTACCCGTGAAGGCTTCAAAATTGCCCACGACATCAGC
TCCTACAGCTTCGTTGCAATGGCAAAAGCTTGCCGCTCCATGCTGAATCCGGGTTCTGCC
CTGCTGACCCTTTCCTACCTTGGCGCTGAGCGCGCTATCCCGAACTACAACGTTATGGGT
CTGGCAAAAGCGTCTCTGGAAGCGAACGTGCGCTATATGGCGAACGCGATGGGTCCGGAA
GGTGTGCGTGTTAACGCCATCTCTGCTGGTCCGATCCGTACTCTGGCGGCCTCCGGTATC
AAAGACTTCCGCAAAATGCTGGCTCATTGCGAAGCCGTTACCCCGATTCGCCGTACCGTT
ACTATTGAAGATGTGGGTAACTCTGCGGCATTCCTGTGCTCCGATCTCTCTGCCGGTATC
TCCGGTGAAGTGGTCCACGTTGACGGCGGTTTCAGCATTGCTGCAATGAACGAACTCGAA
CTGAAATAA

# Drug_Target_91_General_Function:
Lipid transport and metabolism

# Drug_Target_91_General_References:
10201369	Levy CW, Roujeinikova A, Sedelnikova S, Baker PJ, Stuitje AR, Slabas AR, Rice DW, Rafferty JB: Molecular basis of triclosan activity. Nature. 1999 Apr 1;398(6726):383-4.
10398587	Stewart MJ, Parikh S, Xiao G, Tonge PJ, Kisker C: Structural basis and mechanism of enoyl reductase inhibition by triclosan. J Mol Biol. 1999 Jul 23;290(4):859-65.
10493822	Ward WH, Holdgate GA, Rowsell S, McLean EG, Pauptit RA, Clayton E, Nichols WW, Colls JG, Minshull CA, Jude DA, Mistry A, Timms D, Camble R, Hales NJ, Britton CJ, Taylor IW: Kinetic and structural characteristics of the inhibition of enoyl (acyl carrier protein) reductase by triclosan. Biochemistry. 1999 Sep 21;38(38):12514-25.
1364817	Bergler H, Hogenauer G, Turnowsky F: Sequences of the envM gene and of two mutated alleles in Escherichia coli. J Gen Microbiol. 1992 Oct;138(10):2093-100.
8075395	Kater MM, Koningstein GM, Nijkamp HJ, Stuitje AR: The use of a hybrid genetic system to study the functional relationship between prokaryotic and plant multi-enzyme fatty acid synthetase complexes. Plant Mol Biol. 1994 Aug;25(5):771-90.
8119879	Bergler H, Wallner P, Ebeling A, Leitinger B, Fuchsbichler S, Aschauer H, Kollenz G, Hogenauer G, Turnowsky F: Protein EnvM is the NADH-dependent enoyl-ACP reductase (FabI) of Escherichia coli. J Biol Chem. 1994 Feb 25;269(8):5493-6.
8953047	Baldock C, Rafferty JB, Sedelnikova SE, Baker PJ, Stuitje AR, Slabas AR, Hawkes TR, Rice DW: A mechanism of drug action revealed by structural studies of enoyl reductase. Science. 1996 Dec 20;274(5295):2107-10.
9097039	Aiba H, Baba T, Hayashi K, Inada T, Isono K, Itoh T, Kasai H, Kashimoto K, Kimura S, Kitakawa M, Kitagawa M, Makino K, Miki T, Mizobuchi K, Mori H, Mori T, Motomura K, Nakade S, Nakamura Y, Nashimoto H, Nishio Y, Oshima T, Saito N, Sampei G, Horiuchi T, et al.: A 570-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 28.0-40.1 min region on the linkage map. DNA Res. 1996 Dec 31;3(6):363-77.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9298646	Link AJ, Robison K, Church GM: Comparing the predicted and observed properties of proteins encoded in the genome of Escherichia coli K-12. Electrophoresis. 1997 Aug;18(8):1259-313.

# Drug_Target_91_HGNC_ID:
Not Available

# Drug_Target_91_HPRD_ID:
Not Available

# Drug_Target_91_ID:
3678

# Drug_Target_91_Locus:
Not Available

# Drug_Target_91_Molecular_Weight:
27864

# Drug_Target_91_Name:
Enoyl-[acyl-carrier-protein] reductase [NADH]

# Drug_Target_91_Number_of_Residues:
262

# Drug_Target_91_PDB_ID:
1MFP

# Drug_Target_91_Pathway:
Not Available

# Drug_Target_91_Pfam_Domain_Function:
PF00106	adh_short

# Drug_Target_91_Protein_Sequence:
>Enoyl-[acyl-carrier-protein] reductase [NADH]
MGFLSGKRILVTGVASKLSIAYGIAQAMHREGAELAFTYQNDKLKGRVEEFAAQLGSDIV
LQCDVAEDASIDTMFAELGKVWPKFDGFVHSIGFAPGDQLDGDYVNAVTREGFKIAHDIS
SYSFVAMAKACRSMLNPGSALLTLSYLGAERAIPNYNVMGLAKASLEANVRYMANAMGPE
GVRVNAISAGPIRTLAASGIKDFRKMLAHCEAVTPIRRTVTIEDVGNSAAFLCSDLSAGI
SGEVVHVDGGFSIAAMNELELK

# Drug_Target_91_Reaction:
acyl-[acyl-carrier protein] + NAD+ = trans-2,3-dehydroacyl-[acyl-carrier protein] + NADH + H+

# Drug_Target_91_Signals:
None

# Drug_Target_91_Specific_Function:
Acyl-[acyl-carrier-protein] + NAD(+) = trans- 2,3-dehydroacyl-[acyl-carrier-protein] + NADH

# Drug_Target_91_SwissProt_ID:
P0AEK4

# Drug_Target_91_SwissProt_Name:
FABI_ECOLI

# Drug_Target_91_Synonyms:
EC 1.3.1.9
NADH- dependent enoyl-ACP reductase

# Drug_Target_91_Theoretical_pI:
5.67

# Drug_Target_91_Transmembrane_Regions:
None

# Drug_Target_92_Cellular_Location:
Not Available

# Drug_Target_92_Chromosome_Location:
Not Available

# Drug_Target_92_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_92_Essentiality:
Non-Essential

# Drug_Target_92_GenAtlas_ID:
Not Available

# Drug_Target_92_GenBank_ID_Gene:
Not Available

# Drug_Target_92_GenBank_ID_Protein:
Not Available

# Drug_Target_92_GeneCard_ID:
Not Available

# Drug_Target_92_Gene_Name:
celA

# Drug_Target_92_Gene_Sequence:
Not Available

# Drug_Target_92_General_Function:
Not Available

# Drug_Target_92_General_References:
8664281	Choi SK, Ljungdahl LG: Dissociation of the cellulosome of Clostridium thermocellum in the presence of ethylenediaminetetraacetic acid occurs with the formation of trucated polypeptides. Biochemistry. 1996 Apr 16;35(15):4897-905.

# Drug_Target_92_HGNC_ID:
Not Available

# Drug_Target_92_HPRD_ID:
Not Available

# Drug_Target_92_ID:
3689

# Drug_Target_92_Locus:
Not Available

# Drug_Target_92_Molecular_Weight:
1450

# Drug_Target_92_Name:
Endoglucanase A

# Drug_Target_92_Number_of_Residues:
14

# Drug_Target_92_PDB_ID:
Not Available

# Drug_Target_92_Pathway:
Not Available

# Drug_Target_92_Pfam_Domain_Function:
Not Available

# Drug_Target_92_Protein_Sequence:
>Endoglucanase A
AGVPFNTKTPYGPT

# Drug_Target_92_Reaction:
Endohydrolysis of 1,4-beta-D-glucosidic linkages in cellulose, lichenin and cereal beta-D-glucans

# Drug_Target_92_Signals:
None

# Drug_Target_92_Specific_Function:
This enzyme catalyzes the endohydrolysis of 1,4-beta- glucosidic linkages in cellulose, lichenin and cereal beta-D- glucans

# Drug_Target_92_SwissProt_ID:
P0C2S2

# Drug_Target_92_SwissProt_Name:
GUNA_CLOTM

# Drug_Target_92_Synonyms:
Cellulase A
EC 3.2.1.4
EGA
Endo-1,4-beta-glucanase
Fragment

# Drug_Target_92_Theoretical_pI:
9.30

# Drug_Target_92_Transmembrane_Regions:
None

# Drug_Target_9_Cellular_Location:
Not Available

# Drug_Target_9_Chromosome_Location:
Not Available

# Drug_Target_9_Drug_References:
Not Available

# Drug_Target_9_Essentiality:
Non-Essential

# Drug_Target_9_GenAtlas_ID:
Not Available

# Drug_Target_9_GenBank_ID_Gene:
AE004091

# Drug_Target_9_GenBank_ID_Protein:
Not Available

# Drug_Target_9_GeneCard_ID:
Not Available

# Drug_Target_9_Gene_Name:
lecB

# Drug_Target_9_Gene_Sequence:
>348 bp
ATGGCAACACAAGGAGTGTTCACCCTTCCCGCCAACACCCGGTTCGGCGTCACCGCCTTC
GCCAACTCGTCCGGAACCCAGACGGTGAACGTGCTGGTCAACAACGAGACGGCCGCGACC
TTCAGCGGGCAAAGCACCAATAACGCCGTCATCGGCACCCAGGTGCTCAACTCCGGCAGC
AGTGGCAAGGTACAGGTCCAGGTCAGCGTCAACGGCCGCCCCTCGGATCTGGTCTCGGCA
CAGGTAATCCTGACCAACGAGCTGAACTTCGCCCTGGTCGGCTCTGAAGACGGCACCGAC
AACGACTACAACGACGCCGTCGTGGTGATCAACTGGCCGCTCGGCTAG

# Drug_Target_9_General_Function:
Not Available

# Drug_Target_9_General_References:
10984043	Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FS, Hufnagle WO, Kowalik DJ, Lagrou M, Garber RL, Goltry L, Tolentino E, Westbrock-Wadman S, Yuan Y, Brody LL, Coulter SN, Folger KR, Kas A, Larbig K, Lim R, Smith K, Spencer D, Wong GK, Wu Z, Paulsen IT, Reizer J, Saier MH, Hancock RE, Lory S, Olson MV: Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature. 2000 Aug 31;406(6799):959-64.
12415289	Mitchell E, Houles C, Sudakevitz D, Wimmerova M, Gautier C, Perez S, Wu AM, Gilboa-Garber N, Imberty A: Structural basis for oligosaccharide-mediated adhesion of Pseudomonas aeruginosa in the lungs of cystic fibrosis patients. Nat Struct Biol. 2002 Dec;9(12):918-21.
12909014	Loris R, Tielker D, Jaeger KE, Wyns L: Structural basis of carbohydrate recognition by the lectin LecB from Pseudomonas aeruginosa. J Mol Biol. 2003 Aug 22;331(4):861-70.

# Drug_Target_9_HGNC_ID:
Not Available

# Drug_Target_9_HPRD_ID:
Not Available

# Drug_Target_9_ID:
4666

# Drug_Target_9_Locus:
Not Available

# Drug_Target_9_Molecular_Weight:
11863

# Drug_Target_9_Name:
Fucose-binding lectin PA-IIL

# Drug_Target_9_Number_of_Residues:
115

# Drug_Target_9_PDB_ID:
1W8H

# Drug_Target_9_Pathway:
Not Available

# Drug_Target_9_Pfam_Domain_Function:
PF07472	PA-IIL

# Drug_Target_9_Protein_Sequence:
>Fucose-binding lectin PA-IIL
MATQGVFTLPANTRFGVTAFANSSGTQTVNVLVNNETAATFSGQSTNNAVIGTQVLNSGS
SGKVQVQVSVNGRPSDLVSAQVILTNELNFALVGSEDGTDNDYNDAVVVINWPLG

# Drug_Target_9_Reaction:
Not Available

# Drug_Target_9_Signals:
None

# Drug_Target_9_Specific_Function:
Not Available

# Drug_Target_9_SwissProt_ID:
Q9HYN5

# Drug_Target_9_SwissProt_Name:
Q9HYN5_PSEAE

# Drug_Target_9_Synonyms:
Not Available

# Drug_Target_9_Theoretical_pI:
3.83

# Drug_Target_9_Transmembrane_Regions:
None

#END_DRUGCARD DB02379
